UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.DC 20549

 

SCHEDULE 14A

 

(RULE 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT PURSUANT TO SECTION 14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment(Amendment No.     )

 

  Filed by the Registrant  Filed by a Party other than the Registrant

 

Check the appropriate box:
Preliminary Proxy Statement
CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(E)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under §240.14a-12

 

CDW CORPORATION

 

(Name of Registrant as Specified in itsIts Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box)all boxes that apply):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table belowin exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1) Title of each class of securities to which transaction applies:

(2) Aggregate number of securities to which transaction applies:

(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11
(set forth the amount on which the filing fee is calculated and state how it was determined):

(4) Proposed maximum aggregate value of transaction:

(5) Total fee paid:

Fee paid previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1) Amount Previously Paid:

(2) Form, Schedule or Registration Statement No.:

(3) Filing Party:

(4) Date Filed:

 

 
  
    
 Our mission atThere are two things we know for sure – technology will continue to be a critical driver of outcomes and CDW has always been to helpwill be there for our customers navigate and be successful in a changing world.as their trusted technology advisor – to make technology work sopeople can do great things. 

 

Dear Fellow Stockholder, ,

 

2020 was an extraordinary year. CDW coworkers found inspirationOver the past three years the velocity of digital adoption took a quantum leap as the global pandemic forever altered the role of technology in our shared missionlives. Today, technology fuels advancement across every industry and worked unwaveringly to provide our customers with technologies that helped dramatically change how and where they worked, learned, connected and served their own end users and communities. I am proud of the work we did to support these businesses and institutions, all of which epitomized great courage and resilience in the face of the COVID-19 pandemic. Amidst the turmoil of last year, the experiencevirtually every facet of our people,lives. It unlocks and amplifies value and is at the depthepicenter of our capabilities, and the breadth of our scale enabled us to meet the moment – helping our customers address their critical technology and operational needs. The engagement, commitment and productivity of our coworkers fueled another year of record results and market outperformance for CDW.

While the challenges of 2020 tested all of us, I believe they ultimately strengthened CDW's position asprogress. In an industry leader and value creatordefined by relentless change, CDW has always been there for our stakeholders. customers. To help them navigate complexity and achieve their mission. This is at the core of who we are and our value proposition.

As we lookmove into 2023, the macroeconomic environment continues to the future, there is no doubt thatreflect global uncertainty. There are two things we know for sure – technology will be more essential than ever. We will continue to do what we do best – helpbe a critical driver of outcomes and CDW will be there for our customers navigate an ever-changing world and maximizeas their technology investments to succeed in their missions. As a trusted strategic advisor, CDW plays a dual role as a technology advisor and solutions provider to enablemake technology driven transformations. We are confident that we have the right strategy and remain committed to investing in our business to serve our customers for the long term.work so people can do great things.

 

Annual Meeting Invitation

 

On behalf of our Board of Directors, I would like to invite you to CDW’s 20212023 Annual Meeting of Stockholders. The meeting will be held virtually on Thursday, May 20, 2021,18, 2023, at 7:3010:00 a.m. CDT at www.virtualshareholdermeeting.com/CDW2021CDW2023. The attached Notice of Annual Meeting of Stockholders and Proxy Statement will serve as your guide to the business conducted at the meeting. Your vote is very important. Whether or not you plan to attend the Annual Meeting, we urge you to vote either via the Internet, by telephone, or by signing and returning a proxy card. Please vote as soon as possible so that your shares will be represented. For more information on CDW and to take advantage of our many stockholder resources and tools, we encourage you to visit our Investor Relations website at investor.cdw.com. Thank you for your continued trust in CDW and investment in our business.

 

Christine A. Leahy

Chair, President and Chief Executive Officer

April 8 7, 20212023

 

 20212023 Proxy Statement1
 

 

When:

THURSDAY, MAY 20, 202118, 2023

7:3010:00 a.m. CDT

 

Where:

Live webcast online at


www.virtualshareholdermeeting.com/CDW2021CDW2023

 

REVIEW YOUR PROXY STATEMENT AND VOTE IN ADVANCE OF THE ANNUAL MEETING IN ONE OF FOUR WAYS:

BY INTERNET USING
YOUR COMPUTER

Visit 24/7 www.proxyvote.com
  

BY INTERNET USING

YOUR COMPUTER

VisitTELEPHONE
Dial toll-free
24/7 www.proxyvote.com


1-800-690-6903 (registered holders)
1-800-454-8683 (beneficial holders)
  

BY TELEPHONE

Dial toll-free 24/7

1-800-690-6903 (registered holders)

1-800-454-8683 (beneficial holders)

BY MAILING


YOUR PROXY CARD


Cast your ballot, sign your proxy


card and return by mail in the postage


prepaid envelope

  

BY INTERNET USING YOUR TABLET

OR
SMARTPHONE


Scan this QR code 24/7


to vote with your mobile device


(may require free software)

  
Please refer to the enclosed proxy materials or the information forwarded by your broker, bank, broker or other holder of record to see which voting methods are available to you.

NOTICE

of Annual Meeting

of Stockholders

 

 WE ARE PLEASED TO INVITE YOU TO THE CDW CORPORATION ANNUAL MEETING OF STOCKHOLDERS.
   
 Items of business:
   
 1.To elect the ten director nominees named in this proxy statement for a term expiring at the 20222024 Annual Meeting of Stockholders;
 2.To approve, on an advisory basis, named executive officer compensation;
 3.To approve, on an advisory basis, the frequency of the advisory vote to approve named executive officer compensation;
4.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021;2023;
 4.5.To approve the amendment to the Company’s certificateCertificate of incorporationIncorporation to eliminateallow stockholders the supermajority voting requirement in Article Eleven andright to make certain non-substantive changes;call special meetings;
 5.6.To approve the amendment to the Company’s certificateCertificate of incorporationIncorporation to eliminate the obsolete competition and corporate opportunity provision;
6.To approve the CDW Corporation 2021 Long-Term Incentive Plan;
7.To approve the amendment to the CDW Corporation Coworker Stock Purchase Plan;reflect new Delaware law provisions regarding officer exculpation; and
 8.7.To consider any other matters that may properly come before the meeting or any adjournments or postponements of the meeting.

 

RECORD DATE

 

Holders of our common stock at the close of business on March 24, 202122, 2023 are entitled to notice of, and to vote at, the Annual Meeting.

 

HOW TO VOTE

 

Your vote is important to us. Please see “Voting Information” on pages 5-6page 5 for instructions on how to vote your shares.

 

These proxy materials are first being distributed on or about April 8 7, 2021.2023.


 

 20212023 Proxy Statement2
 

ATTENDING THE VIRTUAL ANNUAL MEETING

 

Due to the continuing public health impact of the coronavirus (COVID-19) pandemic, related governmental actions and the importance of safeguarding the health of our stockholders, coworkers and representatives, the Board of Directors has determined that it is prudent to hold thisThis year’s Annual Meeting is being held in a virtual-only format via live audio webcast. To participate in the Annual Meeting online, please visit www.virtualshareholdermeeting.com/CDW2021CDW2023and enter the 16-digit control number included on your Notice of Internet Availability of Proxy Materials, proxy card or the instructions that accompanied your proxy materials. You will be able to vote your shares electronically during the Annual Meeting by following the instructions available on the meeting website. For beneficial holders who do not have a control number, please contact your broker, bank or other nominee as soon as possible and no later than May 13, 2021, so that you can be provided with a control number and gain access to the meeting. If you do not have access to a 16-digit control number, you may access the meeting as a guest by going to www.virtualshareholdermeeting.com/CDW2021CDW2023, but you will not be able to vote during the meeting or ask questions.

 

By Order of the Board of Directors,

 

 

Frederick J. Kulevich

Senior Vice President, General Counsel


and Corporate Secretary

April 8 7, 20212023

 

Important Notice Regarding Availability of Proxy Materials for the Annual Meeting to be Held on May 20, 2021:

18, 2023:
The proxy materials relating to our 20212023 Annual Meeting (notice, proxy statement and annual report) are available at www.proxyvote.com.

 

 20212023 Proxy Statement3
 

TABLE OF CONTENTS

 

NOTICE OF ANNUAL MEETING OF STOCKHOLDERSNotice of Annual Meeting of Stockholders2
Voting Information5
VOTING INFORMATIONProxy Summary57
PROXY SUMMARYBusiness Overview7
Our Business Performance8
Corporate Governance Highlights10
CORPORATE GOVERNANCEBoard Highlights1411
Executive Compensation Highlights12
Our Executive Compensation Practices13
2022 Say-on-Pay Vote13
Corporate Governance14
Corporate Governance Highlights14
Environmental, Social and Governance (ESG) at CDW15
Adoption of Special Meeting Right in Response to 2022 Written Consent Stockholder Proposal17
Independence of Our Board of Directors1618
Board of Directors Leadership Structure1619
Lead Independent Director19
Board and Committee Meetings1620
Board Committees1620
Oversight of Strategy1821
Oversight of Risk1822
Oversight of ESG22
Oversight of Human Capital Management1922
Code of Business Conduct and Ethics1922
Hedging, Short Sales and Pledging Policies1923
Executive Compensation Policies and Practices1923
Communications with the Board of Directors23
PROPOSAL 1—Election of DirectorsCompensation Committee Interlocks and Insider Participation2123
Related Person Transactions24
DIRECTOR COMPENSATIONPROPOSAL 1–Election of Directors2625
Director Nomination Process25
STOCK OWNERSHIPDirector Qualifications25
2023 Nominees for Election to the Board of Directors28
Director Compensation33
Elements of Director Compensation33
Director Compensation Review33
Lead Independent Director and Nominating and Corporate Governance Committee Chair Compensation34
Stock Ownership Guidelines34
2022 Director Compensation Table35
Stock Ownership36
PROPOSAL 2—2–Advisory Vote to Approve Named Executive Officer Compensation3138
COMPENSATION DISCUSSION AND ANALYSISCompensation Discussion and Analysis3239
Our Named Executive Officers3239
Overview3340
What We Pay And Why3643
How We Make Executive Compensation Decisions4349
Compensation Committee Report51
COMPENSATION COMMITTEE REPORT2022 Executive Compensation4552
2022 Summary Compensation Table52
2020 EXECUTIVE COMPENSATION46
EQUITY COMPENSATION PLAN INFORMATION2022 Grants of Plan-Based Awards Table53
2022 Outstanding Equity Awards at Fiscal Year-End Table54
2022 Option Exercises and Stock Vested Table55
2022 Nonqualified Deferred Compensation Table55
2022 Potential Payments Upon Termination or Change in Control56
Pay Ratio60
Pay Versus Performance60
PROPOSAL 3—3–Advisory Vote on the Frequency of the Advisory Vote to Approve Named Executive Officer Compensation65
Equity Compensation Plan Information66
PROPOSAL 4–Ratification of Selection of Independent Registered Public Accounting Firm5467
Engagement of Independent Registered Public Accounting Firm67
AUDIT COMMITTEE REPORTFees Paid to EY5668
Audit Committee Approval Policies and Procedures68
Audit Committee Report69
PROPOSAL 4—5–Approval of the Amendment to the Company’s Certificate of Incorporation to EliminateAllow Stockholders the Supermajority Voting Requirement in Article Eleven andRight to Make Certain Non-Substantive ChangesCall Special Meetings5770
PROPOSAL 5—6–Approval of the Amendment to the Company’s Certificate of Incorporation to Eliminate the Obsolete Competition and Corporate Opportunity ProvisionReflect New Delaware Law Provisions Regarding Officer Exculpation5972
Frequently Asked Questions Concerning the Annual Meeting73
PROPOSAL 6—Approval of the CDW Corporation 2021 Long-Term Incentive PlanAdditional Company Information6076
Stockholder Proposals for the 2024 Annual Meeting77
PROPOSAL 7—Approval of the Amendment to the CDW Corporation Coworker Stock Purchase Plan67
FREQUENTLY ASKED QUESTIONS CONCERNING THE ANNUAL MEETING71
OTHER BUSINESS76
APPENDIX A—CDW Corporation and Subsidiaries A–Non-GAAP Financial Measure Reconciliations7778
APPENDIX B–Forward-Looking Statements80
APPENDIX B—Forward-Looking StatementsC–Proposed Amendments to the Certificate of Incorporation7981
APPENDIX C—Proposed Amendment to the Company’s Certificate of IncorporationD–Special Meeting Bylaw Amendments80
APPENDIX D—Proposed Amendment to the Company’s Certificate of Incorporation84
APPENDIX E—CDW Corporation 2021 Long-Term Incentive Plan86
APPENDIX F—Amended and Restated CDW Corporation Coworker Stock Purchase Plan98

 

 20212023 Proxy Statement4
 
Back to Contents

VOTING INFORMATION

Voting Information

 

Who is Eligible to Vote

 

You are entitled to vote at the virtual2023 Annual Meeting of Stockholders (the “Annual Meeting”) if you were a stockholder of CDW Corporation (the “Company” or “CDW”) as of the close of business on March 24, 2021,22, 2023, the record date for the Annual Meeting.

 

Participate in the Future of CDW—Vote Today

 

Please cast your vote as soon as possible on all of the proposals listed below to ensure that your shares are represented.

 

Proposal Topic More

Information
 Board

Recommendation
Proposal 1 Election of Directors Page 2125 FOR each
Director Nominee
Proposal 2 Advisory Vote to Approve Named Executive Officer Compensation��Page 31 FOR
Proposal 3Page 38 FOR
Proposal 3Advisory Vote on the Frequency of the Advisory Vote to Approve Named Executive Officer CompensationPage 651 YEAR
Proposal 4Ratification of Selection of Independent Registered Public Accounting Firm Page 5467 FOR
Proposal 45 Approval of the Amendment to the Company’s Certificate of Incorporation to EliminateAllow Stockholders the Supermajority Voting Requirement in Article Eleven andRight to Make Certain Non-Substantive ChangesCall Special Meetings Page 5770 FOR
Proposal 56 Approval of the Amendment to the Company’s Certificate of Incorporation to Eliminate the Obsolete Competition and Corporate Opportunity ProvisionReflect New Delaware Law Provisions Regarding Officer Exculpation Page 5972��FOR
Proposal 6Approval of the CDW Corporation 2021 Long-Term Incentive PlanPage 60FOR
Proposal 7Approval of the Amendment to the CDW Corporation Coworker Stock Purchase PlanPage 67FOR

 

Virtual Annual Meeting

 

The Annual Meeting will be held via live audio webcast on Thursday, May 20, 2021,18, 2023, at 7:3010:00 a.m. CDT, in a virtual-only meeting format. There will not be a physical location for the Annual Meeting, and you will not be able to attend the meeting in person.

 

You are entitled to participate in the Annual Meeting if you were a stockholder as of the close of business on March 24, 2021,22, 2023, the record date. To participate in the Annual Meeting online, please visit www.virtualshareholdermeeting.com/CDW2021CDW2023 and enter the 16-digit control number included on your Notice of Internet Availability of Proxy Materials, proxy card or the instructions that accompanied your proxy materials. For beneficial holders who do not have a control number, please contact your broker, bank or other nominee as soon as possible and no later than May 13, 2021, so that you can be provided with a control number and gain access to the meeting. If you do not have access to a 16-digit control number, you may access the meeting as a guest by going to www.virtualshareholdermeeting.com/CDW2021CDW2023, but you will not be able to vote during the meeting or ask questions.

 

Voting in Advance of the Annual Meeting

 

Even if you plan to attend our virtual Annual Meeting via webcast, please read this proxy statement with care and vote right away as described in the Notice on p. 2-32 of this proxy statement. For stockholders of record, have your notice and proxy card in hand and follow the instructions. If you hold your shares through a broker, bank or other nominee, you will receive voting instructions from your broker, bank or other nominee, including whether telephone or Internet options are available.

 

 20212023 Proxy Statement5
 
Back to Contents

Voting at the Annual Meeting

 

You may vote electronically via webcast at the 2021 Annual Meeting of Stockholders, which will be held on Thursday, May 20, 2021, at 7:30 a.m. CDT by following the instructions available on the meeting website.

 

Frequently Asked Questions

 

We provide answers to many frequently asked questions about the meeting and voting under “Frequently Asked Questions Concerning the Annual Meeting” beginning on p. 7173 of this proxy statement.

 

 20212023 Proxy Statement6
 
Back to Contents

PROXY SUMMARY

This summary highlights information contained elsewhere in this proxy statement. This summary does not contain all of the information that you should consider, and you should read the entire proxy statement and our 20202022 Annual Report on Form 10-K carefully before voting at the Annual Meeting of Stockholders. Measures used in this proxy statement that are not based on accounting principles generally accepted in the United States (“non-GAAP”) are each defined and reconciled to the most directly comparable GAAP measure in Appendix A. This proxy statement also contains forward-looking statements; see Appendix B for more information.

 

Business Overview

 

We are a market leading multi-brand provider of information technology (“IT”) solutions to over 250,000 small, medium and large business, government, education and healthcare customers in the United States (“US”), the United Kingdom (“UK”) and Canada. We are a Fortune 500 company and member of the S&P 500 Index with approximately 10,00015,100 coworkers. Our broad array of offerings ranges from discrete hardware and software products to integrated IT solutions and services that include on-premise hybrid and cloud capabilities across data centerhybrid infrastructure, digital experience, and networking, digital workspace, security and virtualization.security.

 

We are vendor, technology, and consumption model “agnostic,” with a solutions portfolio includingoffering more than 100,000 products, services, and servicessolutions from over 1,000 leading and emerging brands. Our solutions are delivered in physical, virtual, and cloud-based environments through approximately 7,00010,600 customer-facing coworkers, including sellers, highly-skilled technology specialists and advanced service delivery engineers. We are a leading sales channel partner for many original equipment manufacturers, software publishers and cloud providers (collectively, our “vendor partners”), whose products we sell or include in the solutions we offer. We provide our vendor partners with a cost-effective way to reach customers and deliver a consistent brand experience through our established customer end-market coverage, technical expertise, and extensive customer access.

 

We simplify the complexities of technology solutions across design, selection, procurement, integration and management for our customers. Our goal is to have our customers, regardless of their size, view us as a trusted adviser and extension of their IT resources. Our multi-brand offering approach across our vendor partners enables us to identifyprovide the products or combination of products from our vendor partnerssolutions and services that best address each customer’s specific IT requirements andto enable their desired business outcomes.

 

We have capabilities to provide integrated IT solutions in more than 150 countries for customers with primary locations in the US, UK, and Canada, which are large and growing markets. According to the International Data Corporation, the total US, UK, and Canadian IT market generated approximately $1$1.4 trillion in sales in 2020.2022. We believe our addressable markets in the US, UK and Canada represent approximately $360$460 billion in annual sales. These are highly fragmented markets served by thousands of IT resellers and solutions providers. We believe that demand for IT will continue to outpace general economic growth in the markets we serve fueled by new technologies, including hybrid and cloud computing, virtualization and mobility as well as growing end-user demand for security, efficiency and productivity.

 

As we have evolved with the IT market, we have built an organization with significant scale, reach and deep intimate knowledge of customer and partner needs. When coupled with our market presence, our broad and deep solutions portfolio, and our large and highly-skilled sales and technical organization, we deliver unique value – for both our customers and our vendor partners.

 

 

 2021 Proxy Statement    7

2023 Proxy Statement7
 
Back to Contents

Our Business Performance

 

2020

2022 Business Highlights

 

Our 20202022 performance demonstrated the balance and strengthpower of our business model when coupled with our broad and strategy asdeep portfolio of technology solutions, and reinforced the diversitystrength of our customer end-markets and broad solutions portfolio enabled usstrategy.

Percentages are year-over-year. See Appendix A for a reconciliation of each non-GAAP financial measure to outperform the market while continuing to invest in our future despite the unprecedented challenges created by the COVID-19 pandemic as discussed below.most directly comparable GAAP measure.

 

There were fourthree main drivers of performance in 2020:2022:

 

First, our balanced portfolio of our diverse customer end-markets, including fivethree US channels –reportable segments - Corporate, Small Business Government, Education and HealthcarePublic, which is comprised of government, education and healthcare customer channels – and our UK and Canadian operations. The diversity of our customer end markets serves us well when macro or other external challenges impact various industries and customers differently. In 2020, our net sales performance varied by segment, channel and customer end-market due to the uneven impact of COVID-19. All customers experienced change or disruption to their technology and to their operations due to the pandemic. Our teams helped businesses – small, medium and large – to work in completely new ways. The crisis posed greater challenges for our commercial customers due to the macroeconomic slowdown, which led to net sales declines of 8.7 percent and 7.5 percent, respectively, for our Corporate and Small Business segments. Public segment net sales increased by 18.5 percent, primarily driven by strong demand from our Education and Government channels, partially offset by a decline in Healthcare. In the Education channel, our teams helped education institutions shift to remote learning solutions for students and teachers driving 43.4 percent growth. In the Government channel, we enabled work from home for government agencies, supported the expansion of first responder capacity, and delivered a complex Device-as-a-Service mobile data collection solution for the US Census Bureau leading to 18.2 percent growth. In the Healthcare channel, our teams enabled healthcare providers to establish mobile virus screening centers, to expand telehealth capabilities, and to provide services in incredibly challenging point of care environments, but, due to Healthcare customer budget constraints, net sales declined 12.0 percent. In addition, net sales for our Other segment, which is comprised of our UK and Canadian operations. Each of the five US sales channels is a meaningful business on its own, with Net sales in 2022 ranging from $1.9 billion to over $10 billion. Within each channel, teams are further segmented to focus on customer end-markets, including geographies, and verticals. We also have our UK and Canadian operations, decreased 3.3 percent in US dollarswhich together delivered sales of $2.9 billion USD. All segments and channels grew year-over-year, with a low double digit decline in Canada and low single digitthe exception of the Education channel, which experienced substantial growth in prior years due to extraordinary circumstances in the UK in local currency asclient devices space. Corporate, healthcare and government led the pandemic similarly impacted customers in those countries.way, with support from our recent acquisition of Sirius Computer Solutions, Inc. (“Sirius”), a leading provider of secure, mission-critical technology-based solutions, while our international business also contributed strong double-digit growth.
Second, the breadth and depth of our product andtechnology solutions portfolioof more than 100,000 products from over 1,000 leading and emerging brands. This breadth ensures we are well-positioned to meet our customers’ needs and pivot quickly to trends in customer demand. This was especially important during the fourth quarter when we delivered record profitability, despite unprecedented shifts in 2020 ascustomer priorities that impacted client device demand. The past few years have demonstrated that technology needs shiftedis essential to all sectors of the economy and became crucial for ourwill play an increasingly important role in the future. We have seen customers to maintain ongoing operations and develop new capabilities for their customers and employees. In 2020, customers were focused onshift priorities from remote enablement optimization, cost reduction, security, and digital transformation, with an increasing focus on cloud.continuity to strengthening, sustaining, and securing infrastructure, platforms, and end points. We have helped our customers smartly deploy their IT resources, navigate through interconnected and complex solutions, and adopt modern software and infrastructure patternsarchitectures and practices whether on-premise, hybrid or in the cloud. Our performance reflected the success of past investments, both organic and inorganic, especially in cloud and security, and our ability to help our customers across the full IT solutions stack and lifecycle.
Third, we continued to make excellent progress against our three-part strategy for growth:growth: (1) to acquire new customers and capture share, (2) to enhance our solutions capabilities, and (3) to expand our services capabilities. The combination of these three interconnected pillars, with our scope and scale, creates powerful differentiation in the market. We benefited from our strong competitive advantages and value proposition in 2020.2022. Customers turned to CDW as a trusted advisor to

 2021 Proxy Statement    8

Back to Contents
help with some of their toughest challenges, to leverage our extensive logistical and distribution capabilities, and as a source of supply in a constrained market.IT challenges. We continued to invest in high-growth solutions and services capabilities, including three acquisitions – IGNW, a leading providerintegration of cloud-native services expertise and software development capabilities, and Aeritae and Southern Dakota Solutions, which expanded our ServiceNow team. As we do every three years, we completed a rigorous, detailed strategic planning process in 2020 andSirius. We remain confident that we have the right strategy to best serve our customers, optimize our productivity, and enhance our competitive position. We believe that technology will be more essential to all sectors of the economy and will play an increasingly important role in the years ahead, making our role as a trusted, strategic partner to our customers more important than ever.

2023 Proxy Statement8
 
Back to ContentsFinally, our ability to adapt and respond to the COVID-19 crisis.At the beginning of the pandemic, we identified three key principles, which have guided us. First, safeguard the health and well-being of our coworkers, second, serve the mission-driven needs of our customers, and third, support our communities. At our distribution centers, we quickly implemented and have maintained precautionary measures advised by public health authorities. Our office coworkers transitioned to work from home in March and have demonstrated strong engagement, productivity and collaboration – testaments to the strength and resiliency of our culture. CDW also contributed meaningfully to support the COVID-19 response efforts locally, in the US, UK and Canada, and around the world. Our team has done an outstanding job of maintaining the high level of customer service we are known for, while safeguarding our coworkers and supporting our communities.

We also made progress against our four 20202022 capital allocation priorities. These priorities are designed to provide stockholders with a balance between receiving short-term capital returns and long-term value creation. During the year, we closely monitored the macro-economic environment, our liquidity, working capital, and leverage and adjusted as needed, including raising additional liquidity in April and pausing share repurchases for two quarters.Our first priority is to increase dividends annually. In November 2022, we increased our dividend forby 18%, the seventhninth consecutive year since going publicof dividend increases. We returned more than $280 million in 2013 and resumedcash to stockholders in 2022 via dividends, temporarily pausing share repurchases.repurchases after completing $1.5 billion in share repurchases in 2021. In 2022, to ensure we have the right capital structure in place, we reduced our borrowings by $936 million. We ended the year inwith a strong liquidity position with net leverage belowratio of 2.6 times, demonstrating strong growth and excellent cash generation and were within our targeted range after satisfying the target range and remain confident incommitments we made after the free cash flow generationfinancing of the business. This confidence led our Board of Directors to authorize a $1.25 billion increase to the Company’s share repurchase program in February 2021.Sirius acquisition.

 

20202022 CAPITAL ALLOCATION PRIORITIES

 

PRIORITIES OBJECTIVESACTIONS
Increase Dividends Annually 
Increase Dividends
Annually
Target ~25% payout
of Non-GAAPnon-GAAP net income; grow in
line with earnings
5.3%18% increase in November 2022 to
$1.60/ $2.36/share annually
Maintain Net
Leverage Ratio(1)
 ~Use FCF After Dividends to Pay Down Debt Until Net Leverage is within Range of 2.5 to 3.0 times
Net leverage ratioTimes
Ended 2020Currently at 1.72.6 times(2); down from 3.4x(3) in 2021
Supplement Organic
Growth with M&A
 Expand CDW’s
strategic capabilitiesLower Priority on M&A Until Net Leverage Ratio is More Firmly in the Target Range
Completed 3 acquisitions in 2020Acquired Sirius on December 1, 2021, for $2.5 billion
Return Excess Free Cash Flow
after Dividends &
M&A Through
Share Repurchases
 Offset to incentive
plan dilution and to
supplement earnings
per share growthLower Priority on Share Repurchases Until Net Leverage Ratio is More Firmly in the Target Range
$341 million1.5 billion of Share Repurchases in share repurchases in 20202021 more than Offset Multiple Years of Incentive Plan Dilution

 

(1)Defined as the ratio of total debt at period-end excluding any unamortized discount and/or premium and deferred financing costs, less cash and cash equivalents, to trailing twelve months Non-GAAP operating income plus depreciation and amortization in selling, general and administrative expenses (excluding amortization expenses for acquisition-related intangible assets).
(2)As of December 31, 2022.
(3)The Net Leverage Ratio of 3.4 times was a result of CDW issuing $2.5 billion of senior notes on December 1, 2021, to fund the acquisition of Sirius.

 

For further details about our performance in 2020,2022, please see the Company’s 20202022 Annual Report on Form 10-K.

 

 2021 Proxy Statement    9

2023 Proxy Statement9
 
Back to Contents

Long-Term Performance

 

Over the past 5 years, our cumulative total shareholder return has outpaced the S&P 500 Index, the S&P 500 Information Technology Index, and our 20202022 compensation peer group set forth in the “Compensation Discussion and Analysis — Comparison to Relevant Peer Group” section of this proxy statement, and we have returned $3.1$4.1 billion to shareholders through dividends and share repurchases.repurchases over that time period.

 

 

(1)The cumulative total shareholder return chart compares the cumulative total shareholder return, including reinvestment of dividends, on $100 invested in CDW common stock for the period from market close on December 31, 2015 through market close on December 31, 2020,

The cumulative total shareholder return chart compares the cumulative total shareholder return, including reinvestment of dividends, on $100 invested in CDW common stock for the period from market close on December 31, 2017 through market close on December 31, 2022, with the cumulative total return for the same time period of the same amount invested in the S&P 500 Index and our 2020 compensation peer group set forth in the “Compensation Discussion and Analysis — Comparison to Relevant Peer Group” section of this proxy statement.

Our COVID-19 Response

We have adhered to three principles in all aspects of our response to the COVID-19 pandemic:

PRINCIPLES Safeguard the health and well-being of our coworkers Serve the mission-driven needs of our customers Support our communities

ACTIONS •Deliberate actions to foster collaboration and coworker engagement and to maintain connectivity and productivity to preserve and bolster our culture while working remote •Thoughtfully planning for when and how to return to the office and where and how our coworkers will work in the future •DistributionS&P 500 Index, the S&P 500 Information Technology Index and configuration centers have adopted precautionary measures advised by public health authorities while maintaining a high level of customer service •Customers focused on remote enablement, resource optimization, cost reduction,security, hybrid and cloud solutions, and digital transformation. •CDW teams are trusted partners to help customers smartly deploy their IT resources and adopt modern software and infrastructure patterns and practices •CDW teams help to design, orchestrate, and manage solutions leveraging our broad portfolio of solutions and services •Pledged $1 million in donations to support COVID-19 response efforts•Contributed meaningfully to support the COVID-19 response efforts2022 compensation peer group set forth in the US, UK“Compensation Discussion and Canada, and around the world •Support local organizations through virtual volunteering

While the COVID-19 pandemic created global economic disruption, uncertainty and business challenges, we are extremely proud of the results delivered by our coworkers. Our team has done an outstanding job of maintaining the high level of customer service we are known for, while safeguarding our coworkers and supporting our communities. In recognitionAnalysis — Comparison to Relevant Peer Group” section of this outstanding performance, during 2020, we paid multiple spot bonuses to front-line coworkers and a stipend to coworkers to help them with the financial challenges of the pandemic. In addition, all coworkers on variable compensation plans received an upward modification to the 2020 formulaic bonuses, consistent with the approach used for the Company’s Named Executive Officers. All coworkers not on a variable compensation or bonus plan also received a one-time $500 bonus to recognize their contributions to our success. Providing bonuses or other performance payouts beyond what plans would dictate is an extraordinary step for us as we have historically relied on the formulaic payout structure of our program design. We determined that that these additional across-the-board adjustments were appropriate to recognize the outstanding efforts of our coworkers during 2020 in safeguarding and fortifying our business, delivering above-market results and continuing to transform and build for our future.proxy statement.

 

 2021 Proxy Statement    10

Back to Contents

Corporate Governance Highlights

 

Independent Chairman

   Annual election of all Directors

directors

   Lead Independent Director

   All of our Directors,directors, other than the Chair of our President and Chief Executive Officer,Board, are independent and the independent Directorsdirectors regularly meet in Executive Session

executive session

   100% independent Audit, Compensation and Nominating and Corporate Governance Committees

Four

   All of our continuing Audit Committee members qualify as “audit committee financial experts” under SEC rules

12

   15 year Board term limit to promote Board refreshment

 

   Our Board of Directors has approved a management proposal to allow stockholders the right to call special meetings (Proposal 5 in this proxy statement)

   Proxy access right

   Majority vote to elect Directorsdirectors with resignation policy

   Restrictions on other board service by Directors

directors

   Annual Board and Audit, Compensation and Nominating and Corporate Governance Committee evaluations

Proposed elimination of

   No supermajority vote requirements

 

   No stockholder rights plan or poison pill

2023 Proxy Statement10
Back to Contents

Director Nominee Highlights

 

Our Board strives to maintain a highly independent, balanced and diverse group of directors that collectively possess the skills and expertise to ensure effective oversight. Over the last five years, the Board has appointed four new directors, all of whom are diverse.

 

Our Director Nominees

 

Name & Professional BackgroundAgeDirector
Since(1)
IndependentCommittee
Memberships
Other Public
Company
Boards
Virginia C. Addicott
Retired President & Chief Executive Officer, FedEx Custom Critical
592016

▪   Audit

▪   Nominating & Corporate Governance

1
James A. Bell
Retired Executive Vice President, Corporate President & Chief Financial Officer, The Boeing Company
742015

▪   Audit (Chair)

▪   Nominating & Corporate Governance

1
Lynda M. Clarizio
Co-Founder and General Partner of The 98 and Former Executive Vice President, Strategic Initiatives, The Nielsen Company (US), LLC
622015

▪   Compensation

▪   Nominating & Corporate Governance

3
Anthony R. Foxx
Former United States Secretary of Transportation
512021

▪   Compensation

▪   Nominating & Corporate Governance

2
Marc E. Jones
Chairman, President and Chief Executive Officer of Aeris Communications, Inc.
642023

▪   Audit

▪   Nominating & Corporate Governance

1
Christine A. Leahy
Chair, President & Chief Executive Officer, CDW Corporation
5820191
Sanjay Mehrotra
President & Chief Executive Officer, Micron Technology, Inc.
642021

▪   Compensation (Chair)

▪   Nominating & Corporate Governance

1
David W. Nelms
(Lead Independent Director) Retired Chairman & Chief Executive Officer, Discover Financial Services, Inc.
622014

▪   Audit

▪   Nominating & Corporate Governance (Chair)

Joseph R. Swedish
Retired Chairman, President & Chief Executive Officer, Anthem, Inc.
712015

▪   Compensation

▪   Nominating & Corporate Governance

2
Donna F. Zarcone
Retired President & Chief Executive Officer, The Economic Club of Chicago
652011

▪   Audit

▪   Nominating & Corporate Governance

1

Key Director Skills
Technology/Digital Solutions(1)OperationsInternational
Vertical Markets (e.g., Healthcare, Public Sector)DistributionEconomic/Business Trends
Strategic Planning/Leadership of Complex OrganizationsFinanceCapital Market Transactions
Board Practices of Major CorporationsSales and MarketingLegal

 2021 Proxy Statement    11

Board Nominees

The chart below provides summary information regarding each of our current directors standing for re-election at the Annual Meeting.

NameAgeDirector
Since(1)
Primary OccupationIndependentCommittee
Memberships
Other Public
Company

Boards
Virginia C. Addicott572016Retired President & Chief Executive Officer, FedEx Custom Critical

  Audit (Chair)

 

  Nominating & Corporate Governance

1
James A. Bell722015Retired Executive Vice President, Corporate President and Chief Financial Officer, The Boeing Company

  Audit

 

•   Nominating & Corporate Governance

2
Lynda M. Clarizio602015Former Executive Vice President, Strategic Initiatives, The Nielsen Company (US), LLC

  Compensation

 

  Nominating & Corporate Governance

2
Paul J. Finnegan682011Co-Chief Executive Officer, Madison Dearborn Partners, LLC

  Compensation

 

  Nominating & Corporate Governance

Anthony R. Foxx492021Chief Policy Officer & Senior Advisor to the President & Chief Executive Officer of Lyft, Inc.

  Audit

 

  Nominating & Corporate Governance

1
Christine A. Leahy562019President & Chief Executive Officer, CDW Corporation____1
Sanjay Mehrotra622021President & Chief Executive Officer, Micron Technology, Inc.

  Compensation

 

  Nominating & Corporate Governance

1
David W. Nelms
(Independent
Chairman)
602014Retired Chairman & Chief Executive Officer, Discover Financial Services

  Audit

 

  Nominating & Corporate Governance (Chair)

Joseph R. Swedish692015Retired Chairman, President and Chief Executive Officer, Anthem, Inc.

  Compensation (Chair)

 

  Nominating & Corporate Governance

2
Donna F. Zarcone632011Retired President and Chief Executive Officer, The Economic Club of Chicago

  Audit

 

  Nominating & Corporate Governance

1

(1)The time period for service as a director of CDW includes service on the Board of Managers of CDW Holdings LLC, our parent company prior to our initial public offering in 2013.

 

2023 Proxy Statement11

Director Nominee Diversity

Executive Compensation Highlights

 

CEO Pay for Performance

 

Our executive compensation program is focused on driving sustained meaningful profitable growth and stockholder value creation. The Compensation Committee seeks to foster these objectives through a compensation system that focuses heavily on variable, performance-based incentives that create a balanced focus on our short-term and long-term strategic and financial goals. As shown in the chart, in 2020,2022, approximately 86%90% of the target compensation of our Chair, President and Chief Executive Officer was variable and is realized only if the applicable financial performance goals are met and/or our stock price increases.

 

 

 2021 Proxy Statement    12

2023 Proxy Statement12
 

Our Executive Compensation Practices

 

Our executive compensation practices include the following, each of which the Compensation Committee believes reinforces our executive compensation objectives:

 

OUR EXECUTIVE COMPENSATION PRACTICES

Our Executive Compensation Practices
Significant percentage of target annual compensation delivered in the form of variable compensation tied to performanceWe do not have 280G tax gross-ups
Long-term objectives aligned with the creation of stockholder valueWe do not have an enhanced severance multiple upon a change in control
Target total compensation at the competitive market medianWe do not have excessive severance benefits
Market comparison of executive compensation against a relevant peer groupWe do not pay dividends or dividend equivalents on unearned equity awards under our long-term incentive plan
Use of an independent compensation consultant reporting directly to the Compensation Committee and providing no other services to the Company
Double-trigger vesting for equity awards in the event of a change in control under our long-term incentive plan
Robust stock ownership guidelines
Clawback policy
Annual say-on-pay vote
Limited perquisites
  
We do not have tax gross-ups*
We do not have an enhanced severance multiple upon a change in control
We do not have excessive severance benefits
We do not pay dividends or dividend equivalents on unearned performance-based awards under our long-term incentive plan
We do not allow repricing of underwater stock options under our long-term incentive plan without stockholder approval
Double-trigger vesting for equity awards in the event of a change in control under our long-term incentive planWe do not allow hedging or short sales of our securities, and we do not allowrestrict pledging of our securities except in limited circumstances with pre-approval
*Excludes tax reimbursements with respect to customary relocation benefits and tax reimbursements made to Mr. Kebo in connection with an expatriate assignment prior to his appointment as an executive officer, consistent withRobust stock ownership guidelines
Clawback policy
Annual say-on-pay vote
Limited perquisites
Annual equity awards are granted following the release of the Company’s practices for expatriate assignments.annual earnings report

 

Extensive information regarding our executive compensation program in place for 20202022 can be found in the “Compensation Discussion and Analysis” section of this proxy statement.

 

2020

2022 Say-on-Pay Vote

 

Stockholders continued to show strong support of our executive compensation program, with approval by approximately 96%94% of the votes cast for the Company’s say-on-pay vote at our 20202022 Annual Meeting of Stockholders and, since our IPOinitial public offering in 2013 (“IPO”), our stockholders have overwhelmingly supported our executive compensation program, with an average approval of approximately 97% of the votes cast for the Company’s say-on-pay vote at the annual meetings of stockholders since our IPO.

 

 

 

 2021 Proxy Statement    13

2023 Proxy Statement13
 

CORPORATE GOVERNANCE

Corporate Governance

 

Our success is built on the trust we have earned from our customers, coworkers, business partners, investors and communities, and that trust sustains our success. Part of this trust stems from our commitment to good corporate governance. Our Company is governed by our Board of Directors (“Board of Directors” or “Board”). The Board is responsible for providing oversight of the strategic and operational direction of the Company and supporting the Company’s long-term interests.

 

To provide a framework for effective governance, our Board has adopted Corporate Governance Guidelines, which outline the operating principles of our Board and the composition and working processes of our Board and its committees. The Nominating and Corporate Governance Committee periodically reviews our Corporate Governance Guidelines and developments in corporate governance and recommends proposed changes to the Board for approval.

 

Our Corporate Governance Guidelines, along with other corporate governance documents such as committee charters and The CDW Way Code (our code of business conduct and ethics), are available on the Governance section of our Investor Relations website at www.cdw.cominvestor.cdw.com. These documents and any other information available on our website are not part of, or incorporated by clicking on Investor Relations and then Corporate Governance.reference into, this proxy statement.

 

Corporate Governance Highlights

 

Annual Election of Directors. All directors are elected annually.
Lead Independent Chairman. Director.David W. Nelms serves as our independent Chairman of the Board.Lead Independent Director.
All Directors Elected Annually. All Directors are elected annually. Our Board of Directors and our stockholders approved the phased declassification of our Board in 2018, which will be complete as of the Annual Meeting.
Independent Board. Our Board of Directors is comprised entirely of independent directors, other than our Chair, who also serves as President and Chief Executive Officer. The independent members of our Board of Directors regularly meet in executive session.
Independent Board Committees. All members of our Audit, Compensation and Nominating and Corporate Governance Committees are independent directors.
Audit Committee Financial Experts.Four of our continuing All members of our Audit Committee qualify as “audit committee financial experts” as defined under SECU.S. Securities and Exchange Commission (“SEC”) rules.
Board Term Limit. Our Corporate Governance Guidelines provide that a director will not be renominated at the next annual meeting of stockholders after 1215 years of service on our Board of Directors, absent special circumstances. Messrs. Alesio, Allen and Chereskin are retiring fromIn 2022, our Board immediately prior toincreased the Annual Meeting under thisBoard term limit policy.from 12 to 15 years to allow for Board stability and continuity, while maintaining a strong refreshment process, ensuring a balance of tenures, perspectives and skill sets.
Stockholder Right to Call Special Meetings. Our Board has approved a management proposal to allow stockholders the right to call special meetings (Proposal 5 in this proxy statement).
Proxy Access. Our Amended and Restated Bylaws (“Bylaws”) permit a stockholder, or a group of up to 20 stockholders, owning at least 3% of our outstanding common stock continuously for at least 3 years to nominate and include in our proxy materials director nominees constituting up to 2 individuals or 20% of the Board, whichever is greater, as further detailed in our Bylaws.
Majority Vote. Directors are elected by majority vote of our stockholders in uncontested elections. We have a resignation policy that applies if a director fails to receive a majority of the votes cast.
Restrictions on Other Board Service. Our Corporate Governance Guidelines restrict the number of public company boards on which our directors may serve. A director who is currently an executive officer of a public company may serve on a total of 2 public company boards (including our Board) and a director who is not currently an executive officer of a public company may serve on a total of 4 public company boards (including our Board).
Annual Board and Committee Evaluations. Our ChairmanLead Independent Director leads the annual Board evaluation process by conducting a one-on-one interview with each director to obtain feedback on and discuss Board performance and effectiveness. The results are then discussed by the Nominating and Corporate Governance Committee, which consists of all of our independent directors. Each of the Audit, Compensation and Nominating and Corporate Governance Committees also conducts an annual self-evaluation to discuss Committee performance and effectiveness.
Proposed Elimination ofNo Supermajority Vote ProvisionsRequirements. . Our BoardSixth Restated Certificate of Directors has approvedIncorporation (“Certificate of Incorporation”) and Bylaws may be amended by the amendmentaffirmative vote of our certificatea majority of incorporation to eliminate supermajority vote provisions (Proposal 4 in this proxy statement).the Company’s outstanding common stock.
No Stockholder Rights Plan. The Company does not have a stockholder rights plan or poison pill.

 

 2021 Proxy Statement    14

2023 Proxy Statement14
 

Environmental, Social and Governance (ESG)

 

At CDW, we make technology work so people can do great things.

This spirit also drives our commitment to making progress in every area of our Environmental, Social and Governance journey.
We operate our business in a responsible manner and are dedicated to making a positive impact for all our stakeholders and the world we share with them.

At CDW, we continue to build upon our long history of providing value to stakeholders, rewarding careers to our coworkers and support to the communities where we live and work.

We are committed to implementation of an increasingly robusta proactive Environmental, Social and proactive environmental, social and governance (ESG)Governance (“ESG”) agenda that reflectswith a focus on topics of highest priority and relevance to CDW. In April 2021, we published our 2020 ESG reportCDW and our firststakeholders. The Nominating and Corporate Governance Committee of our Board of Directors has oversight responsibility for CDW’s ESG programs and policies.

Our annual ESG reports, disclosures under the Sustainability Accounting Standards Board (SASB) and the Task Force on Climate-related Financial Disclosures (TCFD) frameworks which demonstrate this commitment and our progress andEEO-1 data are available on the ESG section of our website at www.cdw.comcdw.com/esg. Also in early 2021,We will include our Board of Directors approved an update to the Nominating and Corporate Governance Committee charter to assign specific ESG oversight responsibility to that committee.2022 EEO-1 data on our website once our 2022 EEO-1 report is filed.

 

While we continued advancingWe focus our ESG strategy in 2020 and into 2021, we also had to pivot and adjust wherever needed to address the unprecedented challenges associated with the COVID-19 pandemic and the social and racial equity issues brought to the forefront by several high-profile tragic events last summer. Our approach to the pandemic focused on three principles: 1) Safeguard the health and well-being of our coworkers; 2) Serve the mission-driven needs of our customers; and 3) Support our communities. Our ESG report includes a detailed discussion of our COVID-19 response efforts and our commitment to implementing our ReunITe plan under the mantra of “Let’s not get back to normal, let’s be even better.”

To address the events of last summer, we accelerated our efforts to listen and learn more about diversity, equity and inclusion. While CDW has been on the pathwaytopics, challenges and opportunities where CDW is uniquely positioned to driving diversity, equitymake the greatest impact and inclusion – a sense of belongingsustainably add value for all – we took several additional steps such as enhancing resource guides, holding frank and open panel discussions on the topic of race and offering training sessions to help supervisors and managers talk about race and its impact on our coworkers. Our ESG report provides additional information on the steps we took to enhance our diversity, equity and inclusion program and address these events.stakeholders:

 

Based on the results of our materiality assessment conducted in 2019, and updated in 2020, the topics below reflect the areas of ESG that are of highest priority and relevance to CDW and our key stakeholders. They guide our activities and our approach to reporting.

2022 ESG MILESTONES
ESG StrategyDuring 2022, we made significant progress in further refining and formalizing our ESG strategy and program structure. Last year’s milestones included: added a global head of ESG to our team; designated risk and ESG champions across the business; engaged leaders and cross-functional teams throughout the enterprise supporting the ESG strategy development process; expanded the ESG Steering Committee to cover the breadth of our business; and initiated an ESG materiality assessment refresh that will be completed in 2023 and guide our strategic focus in the coming years. We are committed to continuing to engage with our investors, customers, key vendor partners and coworkers as we further build out and implement the strategy globally.
EnvironmentalIn 2022, we enabled online searchable access for customers to our portfolio of environmentally certified products (Energy Star, EPEAT and TCO); expanded our participation in electronics recycling programs; outperformed our waste diversion goal of 90%+ for the fourth year in a row at our two US distribution centers; and created a cross-functional, geographically diverse Climate Task Force to drive climate awareness within CDW and lead the development of the company’s global climate strategy.
SocialWe have continued to build our One CDW culture and create a Coworker Experience that meets coworkers at every stage of their careers. Specific coworker efforts include making CDW a premier destination for tech talent and engaging coworkers through our culture of inclusion and belonging, participation in our Business Resource Groups, community involvement, and numerous training and leadership development opportunities. We also have continued to increase our multibillion-dollar spend with certified, small, diverse vendor partners as a member of the Billion Dollar Roundtable; and increased our social impact commitments to address digital equity in schools and communities – based on our belief in the transformative power of technology.
Governance and EthicsAt CDW, we understand that integrity, trust and good corporate governance matter to all our stakeholders. Recent enhancements to support these principles include: continued integration of our risk and audit frameworks and an enhanced information security function under one robust, enterprise-wide organization known as CDW Global Information Security, led by a new Global Chief Information Security Officer. In addition, the company has set forth a proposal to be voted on at this Annual Meeting that would provide stockholders with the right to call a special meeting.

 

 2021 Proxy Statement    15

2023 Proxy Statement15
 

Ultimately, our ESG impact is made possible by continuing to drive our financial performance and shareholder value. Our demonstrated ability in sustaining a successful business is a key contributor to our continued ESG progress.

2020-2021 Recognition SnapshotRecognitions  
Overall ESG AwardsWorkplace Awards

20212022 Nasdaq 100 ESG, Ranked #11
By RepTrak

Silver Rating
By EcoVadis

America’s Most JUST Companies
By JUST Capital

World’s Best Employers 2022
By Forbes

2022 Best Places to Work
By Glassdoor

by Glassdoor

Best Places to Work for 2023
By Built In

 

2021Best Places to Work in IT 2023
By InsiderPro/ComputerWorld

Business Diversity Awards

DEI Awards

2022 Best Places to Work for LGBTQ+ Equality, 100% Corporate Equality IndexPerfect Score


By Human Rights Campaign

 

2020 Culture 500 Champion

By MITSloan & Glassdoor

2021 Gold Military Friendly Employer

By Military Friendly

America’s Most JUST Companies 2020

By JUST Capital

America’s Best Large Employers 2021

By Forbes

America’s Best Employers forDiversity 2020

By Forbes

Best Companies for Women

2022
By Fairygodboss

 

Best Technology Companies Where CEOs SupportGender Diversity

for Women 2022
By Fairygodboss

Best for Vets 2020 Employer

By Military Times

 

2022 Best Place to Work in IT

for Disability Inclusion
By ComputerworldDisability Equality Index

 

Best for Vets 2022 Employer (Gold designation)
By Military Times

2023 Military Friendly Companies (Silver designation)
By Military Friendly

Best of the Best Top Veteran-Friendly Companies 2022
By U.S. Veterans Magazine

Billion Dollar Roundtable

Best of the Best Supplier DiversityProgram 20202022
DIVERSEability Magazine

Best of the Best Supplier Diversity Program 2022
By U.S. Veteran’s Magazine, Professional Woman’s Magazine

Best Supplier Diversity Program 2022
By Black EOE Journal &

Best of the Best Supplier Diversity Program 2022
By HISPANIC Network Magazine

 

Best Technology CompaniesAmerica’s Top Corporations for Women

Women’s Business Enterprises
By Fairygodboss

The Women’s Business Enterprise National Council

 

2023 Proxy Statement16

Adoption of Special Meeting Right in Response to 2022 Written Consent Stockholder Proposal

CDW values input from our stockholders, and regularly seeks and receives stockholder feedback when reviewing our governance practices or policies. At the 2022 annual meeting, holders of 67.2% of our outstanding shares expressed support for a non-binding stockholder proposal to allow action by written consent without a meeting of stockholders (the “2022 written consent proposal”). Of the votes cast, 78.7% supported the 2022 written consent proposal and 21.3% voted against it.

In 2022, our Board recommended voting against the 2022 written consent proposal for the following key reasons:

the written consent process lacks the important protections and advantages that stockholder meetings offer;
the written consent process does not promote transparent decision-making and could disenfranchise stockholders; and
CDW’s strong corporate governance practices demonstrate responsiveness, provide stockholders with means to express their views, and ensure Board accountability.

The Board remains concerned about the disruptive effects of a stockholder written consent right. For example, stockholder action by written consent could impede CDW and our stockholders’ ability to thoroughly consider significant corporate actions and possible alternatives. In addition, stockholders without full economic interests or voting rights in CDW could force CDW to expend significant company resources, and a small number of stockholders could potentially unduly influence corporate actions.

We view our relationship with our stockholders and other stakeholders as fundamental to good corporate governance practices, and have a strong record of stockholder engagement and responsiveness to stockholder concerns. Our Board appreciates that corporate governance practices are evolving, and consistently monitors trends and developments in corporate governance and compares them against current practices. CDW determined that, in light of these considerations, further engagement with our stockholders would be appropriate, both to understand better the vote results with respect to the 2022 written consent proposal and to allow CDW to incorporate stockholder feedback into its decision-making with respect to the appropriate response to the 2022 proposal.

Following the 2022 annual meeting, management, at the request of the Nominating and Corporate Governance Committee, undertook a robust stockholder outreach campaign. CDW solicited specific feedback from stockholders related to the 2022 written consent proposal to better understand why they did or did not vote for the 2022 written consent proposal and stockholders’ views with respect to potential responses to the 2022 proposal. CDW also sought to understand whether stockholder support for the 2022 written consent proposal represented a desire among stockholders for the right to act by written consent, or if stockholders had instead intended their votes to convey other preferences or priorities (for example, a desire for the right to act between annual meetings outside of informal stockholder engagement, such as a stockholder right to call a special meeting). With respect to the possibility of amending the Certificate of Incorporation and Bylaws to allow stockholders to call a special meeting, CDW management also sought feedback to understand stockholder preferences with respect to the ownership threshold at which such a right would apply.

We reached out to holders of approximately 63% of CDW’s outstanding common stock, and received feedback from holders of approximately 37% of the outstanding common stock, including our three largest stockholders who each own 5% or more of our stock (see “Stock Ownership - Principal Stockholders” in this proxy statement) and nine other of CDW’s 30 largest stockholders. Generally, the stockholders we spoke with indicated an understanding of CDW’s approach to seeking additional feedback and conducting further engagement in response to stockholder support for the 2022 proposal.

During the course of this engagement, CDW’s management heard a few key perspectives from stockholders. Even though approximately 72% of the stockholders that provided feedback stated that they voted for the 2022 written consent proposal, all of them preferred a right for stockholders to call a special meeting over the right for stockholders to act by written consent or were indifferent between the two rights. No stockholder expressed a preference for written consent over a right for stockholders to call a special meeting. Many stockholders expressing a preference for a special meeting right indicated that this approach was desirable because it allows stockholders to act in between annual meetings, but also better facilitates participation of all stockholders to discuss the topic under consideration through an orderly and transparent process. Holders of approximately 91% of the shares that provided feedback indicated that providing stockholders with the right to call a special meeting at a 25% threshold would be responsive to the support of CDW’s stockholders for the 2022 written consent proposal, while the remaining stockholders did not express a view on responsiveness.

In addition to the stockholder feedback described above, our Board also considered, among others, the prevailing corporate governance trends and market practices of S&P 500 companies and actions taken by similarly situated companies and the voting policies and guidelines of CDW’s investors and third-party advisory firms regarding the ability of stockholders to act in between annual meetings.

CDW believes that the right for stockholders to call a special meeting is a better alternative to the right for stockholders to act by written consent. Indeed, according to data collected by FactSet, as of March 20, 2023, only approximately 33.2% of S&P 500 companies allow stockholders to act by written consent (excluding those companies where unanimous written consent is required). In contrast, about 69.8% of S&P 500 companies afford stockholders the right to call a special meeting, usually subject to an ownership threshold (with a slight majority of S&P 500 companies that allow stockholders to call special meetings having an ownership threshold of 25% or greater).

2023 Proxy Statement17

Based on the extensive analyses and stockholder feedback described above, our Board concluded that the adoption of a stockholder right to act by written consent would not be in the best interests of CDW and our stockholders. Our Board, however, is mindful of being responsive to stockholders’ expressed wishes regarding the ability to act outside the regular annual meeting cycle. In light of the fact that holders of a substantial majority of CDW’s outstanding shares that provided feedback believe that the right for stockholders to call a special meeting would be preferable to the right for stockholders to act by written consent, our Board has unanimously adopted, and recommends that stockholders approve, an amendment to our Certificate of Incorporation to allow stockholders to call special meetings. See “Proposal 5 - Approval of the Amendment to the Company’s Certificate of Incorporation to Allow Stockholders the Right to Call Special Meetings” (“Proposal 5”).

The right for stockholders to call a special meeting entails some concerns similar to those presented by stockholder action by written consent, in particular, a lack of transparency, the risk of stockholder disenfranchisement and the risk that a small group of CDW’s stockholders could use the process in support of actions that are not supported by a broad cross-section of our stockholders, resulting in an inefficient use of corporate resources, a concern that several of our stockholders expressed during our engagement. To address these risks, and subject to the approval by stockholders of Proposal 5, the Board has approved amendments to our Bylaws that include procedural requirements intended to mitigate the potential for abuse, including, among others:

a 25% ownership threshold for stockholders to call special meetings;
a requirement that the proponent for the special meeting request and such proponent’s affiliates (the “meeting requesting stockholder”) hold their share ownership continuously for one year as of the date of the request for the special meeting, to prevent abuse of the right by stockholders focused on short-term interests;
a requirement that the meeting requesting stockholder must first request in writing that the Board fix a record date to determine the stockholders entitled to request the calling of a special meeting;
a requirement that the meeting requesting stockholder provide certain information that is the same in all material respects as what would be required when stockholders seek to propose action or nominate directors at a stockholders’ meeting under our advance notice bylaws, in order to ensure that stockholders receive adequate information in connection with the special meeting and to improve transparency; and
a time limitation on action initiated within 90 days prior to the first anniversary of the preceding year’s annual meeting and ending on the date of the final adjournment of the next annual meeting of stockholders, to avoid unnecessary waste of resources.

The special meeting right adopted by our Board is consistent with prevailing corporate governance trends and the adopted ownership threshold is supported by a significant number of CDW’s stockholders. Holders of approximately 84% of shares that engaged with us generally supported a 25% ownership threshold to call special meetings, with holders of 9% of shares that engaged with us expressing a preference for a lower threshold and the remaining 7% expressing no preference on the threshold. Moreover, an analysis of market trends showed that 25% is the most prevalent threshold and reflects market practice; according to FactSet, as of March 20, 2023, approximately 50.9% of the S&P 500 companies that provide stockholders the right to call a special meeting have an ownership threshold of 25% or greater.

For all of the reasons described above, CDW determined that it would be consistent with the wishes of the majority of our stockholders, and responsive to the vote on the 2022 proposal, to amend the Certificate of Incorporation and the Bylaws to provide stockholders the right to call special meetings. In view thereof, the Board is presenting to CDW stockholders Proposal 5 to amend CDW’s Certificate of Incorporation to provide stockholders the right to call special meetings. If the proposed amendment is approved by the stockholders, the Bylaws will be amended to specify the procedures for stockholder-requested special meetings, with provisions consistent with feedback from our stockholders and prevailing market trends.

We continue to welcome stockholder feedback on these and other matters of importance to all of our investors and will incorporate such feedback appropriately into our decision-making, actions and approach to stockholder engagement and corporate governance.

Independence of Our Board of Directors

 

Under our Corporate Governance Guidelines and the listing standards of the Nasdaq Global Select Market (“Nasdaq”), a majority of our Board members must be independent. The Board of Directors annually determines whether each of our directors is independent. In determining independence, the Board follows the independence criteria set forth in the Nasdaq listing standards and considers all relevant facts and circumstances.

 

Under the Nasdaq independence criteria, a director cannot be considered independent if he or she has one of the relationships specifically enumerated in the Nasdaq listing standards. In addition, the Board must affirmatively determine that a director does not have a relationship that, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. The Board has affirmatively determined that each of our current directors, other than our Chair, President and Chief Executive Officer, Christine A. Leahy, and each of the directors who served during the last completed fiscal year is independent under the applicable listing standards of Nasdaq, other thanNasdaq.

2023 Proxy Statement18

Board of Directors Leadership Structure

Christine A. Leahy, our President and Chief Executive Officer, Christine A. Leahy.

was appointed Board Chair effective as of Directors Leadership Structure

Christine A. Leahy currently servesJanuary 1, 2023. David W. Nelms, a non-executive and independent director, was elected by the Nominating and Corporate Governance Committee, which is comprised of all of the Board’s independent directors, to serve as our PresidentLead Independent Director. In making the decision to combine the role of Board Chair and Chief Executive Officer of our Company, the Board took into consideration Ms. Leahy’s more than 20 years of leadership at the Company and David W. Nelms serves as our non-executive Chairman.her extensive knowledge of, and experience with, the Company’s business. The Board presently believes that separating the rolescombined role of ChairmanBoard Chair and Chief Executive Officer aidsof our Company, together with the appointment of a Lead Independent Director, the independence of all Board members other than our Chief Executive Officer and the use of regular executive sessions of the independent directors, achieves an appropriate balance between the effective development of key strategic and operational objectives and independent oversight of management’s execution of those objectives.

The Board believes that having the Company’s Chief Executive Officer serve as Board Chair is in the best interest of its stockholders at this time because this structure ensures a seamless flow of communication between management and the Board, in particular with respect to the Board’s oversight responsibility. However,of the Company’s strategic direction and risk management, as well as the Board’s ability to ensure management’s focused execution of that strategy. The Board additionally believes that, because the Chief Executive Officer is the director most familiar with the Company’s business, industry and day-to-day operations, she is well-positioned to help the Board does not believe that a single leadership structure is right for all companies at all times, sofocus on those issues of greatest importance to the Company and its stockholders and to assist the Board periodically reviewswith identifying the Company’s strategic priorities, as well as the short-term and long-term risks and challenges facing the Company. While independent directors have invaluable experience and expertise from outside the Company and its leadership structurebusiness, giving them different perspectives regarding the development of the Company’s strategic goals and objectives, the Chief Executive Officer is well-suited to determine, based on the circumstances at such time, what leadership structure would be most appropriate.bring Company-specific experience and industry expertise to her discussions with independent directors.

 

Lead Independent Director

David Nelms

LEAD INDEPENDENT
DIRECTOR

The primary roles of our Lead Independent Director are to assist the Chair in managing the governance of the Board and to serve as a liaison between the Chair and other directors. The responsibilities of the Lead Independent Director, which are described in the Company’s Corporate Governance Guidelines, include, among others:

RESPONSIBILITYDESCRIPTION
Board MeetingsPresides at all meetings of the Board at which the Chair is not present, including all executive sessions of the non-management and/or independent directors
Executive SessionsHas the authority to call meetings of the non-management and/or independent directors
AgendasProvides input to the Chair on the annual Board calendar, agenda items and schedules for each Board meeting and the materials and information to be presented to the Board
Communicating with StockholdersServes as a contact for and may represent the Board in communications with stockholders and other stakeholders who wish to communicate with non-management directors

2023 Proxy Statement19

Board and Committee Meetings

 

Under our Corporate Governance Guidelines, our directors are expected to attend meetings of the Board and applicable committees and our annual meetings of stockholders.

 

In 2020,2022, the Board held sevenfour meetings. In 2020,2022, each of the directors attended at least 75% of the aggregate of all meetings of the Board and the committees on which he or she served (during the periods for which he or she served on the Board and such committees). In addition, each of our directors serving at the time of our 2020 Annual Meeting of Stockholders attended our 20202022 Annual Meeting of Stockholders.

 

Board Committees

 

Our Board has an Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee. Our Board has adopted charters for each of these committees, which are available on the Governance section of our Investor Relations website at www.cdw.cominvestor.cdw.com. Under the committees’ charters, the committees report regularly to the Board and as the Board requests. Additional information on each of these committees is set forth below.

 

 2021 Proxy Statement    16

 
Back to ContentsAll Members
Independent

Audit Committee

Primary Responsibilities:

 

Chairperson: Virginia C. Addicott

Other Members of the Committee: James A. Bell Benjamin D. Chereskin*, Anthony R. Foxx, (Chair)

Virginia C. Addicott

Marc E. Jones

David W. Nelms

Donna F. Zarcone

Meetings Held in 2020: 8

Primary Responsibilities:

Our Audit Committee is responsible for, among other things: (1) appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm; (2) discussing with our independent registered public accounting firm its independence from management; (3) reviewing with our independent registered public accounting firm the scope and results of its audit; (4) preapproving all audit and permissible non-audit services to be performed by our independent registered public accounting firm; (5) overseeing the accounting and financial reporting process and discussing with management and our independent registered public accounting firm the interim and annual financial statements that we file with the U.S. Securities and Exchange Commission (“SEC”);SEC; (6) reviewing and monitoring our accounting principles, accounting policies and financial and accounting controls; (7) establishing procedures for the confidential and anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters; (8) reviewing and approving or ratifying related person transactions; (9) overseeing our business process assurance function (internal audit);internal audit function; and (10) reviewing the Company’s compliance and ethics and risk management programs, including with respect to cybersecurity.

Meetings Held in 2022: 8

 

Independence:

Each member of the Audit Committee meets the audit committee independence requirements of Nasdaq and the rules under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Board has designated each member of the Chair, Ms. Addicott, Messrs. Bell, Chereskin, and Nelms and Ms. ZarconeAudit Committee as an “audit committee financial expert.” Each member of the Audit Committee is financially literate, knowledgeable and qualified to review financial statements.

 

2023 Proxy Statement20
 

All Members Independent

Compensation Committee

 

Chairperson: Sanjay Mehrotra (Chair)

Lynda M. Clarizio

Paul J. Finnegan

Anthony R. Foxx

Joseph R. Swedish

Other Members of the Committee: Steven W. Alesio*, Barry K. Allen*, Lynda M. Clarizio, Paul J. Finnegan, Sanjay Mehrotra

Meetings Held in 2020: 6

Primary Responsibilities:

Our Compensation Committee is responsible for, among other things: (1) reviewing and approving the compensation of our chief executive officer and other executive officers; (2) reviewing and approving employment agreements and other similar arrangements between CDW and our executive officers; (3) administering our stock plans and other incentive compensation plans; (4) periodically reviewing and recommending to the Board any changes to our incentive compensation and equity-based plans; and (5) reviewing trends in executive compensation. The Compensation Committee may form, and delegate authority to, subcommittees when it deems appropriate.

 

Meetings Held in 2022: 4

Independence:

Each member of the Compensation Committee meets the compensation committee independence requirements of Nasdaq and the rules under the Exchange Act.

*Retiring immediately prior to the Annual Meeting

 

 2021 Proxy Statement    17

 
Back to ContentsAll Members Independent
Nominating and Corporate Governance Committee
Chairperson: David W. Nelms 
Other Members of the Committee:

David W. Nelms

(Chair)

Virginia C. Addicott Steven W. Alesio*, Barry K. Allen*,

James A. Bell Benjamin D. Chereskin*,

Lynda M. Clarizio

Paul J. Finnegan

Anthony R. Foxx

Marc E. Jones

Sanjay Mehrotra

Joseph R. Swedish

Donna F. Zarcone

Primary Responsibilities:

Meetings Held in 2020: 4

Primary Responsibilities:

Our Nominating and Corporate Governance Committee is responsible for, among other things: (1) identifying individuals qualified to become members of our Board of Directors, consistent with criteria approved by our Board; (2) evaluating potential nominees for our Board of Directors recommended by our stockholders and maintaining procedures for the submission of stockholder nominees; (3) overseeing the organization and evaluation of our Board to discharge the Board’s duties and responsibilities properly and efficiently;efficiently and monitoring the outside commitments of directors; (4) identifying best practices and recommending corporate governance principles; (5) developing and recommending to our Board a set of corporate governance guidelines and principles applicable to us; (6) reviewing compliance with The CDW Way Code, our code of business conduct and ethics; (7) reviewing and approving the compensation of our directors; (8) setting performance goals for and reviewing the performance of our chief executive officer; (9) overseeing our environmental, socialESG programs and governance program; andpolicies; (10) executive succession planning.planning; and (11) reviewing stockholder proposals.

Meetings Held in 2022: 4

 

Independence:

Each member of the Nominating and Corporate Governance Committee meets the nominating and corporate governance committee independence requirements of Nasdaq.

 

* Retiring immediately prior to the Annual Meeting

Oversight of Strategy

 

One of the primary responsibilities of the Board is to oversee management’s development and execution of the Company’s long-term strategy. Strategy is a recurring topic of discussion at Board meetings, with periodic additional in-depth strategic planning sessions. Discussions on strategy include updates on the ongoing strategic planning process, progress against various strategic initiatives, the competitive landscape and potential risks to the Company’s long-term strategy.

 

2023 Proxy Statement21

Oversight of Risk

 

Enterprise Risk Management Program

Our Board of Directors, as a whole and through the Audit Committee, oversees our Enterprise Risk Management Program (“ERM Program”), which is designed to drive the identification, analysis, discussion and reporting of our high priority enterprise risks. The ERM Program facilitates constructive dialogue at the senior management and Board levels to proactively identify, prioritize and manage enterprise risks.risks that the Company may face over the short-term, intermediate-term, and long-term. Under the ERM Program, senior management develops a holistic portfolio of enterprise risks by facilitating business and supporting function assessments of strategic, operational, financial, reporting and compliance risks on an ongoing basis, and helps to ensure appropriate response strategies are in place. This includes consulting with outside advisors and experts to anticipate future threats and trends affecting the enterprise risk portfolio.

 

Our Audit Committee is primarily responsible for overseeing our risk management processes on behalf of the full Board. Enterprise risks are considered in business decision making and as part of our overall business strategy. Our management team, including our executive officers, is primarily responsible for managing the risks associated with the operation and business of our company.company, covering all categories and types of risk and including both known and newly identified emerging risks. Senior management provides regular updates to the Audit Committee and periodic updates to the full Board on the ERM Program and reports to both the Audit Committee and the full Board on any identified high priority enterprise risks. This includes risk assessments from management with regard to cybersecurity, including assessments of the overall threat landscape and strategies and infrastructure investments to monitor and mitigate such threats.

In addition, the Board believes that having a Lead Independent Director enhances the Board’s independent oversight of the Company’s risk management provides regular updates toefforts by enabling consultation between the full Board and/or the Audit Committee relating to newly-identifiedChair and evolvingLead Independent Director on high priority risks, such as those presented byenterprise risks.

Oversight of ESG

We are committed to implementation of a proactive ESG agenda with a focus on topics of highest priority and relevance to CDW and our stakeholders. Our Nominating and Corporate Governance Committee has oversight responsibility for CDW’s ESG programs and policies. See the COVID-19 pandemic.“Environmental, Social and Governance” section of this proxy statement for more information regarding our ESG efforts.

 

 2021 Proxy Statement18
Back to Contents

Compensation Risk Assessment

We conducted an assessment of the risks associated with our compensation practices and policies, and determined that risks arising from such policies and practices are not reasonably likely to have a material adverse effect on the Company. In conducting the assessment, we undertook a review of our compensation philosophies, our compensation governance structure and the design and oversight of our compensation programs. Overall, we believe that our programs include an appropriate mix of fixed and variable features, and short- and long-term incentives with compensation-based goals aligning with corporate goals. Centralized oversight helps ensure compensation programs align with the Company’s goals and compensation philosophies and, along with other factors, operate to mitigate against the risk that such programs would encourage excessive risk-taking.

Oversight of Human Capital Management

 

Cultivating a welcoming work environment and inclusive culture that allows all coworkers to feel a sense of belonging, be valued and have the confidence to do great things is fundamental to CDW. We’re a unified team of diverse perspectives, driven by our desire to succeed together. Our Board understands the importance of our inclusive, performance-driven culture to our ongoing success and is actively engaged with our Chair, President and Chief Executive Officer and our Chief Human ResourcesPeople Officer and Senior Vice President, Coworker Success across a broad range of human capital management topics.

On an annual basis, the Board reviews the results of our annual talent review process and succession plans for our Chair, President and Chief Executive Officer and our other executive officers. In addition, talent strategy is regularly discussed with the Board, including culture, diversity and inclusion, recruiting, retention, engagement and talent development. The Compensation Committee also annually reviews compensation trends and developments and the results of a review of risksrisk analysis of our compensation practices and policies.

 

Code of Business Conduct and Ethics

 

We have adopted The CDW Way Code, our code of business conduct and ethics, that is applicable to all of our coworkers and directors. A copy of this code is available on the Governance section of our Investor Relations website at www.cdw.cominvestor.cdw.com. Within The CDW Way Code is a Financial Integrity Code of Ethics that sets forth an even higher standard applicable to our executives, officers, members of our internal disclosure committee and all managers and above in our finance department. We intend to disclose any substantive amendments to, or any waivers from, The CDW Way Code by posting such information on our website or by filing a Form 8-K, in each case to the extent such disclosure is required by rules of the SEC or Nasdaq.

 

2023 Proxy Statement22

Hedging, Short Sales and Pledging Policies

 

Our Policy on Insider Trading, which applies to all coworkers, Board members and consultants, includes policies on hedging, short sales and pledging of our securities. Our policy prohibits hedging or monetization transactions involving Company securities, such as prepaid variable forwards, equity swaps, collars and exchange funds. It also prohibits short sales of our securities, including sales of securities that are owned with delayed delivery. In addition, it prohibits holding Company securities in a margin account or pledging Company securities as collateral for a loan except in limited circumstances with pre-approval from our General Counsel, which pre-approval will only be granted when such person clearly demonstrates the financial capacity to repay the loan without resort to any pledged securities.

 

Executive Compensation Policies and Practices

 

See the “Compensation Discussion and Analysis” for a discussion of the Company’s executive compensation policies and practices. We conducted an assessment of the risks associated with our compensation policies and practices, and determined that risks arising from such policies and practices are not reasonably likely to have a material adverse effect on the Company. In conducting the assessment, we undertook a review of our compensation philosophies, our compensation governance structure and the design and oversight of our compensation programs. Overall, we believe that our programs include an appropriate mix of fixed and variable features, and short- and long-term incentives with compensation-based goals aligning with corporate goals. Centralized oversight helps ensure compensation programs align with the Company’s goals and compensation philosophies and, along with other factors, operate to mitigate against the risk that such programs would encourage excessive risk-taking.

 

 2021 Proxy Statement19
Back to Contents

Communications with the Board of Directors

 

Stockholders who would like to communicate with the Board of Directors or its committees or any individual director may do so by writing to them via the Company’s Corporate Secretary by email at board@cdw.com or by mail at our principal executive offices at CDW Corporation, 200 North Milwaukee Avenue, Vernon Hills, Illinois 60061. Correspondence may be addressed to the collective Board of Directors or to any of its individual members or committees at the election of the sender. Any such communication is promptly distributed to the director or directors named therein unless such communication is considered, either presumptively or in the reasonable judgment of the Company’s Corporate Secretary, to be improper for submission to the intended recipient or recipients. Examples of communications that would presumptively be deemed improper for submission include, without limitation, solicitations, communications that raise grievances that are personal to the sender, communications that relate to the pricing of the Company’s products or services, communications that do not relate directly or indirectly to the Company and communications that are frivolous in nature. In addition, when appropriate, the Chairman of the BoardLead Independent Director is available for engagement with stockholders.

 

Compensation Committee Interlocks and Insider Participation

 

During 2020,2022, our Compensation Committee consisted of Steven W. Alesio, Barry K. Allen, Lynda M. Clarizio, Paul J. Finnegan, Sanjay Mehrotra and Joseph R. Swedish. No member of the Compensation Committee was, during 20202022 or previously, an officer or employee of the Company or its subsidiaries. In addition, during 2020,2022, there were no compensation committee interlocks required to be disclosed.

 

2023 Proxy Statement23

Related Person Transactions

 

Related Person Transactions Approval/Ratification Procedures

 

The Company has written procedures regarding the approval and ratification of related person transactions. Under these procedures, our Audit Committee is responsible for reviewing and approving or ratifying all related person transactions. If the Audit Committee determines that approval or ratification of a related person transaction should be considered by the Board, such transaction will be submitted for consideration by all disinterested members of the Board. The Chair of the Audit Committee has the authority to approve or ratify any related person transaction in which the aggregate amount involved is expected to be less than $300,000 and in which the Chair of the Audit Committee has no direct or indirect interest.

 

For these purposes, a related person transaction is considered to be any transaction that is required to be disclosed pursuant to Item 404 of the SEC’s Regulation S-K, including transactions between us and our directors, director nominees or executive officers, 5% record or beneficial owners of our common stock or immediate family members of any such persons, when such related person has a direct or indirect material interest in such transaction.

 

Potential related person transactions are identified based on information submitted by our officers and managers and then submitted to our Audit Committee for review. The CDW Way Code, our code of business conduct and ethics, requires that our directors and coworkers identify and disclose any material transaction or relationship that could reasonably be expected to create a conflict of interest and interfere with their impartiality or loyalty to the Company. Further, at least annually, each director and executive officer is required to complete a detailed questionnaire that asks questions about any business relationship that may give rise to a conflict of interest and all transactions in which we are involved and in which the executive officer, a director or a related person has a direct or indirect material interest.

 

When deciding to approve or ratify a related person transaction, our Audit Committee takes into account all relevant considerations, including without limitation the following:

the size of the transaction and the amount payable to or by the related person;

 

the size of the transaction and the amount payable to or by the related person;
the nature of the interest of the related person in the transaction;
whether the transaction may involve a conflict of interest;
whether the transaction is at arm’s-length, in the ordinary course or on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances; and
the purpose of the transaction and any potential benefits to us.

Related Person Transactions

The son of Elizabeth H. Connelly, our Senior Vice President, Healthcare and an executive officer of the interestCompany for a portion of 2022, is an Executive Account Manager (sales coworker) at the related personCompany. In 2022, Mr. Connelly had total compensation, including salary, commissions, bonuses and sales incentives, of approximately $315,000 and was eligible to participate in the transaction;

whether the transaction may involve a conflict of interest;

whether the transaction is at arm’s-length, in the ordinary course or on terms no less favorable than terms generallyCompany benefit plans available to an unaffiliated third party under the same or similar circumstances; and

the purpose of the transaction and any potential benefits to us.

Related Person Transactions

similarly situated coworkers. There have been no other transactions since January 1, 20202022 for which disclosure under Item 404(a) of Regulation S-K is required.

 

 20212023 Proxy Statement2024

 

PROPOSAL 1—1

Election of Directors

 

Under our Fifth Amended and Restated Certificate of Incorporation, (as amended, our “Certificate of Incorporation”), the number of Board members is set from time to time by the Board. Our Board presently consists of thirteeneleven directors. ThreeOne of our current directors, Messrs. Alesio, AllenPaul J. Finnegan, is retiring from our Board immediately prior to the 2023 Annual Meeting and Chereskin, arethus will not standingstand for reelection at the 20212023 Annual Meeting and will retire immediately prior to the 2021 Annual Meeting under our twelve year term limit policy.Meeting. We thank Messrs. Alesio, Allen and ChereskinMr. Finnegan for theirhis service to the Company. The Board has decreased the size of the Board to ten directors effective immediately prior to the 20212023 Annual Meeting.

The terms of all of our directors expire on the date of the 20212023 Annual Meeting, subject to the election and qualification of their successors.

 

Director Nomination Process

 

The Board of Directors is responsible for nominating individuals for election to the Board and for filling vacancies on the Board that may occur between annual meetings of stockholders. The Nominating and Corporate Governance Committee is responsible for identifying and screening potential candidates and recommending qualified candidates to the Board for nomination. Third-party search firms may be and have been retained to identify individuals that meet the criteria of the Nominating and Corporate Governance Committee. Each of Mr. Foxx and Mr. MehrotraMarc E. Jones was recommended to the Nominating and Corporate Governance Committee by a third-party search firm.

 

The Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders in the same manner in which it evaluates candidates it identified, if such recommendations are properly submitted to the Company. Stockholders wishing to recommend nominees for election to the Board should submit their recommendations in writing to our Corporate Secretary by email at board@cdw.com or by mail at CDW Corporation, 200 North Milwaukee Avenue, Vernon Hills, Illinois 60061. Nominations for the 20222024 Annual Meeting of Stockholders must be received no earlier than January 20, 202219, 2024 and no later than February 19, 2022.18, 2024. See “Stockholder Proposals for the 20222024 Annual Meeting” for additional information regarding the process for submitting nominations.

 

Our Amended and Restated Bylaws also permit qualified stockholders, or groups of up to 20 stockholders, to nominate and include in our proxy materials director nominees, provided that the stockholder(s) and nominee(s) satisfy the requirements specified in our Amended and Restated Bylaws. Notice of a proxy access nomination must be received no earlier than November 9, 20212023 and no later than December 9, 2021.2023. See “Stockholder Proposals for the 20222024 Annual Meeting” for additional information regarding including director nominees in our proxy materials.

 

Director Qualifications

 

Our Board is committed to regular refreshment and strives to maintain a highly independent, balanced and diverse group of directors that collectively possess the expertise to ensure effective oversight. In selecting director candidates, the Nominating and Corporate Governance Committee and the Board of Directors consider the qualifications, attributes, skills, and skillsexperience of the candidates individually and the composition of the Board as a whole. Under our Corporate Governance Guidelines, the Nominating and Corporate Governance Committee and the Board review the following for each candidate, among other qualifications deemed appropriate, when considering the suitability of candidates for nomination as director:

Principal employment, occupation or association involving an active leadership role

 

Principal employment, occupation or association involving an active leadership role
Qualifications, attributes, skills and/or experience relevant to the Company’s business
Ability to bring diversity to the Board, including gender, race/ethnicity and complementary skills and viewpoints
Other time commitments, including the number of other boards on which the potential candidate may serve
Independence and absence of conflicts of interest as determined by the Board’s standards and policies, the listing standards of Nasdaq and other applicable laws, regulations and rules
Financial literacy and expertise
Personal qualities, including strength of character, maturity of thought process and judgment, values and ability to work collegially

 

Ability to bring diversity to the Board, including gender, race/ ethnicity and complementary skills and viewpoints

Other time commitments, including the number of other boards on which the potential candidate may serve

Independence and absence of conflicts of interest as determined by the Board’s standards and policies, the listing standards of Nasdaq and other applicable laws, regulations and rules

Financial literacy and expertise

Personal qualities, including strength of character, maturity of thought process and judgment, values and ability to work collegially

 20212023 Proxy Statement2125

 

Director Nominee Skills Matrix

In considering each director nominee for the Annual Meeting, the Board and the Nominating and Corporate Governance Committee evaluated such person’s qualifications, attributes, skills and experience to serve as a director.

We believe our Board has a well-rounded variety of qualifications, attributes, skills and experience, and represents a mix of deep knowledge of the Company and fresh perspectives. The table below summarizes some of the qualifications, attributes, skills and experience of each director nominee. This summary is not intended to be an exhaustive list of each director nominee’s skills or contributions to the Board. Further information on each director nominee for this Annual Meeting is set forth in the biographies under “Proposal 1 – Election of Directors — 2023 Nominees for Election to the Board of Directors” in this proxy statement.

  Skills Racial/Ethnic and
Gender Diversity
  Senior
Leadership
 Public Company
Board Service
 Global Technology
Innovation
 Finance,
Accounting and
Risk Management
 People and
Culture
 Government and
Regulatory
 Race/
Ethnicity
 Gender
         
Addicott         White F
Bell         Black M
Clarizio         White F
Foxx         Black M
Jones        Black M
Leahy        White F
Mehrotra        Asian M
Nelms        White M
Swedish         White M
Zarcone         White F
Total 10 10 8 9 10 10 7   4F/6M

SKILLDESCRIPTION
Senior LeadershipExperience as a senior leader in a complex organization
Public Company Board ServiceService on other public company boards
GlobalBroad leadership experience with multinational companies or in international markets
Technology InnovationManaging technology strategies and driving technological change and innovation within an organization
Finance, Accounting and Risk ManagementExperience with finance, accounting, debt or capital markets, M&A, strategic investments or enterprise risk management including cybersecurity
People and CultureExperience managing a large and/or global workforce and building a high performance culture
Government and RegulatoryGovernment service or extensive interactions with the government and government agencies

2023 Proxy Statement26

Diversity of Director Nominees

Our

The balance of age, tenure, race and gender of our director nominees reflects the importance that the Board strives to maintain a highly independent, balanced and diverse grouphas placed on the diversity of its members. Over the last five years, the Board has appointed four new directors, that collectively possess the expertise to ensure effective oversight.all of whom are diverse.

 

 

Diversity of Current Board

BOARD DIVERSITY MATRIX

(As of April 7, 2023)

Total number of directors:        11     
 MaleFemale Non-BinaryGender Undisclosed
Number of directors based on gender identity:74 
Number of directors who identify in any of the categories below:   
African American or Black3 
Alaskan Native or Native American 
Asian1 
Hispanic or Latinx 
Native Hawaiian or Pacific Islander 
White34 
LGBTQ+  1  
Did not disclose demographic background    

Key Director Skills
Technology/Digital SolutionsOperations2023 Proxy StatementInternational
Vertical Markets (e.g., Healthcare, Public Sector)DistributionEconomic/Business Trends
Strategic Planning/Leadership of Complex OrganizationsFinanceCapital Market Transactions
Board Practices of Major CorporationsSales and MarketingLegal27

2021

2023 Nominees for Election to the Board of Directors

 

Each of the ten director nominees listed below is currently a director of the Company. Each of the director nominees, other than Christine A. Leahy, our Chair, President and Chief Executive Officer, has been determined by the Board to be independent.

 

The following biographies describe the business experience of each director nominee. Following the biographical information for each director nominee, we have listed the specific experiencequalifications, attributes, skills, and qualificationsexperience of that nominee that strengthen the Board’s collective qualifications, skills and experience.operation of the Board as a whole. The time period for each of Mr. Finnegan and Ms. Zarcone’s service as a director of CDW includes service on the Board of Managers of CDW Holdings LLC, our parent company prior to our IPO.

 

If elected, each of the director nominees is expected to serve for a term expiring at the 20222024 Annual Meeting of Stockholders, subject to the election and qualification of his or her successor. The Board expects that each of the nominees will be available for election as a director. However, if by reason of an unexpected occurrence one or more of the nominees is not available for election, the persons named in the form of proxy have advised that they will vote for such substitute nominees as the Board may nominate.

 

PROPOSAL 1: The THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE FOLLOWING NOMINEES FOR ELECTION AS DIRECTORS.

VIRGINIA C. ADDICOTTAudit and Nominating and Corporate Governance Committees

INDEPENDENT

Director
since:
2016

Age 59

Ms. Addicott is the retired President and Chief Executive Officer of FedEx Custom Critical, a North American expedited freight carrier, a position she held from June 2007 to December 2019. Ms. Addicott joined FedEx Custom Critical in 1999 as Division Managing Director, Service and Safety, and in 2001 became Division Vice President, Operations and Customer Service. Prior to joining FedEx Custom Critical, Ms. Addicott spent thirteen years at Roberts Express, Inc. (acquired by FedEx Custom Critical in 1999) in various operations roles.

Other Public Company Directorships:

•  Element Fleet Management Corp.

Selected Directorships and Positions:

•  Board of Directors, recommends a vote FOR the following nominees for election as directors.Akron Children’s Hospital

•  Board of Directors, Kent State University Foundation

•  Board of Directors, Smithers - Oasis Company


Key Skills and Qualifications:

•  Senior Leadership

•  Public Company Board Service

•  Global

•  Technology Innovation

•  Finance, Accounting & Risk Management

•  People and Culture


 

VIRGINIA C. ADDICOTTJAMES A. BELLAudit (Chair) and Nominating and Corporate Governance Committees

INDEPENDENT

Director

since: 20162015

Age 57

74

Mr. Bell is the retired Executive Vice President, Corporate President and Chief Financial Officer of The Boeing Company, an aerospace company and manufacturer of commercial jetliners and military aircraft. Mr. Bell served in that role at Boeing from 2008 to 2012. Previously, he served as Boeing’s Executive Vice President, Finance and Chief Financial Officer from 2003 to 2008; Senior Vice President of Finance and Corporate Controller from 2000 to 2003; and Vice President of Contracts and Pricing for Boeing Space and Communications from 1996 to 2000.

Ms. Addicott is the retired President and Chief Executive Officer of FedEx Custom Critical, a North American expedited freight carrier, a position she held from June 2007 to December 2019. Ms. Addicott joined FedEx Custom Critical in 1999 as Division Managing Director, Service and Safety, and in 2001 became Division Vice President, Operations and Customer Service. Prior to joining FedEx Custom Critical, Ms. Addicott spent thirteen years at Roberts Express, Inc. (acquired by FedEx Custom Critical in 1999) in various operations roles.

 

Other Public Company Directorships:

   Element Fleet Management Corp.Apple, Inc.

Former Public Company Directorships
(within the past 5 years):

Selected Directorships and Positions:•  Dow Inc.

   Board of Directors, Akron Children’s HospitalDowDupont Inc.

   Board of Trustees, Kent State UniversityJPMorgan Chase & Co.

   Board of Directors, Smither’s Oasis

 

Key Skills and Qualifications:

•  Senior Leadership

•  Public Company Board Service

•  Global

•  Finance, Accounting & Risk Management

•  People and Culture

•  Government and Regulatory


Director Qualification Highlights:

   Strategic planning and leadership of complex organizations

   Finance

   Operations/Distribution

   Technology/Digital Solutions


 

 20212023 Proxy Statement2228
 
JAMES A. BELLAudit and Nominating and Corporate Governance Committees

INDEPENDENT

Director
since: 2015

Age 72

Mr. Bell is the retired Executive Vice President, Corporate President and Chief Financial Officer of The Boeing Company, an aerospace company and manufacturer of commercial jetliners and military aircraft. Mr. Bell served in that role at Boeing from 2008 to 2012. Previously, he served as Boeing’s Executive Vice President, Finance and Chief Financial Officer from 2003 to 2008; Senior Vice President of Finance and Corporate Controller from 2000 to 2003; and Vice President of Contracts and Pricing for Boeing Space and Communications from 1996 to 2000.

Other Public Company Directorships:

   Apple, Inc.

   Dow Inc. (through April 15, 2021)

Former Public Company Directorships (within the past 5 years):

   DowDupont Inc.

   JPMorgan Chase & Co.

Director Qualification Highlights:

   Strategic planning and leadership of complex organizations

   Finance

   Technology/Digital Solutions

   Board practices of other major corporations


LYNDA M. CLARIZIOCompensation and Nominating and Corporate Governance Committees

INDEPENDENT

Director

since: 2015

Age 60

62

Ms. Clarizio is a strategic advisor to several businesses with a focus on leveraging digital technology and data to drive growth. She also is Co-Founder and General Partner of The 98, an early stage venture fund investing in tech-enabled businesses led by women. Ms. Clarizio served as Executive Vice President, Strategic Initiatives (September 2017 to January 2018) and President of U.S. Media (August 2013 to September 2017) at The Nielsen Company (US), LLC, a global performance management company that provides a comprehensive understanding of what consumers watch and buy. Prior to joining Nielsen, Ms. Clarizio served as Executive Vice President, Corporate Development and Operations of AppNexus, Inc., a programmatic advertising platform, from November 2012 to April 2013. From 2009 to 2012, Ms. Clarizio served as Chief Executive Officer and President of INVISION, Inc., a provider of multiplatform advertising solutions to the media industry. From 1999 to 2009, she held a variety of executive positions with AOL Inc., a media technology company, including President of Platform-A (AOL’s consolidated advertising businesses) and President of Advertising.com (an AOL subsidiary). Prior to joining AOL, Ms. Clarizio was a partner in the Washington, DC law firm of Arnold & Porter, where she practiced law from 1987 to 1999.

Ms. Clarizio is the Co-Founding Partner of Brilliant Friends Investing, a seed investment group funding women-led businesses founded in July 2018, and a strategic advisor to several businesses with a focus on leveraging digital technology and data to drive growth. Ms. Clarizio served as Executive Vice President, Strategic Initiatives (September 2017 to January 2018) and President of U.S. Media (August 2013 to September 2017) at The Nielsen Company (US), LLC, a global performance management company that provides a comprehensive understanding of what consumers watch and buy. Prior to joining Nielsen, Ms. Clarizio served as Executive Vice President, Corporate Development and Operations of AppNexus, Inc., a programmatic advertising platform, from November 2012 to April 2013. From 2009 to 2012, Ms. Clarizio served as Chief Executive Officer and President of INVISION, Inc., a provider of multiplatform advertising solutions to the media industry. From 1999 to 2009, she held a variety of executive positions with AOL Inc., a media technology company, including President of Platform-A (AOL’s consolidated advertising businesses) and President of Advertising.com (an AOL subsidiary). Prior to joining AOL, Ms. Clarizio was a partner in the Washington, DC law firm of Arnold & Porter, where she practiced law from 1987 through 1999.

 

Other Public Company Directorships:

Emerald Holding, Inc.

Intertek Group plc

•  Taboola.com Ltd.

Selected Directorships and Positions:

   Advisory Board, Adjust GmbH

Board of Directors, OpenSlateSimpli.fi Holdings, Inc.

Board of Directors, ResonateCambri Oy

Vice-Chair, Board of Directors, Human Rights First

Leadership Council, Princeton University School of Engineering and Applied Science


 

Key Skills and Qualifications:

•  Senior Leadership

•  Public Company Board Service

•  Global

•  Technology Innovation

•  Finance, Accounting & Risk Management

•  People and Culture


Director Qualification Highlights:

   Strategic planning and leadership of complex organizations

   Technology/Digital Solutions

   Sales and Marketing

   Legal


 

PAUL J. FINNEGANANTHONY R. FOXXCompensation and Nominating and Corporate Governance Committees

INDEPENDENT

Director

since: 20112021

Age 68

51

Mr. Foxx was the seventeenth United States Secretary of Transportation from July 2013 to January 2017. Mr. Foxx also served as Chief Policy Officer and Senior Advisor to the President and Chief Executive Officer of Lyft, Inc., a transportation network in the U.S. and Canada, from October 2018 to January 2022 and served as an advisor to Lyft through the end of 2022. Prior to joining Lyft, Mr. Foxx served as a Managing Partner of Related Infrastructure, the infrastructure development group of Related Companies, a real estate firm, from December 2017 to October 2018. Mr. Foxx also served as Mayor of Charlotte, North Carolina from 2009 to 2013 and as a Charlotte City Council Member at-large representative from 2005 to 2009. Mr. Foxx also has held a variety of legal positions in the public and private sectors.

Mr. Finnegan is the Co-Chief Executive Officer of Madison Dearborn Partners, LLC, a private equity investment firm, a position he has held since 2007. Prior to co-founding Madison Dearborn in 1992, Mr. Finnegan was with First Chicago Venture Capital for ten years. Previously, he held a variety of marketing positions in the publishing industry, both in the United States and Southeast Asia.

 

Other Public Company Directorships:

   None

Selected Directorships and Positions:

   Board of Directors, AIA Corporation

   Chair, Board of Directors, Government Sourcing Solutions, LLC

   Board of Directors, Chicago Council on Global Affairs

   Treasurer, Harvard Corporation

   Chair, Board of Directors, Harvard Management Company

   Advisory Board, Teach for America Chicago-Northwest Indiana

Director Qualification Highlights:

   Strategic planning and leadership of complex organizations

   Finance

   Capital market transactions

   Board practices of other major corporations


 2021 Proxy Statement23
ANTHONY R. FOXXAudit and Nominating and Corporate Governance Committees

INDEPENDENT

Director
since: 2021

Age 49

Mr. Foxx serves as the Chief Policy Officer and Senior Advisor to the President and Chief Executive Officer of Lyft, Inc., a transportation network in the U.S. and Canada, a position he has held since October 2018. Prior to joining Lyft, Mr. Foxx served as a Managing Partner of Related Infrastructure, the infrastructure development group of Related Companies, a real estate firm, from December 2017 to October 2018. From July 2013 to January 2017, Mr. Foxx served as the seventeenth United States Secretary of Transportation. Mr. Foxx also served as Mayor of Charlotte, North Carolina from 2009 to 2013 and as a Charlotte City Council Member at-large representative from 2005 to 2009. Mr. Foxx also has held a variety of legal positions in the public and private sectors.

Other Public Company Directorships:

Martin Marietta Materials, Inc.

•  NXP Semiconductors N.V. (Director Nominee)

Former Public Company Directorships
(within the past 5 years):

•  Shelter Acquisition Corp. (Director Nominee)Corporation I

Selected Directorships and Positions:

Advisory Board, AutoTech Ventures

Director, The Volcker Alliance

Senior Fellow, Harvard University Kennedy School’s Belfer Center for Science & International Affairs

Executive in Residence, Carnegie Mellon University


 

Key Skills and Qualifications:

•  Senior Leadership

•  Public Company Board Service

•  Technology Innovation

•  Finance, Accounting & Risk Management

•  People and Culture

•  Government and Regulatory


2023 Proxy Statement29
MARC E. JONESAudit and Nominating and Corporate Governance Committees

INDEPENDENT

Director
since:
2023

Age 64

Marc Jones serves as the Chairman, President and Chief Executive Officer of Aeris Communications, Inc., a provider of machine to machine and Internet of Things communications services. Mr. Jones has served as Chairman of Aeris since 2005 and President and Chief Executive Officer of Aeris since 2008. He also served as Chairman of Visionael Corporation, a network service business software and service provider, from 2004 to 2009 and as President and Chief Executive Officer of Visionael from 1998 to 2004. Prior to joining Visionael, Mr. Jones served as President and Chief Operating Officer of Madge Networks, a supplier of networking hardware, from 1993 to 1997; Senior Vice President, Integrated System Products at Chips and Technologies, Inc., one of the first fabless semiconductor companies, from 1988 to 1992; and Senior Vice President, Corporate Finance at LF Rothschild Unterberg Towbin & Co., a merchant and investment banking firm, from 1986 to 1987.
 

Other Public Company Directorships:

•  Ingersoll Rand Inc.

Selected Directorships and Positions:

•  Chairman, Board of Directors, Aeris Communications, Inc.

•  Board of Trustees, Stanford University

•  Chairman, Board of Directors, Stanford Health Care


Key Skills and Qualifications:

•  Senior Leadership

•  Public Company Board Service

•  Global

•  Technology Innovation

•  Finance, Accounting & Risk Management

•  People and Culture

•  Government and Regulatory


CHRISTINE A. LEAHY 

Director Qualification Highlights:

   Strategic planning and leadership of complex organizationsCHAIR

   Vertical Markets (Public Sector)

   Legal

   Technology/Digital Solutions


CHRISTINE A. LEAHY

Director

since: 2019

Age 56

58

Ms. Leahy is our Chair, President and Chief Executive Officer. Ms. Leahy has served as President and Chief Executive officer since January 2019 and as Chair since January 2023. Prior to her current role, Ms. Leahy served as our Chief Revenue Officer from July 2017 to December 2018 and was responsible for all customer-facing units of the Company, including its corporate, public, small business, international and integrated technology solutions organizations. Prior to that role, Ms. Leahy served as our Senior Vice President-International from May 2016 to July 2017, where she led the development of the Company’s international strategy and was responsible for the performance of the Company’s international business. Ms. Leahy also was our Chief Legal Officer/General Counsel and Corporate Secretary from January 2002 to July 2017. Prior to joining CDW as the Company’s first general counsel, Ms. Leahy was a corporate partner in the Chicago office of Sidley Austin, an international business law firm, where she practiced law from 1991 to 2002.

Ms. Leahy is our President and Chief Executive Officer, a position she has held since January 2019. Prior to her current role, Ms. Leahy served as our Chief Revenue Officer from July 2017 to December 2018 and was responsible for all customer-facing units of the Company, including its corporate, public, small business, international and integrated technology solutions organizations. Prior to that role, Ms. Leahy served as our Senior Vice President-International from May 2016 to July 2017, where she led the development of the Company’s international strategy and was responsible for the performance of the Company’s international business. Ms. Leahy also was our Chief Legal Officer/General Counsel and Corporate Secretary from January 2002 to July 2017. Prior to joining CDW as the Company’s first general counsel, Ms. Leahy was a corporate partner in the Chicago office of Sidley Austin, an international business law firm, where she practiced law from 1991 to 2002.

 

Other Public Company Directorships:

Target Corporation

Selected Directorships and Positions:

Board of Trustees, Children’s Home & Aid

Board of Directors, Northwestern Memorial Hospital

Board of Directors, Junior Achievement of Chicago

Board of Directors, The Economic Club of Chicago


 

Key Skills and Qualifications:

•  Senior Leadership

•  Public Company Board Service

•  Global

•  Technology Innovation

•  Finance, Accounting & Risk Management

•  People and Culture

•  Government and Regulatory


2023 Proxy Statement30
 

Director Qualification Highlights:

   Strategic planning and leadership of complex organizations

   Technology/Digital Solutions

Back to Contents

   International

   Operations/Distribution


SANJAY MEHROTRACompensation (Chair) and Nominating and Corporate Governance Committees

INDEPENDENT

Director

since: 2021

Age 62

64

Mr. Mehrotra is the President and Chief Executive Officer of Micron Technology, Inc., a producer of memory and storage solutions, a position he has held since May 2017. Prior to joining Micron, Mr. Mehrotra was the President and Chief Executive Officer of SanDisk Corporation, a provider of flash storage solutions, from January 2011 until its May 2016 sale to Western Digital Corp. Mr. Mehrotra co-founded SanDisk in 1988 and held positions of increasing authority prior to his position as President and Chief Executive Officer. Prior to SanDisk, Mr. Mehrotra held design engineering positions at Integrated Device Technology, Inc., SEEQ Technology and Intel Corporation.

Mr. Mehrotra is the President and Chief Executive Officer of Micron Technology, Inc., a producer of memory and storage solutions, a position he has held since May 2017. Prior to joining Micron, Mr. Mehrotra was the President and Chief Executive Officer of SanDisk Corporation, a provider of flash storage solutions, from January 2011 until its May 2016 sale to Western Digital Corp. Mr. Mehrotra co-founded SanDisk in 1988 and held positions of increasing authority prior his position as President and Chief Executive Officer. Prior to SanDisk, Mr. Mehrotra held design engineering positions at Integrated Device Technology, Inc., SEEQ Technology and Intel Corporation.

 

Other Public Company Directorships:

Micron Technology, Inc.

 

Former Public Company Directorships (within
(within
the past 5 years):

Cavium, Inc.

   Western Digital Corp.

Sandisk Corp.

Selected Directorships and Positions:

Board of Directors, Stanford Health Care

Engineering Advisory Board, University of California, Berkeley


 

Key Skills and Qualifications:

•  Senior Leadership

•  Public Company Board Service

•  Global

•  Technology Innovation

•  Finance, Accounting & Risk Management

•  People and Culture

•  Government and Regulatory


Director Qualification Highlights:

   Strategic planning and leadership of complex organizations

   Technology/Digital Solutions

   International

   Board practices of other major corporations


 2021 Proxy Statement24

DAVID W. NELMSAudit and Nominating and Corporate Governance (Chair) Committees

CHAIRMAN
LEAD
INDEPENDENT
DIRECTOR

Director

since: 2014

Age 60

62

Mr. Nelms currently serves as the Lead Independent Director of our Board of Directors, a position he has held since January 2023. Mr. Nelms previously served as the Non-Executive Chair from January 2020 and as our Lead Independent Director from January 2019. He is the retired Chairman and Chief Executive Officer of Discover Financial Services, a direct banking and payment services company. Mr. Nelms was named Chief Executive Officer of Discover in 2004 and was elected Chairman in 2009. He retired in September 2018 and continued as Executive Chairman of Discover until December 2018 and as an advisor until March 2019. Mr. Nelms joined Discover in 1998 as President and Chief Operating Officer. Prior to joining Discover, Mr. Nelms was with MBNA America Bank from 1991 to 1998, most recently as Vice Chairman. From 1990 to 1991, Mr. Nelms was a senior product manager for Progressive Insurance and from 1986 to 1990 he was a management consultant with Bain & Company.

Mr. Nelms currently serves as the Non-Executive Chair of our Board of Directors, a position he has held since January 1, 2020. Mr. Nelms previously served as our Lead Director from January 1, 2019. He is the retired Chairman and Chief Executive Officer of Discover Financial Services a direct banking and payment services company. Mr. Nelms was named Chief Executive Officer of Discover in 2004 and was elected Chairman in 2009. He retired in September 2018 and continued as Executive Chairman of Discover until December 2018 and as an advisor until March 2019. Mr. Nelms joined Discover in 1998 as President and Chief Operating Officer. Prior to joining Discover, Mr. Nelms was with MBNA America Bank from 1991 to 1998, most recently as Vice Chairman. From 1990 to 1991, Mr. Nelms was a senior product manager for Progressive Insurance and from 1986 to 1990 he was a management consultant with Bain & Company.

 

Other Public Company Directorships:

None

 

Former Public Company Directorships (within
(within
the past 5 years):

Discover Financial Services, Inc.

Selected Directorships and Positions:

Executive Board, University of Florida Foundation

•  Board of Directors, Conserving Carolina


 

Key Skills and Qualifications:

•  Senior Leadership

•  Public Company Board Service

•  Global

•  Technology Innovation

•  Finance, Accounting & Risk Management

•  People and Culture

•  Government and Regulatory


2023 Proxy Statement31
 

Director Qualification Highlights:

   Strategic planning and leadership of complex organizations

   Finance

Back to Contents

   Technology/Digital Solutions

   Board practices of other major corporations


JOSEPH R. SWEDISHCompensation (Chair) and Nominating and Corporate Governance Committees

INDEPENDENT

Director

since: 2015

Age 69

71

Mr. Swedish is the retired Chairman, President and Chief Executive Officer of Anthem, Inc., a health benefits provider, now known as Elevance Health, Inc. Mr. Swedish served as President and Chief Executive Officer of Anthem from 2013 to November 2017, became Chairman in 2015 and became Executive Chairman in November 2017. From his retirement in May 2018 to May 2020, Mr. Swedish served as a Senior Advisor to Anthem. Prior to joining Anthem, Mr. Swedish was President and Chief Executive Officer of Trinity Health, an eighteen- state integrated health care delivery system, from 2004 to 2013. From 1993 to 2013, Mr. Swedish held CEO and senior executive leadership positions with Centura Health, Hospital Corporation of America and other healthcare enterprises. Mr. Swedish also is the co-founder and partner of Concord Health Partners, LLC, a private equity firm focused on strategic investing in healthcare portfolio companies.

Mr. Swedish is the retired Chairman, President and Chief Executive Officer of Anthem, Inc., a health benefits provider. Mr. Swedish served as President and Chief Executive Officer of Anthem from 2013 to November 2017, became Chairman in 2015 and became Executive Chairman in November 2017. From his retirement in May 2018 through May 2020, Mr. Swedish served as a Senior Advisor to Anthem. Prior to joining Anthem, Mr. Swedish was President and Chief Executive Officer of Trinity Health, an eighteen-state integrated health care delivery system, from 2004 to 2013. Mr. Swedish also has held CEO and senior leadership positions with Centura Health, Hospital Corporation of America and other healthcare enterprises. Mr. Swedish also is the co-founder and partner of Concord Health Partners, LLC, a private equity firm focused on strategic investing in healthcare portfolio companies.

 

Other Public Company Directorships:

IBM Corporation

Chair, Mesoblast Limited

 

Former Public Company Directorships (within
(within
the past 5 years):

Anthem, Inc. (now known as Elevance Health, Inc.)

•  CHP Merger Corp.

Selected Directorships and Positions:

Board of Directors, Centrexion Therapeutics Corporation

Board of Visitors, Duke University’s Fuqua School of Business


 

Key Skills and Qualifications:

•  Senior Leadership

•  Public Company Board Service

•  Technology Innovation

•  Finance, Accounting & Risk Management

•  People and Culture

•  Government and Regulatory


Director Qualification Highlights:

   Strategic planning and leadership of complex organizations

   Technology/Digital Solutions

   Vertical Markets (Healthcare)

   Board practices of other major corporations


 

DONNA F. ZARCONEAudit and Nominating and Corporate Governance Committees

INDEPENDENT

Director

since: 2011

Age 63

65

Ms. Zarcone is the retired President and Chief Executive Officer of The Economic Club of Chicago, a civic and business leadership organization, a position she held from February 2012 to July 2020. Ms. Zarcone served as Interim President of The Economic Club of Chicago from October 2011 to February 2012. From January 2007 to February 2012, she served as the President and Chief Executive Officer of D.F. Zarcone & Associates LLC, a strategy advisory firm that she founded. Prior to founding D.F. Zarcone & Associates, Ms. Zarcone was President and Chief Operating Officer of Harley-Davidson Financial Services, Inc., a provider of wholesale and retail financing, credit card and insurance services for dealers and customers of Harley-Davidson. After joining Harley-Davidson Financial Services, Inc. in 1994 as Vice President and Chief Financial Officer, Ms. Zarcone was named President and Chief Operating Officer in 1998 and served in that role until 2006. Prior to joining Harley-Davidson Financial Services, Inc., Ms. Zarcone served as Executive Vice President, Chief Financial Officer and Treasurer of Chrysler Systems Leasing, Inc. from 1982 to 1994 and in various management roles at KPMG/Peat Marwick from 1979 to 1982. Ms. Zarcone is a certified public accountant and holds a Certificate in Cybersecurity Oversight from Carnegie Mellon University.

Ms. Zarcone is the retired President and Chief Executive Officer of The Economic Club of Chicago, a civic and business leadership organization, a position she held from February 2012 to July 2020. Ms. Zarcone served as Interim President of The Economic Club of Chicago from October 2011 to February 2012. From January 2007 to February 2012, she served as the President, CEO and founder of D.F. Zarcone & Associates LLC, a strategy advisory firm. Prior to founding D.F. Zarcone & Associates, Ms. Zarcone was President and Chief Operating Officer of Harley-Davidson Financial Services, Inc., a provider of wholesale and retail financing, credit card and insurance services for dealers and customers of Harley-Davidson. After joining Harley-Davidson Financial Services, Inc. in 1994 as Vice President and Chief Financial Officer, Ms. Zarcone was named President and Chief Operating Officer in 1998 and served in that role until 2006. Prior to joining Harley-Davidson Financial Services, Inc., Ms. Zarcone served as Executive Vice President, Chief Financial Officer and Treasurer of Chrysler Systems Leasing, Inc. from 1982 through 1994 and in various management roles at KPMG/Peat Marwick from 1979 through 1982. Ms. Zarcone is a certified public accountant and holds a Certificate in Cybersecurity Oversight from Carnegie Mellon University.

 

Other Public Company Directorships:

Cigna Corporation

Selected Directorships and Positions:

Board of Managers, Duchossois Capital Management

•  Board of Directors, The Duchossois GroupQuinnox

Advisory Board, of Directors, The University of Chicago Polsky Center for Entrepreneurship and Innovation

National Board of the Smithsonian Institution

   Governance Fellow and Directorship Certification, National Association of Corporate Directors


 

Key Skills and Qualifications:

•  Senior Leadership

•  Public Company Board Service

•  Global

•  Technology Innovation

•  Finance, Accounting & Risk Management

•  People and Culture


Director Qualification Highlights:

   Strategic planning and leadership of complex organizations

   Finance

   National and global economic and business trends

   Board practices of other major corporations


2023 Proxy Statement32

 2021 Proxy Statement25
 

DIRECTOR COMPENSATION

Director Compensation

 

Elements of Director Compensation

 

In 2020,2022, each non-employee director received annual compensation in the form of a $102,500 annual$112,500 cash retainer and a $152,500$177,500 restricted stock unit award, as well as additional retainers for committee chairs, which remained the samechairs. During 2022, David W. Nelms served as compared to the 2019 non-employee director compensation program. In 2020, after considering the inputChairman of the Compensation Committee’s independent compensation consultant, we modified our non-employee director compensation program to includeBoard. Mr. Nelms received an additional annual restricted stock unit award of $150,000 for service as our Chairman. Our Chairman also serves as Chair of the Nominating and Corporate Governance Committee, but did not receive an additional Chair retainer for that service in 2020. Christine A. Leahy, our President and Chief Executive Officer and a director in 2022, did not receive any additional compensation for serving as a director in 2020.director. Please see the “2022 Summary compensation Table” for the compensation received by Ms. Leahy with respect to 2022.

 

 

All cash retainers are paid quarterly in arrears and, if applicable, are prorated based upon Board or chair service during the calendar year. Board members may defer cash retainers under the CDW Director Deferred Compensation Plan. Amounts credited to the CDW Director Deferred Compensation Plan will be notionally invested, as elected by the director, in the same investment options as available under the Company’s coworker 401(k) plan.

 

The annual Board and Chairman restricted stock unit grants vest on the first anniversary of the grant date and entitle the director to receive shares of our common stock upon vesting, subject to deferral in five-year increments. In the year of appointment to the Board, a director receives a prorated portion of the annual restricted stock unit grant value based upon the number of months between appointment and the vesting date of the most recent annual grant to incumbent directors, which prorated award vests on the same vesting date as the most recent annual grant to incumbent directors. The annual Board restricted stock unit grant vests on a prorated basis if a director does not stand for re-election or is not re-nominated for election at an annual meeting during the vesting period. The annual Chairman restricted stock unit grant vests on a prorated basis if service as Chairman terminates.

 

Director Compensation Review

In 2021, the Nominating and Corporate Governance Committee, in consultation with the Compensation Committee, reviewed the design and competitiveness of our non-employee director compensation program. The Nominating and Corporate Governance Committee considered input from the Compensation Committee’s independent compensation consultant and market data for the 2021 peer group of companies that the Compensation Committee used for determining executive compensation. Upon review, the Nominating and Corporate Governance Committee determined that the design of the Company’s non-employee director compensation program continued to be aligned with market trends, but the total compensation was below the median of the peer group. The Nominating and Corporate Governance Committee approved the following increases for 2022 to further align director compensation with the market median range: (1) the cash retainer for Board service was increased by $10,000 to $112,500; (2) the Compensation Committee Chair retainer was increased by $5,000 to $20,000; and (3) the annual restricted stock unit grant value was increased by $25,000 to $177,500. The Nominating and Corporate Governance Committee also approved the deferral of Board cash retainers under the CDW Director Deferred Compensation Plan commencing in 2022.

2023 Proxy Statement33

Lead Independent Director and Nominating and Corporate Governance Committee Chair Compensation

David W. Nelms served as our Chairman of the Board in 2022 and was appointed as Lead Independent Director effective January 1, 2023 upon the election of Christine A. Leahy as our Chair of the Board. Mr. Nelms also serves as Chair of the Nominating and Corporate Governance Committee. In the beginning of 2023, the Nominating and Corporate Governance Committee, in consultation with the Compensation Committee, approved (1) an additional annual restricted stock unit award of $35,000 for the Lead Independent Director, subject to the same terms as the annual restricted stock unit award for all Board members and with vesting on a prorated basis if service as Lead Independent Director terminates and (2) a $15,000 annual cash retainer for the Chair of the Nominating and Corporate Governance Committee. In determining this compensation, the Nominating and Corporate Governance Committee considered input from the Compensation Committee’s independent compensation consultant and market data for the peer group of companies that the Compensation Committee uses for evaluating executive compensation as set forth in the “Compensation Discussion and Analysis - Comparison to Relevant Peer Group” section of this proxy statement.

Stock Ownership Guidelines

 

The Board believes that in order to more closely align the interests of directors with the interests of the Company’s other stockholders, each non-employee director should maintain a minimum level of equity interests in the Company’s common stock. The Nominating and Corporate Governance Committee is responsible for periodically reviewing the stock ownership guidelines for non-employee directors and making recommendations to the Board.

 

Pursuant to our Corporate Governance Guidelines, each non-employee director must hold equity interests in the Company’s common stock equal to at least five times the Board’s annual cash retainer. Until such guidelines are met, a director is required to retain 100% of the after-tax value of all vested equity awards earned under the Company’s non-employee director compensation program. As of the record date for the Annual Meeting, all of our non-employee directors were in compliance with the Company’s stock ownership guidelines.

 

WHAT COUNTS
TOWARD THE GUIDELINE
 2021WHAT DOES NOT COUNT
TOWARD THE GUIDELINE
Shares owned by the director, immediate family or director trustUnvested restricted stock units
Vested restricted stock units for which settlement has been deferred

2023 Proxy Statement2634
 

Hedging, Short Sales and Pledging Policies

Our directors are prohibited from hedging and short sales transactions with respect to our securities. In addition, our directors are prohibited from pledging our securities except in limited circumstances with pre-approval. For a further description of these policies, please see “Corporate Governance – Hedging, Short Sales and Pledging Policies.”

2020

2022 Director Compensation Table

 

The table below summarizes the compensation paid by the Company to our non-employee directors for the fiscal year ended December 31, 2020.2022.

 

Name Fees earned
or paid in cash
($)
  Stock Awards
($)(1)(2)
  Total
($)
Virginia C. Addicott 122,500  152,500  275,000
Steven W. Alesio 108,351(3)  152,500  260,851
Barry K. Allen 102,500  152,500  255,000
James A. Bell 102,500  152,500  255,000
Benjamin D. Chereskin 102,500  152,500  255,000
Lynda M. Clarizio 102,500  152,500  255,000
Paul J. Finnegan(4) 102,500  152,500  255,000
David W. Nelms 102,500  302,500(5)  405,000
Joseph R. Swedish 111,648(3)  152,500  264,148
Donna F. Zarcone 102,500  152,500  255,000
Name Fees Earned
or Paid in Cash
($)
  Stock
Awards
($)(1)(2)
  Total
($)
Virginia C. Addicott(3)  125,054   177,500   302,554
James A. Bell(3)  119,946   177,500   297,446
Lynda M. Clarizio  112,500   177,500   290,000
Paul J. Finnegan(4)  112,500   177,500   290,000
Anthony R. Foxx  112,500   177,500   290,000
Sanjay Mehrotra  112,500   177,500   290,000
David W. Nelms  112,500   327,500   440,000
Joseph R. Swedish  132,500   177,500   310,000
Donna F. Zarcone  112,500   177,500   290,000
(1)Stock Awards. The amounts reported represent the grant date fair value of restricted stock units granted in 2020,2022, calculated based on the closing stock price on the date of grant in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation-Stock Compensation (“ASC 718”). Mr. Nelms’ service as Chairman of our Board ended on December 31, 2022, at which time he became Lead Independent Director. The 2022 Chairman restricted stock units granted to Mr. Nelms in 2022 vested on a pro-rated basis for his service as Chairman through December 31, 2022 in accordance with the terms of the underlying award agreement.
(2)Outstanding Stock Awards.The following table summarizes outstanding stock awards held by each above director on December 31, 2020,2022, including restricted stock units onfor which settlement has been deferred and restricted stock units acquired through the deemed reinvestment of dividend equivalents:
Name 
NameRestricted Stock
Units Outstanding


(#)
Virginia C. Addicott11,251
Steven W. Alesio11,207
Barry K. Allen20,30613,552
James A. Bell14,516
Benjamin D. Chereskin7,59316,888
Lynda M. Clarizio1,5741,048
Paul J. Finnegan5,1486,308
Anthony Foxx2,254
Sanjay Mehrotra2,042
David W. Nelms21,85326,263
Joseph R. Swedish1,5742,057
Donna F. Zarcone20,30618,057
(3)
(3)Each of Mr. AlesioMs. Addicott and Mr. Swedish received a prorated CompensationBell each served as Audit Committee Chair retainer, based upon services as Chair for a portion of 2020.2022 and received pro-rated fees for such service.
(4)In 2020,2022, Mr. Finnegan’s cash compensation for Board service was paid to Madison Dearborn Partners, LLC.
(5)Includes the additional $150,000 award for service as Chairman during 2020, as described above.

 

 20212023 Proxy Statement2735
 

STOCK OWNERSHIP

Stock Ownership

 

Ownership of Our Common Stock

The following tables show information regarding the beneficial ownership of our common stock by:

 

each member of our Board of Directors, each director nominee and each of our named executive officers;
all members of our Board and our executive officers as a group; and
each person or group who is known by us to own beneficially more than 5% of our common stock.

 

Beneficial ownership of shares is determined under the rules of the SEC and generally includes any shares over which a person exercises sole or shared voting or investment power. Shares of common stock subject to options currently exercisable or exercisable within 60 days of March 1, 20212023, and restricted stock units that are currently vested but deferred or that will be settled into sharesvesting within 60 days as of March 1, 20212023, including vested restricted stock units for which settlement has been deferred, are deemed to be outstanding and beneficially owned by the person. Except as noted by footnote, and subject to community property laws

where applicable, we believe based on the information provided to us that the persons and entities named in the table below have sole voting and investment power with respect to all shares of our common stock shown as beneficially owned by them.

 

Except as otherwise indicated, all stockholdings are as of March 1, 20212023, and the percentage of beneficial ownership is based on 141,095,448134,454,209 shares of common stock outstanding as of March 1, 2021.2023.

 

Directors and Executive Officers

 

Name Aggregate

Number of

Shares

Beneficially


Owned
 Percent of

Outstanding


Shares
 Additional Information
Christine A. Leahy 354,440488,414 * Includes 264,543405,592 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2021.2023. Also includes 17,250 shares indirectly held by the Christine A. Leahy Gift Trust for the benefit of the reporting person’s children.
Collin B. KeboAlbert J. Miralles 141,14223,762 * Includes 99,43210,882 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2021.
Sona Chawla17,915*Includes 17,276 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2021.
Christina M. Corley242,594*Includes 194,859 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2021.
Douglas E. Eckrote183,972*Includes 118,505 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2021.
Mark C. Chong87,345*Includes 67,826 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2021.
Elizabeth H. Connelly13,220*Includes 12,829 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2021.
Virginia C. Addicott11,251*Includes 11,2512023 and 8,082 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021.2023.
Steven W. AlesioSona Chawla 20,19797,837 * Includes 7,67785,872 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2023.
Christina M. Corley322,567*Includes 260,031 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2023.
Frederick J. Kulevich77,651*Includes 57,813 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2023.
Virginia C. Addicott13,552*Includes 13,552 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021.2023.
Barry K. AllenJames A. Bell 34,13320,473 * Includes 20,30616,888 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021. Also includes 1,854 shares held by Allen Enterprises LLC, a limited liability company of which Mr. Allen is the sole member.2023.
James A. BellLynda M. Clarizio 18,10111,964 * Includes 14,5161,048 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021.2023.
Paul J. Finnegan23,589*Includes 6,308 restricted stock units that are currently vested or vesting within 60 days of March 1, 2023. Also includes 8,141 shares indirectly owned by Glen Lake Partners L.P. Mr. Finnegan is the trustee of Glen Lake Partners Management Trust I, a general partner of Glen Lake Partners, L.P. Mr. Finnegan’s wife, Mary M. Finnegan, is the trustee of Glen Lake Partners Management Trust II, the other general partner of Glen Lake Partners.
Anthony R. Foxx2,254*Includes 2,254 restricted stock units that are currently vested or vesting within 60 days of March 1, 2023.
Marc E. Jones145*Includes 145 restricted stock units that are currently vested or vesting within 60 days of March 1, 2023.
Sanjay Mehrotra2,042*Includes 2,042 restricted stock units that are currently vested or vesting within 60 days of March 1, 2023.

 

 20212023 Proxy Statement2836
 
NameAggregate
Number of Shares
Beneficially
Owned
Percent of
Outstanding
Shares
Additional Information
David W. Nelms26,132*Includes 26,132 restricted stock units that are currently vested or vesting within 60 days of March 1, 2023.
Joseph R. Swedish14,614*Includes 2,057 restricted stock units that are currently vested or vesting within 60 days of March 1, 2023.
Donna F. Zarcone18,057*Includes 18,057 restricted stock units that are currently vested or vesting within 60 days of March 1, 2023.
All directors and executive officers as a group (16 persons)1,143,054*Includes 96,566 restricted stock units that are currently vested or vesting within 60 days of March 1, 2023. Also includes 820,190 shares subject to options currently exercisable or exercisable within 60 days of March 1, 2023.
Name Aggregate
Number of
Shares
Beneficially
Owned
 Percent of
Outstanding
Shares
 Additional Information
Benjamin D. Chereskin 209,476 * Includes 7,593 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021. Also includes 175,163 shares held by the Chereskin Family Dynasty Trust and 6,936 shares held by the Benjamin D. Chereskin Dynasty Trust which are deemed to be beneficially owned by Mr. Chereskin.
Lynda M. Clarizio 10,488 * Includes 1,574 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021.
Paul J. Finnegan 23,797 * Includes 5,148 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021. Also includes 8,141 shares indirectly owned by Glen Lake Partners LP. Mr. Finnegan is the trustee of Glen Lake Partners Management Trust I, a general partner of Glen Lake Partners, L.P. Mr. Finnegan’s wife, Mary M. Finnegan, is the trustee of Glen Lake Partners Management Trust II, the other general partner of Glen Lake Partners, L.P.
Anthony R. Foxx 193 * Appointed to the Board on January 1, 2021. Includes 193 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021.
Sanjay Mehrotra   Appointed to the Board on March 24, 2021.
David W. Nelms 21,853 * Includes 21,853 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021.
Joseph R. Swedish 12,553 * Includes 1,574 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021.
Donna F. Zarcone 27,312 * Includes 20,306 restricted stock units that are currently vested or vesting within 60 days of March 1, 2021.
All directors and executive officers as a group (20 persons) 1,477,042 1.04% Includes 111,991 restricted stock units held by directors that are currently vested or vesting within 60 days of March 1, 2021. Also includes 803,589 shares subject to options held by executive officers currently exercisable or exercisable within 60 days of March 1, 2021.
*Denotes less than 1.0%

 2021 Proxy Statement29

Principal Stockholders

Name Aggregate
Number of Shares
Beneficially Owned
 Percent of
Outstanding Shares
The Vanguard Group(1)
100 Vanguard Boulevard
Malvern, Pennsylvania 19355
 16,238,051 12.1%
BlackRock, Inc.(2)
55 East 52nd Street
New York, New York 10055
 10,689,019 7.9%
Select Equity Group, L.P.(3)
George S. Loening
380 Lafayette Street
6th Floor
New York, New York 10003
 6,780,830 5.0%

Principal Stockholders

Name Aggregate Number of Shares
Beneficially Owned
 Percent of
Outstanding Shares
The Vanguard Group(1) 15,882,926 11.11%
100 Vanguard Boulevard    
Malvern, Pennsylvania 19355    
BlackRock, Inc.(2) 9,694,947 6.8%
55 East 52nd Street    
New York, New York 10055    
Wellington Management Group LLP 8,062,092 5.64%
Wellington Investment Advisors Holdings LLP    
Wellington Group Holdings LLP(3)    
c/o Wellington Management Company LLP    
280 Congress Street    
Boston, Massachusetts 02210    
Select Equity Group, L.P. 7,460,535 5.22%
George S. Loening(4)    
380 Lafayette Street    
6th Floor    
New York, New York 10003    
(1)This information is based on a Schedule 13G/A filed by The Vanguard Group with the SEC on February 10, 20219, 2023 reporting beneficial ownership as of December 31, 2020.30, 2022. The Vanguard Group reported that it has shared voting power with respect to 249,524202,251 shares of our common stock, sole dispositive power with respect to 15,241,83415,666,959 shares of our common stock and shared dispositive power with respect to 641,092571,092 shares of our common stock.
(2)This information is based on a Schedule 13G/A filed by BlackRock, Inc. with the SEC on January 29, 2021February 3, 2023 reporting beneficial ownership as of December 31, 2020.2022. BlackRock, Inc. reported that it has sole voting power with respect to 8,589,6499,694,397 shares of our common stock and sole dispositive power with respect to 9,694,94710,689,019 shares of our common stock.
(3)This information is based on a Schedule 13G filed by Wellington Management Group LLP, Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP (collectively, “Wellington Group”) with the SEC on February 3, 2021 reporting beneficial ownership as of December 31, 2020. The Wellington Group reported that it has shared voting power with respect to 7,158,912 shares of our common stock and shared dispositive power with respect to 8,062,092 shares of our common stock.
(4)This information is based on a Schedule 13G13G/A filed by Select Equity Group, L.P. and George S. Loening with the SEC on February 12, 202114, 2023 reporting beneficial ownership as of December 31, 2020.2022. George S. Loening is the majority owner of Select Equity Group, L.P. and managing member of its general partner. Select Equity Group, L.P. and George S. Loening reported that they have shared voting power with respect to 7,460,5356,780,830 shares of our common stock and shared dispositive power with respect to 7,460,5356,780,830 shares of our common stock.

 

Delinquent Section 16(a) Reports

Our directors, executive officers, and owners of more than 10% of our common stock must file reports with the SEC under Section 16(a) of the Exchange Act regarding their ownership of and transactions in our common stock and securities related to our common stock. Based upon a review of these reports and inquiries we have made, we believe that all reports required to be filed by our directors, executive officers and holders of more than 10% of our common stock pursuant to Section 16(a) of the Exchange Act since January 1, 2020, were filed on a timely basis except that one transaction, relating to the withholding of shares to cover taxes incurred in connection with the vesting of a restricted stock unit award granted to Sona Chawla, our Chief Growth and Innovation Officer, was not timely reported on a Form 4 due to administrative error by the Company.

 20212023 Proxy Statement3037
 

PROPOSAL 2—2

Advisory Vote to Approve Named Executive Officer Compensation

 

We are offering our stockholders an opportunity to cast an advisory vote to approve the compensation of our named executive officers, as disclosed in this proxy statement, pursuant to Section 14A of the Exchange Act (commonly referred to as a “say-on-pay” vote). Although the vote is non-binding, we value continuing and constructive feedback from our stockholders on compensation and other important matters and we expect to hold this vote on an annual basis for the foreseeable future.future (see “Proposal 3 - Advisory Vote on the Frequency of the Advisory Vote to Approve Named Executive Officer Compensation” in this proxy statement). The Board of Directors and the Compensation Committee will consider the voting results when making future compensation decisions. At our 20202022 Annual Meeting of Stockholders, approximately 96%94% of the votes cast by our stockholders approved the compensation of our named executive officers as disclosed in the 20202022 proxy statement.

 

In deciding how to vote on this proposal, we encourage you to review the “Compensation Discussion and Analysis” and “2020“2022 Executive Compensation” sections of this proxy statement for a detailed description of our executive compensation program.

 

As described in the Compensation Discussion and Analysis, the Compensation Committee has designed our executive compensation program with the objective of driving sustained meaningful profitable growth and stockholder value creation through its focus on three long-standing CDW compensation philosophies:

 

Pay for Performance.A significant percentage of an executive’s compensation should be directly aligned with Company performance, with a balance between short-term and long-term performance.
Align with Stockholder Interests.Executives’ interests should be aligned with stockholder interests through the risks and rewards of CDW equity ownership.
Attract and Retain the Right Talent.Executive compensation should be market-competitive in order to attract and retain highly motivated talent with a performance- and service-driven mindset.
PROPOSAL 2: The Board of Directors recommends a voteTHE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR approval on an advisory basis of the compensation of our named executive officers as disclosed in the Compensation Discussion and Analysis, the Summary Compensation Table and the other related disclosure and tables in this proxy statement. APPROVAL ON AN ADVISORY BASIS OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE COMPENSATION DISCUSSION AND ANALYSIS, THE SUMMARY COMPENSATION TABLE AND THE OTHER RELATED DISCLOSURE AND TABLES IN THIS PROXY STATEMENT.

 

 20212023 Proxy Statement3138
 

COMPENSATION DISCUSSION AND ANALYSIS

Compensation Discussion and Analysis

 

OUR NAMED EXECUTIVE OFFICERS

Our Named Executive Officers

 

 NameTitle
Christine A. LeahyPresident and Chief Executive Officer
 Collin B. KeboAlbert J. MirallesSenior Vice President and Chief Financial Officer
 Sona ChawlaChief Growth and Innovation Officer
 Christina M. CorleyChief Commercial and Operating OfficerFrederick J. Kulevich
Chair, President and
Chief Executive Officer
Douglas E. Eckrote*Senior Vice President – Small Business Sales and eCommerce
Chief Financial Officer
 Mark C. Chong*Chief Growth and
Innovation Officer
Chief Commercial and
Operating Officer
Senior Vice President, – Strategy and Marketing
Elizabeth H. ConnellySenior Vice President – Coworker Services
General Counsel &
Corporate Secretary
*During 2020, the Board re-assessed the composition of the Section 16 reporting group and determined that the positions held by Messrs. Chong and Eckrote would cease to be Section 16 reporting positions. Under SEC executive compensation disclosure rules, Messrs. Chong and Eckrote are considered Named Executive Officers for 2020.

 

Our Compensation Discussion and Analysis (“CD&A&A”) is divided into three sections:

 

Overview20202022 Business Highlights
 Long-Term Performance
Our COVID-19 Response
 Our Executive Compensation Program
 Our Executive Compensation Practices
 20202022 Say-on-Pay Vote
What We Pay andAnd Why20202022 Executive Compensation Decisions
 Alignment of Executive Compensation Program with Operational Performance and Stakeholder Interests
 Base Salary
 Annual Cash Incentive Awards
 Long-Term Incentive Program
 Other Elements of Our 20202022 Executive Compensation Program
How We Make Executive
Compensation Decisions
Our Executive Compensation Philosophies and Objectives
Role of the Board, Compensation Committee and our Executive Officers
 Guidance from Independent Compensation Consultant
 Comparison to Relevant Peer Group

 

 20212023 Proxy Statement3239
 

OVERVIEW

Overview

 

2020

2022 Business Highlights

 

Our 20202022 performance demonstrated the balance and strengthpower of our business model when coupled with our broad and strategy asdeep portfolio of technology solutions, and reinforced the diversitystrength of our customer end-markets and broad solutions portfolio enabled usstrategy.

Percentages are year-over-year. See Appendix A for a reconciliation of each non-GAAP financial measure to outperform the market while continuing to invest in our future despite the unprecedented challenges created by the COVID-19 pandemic as discussed below.most directly comparable GAAP measure.

 

For additional information regarding 20202022 business highlights, please see the “Proxy Summary.”

 

Long-Term Performance

 

Over the past 5 years, our cumulative total shareholder return has outpaced the S&P 500 Index, the S&P 500 Information Technology Index, and our 20202022 compensation peer group set forth below inunder “Comparison to Relevant Peer Group”,Group,” and we have returned $3.1$4.1 billion to shareholders through dividends and share repurchases.repurchases over that time period.

 

 

(1)The cumulative total shareholder return chart compares the cumulative total shareholder return, including reinvestment of dividends, on $100 invested in CDW common stock for the period from market close on December 31, 20152017 through market close on December 31, 2020,2022, with the cumulative total return for the same time period of the same amount invested in the S&P 500 Index, the S&P 500 Information Technology Index and our 20202022 compensation peer group set forth below inunder “Comparison to Relevant Peer Group .”Group”.

 

Our COVID-19 Response

The COVID-19 pandemic created global economic disruption, uncertainty and business challenges. At the beginning of the pandemic, we identified three key principles, which have guided us. First, safeguard the health and well-being of our coworkers, second, serve the mission-driven needs of our customers, and third, support our communities. Examples of actions that we took to support these key principles are described in further detail on page 10 of this proxy statement.

 20212023 Proxy Statement3340
 

Our team has done an outstanding job of maintaining the high level of customer service we are known for, while safeguarding our coworkers and supporting our communities. In recognition of this outstanding performance, during 2020, we paid multiple spot bonuses to front-line coworkers and a stipend to coworkers to help them with the financial challenges of the pandemic. In addition, all coworkers on variable compensation plans received an upward modification to the 2020 formulaic bonuses, consistent with the approach used for the Company’s Named Executive Officers. All coworkers not on a variable compensation or bonus plan also received a one-time $500 bonus to recognize their contributions to our success. Providing bonuses or other performance payouts beyond what our plans would dictate is an extraordinary step for us as we have historically relied on the formulaic payout structure of our program design. We determined that these additional across-the-board adjustments were appropriate to recognize the outstanding efforts of our coworkers during 2020 in safeguarding and fortifying our business, delivering above-market results and continuing to transform and build for our future.

Our Executive Compensation Program

 

Our executive compensation program is designed to drive above-market results andresults. The program is built upon our performance-driven culture and long-standing executive compensation philosophies and objectives, as described below under “Our Executive Compensation Philosophies and Objectives,” which we believe have been key contributors to our long-term success. The table below outlines each of the principal elements of the Company’s executive compensation program:

 

 

*Because this chart illustrates the principal annual elements of the Company’s executive compensation program, this chart excludes the sign-on inducement compensation delivered to Ms. Chawla in the form of restricted stock units (“RSU”) and a cash sign-on award. Please see the “Employment Arrangements” section of this CD&A for further detail.

 2021 Proxy Statement34

The chart belowto the right illustrates the pay-for-performance design of our 20202022 executive compensation program. For 2020,2022, approximately 86%90% of the target compensation of our Chair, President and Chief Executive Officer was variable and is realized only if the applicable financial performance goals are met and/or our stock price increases.

 

 

2023 Proxy Statement41

Our Executive Compensation Practices

 

The Compensation Committee reviews on an ongoing basis the Company’s executive compensation program to evaluate whether it supports the Company’s executive compensation philosophies and objectives and is aligned with stockholder interests. Our executive compensation practices include the following, each of which the Compensation Committee believes reinforces our executive compensation objectives:

 

Our Executive Compensation PracticesOUR EXECUTIVE COMPENSATION PRACTICES
Significant percentage of target annual compensation delivered in the form of variable compensation tied to performanceWe do not have 280G tax gross-ups    
Long-term objectives aligned with the creation of stockholder valueWe do not have an enhanced severance multiple upon a change in control
Target total compensation at the competitive market medianWe do not have excessive severance benefits  
 Market comparison of executive compensation against a relevant peer group We do not pay dividends or dividend equivalents on unearned equity awards under our long-term incentive plan
Use of an independent compensation consultant reporting directly to the Compensation Committee and providing no other services to the Company
Double-trigger vesting for equity awards in the event of a change in control under our long-term incentive plan
Robust stock ownership guidelines
Clawback policy
Annual say-on-pay vote
Limited perquisites
 
We do not have tax gross-ups*
We do not have an enhanced severance multiple upon a change in control
We do not have excessive severance benefits
We do not pay dividends or dividend equivalents on unearned performance-based awards under our long-term incentive plan
We do not allow repricing of underwater stock options under our long-term incentive plan without stockholder approval
Double-trigger vesting for equity awards in the event of a change in control under our long-term incentive planWe do not allow hedging or short sales of our securities, and we do not allowrestrict pledging of our securities except in limited circumstances with pre-approval
 Robust stock ownership guidelines  
*Clawback policyExcludes tax reimbursements with respect to customary relocation benefits and tax reimbursements made to Mr. Kebo in connection with an expatriate assignment prior to his appointment as an executive officer, consistent with
Annual say-on-pay vote
Limited perquisites
Annual equity awards are granted following the release of the Company’s standard practices for expatriate assignments.annual earnings report
   

 

2022 Say-on-Pay Vote

As noted above, in its compensation review process, the Compensation Committee considers whether the Company’s executive compensation program is aligned with the interests of the Company’s stockholders. Our stockholders have overwhelmingly supported our executive compensation program, with an average approval of approximately 97% of the votes cast for the Company’s say-on-pay vote at the annual meetings of stockholders since our IPO in 2013. As part of its review of the Company’s executive compensation program, the Compensation Committee considered the approval by approximately 94% of the votes cast for the Company’s say-on-pay vote at our 2022 Annual Meeting of Stockholders. The Compensation Committee determined that the Company’s executive compensation philosophies and objectivesand compensation elements continued to be appropriate and did not make any changes to the Company’s executive compensation program in response to the 2022 say-on-pay vote.

 20212023 Proxy Statement3542
 
2020 Say-on-Pay Vote
As noted above, in its compensation review process, the Compensation Committee considers whether the Company’s executive compensation program is aligned with the interests of the Company’s stockholders. Since our IPO in 2013, our stockholders have overwhelmingly supported our executive compensation program, with an average approval of 97% of the votes cast for the Company’s say-on-pay vote at the annual meetings of stockholders since our IPO. As part of its review of the Company’s executive compensation program, the Compensation Committee considered the approval by approximately 96% of the votes cast for the Company’s say-on-pay vote at our 2020 Annual Meeting of Stockholders. The Compensation Committee determined that the Company’s executive compensation philosophies and objectives and compensation elements continued to be appropriate and did not make any changes to the Company’s executive compensation program in response to the 2020 say-on-pay vote.
 

What We Pay and Why

 

WHAT WE PAY AND WHY

20202022 Executive Compensation Decisions

 

Consistent with our pay-for-performance philosophy and executive compensation program objectives described below, under “Our Executive Compensation Philosophies and Objectives,” in determining the 20202022 pay mix and target executive compensation levels and the mix of compensation elements for each Named Executive Officer, the Compensation Committee and our Chair, President and Chief Executive Officer (in making recommendations regarding Named Executive Officer compensation other than her own) considered, as applicable, applicable:

each Named Executive Officer’s prior performance, Company performance, tenure and leadership, including leadership on ESG initiatives, including those related to diversity, equity and inclusion;
Company performance;
the compensation levels paid to similarly situated executive officers at the Company;
the competitive median of the market to provide a perspective on external practices, with adjustments made to more closely align compensation with the median of the market data for executives with similar positions; and
input from the Compensation Committee’s independent compensation consultant.

Specifically, with respect to 2022, compensation adjustments were driven by a particularly strong labor market and the Company’s desire to invest in a transformative leadership team and make compensation levels paiddecisions to similarly situatedsupport the Company’s executive officers at the Company, the competitive median of the market to provide a perspective on external practices, and input fromsuccession planning strategy. In determining compensation adjustments, the Compensation Committee’s independent compensation consultant. Finally, consistentCommittee took actions to further emphasize the Company’s long-term strategy, enhance talent retention, and bolster alignment between management and investors.

Consistent with the Company’s long-standing compensation philosophy, a significant portion of aligning executive officers’each Named Executive Officer’s 2022 annual target cash compensation was at risk to provide a strong connection between pay and performance and a majority of total target direct compensation was delivered in the form of long-term incentive awards to align the Named Executive Officers’ interests with stockholders through the risks and rewards of equity ownership and to further support the Compensation Committee allocated the majorityexecution of the total target direct compensation increases to the Named Executives Officers’ target equity grant levels.Company’s long-term strategy.

 

Alignment of Executive Compensation Program with Operational Performance and Stakeholder Interests

 

Our executive compensation program is designed to drive sustained meaningful profitable growth and stockholder value creation by paying-for-performance, aligning with stockholder interests through the risks and rewards of CDW equity ownership and attracting and retaining the right talent. A fundamental design of our executive compensation program is to align all members of senior management around common performance goals. The Compensation Committee selects performance goals that it believes are core drivers of the Company’s performance and success and are aligned with the interests of our various stakeholders, including coworkers, customers, partners and stockholders. By using performance goals under the Company’s incentive programs that are based on operating income, earnings per share and free cash flow, as adjusted in accordance with the terms of the awards, as well as market share gains, the Compensation Committee believes that the program reflects an appropriate balance with respect to incentivizing top-line growth, profitability and cash flow generation. 

To drive performance against these program goals, when communicating the goals to the senior management team, the Company includes extensive communications on what members of senior management, together with their teams, can do on a daily basis to impact achievement of these goals. We believe this understanding of the link between individual/team performance and the achievement of the Company’s performance goals helps the entire organization focus on those actions that have the greatest potential to drive sustained meaningful profitable growth and stockholder value creation.

 

While the Compensation Committee’s practice has been to establish and communicate goals at the beginning of each year, the Compensation Committee also retains flexibility to modify the Company’s executive compensation program when circumstances warrant in order to continue to drive operational performance and attract and retain key talent. Consistent with our prior annual incentive design, the Compensation Committee set the original goals based on assumptions about the IT market and the broader economy at the time

 20212023 Proxy Statement3643
 

the goals were set. While the Company always experiences unforeseen events and deviations from the assumptions used to set targets, the pandemic drove unprecedented disruption, such as instantaneous and extreme shifts in customer demand and working methods and conditions. In light of the broad and severe impact of the COVID-19 pandemic across all industries and the lack of visibility into the extent or duration of the pandemic, the Compensation Committee determined that it was extremely important to retain flexibility to determine 2020 compensation in order to allow the Company to reward results that had become more relevant to the business as the year progressed. Accordingly, with respect to 2020 the Compensation Committee incorporated additional performance factors to be considered by the Compensation Committee when determining 2020 compensation. These additional performance factors were designed to help the Company manage the severe impact of the pandemic and emerge even stronger, with a focus on safeguarding and fortifying our business, delivering above-market results and continuing to transform and build for our future. The Compensation Committee believes that maintaining this flexibility and administering it in a structured manner allowed the Company to appropriately adapt to the broad and severe impact of the COVID-19 pandemic, to reward performance in areas deemed critical to the Company’s long-term strategy and to position the Company to continue to deliver stockholder value in the future.

Base Salary

 

Base Salary

The Compensation Committee generally sets base salaries for executives, including our Named Executive Officers, below the competitive market median of salaries for executives in similar positions. Aligned with our compensation philosophies and objectives, a significant portionFor each of eachthe Named Executive Officer’sOfficers other than Mr. Miralles (who joined the Company in September 2021), the Compensation Committee approved increases in the annual target cash compensation is at risk, to provide a strong connection between pay and performance. Accordingly, in 2020, our President and Chief Executive Officer’s annual target cash compensation was weighted 40% base salary and 60% annual incentive target.levels over the 2021 levels based on the factors described above under “2022 Executive Compensation Decisions.” The table below sets forth the 20202022 annual base salary level for each of our Named Executive Officers:

 

Named Executive Officer 2020 Base Salary 
Christine A. Leahy               $925,000 
Collin B. Kebo $525,000 
Sona Chawla $525,000 
Christina M. Corley $525,000 
Douglas E. Eckrote $447,188 
Mark C. Chong $429,000 
Elizabeth H. Connelly $425,000 
Named Executive Officer 2022 Base Salary
Christine A. Leahy           $1,000,000
Albert J. Miralles $650,000
Sona Chawla $675,000
Christina M. Corley $675,000
Frederick J. Kulevich $500,000

 

Annual Cash Incentive Awards

 

We provide our senior management with an opportunity to earn short-term incentive compensation through our annual cash incentive bonus program, the Senior Management Incentive Plan (“(���SMIP”). In general, the SMIP opportunity represents a majority of a Named Executive Officer’s total target cash compensation opportunity.

 

Setting the Target Opportunity under SMIP

 

Because our Named Executive Officer base salary levels historically have been targeted to be below the competitive market median, the Compensation Committee uses an above-median target SMIP opportunity to bring targeted total cash compensation within the median range. InFor each of the case of Ms. Leahy, herNamed Executive Officers other than Mr. Miralles (who joined the Company in September 2021), SMIP target opportunityopportunities in 2022 were increased as a percentage of base salary, from 140% in 2019compared to 150% in 2020 to bring her closer in line with the median range for total direct compensation and in recognition of her strong performance during her first full year as CEO.2021 SMIP target opportunities based on the factors described above under “2022 Executive Compensation Decisions.”

 

2020

2022 SMIP Pay for Performance Alignment

 

Each year, the Compensation Committee undertakes a rigorous review and analysis to establish annual performance goals under SMIP that require above-market performance. Such review was conducted in late 2019 and early 2020 with respect to the 2020 SMIP and the performance parameters were established prior to the onset of the COVID-19 global pandemic and before the extent of the broad and severe impact of the COVID-19 global pandemic would be known. The Compensation Committee utilizedused the same methodology it had in prior years to set 20202022 SMIP targets, with 20192021 performance as a baseline from which to measure growth. Factors considered by the Compensation Committee in establishing the performance goals at the time included U.S. IT market growth rate expectations and our market share gain expectations, as well as assumptions regarding our productivity gains and investments, with each of the expectations and assumptions based on the operating environment at the time.

 

 2021 Proxy Statement37

At the beginning of 2020,For 2022, the Compensation Committee established the following goals and payout levels under the 20202022 SMIP:

 

Consistent with the 20192021 SMIP design, the Compensation Committee chose non-GAAP operating income and market share growth (based upon sales growth relative to market) as the 20202022 SMIP performance goals. The Compensation Committee chose this combination of non-GAAP operating income and market share growth as performance goals because together they take into account not only the Company’s absolute performance but also performance relative to the market.
The non-GAAP operating income performance goal was set at $1,487.3$1,961.8 million, which was based on the Company’s operating plan at the time and on a growth rate above U.S. IT market growth rate expectations. The Company’s operating plan included expected contributions from Sirius Computer Solutions, which had been acquired by the Company in December 2021. When establishing the performance goals under SMIP, the Compensation Committee determined to exclude the items set forth in the non-GAAP operating income reconciliation included in Appendix A. In addition, the Compensation Committee determined to exclude from the payout calculations the effect of currency fluctuations from the payout calculationsas well as the Compensation Committee believedpositive impact on non-GAAP operating income of other items that compensation should not be based on factorswere viewed as outside of the control of the SMIP participants.
No formulaic payout unless 20202022 non-GAAP operating income at or above final 20192021 non-GAAP operating income results.
Formulaic payout range from 0% to 200% of target awards for performance against the non-GAAP operating income performance goal.
Market share governor would reduce operating income-based payouts at all performance levels unless the Company gained market share.

2023 Proxy Statement44

The threshold, target and maximum payout opportunities under the 20202022 SMIP formulaic payout curve are set forth below:

 

 Non-GAAP Operating Income performance goal(2) Market share governor(3)
Payout opportunity(1) Non-GAAP
Operating Income
(in millions)
 % attainment of
performance goal
 Grow (% of
target bonus)
 
Constant/Decline
(% of target bonus)
Maximum $ 1,636.0 110% 200% 180%
Non-GAAP Operating Income Target $ 1,487.3 100% 100% 90%
Threshold $ 1,368.3 92% 25% 15%
  Non-GAAP Operating Income performance goal(2)  Market share governor(3) 
Payout opportunity(1) Non-GAAP
Operating Income
(in millions)
  % attainment of
performance goal
  Grow (% of
target bonus)
  Constant/Decline
(% of target bonus)
 
Maximum         $2,158.0   110%  200%  180%
Non-GAAP Operating Income Target $1,961.8   100%  100%  90%
Threshold $1,645.4   84%  25%  15%
(1)Payouts are determined based on various performance achievement levels for non-GAAP operating income and market share changes. Payouts are determined based on various performance achievement levels, including but not limited to threshold, target and maximum, with payouts for performance between these various performance achievement levels are calculated using straight line interpolation.
(2)See Appendix A for a reconciliation of non-GAAPNon-GAAP operating income is defined as operating income, adjusted for the items set forth in the Company’s earnings releases, which may include, among other items, charges related to operating income.the amortization of acquisition-related intangible assets, equity-based compensation and related payroll taxes, and acquisition and integration expenses.
(3)Market share changes were measured based on data from four industry surveys and reports and two gross domestic product (GDP) reports.

 

As noted above, the 2020 SMIP goals were implemented prior to the onset of the COVID-19 global pandemic. Beginning in April 2020, the Compensation Committee re-evaluated the 2020 SMIP, considering the broad and severe impact of the COVID-19 pandemic and the Company’s priorities of safeguarding and fortifying our business, delivering above-market results and continuing to transform and build for our future. The Compensation Committee considered the challenges associated with using the pre-pandemic performance metrics and payout curve to assess 2020 performance, particularly given that 2019 performance was a baseline from which to measure growth under the SMIP design, there would be no formulaic payout unless 2020 non-GAAP operating income was at or above final 2019 non-GAAP operating income results, and the threshold performance goal required achievement of 92% of the above-market performance target in order to achieve a payout of 25% of the target opportunity. Following this review of the SMIP design and after considering the input of the Compensation Committee’s independent compensation consultant, the Compensation Committee adopted the “Structured Performance Framework” set forth below to use as a guide in its evaluation of Company and coworker performance in order to appropriately align our coworkers with our priorities of safeguarding and fortifying our business, delivering above-market results and continuing to transform and build for our future.

Business PrioritiesPerformance Factors
Safeguard and Fortify the BusinessLiquidity, Capital Allocation, Business Continuity and Coworker Safety
Deliver ResultsMarket Share Gains, Sales Growth Compared to Market Growth and Achievement of Key Operational Results
Build for the FutureExecution and Acceleration of the Company’s Long-Term Strategic Operating Plan, Cost Structure and Coworker Well-Being and Engagement

2020

2022 SMIP Results and Payouts

 

Consistent with the approach for all SMIP participants, following the conclusion of 2020, the Compensation Committee evaluated Company performance based on results versus the original pre-pandemic financial goals as well as the Structured Performance Framework discussed above. Based on such evaluation,the methodology described above, our 2022 Non-GAAP operating income measured for SMIP purposes was $2,050.2 million, and the Compensation Committee determined to fund the SMIP payouts at 95%that we had achieved 104.5% of target for the Named Executive Officers. Based solely on the financial goals established pre-pandemic and the Company’s achievement ofour Non-GAAP operating income measured on a constant currency basis of $1,405.6 millionperformance goal. In addition, based upon industry and GDP surveys and reports (see footnote (3) above), the Company’s growth inCompensation Committee determined that our market share the formulaicgrew. The SMIP payout was 56.24% of target and the Committee increased the overall

 2021 Proxy Statement38

payoutpercentage for the Named Executive Officers to 95% based on its assessmenttherefore was 145% of performance against each of the criteria set forth in the Structured Performance Framework. In determining these bonuses, the Compensation Committee noted that despite the major challenges confronting the Company and its coworkers and customers as a result of the broad and severe impact of the COVID-19 pandemic, the Company’s coworkers rose to the challenge and fortified the business and delivered exemplary performance and results while building for our future. Key achievements included the Company’s continued growth in market share as compared to a declining U.S. IT market, the Company meeting the demands of its essential service customers, the acceleration of the implementation of the Company’s strategic operating plan and improved liquidity while still paying its quarterly dividend. The Compensation Committee determined that these exceptional achievements were the result of the coordinated, cross-functional focus and effort of the Company’s coworkers, including the Named Executive Officers. their 2022 SMIP targets.

The table below sets forth the 20202022 SMIP bonus targets and payouts to each of our Named Executive Officers based upon 20202022 performance.

 

Named Executive OfficerSMIP Bonus Target  2020 SMIP
Payout
 
Christine A. Leahy  $1,387,500  $1,318,125 
Collin B. Kebo $675,000  $641,250 
Sona Chawla $725,000  $688,750 
Christina M. Corley $725,000  $688,750 
Douglas E. Eckrote $592,211  $562,601 
Mark C. Chong $431,000  $409,450 
Elizabeth H. Connelly $425,000  $403,750 
Named Executive Officer SMIP Bonus Target  2022 SMIP Payout
Christine A. Leahy          $2,000,000        $2,900,000
Albert J. Miralles $800,000  $1,160,000
Sona Chawla $825,000  $1,196,250
Christina M. Corley $825,000  $1,196,250
Frederick J. Kulevich $550,000  $797,500

 

Long-Term Incentive Program

 

Under our long-term incentive program, the Compensation Committee has the authority to award various forms of long-term incentive grants, including stock options, performance-based awards and restricted stock units.RSUs. The Compensation Committee’s objectives for the 20202022 long-term incentive awards were to:

 

Focus executives on key performance metrics aligned with long-term stockholder value creation and the Company’s long-term strategic plan and capital allocation plan.
Establish a direct link between compensation and the achievement of longer-term financial objectives.
Retain the services of executives through multi-year vesting provisions.

 

For 2020,2022, the annual long-term incentive grant was delivered in the form of performance share units (“PSUs”) and stock options, with the following key elements to drive Company performance and align with stockholder interests:

 

Performance SharePSUs50% of target long-term incentive opportunity
Units2020-20222022-2024 performance period with 0% - 200% payout curve (threshold payout of 50%25%)
 Vest at the end of the performance period based upon attainment of (1) cumulative annual adjusted free cash flow (“adjusted FCF”) and (2) cumulative annual Non-GAAP net income per diluted share (“adjusted EPS”) performance goals, each calculated independently as described below and weighted equally
Stock Options50% of target long-term incentive opportunity
 Only have value if CDW stock price increases
 Vest in 1/3 annual increments with 10 year maximum term

 

2020

2023 Proxy Statement45

2022 Long-Term Incentive Program Pay for Performance Alignment

 

For 2020,2022, 100% of the long-term incentive awards granted to the Named Executive Officers consisted of performance-based equity awards, with the exception of the sign-on RSU award granted to Ms. Chawla.awards. Stock options have value to an award recipient only if our stock price appreciates, while PSUs have value if and only to the extent that the pre-established quantitative performance metrics relating to adjusted FCF and adjusted EPS, as described below and weighted equally, are achieved during the three-year performance period. The Compensation Committee selected adjusted FCF and adjusted EPS as the metrics for the PSUs because it believes successful performance against these measures promotes the creation of long-term stockholder value. In selecting these metrics, the Compensation Committee focused on cash flow and earnings as critical measures of operational success and value creation, but distinguished the PSU metrics from the SMIP metric (Non-GAAP operating income). By including interest and taxes in both metrics and working capital in adjusted FCF, the Compensation Committee intends to provide a stronger linkage to longer-term growth in stockholder value.

 

 2021 Proxy Statement39

The adjusted EPS performance goals and adjusted EPS results under the 2020 PSU awards will be determined on a constant currency basis as the Compensation Committee believed that compensation should not be based on factors outside of the control of program participants.

The Compensation Committee established the PSU performance goals to encourage strong, focused performance. Given the economic and market conditions at the time the targets were set, the target payout levels were designed to be challenging but achievable, while payouts at the maximum levels were designed to be stretch goals.

 

Under the PSU agreements, adjusted EPS and adjusted FCF are generally calculated as follows:

 

(1)The adjusted EPS performance goals and adjusted EPS results under the 2022 PSU awards will be determined on a constant currency basis as the Compensation Committee believed that compensation should not be based on factors outside of the control of program participants.
(2)Non-GAAP net income is defined as net income, adjusted for the items set forth in the Company’s earnings releases which may include, among other items, amortization of intangibles, non-cash equity-based compensation and associated taxes, losses or gains from the extinguishment of debt and acquisition and integration expenses. Free cash flow is defined as net cash from operating activities minus capital expenditures plus or minus net change in accounts payable–inventory financing each year during the performance period.
(2)(3)The impact of extraordinary, unusual, infrequently occurring,Other non-recurring and unanticipated events will be excluded, such as severance expenses attributable to a reductionnot already adjusted for in force, asset impairments, reserves for uncertain tax positions and reserves for loss contingencies (or payments for settlements or judgments), each as determined under GAAP; and the effect of any change in tax laws, accounting principles or other laws or regulations affecting results.non-GAAP net income.

 

Setting Award Levels under 20202022 Long-Term Incentive Program

 

In determining the 20202022 annual long-term incentive award levels for Named Executive Officers, the Compensation Committee compared the target total direct compensation of each Named Executive Officer to the competitive market median. In the case of Ms. Leahymedian and Mr. Kebo, their long-term incentive targetincreased 2022 award values increasedlevels as compared to 2019 to bring each closer in line with2021 award levels based on the median range for total direct compensation and in recognition of their strong performance since assuming their respective positions. Consistent with the Company’s long-standing compensation philosophy of aligning executive officers’ interests with stockholders through the risks and rewards of equity ownership, thefactors described above under “2022 Executive Compensation Committee allocated the majority of the total target direct compensation increases to the Named Executives Officers’ target equity grant levels.Decisions.”

 

The table below sets forth the target award value, as of the date of grant, of the annual long-term incentive awards received by each Named Executive Officer under our 20202022 long-term incentive program, which was delivered 50% in PSUs and 50% in stock options:

 

Executive Amount 
Christine A. Leahy $4,100,000 
Collin B. Kebo $1,600,000 
Sona Chawla $2,000,000 
Christina M. Corley $2,000,000 
Douglas E. Eckrote $650,000 
Mark C. Chong $960,000 
Elizabeth H. Connelly $575,000 
Executive Amount
Christine A. Leahy $   7,000,000
Albert J. Miralles $2,200,000
Sona Chawla $2,850,000
Christina M. Corley $2,850,000
Frederick J. Kulevich $1,550,000

 

The award levels noted above for Ms. Corley and Mr. Eckrote do not reflect additional one-time long-term incentive awards with targeted grant date values of $500,000 and $150,000, respectively, and delivered with the same mix and terms as Ms. Corley and Mr. Eckrote’s annual long-term incentive awards described above. These additional grants were awarded to support the execution of the Company’s strategic objectives. In addition, the award levels noted above exclude Ms. Chawla’s sign-on RSU award, which is described further below.

 20212023 Proxy Statement4046
 

2018

2020 Long-Term Incentive Program Results and Payouts

 

Under the terms of the PSUs granted as part of the 20182020 long-term incentive program, 20202022 represented the final year of the three-year performance period for the 20182020 PSUs. The 20182020 PSUs vested based on the attainment of cumulative performance goals relating to adjusted FCF and adjusted EPS during the 2018-20202020-2022 performance period, with each goal weighted equally in the determination of the vesting level. These performance goals were set in 2018February 2020 based on the Company’s strategic plans at the time and the Compensation Committee did not make any discretionary adjustments to the performance goals or results to adjust for the COVID-19 pandemic. Based on performance, participants were eligible to receive a payout ranging from 0% - 200% of target, with a threshold payout opportunity equal to 25% of target if threshold performance for only one performance goal is achieved and 50% of target.target if threshold performance for both goals is achieved.

 

The threshold, target and maximum payout opportunities under the 20182020 PSU payout curve are set forth below:

 

  2018-2020 Performance Goals(1)
    Adjusted Earnings Per Share Adjusted Free Cash Flow
Payout opportunity(2) Payout
(% of target)
 Adjusted Earnings
Per Share
 % attainment of
performance goal
 Adjusted Free Cash
Flow (in millions)
 % attainment of
performance goal
Maximum 200% $      18.27 115% $    2,334.4 115%
Target 100% $      15.89 100% $    2,029.9(3) 100%
Threshold 50% $      14.25 89.7% $    1,725.4 85%
2020-2022 PERFORMANCE GOALS(1) 
  Adjusted Earnings Per Share  Adjusted Free Cash Flow 
Payout opportunity(2)   Payout
(% of target)
  Adjusted Earnings
Per Share
 % attainment of
performance goal
  Adjusted Free Cash
Flow (in millions)
   % attainment of
performance goal
 
Maximum 200%                 $25.63 115.0%                 $2,985.8  115.0%
Target 100% $22.29 100.0% $2,596.4(4)  100.0%
Threshold 50%(3)  $19.99 89.7% $2,206.9  85.0%
(1)Under the terms of the 20182020 PSU agreements, adjusted EPS and adjusted FCF were each weighted equally and calculated as described above with respect to the 20202022 PSU awards.
(2)Payouts are determined based on various performance achievement levels for adjusted EPS and adjusted FCF. Payouts are determined based on various performance achievement levels, including but not limited to threshold, target and maximum, with payouts for performance between these various performance achievement levels are calculated using straight line interpolation.
(3)Threshold payout for purposes of this table assumes that threshold performance of each goal is achieved. If threshold performance for only one goal is achieved, then the payout, as a percentage of target, would be 25%.
(4)Under the payout curve, the Compensation Committee established a range of $1,969.0$2,518.5 million to $2,090.8$2,674.3 million (97%(97.0% to 103%103.0% of target) for the achievement levels that would have resulted in a target payout for the adjusted FCF performance goal.

 

For the 2018-20202020-2022 performance period, the Company achieved cumulative adjusted EPS and cumulative adjusted FCF of $17.89$24.31 and $2,734.1$3,113 million, respectively, resulting in the vesting level for the 20182020 PSU awards at 191.97%180% of target.

 

The table below sets forth the target number of 20182020 PSUs and the number of shares earned based on actual performance during the 2018-20202020-2022 performance period:

 

Named Executive Officer 2018 Target
PSUs (#)
 Shares Earned under
2018 PSUs (#)(1)
Christine A. Leahy 8,164 15,672
Collin B. Kebo 4,082 7,836
Sona Chawla  
Christina M. Corley 6,123 11,754
Douglas E. Eckrote 3,572 6,857
Mark C. Chong 7,121 13,670
Elizabeth H. Connelly  
Named Executive Officer     2020 Target PSUs (#)     Shares Earned under 2020 PSUs (#)(1)
Christine A. Leahy 20,874 37,617
Albert J. Miralles  
Sona Chawla 10,182 18,349
Christina M. Corley 12,728 22,937
Frederick J. Kulevich 2,927 5,275
(1)Pursuant to the terms of the award agreements, participants are eligible to receive dividend equivalents with respect to dividends paid prior to the settlement of the award. The earned shares reported in this table do not include additional shares acquired through the deemed reinvestment of dividend equivalents prior to settlement of the award. The earned shares, including shares acquired through the deemed reinvestment of dividends through December 31, 2020,2022, are reported in the 20202022 Option Exercises and Stock Vested Table. PSU award recipients receive fractional shares upon settlement; however, for purposes of this table, share numbers have been rounded to the nearest whole share.

 

Other Elements of Our 20202022 Executive Compensation Program

 

Employment Arrangements

 

The Company generally executes an offer of employment before an executive joins the Company. This offer describes the basic terms of the executive’s employment, including his or her initial base salary, SMIP target and long-term incentive award target. The terms of the executive’s employment are based thereafter on sustained good performance and the executive’s compensation protection agreement (the “Compensation Protection Agreement”) described below. The terms of the offer letter are determined after considering the compensation levels paid to similarly situated executive officers at the Company, the competitive median of the market data to provide a perspective on external practices, input from the Compensation Committee’s independent compensation consultant and the compensation deemed necessary to induce the executive to join the Company.

 

In late 2019, the Company extended an offer of employment to Ms. Chawla, which outlined the initial terms of Ms. Chawla’s employment. In addition to setting forth Ms. Chawla’s initial base salary, SMIP target, long-term incentive award target and her entitlement to a Compensation Protection Agreement, Ms. Chawla’s offer of employment also included cash and RSU sign-on inducement awards. Ms. Chawla received a cash sign-on

Severance Arrangements

 

 2021 Proxy Statement41

inducement award in the amount of $500,000, which was subject to repayment in the event Ms. Chawla voluntarily resigned from the Company or was terminated for cause prior to the one-year anniversary of her start date. Ms. Chawla also received a one-time sign-on inducement award in the form of RSUs with a target grant date fair value of $500,000, with the RSUs scheduled to vest in one-third annual installments on the first, second and third anniversaries of the grant date, subject to Ms. Chawla’s continued employment through the applicable vesting date. In addition, in order to induce Ms. Chawla to join the Company and relocate to the Company’s corporate headquarters, the Company agreed to provide Ms. Chawla with competitive relocation benefits, including up to $75,000 to cover costs associated with the sale of her existing home. Any relocation benefits will be reflected as compensation in the Summary Compensation Table in the year in which the underlying expense is incurred.

Severance Arrangements

During 2020,2022, each of the Named Executive Officers were each subject to a Compensation Protection Agreement that provided for severance benefits upon certain qualifying terminations of employment with the Company. The Compensation Committee

2023 Proxy Statement47

believes that these severance benefits: (1) help secure the continued employment and dedication of our Named Executive Officers; (2) enhance the Company’s value to a potential acquirer because our Named Executive Officers have noncompetition, nonsolicitation and confidentiality provisions that apply after any termination of employment, including after a change in control of the Company; and (3) are important as a recruitment and retention device, as many of the companies with which we compete for executive talent have similar agreements in place for their senior management. Consistent with market practices, the Compensation Protection Agreements do not include change in control-related tax gross-ups and are for a three-year fixed term (expiring(which was scheduled to expire on January 1, 2023)2023 and renewed until January 1, 2026 in November 2022), with certain term extensions in the event of a “potential change in control” or “change in control” during the term.

 

Additional information regarding the employment arrangements with each of our Named Executive Officers, including, with respect to each of our Named Executive Officers, a quantification of benefits that would have been received by each such Named Executive Officer had his or her employment terminated on December 31, 2020,2022, is provided under “2020“2022 Potential Payments upon Termination or Change in Control.”

 

Nonqualified Deferred Compensation Plan

In May 2021, the Company adopted the CDW LLC Nonqualified Deferred Compensation Plan, effective as of July 1, 2021 (the “NQDC Plan”). The NQDC Plan allows coworkers who meet the plan eligibility requirements, including the Named Executive Officers, to elect to defer the receipt of a portion of their base salaries and bonuses. The NQDC Plan permits the crediting by the employer of additional amounts to the deferral accounts of participants, although no such additional contributions were made for 2022. The Compensation Committee believes that the adoption of the NQDC Plan supports the Company’s compensation objectives of attracting and retaining talent. Consistent with our performance-based culture, we do not offer a service-based defined benefit pension plan to our coworkers. Additional information regarding the NQDC Plan is provided under “2022 Nonqualified Deferred Compensation.”

Other Benefits

 

Our Named Executive Officers participate in our corporate-wide benefit programs. Our Named Executive Officers are offered benefits that generally are commensurate with the benefits provided to all of our full-time coworkers, which includes participation in our qualified defined contribution plan.

 

ConsistentThe Company also maintains an executive health program for members of the Company’s executive committee, including each of the Named Executive Officers, pursuant to which the Named Executive Officers are each eligible to receive an executive physical exam. The Compensation Committee believes that providing executive physical exams is in the interests of the Company and its stockholders and, as in the case of the NQDC Plan, supports the Company’s compensation objectives of attracting and retaining talent. In addition, with our performance-based culture, we do not offerrespect to 2022, the Compensation Committee approved the use of chartered aircraft and reimbursed commercial flights along with the reimbursement of taxes for such travel with respect to Ms. Leahy for certain personal travel. While the Company generally limits supplemental benefits provided to senior executives, the Compensation Committee believes that this benefit serves the interests of the Company and its stockholders by allowing for continued travel in a service-based definedsafe manner and increasing her efficiency and availability to attend to Company matters. This benefit pension plan or other similar benefits to our coworkers. During 2020, we did not provide nonqualified retirement programs or perquisites that are oftenis reflected as a supplemental benefit provided at other companies to our executive officers.by the Company in the “2022 Summary Compensation Table.”

 

Clawback Policy

 

The Compensation Committee adopted a clawback policy in the event the Company is required to prepare an accounting restatement due to material non-compliance with a financial reporting requirement under the federal securities laws. If a current or former executive officer engaged in intentional misconduct that caused or partially caused the need for the restatement, the Compensation Committee may, in its discretion and to the full extent permitted by governing law, require reimbursement of that portion of any cash bonus paid to, or PSUs earned by, such executive officer during the three-year period preceding the date on which the Company is required to prepare the restatement, which is in excess of what would have been paid or earned by such executive officer had the financial results been properly reported. The Company will review and modify the policy as necessary to reflect the final Nasdaq listing rules adopted to implement the compensation recovery requirements under the Dodd-Frank Wall Street Reform and Consumer Protection Act.

 

Stock Ownership Guidelines

 

The Compensation Committee believes that, in order to more closely align the interests of executives with the interests of the Company’s other stockholders, all executives should maintain a minimum level of equity interests in the Company’s common stock. The Compensation Committee has adopted stock ownership guidelines requiring ownership of six times base salary for our President and Chief Executive Officer, five times base salary for our Chief Commercial and Operating Officer and our Chief Growth and Innovation Officer and three times base salary for our other executive officers. Until the guidelinethis minimum level is met, an executive officer is required to retain 50% of the after-tax shares acquired upon exercise of stock options and vesting of PSUsperformance shares/units and restricted share shares/units. The charts below show the salary multiple guidelines and the equity holdings that count towards these guidelines. As of the record date, all of our Named Executive Officers were in compliance with the Company’s stock ownership guidelines.

 

Named Executive OfficerGuideline
Chair, President and Chief Executive Officer6x salary
Chief Commercial and Operating Officer5x salary
Chief Growth and Innovation Officer5x salary
Other Executive Officers3x salary

WHAT COUNTS
TOWARD THE GUIDELINE
WHAT DOES NOT COUNT
TOWARD THE GUIDELINE
Shares owned by the executive, immediate family or executive trustVested and unvested stock options
Shares owned through the Company’s Coworker Stock Purchase PlanUnvested RSUs and PSUs

2023 Proxy Statement48

Hedging, Short Sales and Pledging Policies

 

Our executive officers are prohibited from hedging and short sales transactions with respect to our securities. In addition, our executive officers are prohibited from pledging our securities except in limited circumstances with pre-approval. For a further description of these policies, please see “Corporate Governance - Hedging, Short Sales and Pledging Policies.”

 

 2021 Proxy Statement42

HOW WE MAKE EXECUTIVE COMPENSATION DECISIONS

How We Make Executive Compensation Decisions

 

Our Executive Compensation Philosophies and Objectives

 

The Compensation Committee believes that our executive compensation program should reward actions and behaviors that drive sustained meaningful profitable growth and stockholder value creation. The Compensation Committee seeks to foster these objectives through a compensation system that focuses heavily on variable, performance-based incentives that create a balanced focus on our short-term and long-term strategic and financial goals. The Compensation Committee’s goal has been to implement an executive compensation program that continues to drive above-market results and that is built upon our long-standing executive compensation philosophies and objectives, as outlined below, which we believe have been key contributors to our long-term success:

 

Sustained Meaningful Profitable Growth and Stockholder Value Creation

Pay-for-Performance.

A significant percentage of an executive’s compensation should be directly aligned with Company performance, with a balance between short-term and long-term performance.

Align with Stockholder Interests.

Executives’ interests should be aligned with stockholder interests through the risks and rewards of CDW equity ownership.

Attract and Retain the Right Talent.

Executive compensation should be market-competitive in order to attract and retain highly motivated talent with a performance- and service-driven mindset.

 

Role of the Board, Compensation Committee and our Executive Officers

 

The Compensation Committee is responsible for determining the compensation of our Chair, President and Chief Executive Officer and each of our other executive officers. In setting the compensation of our Chair, President and Chief Executive Officer, the Compensation Committee takes into account the Nominating and Corporate Governance Committee’s review of our Chair, President and Chief Executive Officer’s performance. In setting the compensation of our other executive officers, the Compensation Committee takes into account our Chair, President and Chief Executive Officer’s review of each executive officer’s performance and her recommendations with respect to their compensation. The Compensation Committee’s responsibilities regarding executive compensation are further described in the “Corporate Governance” section of this proxy statement.

 

Guidance from Independent Compensation Consultant

 

Frederic W. Cook & Co., Inc. (the “Compensation Consultant”) provides executive compensation consulting services to the Compensation Committee. With respect to 2020,2022, the Compensation Consultant provided services related to the review of 20202022 compensation adjustments, including a review of peer group compensation data, awards under our long-term incentive program, the setting of performance goals in our variable incentive plans including the payout leverage for results above and below the target performance levels, support regarding the evaluation of the impact of COVID-19 on our compensation programs, trends and tax and regulatory developments with respect to executive compensation, our compensation peer group and assistance with this CD&A.proxy statement. The Compensation Consultant is retained by and reports to the Compensation Committee and, at the request of the Compensation Committee, participates in committee meetings. Other than services provided to the Compensation Committee, the Compensation Consultant did not provide any services to the Company with respect to 2020.2022. The Compensation Committee reviewed the independence of the Compensation Consultant under Nasdaq and SEC rules and concluded that the work of the Compensation Consultant has not raised any conflict of interest.

 

 20212023 Proxy Statement4349
 

Comparison to Relevant Peer Group

 

To obtain a broad view of competitive practices among industry peers and competitors for executive talent, the Compensation Committee reviews market data for peer group companies as well as a general industry survey. In selecting companies for our peer group, the Compensation Committee considers all publicly traded companies in the US or Canada classified in a broad range of industries that meet one or more of the following peer group selection criteria established by the Compensation Committee:

 

Similar size in terms of revenue and/or enterprise valuemarket capitalization
Operates in a business-to-business distribution environment
Member of the technology industry
Similar customers (i.e., business, government, healthcare, and education)
Services and/or solutions provider
Similar margins
SimilarMeaningful percentage of international sales
The Company is frequently identified as a peer by the other peer companies or the leading proxy advisory firms
Identified by the Company as a competitor

For 2020 compensation decisions,During 2021, the Compensation Consultant presented, and the Compensation Committee utilizedapproved, a revised peer group to better reflect the Company’s evolving business model as a distributor with a significant services and solutions presence, to improve the Company’s relative positioning on various size and performance measures as compared to the peer group, set forth below, which wasand to reflect the acquisition of several peer group companies during 2020 and 2021. The revised peer group consists of the same peer group that was utilized for evaluating 2019used to establish the initial 2021 compensation decisions.levels, but with (i) the removal of Anixter International, Inc., Patterson Companies, Inc., and Tech Data Corporation, and (ii) the addition of Accenture plc, Best Buy Co., Inc., Flex, Hewlett Packard Enterprise Company, and Jabil Inc. Based on data compiled by the Compensation Consultant at the time of the peer group review,was approved, our revenues EBITDA and market capitalization were between the median and 75th percentile of our peer group, and our market capitalization was between the 75th and 100th percentile of our peer group. This peer group was used for evaluating 2022 compensation decisions with respect to the Named Executive Officers.

 

2020 Compensation Peer Group
Anixter International, Inc.Insight Enterprises, Inc.
Arrow Electronics, Inc.LKQ Corporation
Avnet, Inc.Patterson Companies, Inc.
CGI Group Inc.SYNNEX Corporation
Cognizant Technology Solutions CorporationTech Data Corporation
DXC Technology CorporationW.W. Grainger, Inc.
Genuine Parts CompanyWesco International, Inc.
Henry Schein, Inc.

* Synnex Corporation at time of approval of peer group

 

The Compensation Consultant provides competitive data utilizing peer group proxy data and Aon provides revenue size-adjusted competitive data from itstheir general industry database. In reviewing the size-adjusted competitive data from the Aon general industry database, the Compensation Committee does not review data from the specific companies included in the database.databases. For Ms. Leahy, the peer group was the primary market data source for evaluating 20202022 base salary, annual cash incentive award opportunity and long-term incentive opportunity, given the availability of chief executive officer compensation data in public filings, with the compensation survey data providing a supplemental viewpoint. For our other Named Executive Officers, the Compensation Committee reviewed both peer group data and compensation survey data when evaluating the 20202022 base salary, annual cash incentive award opportunities and long-term incentive opportunities. For purposes of this CD&A, the peer group data and compensation survey data are collectively referred to as “market data.”

 

 20212023 Proxy Statement4450
 

COMPENSATION COMMITTEE REPORT

Compensation Committee Report

 

Our Compensation Committee has reviewed and discussed the section entitled “Compensation Discussion and Analysis” with our management. Based upon this review and discussion, the Compensation Committee recommended to the Board of Directors that the section entitled “Compensation Discussion and Analysis” be included in this proxy statement, which will be incorporated by reference into our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.2022.

 

Respectfully submitted by the Compensation Committee of the Board of Directors.

 

Lynda M. Clarizio

Paul J. Finnegan

Anthony R. Foxx*

Sanjay Mehrotra, Chair

Joseph R. Swedish

*Appointed to the Compensation Committee as of February 17, 2023

Steven W. Alesio
2023 Proxy StatementBarry K. Allen
Lynda M. Clarizio
Paul J. Finnegan
Joseph R. Swedish, Chair51

 2021 Proxy Statement45
 

2020 EXECUTIVE COMPENSATION

2022 Executive Compensation

 

2020

2022 Summary Compensation Table

 

The following table provides information regarding the compensation earned by our Named Executive Officers for fiscal year ended December 31, 20202022 and, to the extent required under the SEC executive compensation disclosure rules, the fiscal years ended December 31, 20192021 and 2018.2020.

 

Name and principal
position11
 Year Salary
($)
 Bonus
($)(1)
 Stock
Awards
($)(2)
 Option
Awards
($)(3)
 Non-equity
Incentive Plan
Compensation
($)(4)
 All Other
Compensation
($)(5)
 Total
($)
Christine A. Leahy
President and Chief Executive Officer
 2020 910,577  2,050,036 2,049,505 1,318,125 14,431 6,342,674
 2019 842,160  1,749,982 1,761,389 1,819,510 18,756 6,191,797
 2018 506,188  599,972 608,967 1,029,480 9,755 2,754,362
Collin B. Kebo
Senior Vice President and Chief Financial Officer
 2020 520,192  800,019 799,802 641,250 22,896 2,784,159
 2019 483,038  599,988 603,898 917,400 76,838 2,681,162
 2018 408,846  299,986 304,484 668,026 51,143 1,732,485
Sona Chawla
Chief Growth and Innovation Officer
 2020 482,596 500,000 1,499,932 999,762 688,750  4,171,040
                
Christina M. Corley
Chief Commercial and Operating Officer
 2020 522,981  1,250,017 1,249,703 688,750 14,129 3,725,580
 2019 497,032  899,983 905,856 1,070,300 15,731 3,388,902
 2018 369,551  449,979 456,733 766,961 9,453 2,052,677
Douglas E. Eckrote
Senior Vice President, Small Business Sales and eCommerce
 2020 447,188  400,009 399,901 562,601 14,431 1,824,130
 2019 447,188  299,994 301,958 905,491 14,086 1,968,717
 2018 442,757  262,506 266,421 937,470 9,755 1,918,909
Mark C. Chong
Senior Vice President, Strategy and Marketing
 2020 428,231  479,952 479,877 409,450 14,129 1,811,639
 2019 421,231  450,039 452,928 649,825 13,784 1,987,807
Elizabeth H. Connelly
Senior Vice President – Coworker Services
 2020 420,192  287,461 287,421 403,750 15,288 1,414,112
                
Name and Principal Position Year Salary
($)
 Bonus
($)(1)
 Stock
Awards
($)(2)
 Option
Awards
($)(3)
 Non-equity
Incentive Plan
Compensation
($)(4)
 All Other
Compensation
($)(5)
 Total
($)
Christine A. Leahy
Chair, President and Chief Executive Officer
 2022 985,288  3,500,002 3,536,819 2,900,000 193,713 11,115,822
 2021 925,000  2,750,029 2,823,088 2,430,900 14,886 8,943,903
 2020 910,577  2,050,036 2,049,505 1,318,125 14,431 6,342,674
Albert J. Miralles
Senior Vice President and Chief Financial Officer
 2022 650,000  1,099,917 1,111,551 1,160,000 13,094 4,034,562
 2021 185,000 300,000 3,249,987 359,179 1,401,600 4,295 5,500,061
                
Sona Chawla
Chief Growth and Innovation Officer
 2022 645,577  1,425,045 1,439,969 1,196,250 17,114 4,723,955
 2021 525,000  1,350,068 1,385,861 1,270,200 251,128 4,782,257
 2020 482,596 500,000 1,499,932 999,762 688,750  4,171,040
Christina M. Corley
Chief Commercial and Operating Officer
 2022 645,577  1,425,045 1,439,969 1,196,250 21,020 4,727,861
 2021 525,000  1,350,068 1,385,861 1,270,200 14,584 4,545,713
 2020 522,981  1,250,017 1,249,703 688,750 14,129 3,725,580
Frederick J. Kulevich
General Counsel & Corporate Secretary
 2022 485,288  774,961 783,132 797,500 19,600 2,860,481
                
                
(1)Bonus. The amountamounts reported in this column for Mr. Miralles and Ms. Chawla represents arepresent cash sign-on bonus,bonuses, which waswere subject to repayment in the event that Ms. Chawlathe executive voluntarily resigned from the Company or if the Company terminated Ms. Chawla’sthe executive’s employment for cause within one year of herthe executive’s start date.
(2)Stock awards. The amounts reported in this column represent the grant date fair value of PSUs and RSUs granted in the applicable year, calculated in accordance with ASC 718. The amounts included in 20202022 for the PSU awards are calculated based on the closing stock price and the probable satisfaction of the performance conditions for such awards as of the date of grant. Assuming the highest level of performance is achieved for the 20202022 PSU awards, the maximum value of these awards at the grant date would be as follows: Ms. Leahy-$4,100,071;7,000,004; Mr. Kebo-Miralles-$1,600,037;2,199,834; Ms. Chawla-$1,999,948;2,850,090; Ms. Corley-$2,500,034;2,850,090; and Mr. Eckrote-Kulevich-$800,019; Mr. Chong-$959,905; and Ms. Connelly-$574,921. The amounts included in 2020 for the RSU awards are calculated by multiplying the number of RSUs granted by the closing stock price of a share of Company common stock on the date of grant.1,549,922.
(3)Option awards. The amounts reported in this column represent the grant date fair value of stock option awards granted in the applicable year, calculated in accordance with ASC 718. See Note 1413 to the Audited Financial Statements included in our Form 10-K for the fiscal year ended December 31, 20202022 (the “Audited Financial Statements”) for a discussion of the relevant assumptions used in calculating these amounts.
(4)Non-equity incentive plan compensation. The amounts reported for 20202022 represent cash awards paid to the Named Executive Officers under the SMIP. Please see the CD&A for further information regarding the 20202022 SMIP.
(5)All other compensation. “All Other Compensation” for 20202022 consists of (i) Company-paid supplemental disability premiums, (ii) the costs associated with an executive physical, which for healthcare privacy reasons each of the Named Executive Officers, (ii)Officer has been attributed a cost of $4,295 regardless of whether such benefit was used, (iii) matching and profit sharing contributions to the 401(k) accounts, of each of(iv) for Ms. Corley, a service recognition gift provided to all coworkers upon certain service anniversaries, a gift received at a sales event by all event attendees, and a product purchased with wellness credits redeemed through the Named Executive Officers, and (iii) legacy payments for tax preparation, tax equalization and the related tax gross-ups on these payments ($3,546)Company’s health insurer, (v) for Mr. KeboMIralles, a gift received at a sales event by all event attendees; and (vi) for Ms. Leahy, a gift received at a sales event by all attendees and reimbursements for certain personal travel in connection with an expatriate assignment priorthe amount of $174,396, including $42,754 for the reimbursement of taxes for such travel. Ms. Leahy’s personal travel expenses reported in this column were valued on the basis of aggregate incremental cost to his appointmentthe Company and represent the amount accrued for payment or paid directly to the third-party vendor from which the Company leases corporate aircraft or reimbursed to Ms. Leahy, as an executive officer, consistent with the Company’s standard practices for expatriate assignments.applicable.

 

 2021 Proxy Statement    46

2023 Proxy Statement52
 

2020

2022 Grants of Plan-Based Awards Table

 

The following table provides information regarding the possible payouts to our Named Executive Officers in 20202022 under the SMIP and the equity awards received by our Named Executive Officers in 20202022 under the CDW Corporation Amended and Restated 20132021 Long-Term Incentive Plan (“20132021 LTIP”).

 

                  All Other All Other   Grant
      Estimated Possible Payouts Estimated Possible Payouts Stock Option   Date Fair
      Under Non-equity Under Equity Incentive Awards: Awards: Exercise Value of
      Incentive Plan Awards(1) Plan Awards(2) Number of Number of or Base Stock
                  Shares of Securities Price of and
                  Stock or Underlying Option Option
  Grant Approval Threshold Target Maximum Threshold Target Maximum Units Units Options Awards Awards
Name date Date ($) ($) ($) (#) (#) (#) (#)(3) (#)(4) ($) ($)(5)
Christine A. Leahy   208,125 1,387,500 2,775,000       
  3/9/2020 3/9/2020    10,437 20,874 41,748    2,050,036
  3/9/2020 3/9/2020        106,247 98.21 2,049,505
Collin B. Kebo   101,250 675,000 1,350,000       
  3/9/2020 3/9/2020    4,073 8,146 16,292    800,019
  3/9/2020 3/9/2020        41,462 98.21 799,802
Sona Chawla   108,750 725,000 1,450,000       
  1/21/2020 12/17/2019       3,674   499,958
  3/9/2020 3/9/2020    5,091 10,182 20,364    999,974
  3/9/2020 3/9/2020        51,828 98.21 999,762
Christina M. Corley   108,750 725,000 1,450,000       
  3/9/2020 3/9/2020    5,091 10,182 20,364    999,974
  3/9/2020 3/9/2020    1,273 2,546 5,092    250,043
  3/9/2020 3/9/2020        51,828 98.21 999,762
  3/9/2020 3/9/2020        12,957 98.21 249,941
Douglas E. Eckrote   88,832 592,211 1,184,422       
  3/9/2020 3/9/2020    1,655 3,309 6,618    324,977
  3/9/2020 3/9/2020    382 764 1,528    75,032
  3/9/2020 3/9/2020        16,844 98.21 324,921
  3/9/2020 3/9/2020        3,887 98.21 74,980
Mark C. Chong   64,650 431,000 862,000       
  3/9/2020 3/9/2020    2,444 4,887 9,774    479,952
  3/9/2020 3/9/2020        24,877 98.21 479,877
Elizabeth H. Connelly   63,750 425,000 850,000       
  3/9/2020 3/9/2020    1,464 2,927 5,854    287,461
  3/9/2020 3/9/2020        14,900 98.21 287,421
    Estimated Possible Payouts
Under Non-equity Incentive
Plan Awards(1)
 Estimated Possible Payouts
Under Equity Incentive
Plan Awards(2)
 All Other
Stock
Awards:
Number
 All Other
Option
Awards:
Number of
 Exercise
or Base
 Grant Date
Fair Value
Name     Grant date     Threshold
($)
     Target
($)
     Maximum
($)
     Threshold
(#)
     Target
(#)
     Maximum
(#)
     of Shares
of Stock
or Units
(#)
     Securities
Underlying
Options
(#)(3)
     Price of
Option
Awards
($)
     of Stock
and Option
Awards
($)(4)
Christine A. Leahy  300,000 2,000,000 4,000,000       
 2/24/2022    5,108 20,432 40,864    3,500,002
 2/24/2022        82,137 171.30 3,536,819
Albert J. Miralles  120,000 800,000 1,600,000       
 2/24/2022    1,605 6,421 12,842    1,099,917
 2/24/2022        25,814 171.30 1,111,551
Sona Chawla  123,750 825,000 1,650,000       
 2/24/2022    2,080 8,319 16,638    1,425,045
 2/24/2022        33,441 171.30 1,439,969
Christina M. Corley  123,750 825,000 1,650,000       
 2/24/2022    2,080 8,319 16,638    1,425,045
 2/24/2022        33,441 171.30 1,439,969
Frederick J. Kulevich  82,500 550,000 1,100,000       
 2/24/2022    1,131 4,524 9,048    774,961
 2/24/2022        18,187 171.30 783,132
(1)These amounts represent threshold, target and maximum cash award levels set in 20202022 under the SMIP. The amount actually paid to each Named Executive Officer under the SMIP is reported as Non-Equity Incentive Plan Compensation in the 20202022 Summary Compensation Table.
(2)These amounts represent the threshold, target and maximum PSUs granted under the 20132021 LTIP. Because the performance goals are measured independently, the threshold PSUs reported in this table reflect payout for threshold performance with respect to only one of the performance goals. PSU award recipients receive fractional shares upon settlement; however, for purposes of this table, share numbers have been rounded to the nearest whole share. For actively employed executives, these PSUs are scheduled to vest on December 31, 2022,2024, subject to the achievement of the threshold performance goals relating to adjusted FCF and adjusted EPS over the 2020-20222022-2024 performance period. The number of units subject to a PSU award increases as a result of the deemed reinvestment of dividend equivalents prior to settlement of the award and such additional units are subject to the same vesting conditions as the underlying PSUs. Please see the CD&A for further information regarding this award.
(3)RSUs allow the grantee to receive the number of shares of common stock subject to the award upon vesting. The RSUs granted to Ms. Chawla on January 21, 2020 vest in one-third increments on each of the first through third year anniversaries of the date of grant, subject to Ms. Chawla’s continued employment through the applicable vesting date. During the vesting period, the RSUs will be adjusted to reflect the accrual of dividend equivalents, which will be distributed in cash at the same time and to the extent the underlying shares vest.
(4)These amounts represent stock options granted under the 20132021 LTIP. For actively employed executives, these options vest in one-third increments on each of the first through third year anniversaries of the date of grant.
(5)(4)The amounts reported represent the grant date fair value associated with the grant of these PSUs RSUs and stock option awards, as computed in accordance with ASC 718. In the case of the PSUs, the grant date fair value is calculated based on the closing stock price on the date of grant and the probable satisfaction of the performance conditions for such awards as of the date of grant. See Note 1413 to the Audited Financial Statements for a discussion of the relevant assumptions used in calculating these amounts.

 

 2021 Proxy Statement    47

2023 Proxy Statement53
 

2020

2022 Outstanding Equity Awards at Fiscal Year-End Table

 

The following table summarizes outstanding option awards and unvested stock awards held by each Named Executive Officer on December 31, 2020.2022.

 

  Option Awards Stock Awards
    Equity            
    Incentive       Market Equity Incentive Equity Incentive
    Plan Awards:     Number Value of Plan Awards: Plan Awards:
  Number of Number of     of Shares Shares Number of Market or
  Securities Securities     or Units or Units Unearned Payout Value of
  Underlying Underlying     of Stock of Stock Shares, Units, Unearned Shares,
  Unexercised Unexercised Option   That That or Other Rights Units or Other
  Options Unearned Exercise Option Have Not Have Not that Have Not Rights that Have
  Exercisable Options Price Expiration Vested Vested Vested Not Vested
Name (#) (#) ($) Date (#) ($)(5) (#)(6) ($)(5)
Christine A. Leahy 20,140  24.29 2/25/2024    
  31,754  37.79 2/19/2025    
  33,928  39.79 3/2/2026    
  40,917  58.90 2/28/2027    
  27,486(1) 13,744(1) 73.49 2/27/2028    
  30,579 61,160(2) 95.57 2/25/2029   18,766(7) 2,473,134
   106,247(3) 98.21 3/9/2030   21,152(8) 2,787,648
Collin B. Kebo 8,534  37.79 2/19/2025    
  1,582  42.68 12/14/2025    
  11,309  39.79 3/2/2026    
  12,275  58.90 2/28/2027    
  10,329  70.00 11/2/2027    
  13,743(1) 6,872(1) 73.49 2/27/2028    
  10,484 20,969(2) 95.57 2/25/2029   6,434(7) 847,924
   41,462(3) 98.21 3/9/2030   8,255(8) 1,087,871
Sona Chawla  51,828(3) 98.21 3/9/2030 3,723(4) 490,649 10,318(8) 1,359,770
Christina M. Corley 27,789  24.29 2/25/2024    
 23,816  37.79 2/19/2025    
  24,504  39.79 3/2/2026    
  34,779  58.90 2/28/2027    
  20,615(1) 10,308(1) 73.49 2/27/2028    
  15,726(2) 31,454(2) 95.57 2/25/2029   9,651(7) 1,271,882
   64,785(3) 98.21 3/9/2030   12,898(8) 1,699,780
Douglas E. Eckrote 27,789  24.29 2/25/2024    
 17,862  37.79 2/19/2025    
  16,964  39.79 3/2/2026    
  20,458  58.90 2/28/2027    
  12,025(1) 6,013(1) 73.49 2/27/2028    
  5,242(2) 10,485(2) 95.57 2/25/2029   3,217(7) 423,961
   20,731(3) 98.21 3/9/2030   4,127(8) 543,934
Mark C. Chong 19,846  58.90 2/28/2027    
 23,974(1) 11,988(1) 73.49 2/27/2028    
  7,863(2) 15,727(2) 95.57 2/25/2029   4,826(7) 636,013
   24,877(3) 98.21 3/9/2030   4,952(8) 652,643
Elizabeth H. Connelly 3,931 7,864 95.57 2/25/2029   2,412(7) 317,938
  14,900(3) 98.21 3/9/2030   2,966(8) 390,892
  Option Awards Stock Awards
Name  Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
  Equity Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
(#)
  Option
Exercise
Price
($)
  Option
Expiration
Date
  Number
of Shares
or Units of
Stock That
Have Not
Vested
(#)(5)
  Market
Value of
Shares or
Units of
Stock That
Have Not
Vested
($)(8)
  Equity Incentive
Plan Awards:
Number of
Unearned
Shares, Units,
or Other Rights
that Have Not
Vested
(#)(5)
  Equity Incentive
Plan Awards:
Market or
Payout Value
of Unearned
Shares, Units or
Other Rights that
Have Not Vested
($)(8)
Christine A. Leahy 17,509  37.79 2/19/2025    
 33,928  39.79 3/2/2026    
 40,917  58.90 2/28/2027    
 41,230  73.49 2/27/2028    
 91,739  95.57 2/25/2029    
 70,831 35,416(1) 98.21 3/9/2030    
 23,321 46,644(2) 154.47 3/9/2031   18,189(9) 3,248,217
  82,137(3) 171.30 2/24/2032   20,677(10) 3,692,567
Albert J. Miralles 2,278 4,557(4) 201.25 9/7/2031 11,619(6) 2,074,987 1,768(9) 315,726
  25,814(3) 171.30 2/24/2032   6,498(10) 1,160,434
Sona Chawla 34,552 17,276(1) 98.21 3/9/2030 1,268(7) 226,482  
 11,448 22,898(2) 154.47 3/9/2031   8,930(9) 1,594,644
  33,441(3) 171.30 2/24/2032   8,419(10) 1,503,451
Christina M. Corley 23,816  37.79 2/19/2025    
 24,504  39.79 3/2/2026    
 34,779  58.90 2/28/2027    
 30,923  73.49 2/27/2028    
 47,180  95.57 2/25/2029    
 43,190 21,595(1) 98.21 3/9/2030    
 11,448 22,898(2) 154.47 3/9/2031   8,930(9) 1,594,644
  33,441(3) 171.30 2/24/2032   8,419(10) 1,503,451
Frederick J. Kulevich 13,743  73.49 2/27/2028    
 14,416  95.57 2/25/2029    
 9,933 4,967(1) 98.21 3/9/2030    
 4,346 8,693(2) 154.47 3/9/2031   3,390(9) 605,379
  18,187(3) 171.30 2/24/2032   4,578(10) 817,600
(1)These stock options were awarded on February 27, 2018, and vest in one-third increments on each of the first through third year anniversaries of the date of grant.
(2)These stock options were awarded on February 25, 2019, and vest in one-third increments on each of the first through third year anniversaries of the date of grant.
(3)These stock options were awarded on March 9, 2020, and vest in one-third increments on each of the first through third year anniversaries of the date of grant.

 2021 Proxy Statement    48

(2)These stock options were awarded on March 9, 2021, and vest in one-third increments on each of the first through third year anniversaries of the date of grant.
Back(3)The stock options were awarded on February 24, 2022, and vest in one-third increments on each of the first through third year anniversaries of the date of grant.
(4)These stock options were awarded on September 7, 2021, and vest in one-third increments on each of the first through third year anniversaries of the date of grant.
(5)RSU and PSU award recipients receive fractional shares upon settlement; however, for purposes of this table, share numbers have been rounded to Contentsthe nearest whole share.
(6)These RSUs were awarded on September 7, 2021, and vest as follows: (i) on March 15, 2023 with respect to 8,082 RSUs; and (ii) on March 15, 2024 with respect to 3,537 RSUs. The amount reported includes RSUs acquired through the deemed reinvestment of dividend equivalents.
(4)(7)These RSUs were awarded on January 21, 2020, and vest in one-third increments on the first through third anniversaries of the date of grant. RSU award recipients receive fractional shares upon settlement; however, for purposesThe amount reported includes RSUs acquired through the deemed reinvestment of this table, share numbers have been rounded to the nearest whole share.dividend equivalents.
(5)(8)The market value of shares or units of stock that have not vested reflects a stock price of $131.79,$178.58, our closing stock price on December 31, 2020.30, 2022. 
(6)(9)PSU award recipients receive fractional shares upon settlement; however, for purposes of this table, share numbers have been rounded to the nearest whole share.
(7)These PSUs were awarded on February 25, 2019March 9, 2021 (with the exception of the PSUs for Mr. Miralles, which were awarded on September 7, 2021) and vest on December 31, 2021,2023, subject to the achievement of the threshold performance goals relating to adjusted FCF and adjusted EPS over the 2019-20212021-2023 performance period. The amounts reported in this column are based on target achievement of the applicable performance goals and include PSUs acquired through the deemed reinvestment of dividend equivalents.
(8)(10)These PSUs were awarded on March 9, 2020February 24, 2022 and vest on December 31, 2022,2024, subject to the achievement of the threshold performance goals relating to adjusted FCF and adjusted EPS over the 2020-20222022-2024 performance period. The amounts reported in this column are based on target achievement of the applicable performance goals and include PSUs acquired through the deemed reinvestment of dividend equivalents.

 

2020

2023 Proxy Statement54

2022 Option Exercises and Stock Vested Table

 

The following table provides information concerning the exercise of stock options and vesting of stock awards during 20202022 for each of the Named Executive Officers.

 

  Option Awards  Stock Awards
Name Number of
Shares Acquired
on Exercise (#)
  Value Realized
on Exercise ($)
  Number of
Shares Acquired
on Vesting (#)(1)
  Value Realized
on Vesting ($)(2)
Christine A. Leahy        16,237   2,139,866
Collin B. Kebo  10,807   1,172,992   8,119   1,069,938
Sona Chawla           
Christina M. Corley        12,178   1,604,902
Douglas E. Eckrote        7,104   936,268
Mark C. Chong  21,358   1,521,291   14,163   1,866,484
Elizabeth H. Connelly           
  Option Awards Stock Awards
Name Number of
Shares Acquired
on Exercise (#)
 Value Realized
on Exercise ($)
 Number of
Shares Acquired
on Vesting (#)(1)
 Value Realized
on Vesting ($)(2)
Christine A. Leahy     38,945 6,954,830
Albert J. Miralles     3,003 517,440
Sona Chawla     20,250 3,623,875
Christina M. Corley     23,747 4,240,737
Frederick J. Kulevich     5,461 975,222
(1)TheIn the case of each of the Named Executive Officers other than Mr. Miralles, the shares reported in this column represent shares acquired upon the vesting of PSU awards granted on February 27, 2018March 9, 2020 and which vested on December 31, 20202022 based on the achievement of performance goals relating to adjusted FCF and adjusted EPS over the 2018-20202020-2022 performance period, including shares acquired through the deemed reinvestment of dividend equivalentsequivalents. The shares reported in this column with respect to Mr. Miralles represent shares acquired upon the vesting of RSUs granted on September 7, 2021 and which vested on March 15, 2022, including shares acquired through December 31, 2020.the deemed reinvestment of dividend equivalents. The shares reported in this column with respect to Ms. Chawla represent both (i) shares acquired upon the vesting of PSU awards as described above, and (ii) shares acquired upon the vesting of RSUs granted on January 21, 2020 and which vested on January 21, 2022, including shares acquired through the deemed reinvestment of dividend equivalents. PSU and RSU award recipients receive fractional shares upon settlement; however, for purposes of this table, share numbers have been rounded to the nearest whole share.
(2)The market value for the 2018 PSU and RSU awards that vested on December 31, 2020during 2022 is based on a stock price of $131.79, ourupon the closing stock price on the applicable date.

2022 Nonqualified Deferred Compensation Table

Pursuant to the NQDC Plan, certain executives, including each of the Named Executive Officers, may defer base salary and amounts payable under the SMIP. Executives may elect to defer up to 50% of their base salary and up to 90% of their SMIP payout. Under the terms of the NQDC Plan, company matching or employer contributions may be credited to the plan, although no such matching or employer contributions were made for 2022. Any matching or employer contributions are subject to vesting in 20% increments over five years. Participants may elect to have amounts paid upon a termination of employment or specified date, with the payout period ranging from five to 15 years, subject to earlier payout upon death or disability. Amounts credited to the NQDC Plan are notionally invested, as elected by the participant, in the same investment options as available under the Company’s 401(k) plan.

2022 Nonqualified Deferred Compensation Table

The following table provides information concerning participation in the NQDC Plan during 2022.

NameExecutive
Contributions
in Last FY
($)(1)
Registrant
Contributions
in Last FY
($)
Aggregate
Earnings in
Last FY
($)(2)
Aggregate
Withdrawals /
Distributions
($)
Aggregate
Balance at
Last FYE
($)(2)
Christine A. Leahy(110,790)776,245
Albert J. Miralles232,000232,000
Sona Chawla
Christina M. Corley
Frederick J. Kulevich
(1)Represents amounts credited in early 2023 with respect deferrals of the 2022 SMIP payout. These amounts are also reported in the “Non-equity incentive plan compensation” column for 2022 in the 2022 Summary Compensation Table.
(2)Because amounts were credited to Mr. Miralles’s account after December 31, 2020.2022, there were no earnings notionally credited to his account with respect to 2022.
(3)Amounts in this column include the following amounts that were previously reported in the Summary Compensation Table as compensation for 2021 and 2020: Ms. Leahy, 2021 - $887,035; 2020 - $0.

 

2020

2023 Proxy Statement55

2022 Potential Payments Upon Termination or Change in Control

 

During 2020,2022, the Named Executive Officers were each subject to a compensation protection agreementCompensation Protection Agreement that provided for certain severance benefits upon a qualifying termination of employment (the “Compensation Protection Agreements”).employment. These severance arrangements have a three-year fixed term (with an expiration date of(which was scheduled to expire on January 1, 2023)2023 and renewed until January 1, 2026 in November 2022), with certain term extensions in the event of a “potential change in control” or “change in control” during the term. Each Named Executive Officer is also a participant in the Company’s equity award program, which provides for accelerated vesting of outstanding equity awards upon certain termination events or a sale of the Company.

 

A description of the material terms of each of the employment and service arrangements that were in effect on December 31, 20202022 and the equity award program as well as estimates of the payments and benefits each Named Executive Officer would receive upon a termination of employment or sale of the Company, are set forth below. The estimates have been calculated assuming a termination date on December 31, 20202022 and the closing price of a share of our common stock on December 31, 2020.30, 2022. The amounts reported below are only estimates and actual payments and benefits to be paid upon a termination of a Named Executive Officer’s employment with the Company or sale of the Company under these arrangements can only be determined at the time of termination or sale of the Company.

 

Compensation Protection Arrangements

 

For purposes of determining severance benefits under the Named Executive Officers’ Compensation Protection Agreements, a qualifying termination means termination of the Named Executive Officer’s employment (1) by the Company other than (A) for “cause,” (B) the Named Executive Officer’s death or (C) the Named Executive Officer’s disability, or (2) by the Named Executive Officer for “good reason.”

 

If the employment of a Named Executive Officer is terminated for any reason other than a qualifying termination of employment, the Named Executive Officer is entitled to receive his or her “accrued obligations.” Accrued obligations include the following: (1) accrued and unpaid base salary; (2) any SMIP bonus, deferred compensation and other cash compensation accrued by the Named Executive Officer to the extent not paid as of the date of termination; and (3) vacation pay, expense reimbursements and other cash entitlements accrued by the Named Executive Officer to the extent not paid as of the date of termination.

 2021 Proxy Statement    49

If the employment of a Named Executive Officer is terminated due to retirement under a retirement plan of the Company or by resignation of the executive other than for Good Reason, the Named Executive Officer also may, in the discretion of the Compensation Committee, be awarded an annual incentive bonus, prorated through the effective date of the Named Executive Officer’s termination of employment. If the employment of a Named Executive Officer is terminated due to the Named Executive Officer’s death or disability, the Named Executive Officer or his or her estate, as applicable, also is entitled to receive the following payments under his or her Compensation Protection Agreement: (1) accrued obligations as defined above and (2) an annual incentive bonus (based on the target bonus under the Company’s SMIP), prorated through the effective date of the Named Executive Officer’s termination of employment.

 

If the employment of a Named Executive Officer is terminated due to a qualifying termination, the Named Executive Officer is entitled to receive the following payments and benefits under his or her Compensation Protection Agreement: (1) accrued obligations as defined above; (2) the portion of the unpaid SMIP bonus that the Named Executive Officer would have received had he or she remained employed by the Company for the full year in which the termination occurs, based on actual performance and prorated through the date of termination; (3) continuation in accordance with the Company’s regular payroll practices of two times the Named Executive Officer’s base salary; (4) payment of two times the Named Executive Officer’s SMIP bonus that would have been earned had the Named Executive Officer remained employed by the Company for the full year in which the termination occurs, based on actual performance (provided that if the termination occurs after a change in control, the SMIP bonus will be equal to two times the Named Executive Officer’s average SMIP bonus for each of the three fiscal years ending prior to the change in control); (5) continuation of certain health and welfare benefits for two years or, if earlier, the date that the Named Executive Officer becomes eligible for each such type of insurance coverage from a subsequent employer (provided, however, that if the Company is unable to provide such continuation benefits to the Named Executive Officer, the Company will instead provide a cash payment, subject to any applicable withholding taxes, that is sufficient to purchase comparable benefits); and (6) outplacement services of up to $20,000.$20,000 (increased to $30,000, effective January 1, 2023). The Compensation Protection Agreements for Ms. Leahy and Ms. Chawla (and, effective January 1, 2023, Ms. Corley) provide that in the event of a termination of employment for any reason other than a termination by the Company for “cause,” then upon the expiration of any continued medical coverage period under her Compensation Protection Agreement and the COBRA continuation coverage period, the executive and her spouse and dependents are entitled to continued access to the Company’s medical plan until the executive and her spouse become eligible for Medicare (or the earlier occurrence of certain other events specified in the executive’s Compensation Protection Agreement), with the full cost of such continued coverage to be paid by the executive. The receipt of all of the payments and benefits above, except payment of accrued obligations, is conditioned upon the Named Executive Officer’s execution of a general release agreement in which he or she waives all claims that he or she might have against the Company and certain associated individuals and entities.

 

Under the terms of the Compensation Protection Agreements, if the payments and benefits to a Named Executive Officer under his or her respective Compensation Protection Agreement or another plan, arrangement or agreement would subject the Named Executive Officer to the excise tax imposed by Section 4999 of the Internal Revenue Code, then such payments will be reduced by the minimum amount necessary to avoid such excise tax, but only if such reduction will result in the Named Executive Officer receiving a higher net after-tax amount.

 

2023 Proxy Statement56

Outstanding Equity Awards

 

Under the terms of the 2020, 20192022, 2021 and 20182020 option awards, the options will become 100% vested upon (i) a termination of employment due to death or disability, (ii) a termination of employment by the Company without cause or by the Named Executive Officer for good reason within two years following a change in control or (iii) a change in control pursuant to which the option awards are not effectively assumed or continued in such transaction. In addition, in the event of the Named Executive Officer’s retirement after the six month anniversary of the date of grant, the options will continue to vest in accordance with the vesting schedule set forth in the award agreement so long as the Named Executive Officer continues to comply with restrictive covenants relating to non-competition, non-solicitationnoncompetition, nonsolicitation and confidentiality through the vesting period.

 

With respect to the outstanding PSU awards, upon a termination of employment due to death or disability, then the PSUs will become fully vested, with the performance goals deemed satisfied at target levels (in the event of a death or termination for disability occurring prior to the 24-month anniversary of the first day of the performance period) or based on the projected level of performance through the end of the performance period (in the event of a death or termination for disability occurring on or after the 24-month anniversary of the first day of the performance period). Upon a termination of employment due to retirement after the six month anniversary of the date of grant, the Named Executive Officer will be entitled to a prorated award based on actual performance through the end of the performance period, subject to the Named Executive Officer’s continued compliance with restrictive covenants relating to non-competition, non-solicitationnoncompetition, nonsolicitation and confidentiality. In the event of a change in control prior to the 24-month anniversary of the first day of the performance period, the performance goals will be deemed to have been satisfied at target performance. If, however, the change in control occurs on or after the 24-month anniversary of the first day of the performance period, the performance goals will be determined by the Compensation Committee based on the projected level of performance through the end of the performance period. In the event of a change in control in which the awards are not effectively assumed, the awards will be settled within 70 days of such change in control. For awards effectively assumed in a change in control, the settlement of the awards will be accelerated if the Named Executive Officer’s employment is terminated without cause or due to good reason within 24 months following the change in control.

 

With respect to Ms. Chawla’s and Mr. Miralles’ outstanding RSU awards, the RSUs will become 100% vested upon (i) a termination of employment due to death or disability, (ii) a termination of employment by the Company without cause or by the Named Executive Officer for good reason within two years following a change in control or (iii) a change in control pursuant to which the RSUs are not effectively assumed or continued in such transaction.

 

 2021 Proxy Statement    50

For purposes of the 2013 LTIP,Company’s equity plans, a change in control generally occurs upon (1) an unapproved change in the majority composition of the Board during a 24-month period, (2) certain acquisitions of 35% or more of the Company’s outstanding voting securities, or (3) certain corporationcorporate transactions, including certain mergers, dissolutions, liquidations or the sale of substantially all of the Company’s assets.

 

With respect to each equity award under the Company’s equity plans, retirement means the Named Executive Officer’s termination of employment after the six month anniversary of the date of grant of the applicable equity award and at a time when (1) the Named Executive Officer has attained age 55 and (2) the sum of the Named Executive Officer’s age and years of employment with or service to the Company or its subsidiaries equals or exceeds 65.

2023 Proxy Statement57

Potential Payments Upon a Qualifying Termination of Employment Absent a Change in Control(1)

 

Name Severance
Payment
($)(2)
  Value of
Accelerated
Equity Awards
($)
  Welfare
Benefits
($)(3)
  Outplacement
($)(4)
  Aggregate
Payments
($)
Christine A. Leahy  4,486,250      37,841   20,000   4,544,091
Collin B. Kebo  2,332,500      35,307   20,000   2,387,807
Sona Chawla  2,427,500      22,508   20,000   2,470,008
Christina M. Corley  2,427,500      37,486   20,000   2,484,986
Douglas E. Eckrote  2,019,577      33,087   20,000   2,072,664
Mark C. Chong  1,676,900      36,082   20,000   1,732,982
Elizabeth H. Connelly  1,657,500      39,805   20,000   1,717,305
NameSeverance
Payment
($)(2)
Value of
Accelerated
Equity Awards
($)
Welfare
Benefits
($)(3)
Outplacement
($)(4)
Aggregate
Payments
($)
Christine A. Leahy7,800,00044,83220,0007,864,832
Albert J. Miralles3,620,00044,18820,0003,684,188
Sona Chawla3,742,50039,66620,0003,802,166
Christina M. Corley3,742,50048,50820,0003,811,008
Frederick J. Kulevich2,595,00044,63820,0002,659,638
(1)A qualifying termination means termination of the Named Executive Officer’s employment (1) by the Company other than (A) for “cause,” (B) the Named Executive Officer’s death or (C) the Named Executive Officer’s disability, or (2) by the Named Executive Officer for “good reason.”
(2)Amounts reported in this column represent two times the sum of (i) the Named Executive Officer’s base salary and (ii) the Named Executive Officer’s annual incentive bonus target for 20202022 multiplied by the 20202022 SMIP payout percentage. Under the Compensation Protection Agreements, the Named Executive Officers are also entitled to a pro rata bonus based on the Company’s actual performance for the year in which termination occurs. Because the SMIP bonus is considered earned as of December 31, 2020,2022, amounts related to the pro rata bonus have been excluded from this table and are reported in the 20202022 Summary Compensation Table as 20202022 compensation.
(3)Represents the estimated value of continued welfare benefits that all Named Executive Officers would be entitled to receive upon a qualifying termination of employment.
(4)Represents the maximum value of outplacement services that all Named Executive Officers would be entitled to receive upon a qualifying termination of employment.

 

Potential Payments Upon Death or Disability or Retirement Table(1)

 

Name Severance
Payment
($)(2)
  Value of
Accelerated
Equity Awards
($)(3)
  Aggregate
Payments
($)
Christine A. Leahy     9,162,237   9,162,237
Collin B. Kebo     3,480,335   3,480,335
Sona Chawla     2,684,290   2,684,290
Christina M. Corley     5,330,215   5,330,215
Douglas E. Eckrote     1,890,423   1,890,423
Mark C. Chong     2,745,458   2,745,458
Elizabeth H. Connelly     1,127,432   1,127,432
NameSeverance
Payment
($)(1)
Value of
Accelerated
Equity Awards
($)(2)
Aggregate
Payments
($)
Christine A. Leahy11,509,71111,509,711
Albert J. Miralles3,739,0733,739,073
Sona Chawla5,508,5715,508,571
Christina M. Corley5,629,2075,629,207
Frederick J. Kulevich2,164,1662,164,166
(1)As noted above, the terms of our outstanding equity awards include retirement vesting provisions and, as of December 31, 2020, Ms. Leahy and Mr. Eckrote were eligible for retirement vesting under such equity awards. Under the terms of the 2020, 2019 and 2018 equity awards, each of these individuals would continue to vest in their option grants and receive prorated payouts based upon actual performance with respect to their PSU awards upon retirement, provided that they continued to comply with non-competition, non-solicitation and confidentiality restrictive covenants during the vesting period.
(2)The Named Executive Officers are entitled to a pro rata bonus based on target for the year in which termination occurs upon death or a termination due to disabilitydisability. Because the SMIP bonus is considered earned as of December 31, 2022, amounts related to the pro rata bonus have been excluded from this table and are reported in the 2022 Summary Compensation Table as 2022 compensation.
(2)Represents the value of the accelerated vesting of the 2022, 2021 and 2020 stock option awards and the 2022 and 2021 PSUs, assuming target achievement of the applicable performance goals upon death or a termination due to disability. The value of the accelerated vesting of the equity awards reported in this table is based upon our closing stock price of $178.58 on December 30, 2022. Excluded from this column are the 2020 PSUs that vested based upon Company performance and continued service of the Named Executive Officer through December 31, 2022 and which are reflected in the 2022 Option Exercises and Stock Vested Table.

Potential Payments Upon Retirement Table(1)

NameSeverance
Payment
($)(2)
Value of
Accelerated
Equity Awards
($)(3)
Aggregate
Payments
($)
Christine A. Leahy7,965,2617,965,261
Albert J. Miralles
Sona Chawla
Christina M. Corley
Frederick J. Kulevich1,417,3071,417,307
(1)As noted above, the terms of our outstanding equity awards include retirement vesting provisions and, as of December 31, 2022, Ms. Leahy and Mr. Kulevich were eligible for retirement vesting under such equity awards.
(2)The Named Executive Officers may receive, at the Compensation Committee’s discretion, a pro rata bonus for the year of retirement. Because the SMIP bonus is considered earned as of December 31, 2020,2022, amounts related to the pro rata bonus have been excluded from this table and are reported in the 20202022 Summary Compensation Table as 20202022 compensation.
(3)Represents the value of the accelerated vesting in the case of death or disability and continued vesting in the case of retirement of the 2020, 20192022, 2021 and 20182020 stock option awards and the pro rata vesting of the 20202022 and 20192021 PSUs, assuming target achievement of the applicable performance goals.goals upon retirement and continued compliance with noncompetition, nonsolicitation and confidentiality restrictive covenants during the vesting period. The value of the accelerated vesting of the equity awards reported in this table is based upon our closing stock price of $131.79$178.58 on December 30, 2022. Excluded from this column are the 2020 PSUs that vested based upon Company performance and continued service of the Named Executive Officer through December 31, 2020.2022 and which are reflected in the 2022 Option Exercises and Stock Vested Table.

 

 2021 Proxy Statement    51

2023 Proxy Statement58
 

Potential Payments Upon a Qualifying Termination of Employment Following a Change in Control(1)

 

Name Severance
Payment
($)(2)
  Value of
Accelerated
Equity
Awards
($)(3)
  Welfare
Benefits
($)(4)
  Outplacement
($)(5)
  Aggregate
Payments
($)
Christine A. Leahy  4,103,077   11,845,047   37,841   20,000   16,005,965
Collin B. Kebo  2,307,492   4,488,224   35,307   20,000   6,851,023
Sona Chawla  2,500,000   3,590,803   22,508   20,000   6,133,311
Christina M. Corley  2,538,068   6,887,362   37,486   20,000   9,482,916
Douglas E. Eckrote  2,500,126   2,394,366   33,087   20,000   4,947,579
Mark C. Chong  1,703,107   3,392,558   36,082   20,000   5,151,747
Elizabeth H. Connelly  2,073,200   1,494,006   39,805   20,000   3,627,011
NameSeverance
Payment
($)(2)
Value of
Accelerated
Equity Awards
($)(3)
Welfare
Benefits
($)(4)
Outplacement
($)(5)
Aggregate
Payments
($)
Christine A. Leahy5,712,35711,509,71144,83220,00017,286,900
Albert J. Miralles4,103,2003,739,07344,18820,0007,906,461
Sona Chawla3,308,9505,508,57139,66620,0008,877,187
Christina M. Corley3,369,5005,629,20748,50820,0009,067,215
Frederick J. Kulevich2,122,3332,164,16644,63820,0004,351,137
(1)A qualifying termination means termination of the Named Executive Officer’s employment following a change in control (1) by the Company other than (A) for “cause,” (B) the Named Executive Officer’s death or (C) the Named Executive Officer’s disability, or (2) by the Named Executive Officer for “good reason.” Under the terms of the Compensation Protection Agreements, if the payments and benefits to a Named Executive Officer under his or her respective Compensation Protection Agreement or another plan, arrangement or agreement would subject the Named Executive Officer to the excise tax imposed by Section 4999 of the Internal Revenue Code, then such payments will be reduced by the minimum amount necessary to avoid such excise tax, if such reduction would result in the Named Executive Officer receiving a higher net after-tax amount. The amounts reflected in this table do not reflect the application of any reduction in compensation or benefits pursuant to the terms of the Compensation Protection Agreements.
(2)Amounts reported in this column represent two times the sum of (i) the Named Executive Officer’s base salary and (ii) the Named Executive Officer’s average SMIP bonus for each of the three fiscal years ending prior to the change in control (or such shorter period of time if the Named Executive Officer has been employed by the Company for less than three full calendar years or target opportunity if the Named Executive Officer has been employed for less than one year). Under the Compensation Protection Agreements, the Named Executive Officers are also entitled to a pro rata bonus based on the Company’s actual performance for the year in which termination occurs. Because the SMIP bonus is considered earned as of December 31, 2020,2022, amounts related to the pro rata bonus have been excluded from this table and are reported in the 20202022 Summary Compensation Table as 20202022 compensation.
(3)Represents the value of equity awards that would become vested upon a qualifying termination of employment within two years following a change in control or upon a change in control in which the outstanding awards are not effectively assumed, assuming target achievement of the applicable performance goals. The value of the accelerated vesting of the equity awards reported in this table is based upon our closing stock price of $131.79$178.58 on December 31, 2020.30, 2022.
(4)Represents the estimated value of continued welfare benefits that all Named Executive Officers would be entitled to receive upon a qualifying termination of employment.
(5)Represents the maximum value of outplacement services that all Named Executive Officers would be entitled to receive upon a qualifying termination of employment.

 

2023 Proxy Statement59

Pay Ratio

 

As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, the Company is providing the following disclosure about the relationship of the annual total compensation of our coworkers to the annual total compensation of Ms. Leahy, our Chair, President and Chief Executive Officer. SEC rules for identifying the median employee and calculating the pay ratio allow companies to apply various methodologies and assumptions and, as a result, the pay ratio reported by us may not be comparable to the pay ratio reported by other companies. Given the leverage of our executive compensation program towards performance-based elements, we expect that our pay ratio disclosure will fluctuate year-to-year based on the Company’s performance against the pre-established performance goals.

 

Ratio

 

For 2020,2022,

 

The median of the annual total compensation of all of our coworkers, other than Ms. Leahy, was $96,922.$107,403.
Ms. Leahy’s annual total compensation, as reported in the Total column of the 20202022 Summary Compensation Table, was $6,342,674.$11,115,822.
Based on this information, the ratio of the annual total compensation of Ms. Leahy to the median of the annual total compensation of all coworkers is estimated to be 65103 to 1. We believe this ratio is a reasonable estimate calculated in a manner consistent with Item 402(u) of Regulation S-K.

 

Identification of Median Coworker

 

We selectedAs permitted under the SEC executive compensation disclosure rules, we are electing to use the same median employee that we used for purposes of preparing our 2021 pay ratio disclosure. Since December 1, 2020 as2021 (the date used to select the date on which to determine our2021 median coworker.employee), there have been no changes in the Company’s employee population or employee compensation arrangements that we believe would significantly impact the pay ratio disclosure. For purposes of identifying the median coworker from our 20202021 coworker population base of approximately 10,00013,800 coworkers, we considered the gross cash compensation of all of our coworkers, as compiled from our payroll records. We selected gross cash compensation as it represents the principal form of compensation delivered to all of our coworkers and is readily available in each country. In addition, we measured compensation for purposes of determining the median coworker using the 12-month period ending December 1, 2020.2021. Compensation paid in foreign currencies was converted to U.S. dollars based on a weighted average exchange rate for the relevant period.

 

Pay Versus Performance

 2021 Proxy Statement    52

Provided below is the Company’s “Pay Versus Performance” disclosure as required pursuant to Item 402(v) of Regulation S-K under the Exchange Act. As required by Item 402(v), we have included:

A list of the most important measures that our Compensation Committee used in 2022 to link pay calculated in accordance with Item 402(v) (referred to as “Compensation Actually Paid” or “CAP”) to Company performance;
A table that compares the total compensation of our Named Executive Officers as presented in the Summary Compensation Table (“SCT”) for each year to CAP and that compares CAP to specified performance measures; and
Graphs and narratives that describe:
— the relationship between our cumulative total shareholder return (“TSR”) and the TSR of the S&P 500 Information Technology Index (“Peer Group TSR”); and
the relationship between CAP and our TSR;
the relationship between CAP and adjusted EPS, which is our Company Selected Measure (“CSM”); and
the relationship between CAP and Net Income.

This disclosure has been prepared in accordance with Item 402(v) and does not necessarily reflect value actually realized by the Named Executive Officers or how the Compensation Committee evaluates compensation decisions in light of Company or individual performance. In particular, the Compensation Committee does not use CAP as a basis for making compensation decisions. Please refer to the CD&A section of this proxy statement for a discussion of our executive compensation program objectives and the ways in which we design our program to align executive compensation with Company performance.

2023 Proxy Statement60
 

Performance Measures Used to Link Company Performance and CAP to the Named Executive Officers

The following is a list of financial performance measures, which in our assessment represent the most important measures used by the Company to link CAP for the Named Executive Officers in 2022. Please see the CD&A for a further description of these metrics, including how they are calculated for incentive purposes, and how they are used in the Company’s executive compensation program, including the SMIP and 2022 long-term incentive program.

Measure

CDW Stock Price
Adjusted EPS
Adjusted FCF
Non-GAAP Operating Income

Pay Versus Performance Table

      Average Summary Average Value of Initial Fixed $100
Investment Based On:(4)
    
Year(1) Summary
Compensation
Table Total for
PEO
($)(2)
 Compensation
Actually Paid
to PEO
($)(3)
 Compensation
Table Total for
Non-PEO Named
Executive Officers
($)(2)
 Compensation
Actually Paid to
Non-PEO Named
Executive Officers
($)(3)
 Total
Shareholder
Return
($)
 Peer Group
Total
Shareholder
Return
($)(5)
 Net Income
($) (In
Millions)
 Adjusted
EPS
($)(6)
2022 11,115,822 8,181,554 4,086,715 3,226,746 129.37 134.82 1,114.5 9.86
2021 8,943,903 30,941,939 4,110,659 10,533,615 146.60 189.64 988.6 7.96
2020 6,342,674 8,005,224 2,621,777 3,104,330 93.45 142.21 788.5 6.59
(1)Ms. Leahy has served as the Principal Executive Officer (“PEO”) for the entirety of 2022, 2021 and 2020 and our other Named Executive Officers for the applicable years were as follows:
2022: Albert J. Miralles; Sona Chawla; Christina M. Corley; and Frederick J. Kulevich.
2021: Albert J. Miralles; Sona Chawla; Christina M. Corley; Elizabeth H. Connelly; and Collin B. Kebo.
2020: Collin B. Kebo; Sona Chawla; Christina M. Corley; Douglas E. Eckrote; Mark C. Chong; and Elizabeth H. Connelly
(2)Amounts reported in this column represent (i) the total compensation reported in the SCT for the applicable year in the case of Ms. Leahy and (ii) the average of the total compensation reported in the SCT for the applicable year for our other Named Executive Officers reported for the applicable year other than Ms. Leahy.
(3)To calculate CAP, adjustments were made to the amounts reported in the SCT for the applicable year. The primary difference between the calculation of SCT total compensation and CAP relates to the calculation of stock and option awards:

SCT CALCULATION IS BASED ON:COMPANY CAP CALCULATION IS BASED ON:
Grant date fair value of stock and option awards granted during the yearYear over year change in the fair value of stock and option awards that are unvested as of the end of the year, or vested or were forfeited during the year

2023 Proxy Statement61

EQUITY COMPENSATION PLAN INFORMATIONA reconciliation of the adjustments for Ms. Leahy and for the average of the other Named Executive Officers is set forth in the table below.

 

        Year Summary
Compensation
Table Total
($)(a)
 (Minus)
Grant Date
Fair Value of
Stock Option and
Stock Awards
Granted in
Fiscal Year
($)(b)
 Plus
Fair Value at
Fiscal Year-End of
Outstanding and
Unvested Stock
Option and Stock
Awards Granted in
Fiscal Year
($)(c)
 Plus/(Minus)
Change in
Fair Value of
Outstanding and
Unvested Stock
Option and Stock
Awards Granted in
Prior Fiscal Years
 ($)(d)
 Plus
Fair Value at
Vesting of Stock
Option and Stock
Awards Granted
in Fiscal Year that
Vested During
Fiscal Year
 ($)(e)
  Plus/(Minus)
Change in Fair Value
as of Vesting Date
of Stock Option
and Stock Awards
Granted in Prior Years
for which Applicable
Vesting Conditions
were Satisfied During
Fiscal Year
($)(f)
 (Minus)
Fair Value as of Prior
Fiscal Year-End of
Stock Option and
Stock Awards Granted
in Prior Fiscal Years
that Failed to Meet
Applicable Vesting
Conditions During
Fiscal Year
($)(g)
 Equals
Compensation
Actually Paid
($)
 PEO                   
 2022 11,115,822 7,036,821 9,036,522 (2,226,247)   (2,707,722)  8,181,554
 2021 8,943,903 5,573,117 12,199,333 11,574,105    3,797,715   30,941,939
 2020 6,342,674 4,099,541 6,618,206 379,714    (1,235,829)  8,005,224
 Other Named Executive Officers (Average)(h)            
 2022 4,086,715 2,374,897 3,051,560 (774,976)   (761,656)  3,226,746
 2021 4,110,659 2,348,185 4,364,838 3,546,967    859,335   10,533,615
 2020 2,621,777 1,488,976 2,351,071 56,279    (435,820)  3,104,330
(a)Represents Total Compensation as reported in the SCT for the indicated fiscal year. For the other Named Executive Officers, amounts shown represent averages.
(b)Represents the grant date fair value of the stock option and stock awards granted during the indicated fiscal year, calculated in accordance with ASC718. See Note 13 to the Audited Financial Statements included in our Form 10-K for the fiscal year ended December 31, 2022 for a discussion of the relevant assumptions used in calculating these amounts.
(c)Represents the fair value as of the indicated fiscal year-end of the outstanding and unvested option awards and stock awards granted during such fiscal year, calculated in accordance with the methodology used for financial reporting purposes, including the value associated with the accrual of any dividend equivalent rights. 
(d)Represents the change in fair value during the indicated fiscal year of each option award and stock award that was granted in a prior fiscal year and that remained outstanding and unvested as of the last day of the indicated fiscal year, calculated in accordance with the methodology used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on an estimate of the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year, including the value associated with the accrual of any dividend equivalent rights.  
(e)Represents the fair value at vesting of the option awards and stock awards that were granted and vested during the indicated fiscal year, calculated in accordance with the methodology used for financial reporting purposes, including the value associated with the accrual of any dividend equivalent rights.  
(f)Represents the change in fair value, measured from the prior fiscal year-end to the vesting date, of each option award and stock award that was granted in a prior fiscal year and which vested during the indicated fiscal year, calculated in accordance with the methodology used for financial reporting purposes, including the value associated with the accrual of any dividend equivalent rights. 
(g)Represents the fair value as of the last day of the prior fiscal year of the option award and stock awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, calculated in accordance with the methodology used for financial reporting purposes. 
(h)See footnote 1 above for the Named Executive Officers included in the average for each year.

(4)Pursuant to rules of the SEC, the comparison assumes $100 was invested on December 31, 2019. Historic stock price performance is not necessarily indicative of future stock price performance.
(5)The TSR Peer Group consists of S&P 500 Information Technology Index.
(6)The Company determined that adjusted EPS is the most important financial performance measure used to link CAP to Company performance given it impacts the vesting of 50% of the PSUs and also encompasses Non-GAAP operating income performance, the sole financial measure under our SMIP. In addition, we believe that over the long-term, our earnings per share is the most significant driver of CDW’s stock price performance, which impacts the value of equity awards granted to the Named Executive Officers, the largest component of our executive compensation program. Adjusted EPS is defined as non-GAAP net income plus/minus extraordinary, non-recurring items divided by the weighted average common shares outstanding on a diluted basis. For purposes of determining adjusted EPS, non-GAAP net income is defined as net income, adjusted for the items set forth in the Company’s earnings releases which may include, among other items, amortization of intangibles, non-cash equity-based compensation and associated taxes, losses or gains from the extinguishment of debt and acquisition and integration expenses. The amount reported for each reporting year in this table represents the adjusted EPS, as calculated for the first year of the PSU performance cycle that commenced in the applicable reporting year.

Relationship Between Pay and Performance

As discussed in our CD&A, our executive compensation program is designed to drive sustained meaningful profitable growth and stockholder value creation. We believe our executive compensation programs are well designed and aligned to shareholder interests. The CAP for each of our Named Executive Officers is reflective of our stock price performance over time as well as varying levels of achievement under our annual and long-term incentive programs.

2023 Proxy Statement62

1. TSR: Company versus Peer Group

As shown in the chart below, the Company’s 3-year cumulative TSR for the period of 2020-2022 is less than the 3-year cumulative TSR for companies included in our peer group TSR. However, the Company’s TSR performance for the 5-year TSR (2018-2022) outperformed the peers, which is also illustrated in our 2022 10-K performance graph.

2. CAP Versus TSR

As shown in the chart below, the PEO’s and other Named Executive Officers’ CAP amounts align with the Company’s TSR over the three-year period reported in the chart. This is due primarily to the Company’s use of long-term incentives, particularly a significant weighting in stock options, the value of which are tied directly to stock price.

2023 Proxy Statement63

3. CAP Versus Adjusted EPS (Company Selected Measure)

The chart below demonstrates the relationship between CAP amounts for our PEO and our other Named Executive Officers and our adjusted EPS for the applicable fiscal year. Variations in the CAP amounts for our PEO and other Named Executives Officers are due in large part to the significant emphasis the Company places on long-term incentives, the value of which fluctuates most significantly based on the vesting level of our PSU awards and changes in stock price over time. Adjusted EPS is viewed as the most important financial measure to link CAP and Company performance given it impacts the vesting of 50% of the PSUs and it also encompasses Non-GAAP operating income performance, the sole financial measure under our SMIP. In addition, we believe that over the long-term, our earnings per share is the most significant driver of CDW’s stock price performance, which impacts the value of equity awards granted to the PEO and other Named Executive Officers, the largest component of our executive compensation program.

4. CAP Versus Net Income

The chart below demonstrates the relationship between CAP amounts for our PEO and our other Named Executive Officers and our net income. Variations in the CAP amounts for our PEO and other Named Executives Officers are due in large part to the significant emphasis the Company places on long-term incentives, the value of which fluctuates most significantly based on the vesting level of our PSU awards and changes in stock price over time.

2023 Proxy Statement64

PROPOSAL 3

Advisory Vote on the Frequency of the Advisory Vote to Approve Named Executive Officer Compensation

Pursuant to Section 14A of the Exchange Act, we are offering our stockholders an opportunity to cast an advisory vote on the frequency of the non-binding stockholder advisory vote to approve named executive officer compensation. The options are to hold the advisory vote to approve named executive officer compensation every year, every two years or every three years. When this advisory vote was last held in 2017, stockholders indicated their support for the non-binding advisory vote to approve named executive officer compensation to be held every year and the Company continued to hold this non-binding advisory vote every year. Although the vote is non-binding, we value continuing and constructive feedback from our stockholders on executive compensation and other important matters. The Board of Directors and the Compensation Committee will take into consideration the voting results when determining how often a non-binding stockholder advisory vote to approve the compensation of our named executive officers should occur in the future.

The Board continues to believe that holding an advisory vote to approve named executive officer compensation every year is the best approach for the Company at this time based on a number of considerations. These considerations include that this frequency aligns with the interests of stockholders, provides more consistent and direct communication and reflects sound corporate governance principles. While the Board recommends an annual advisory vote to approve named executive officer compensation, the proxy card provides stockholders with four choices with respect to this proposal: (1) 1 year; (2) 2 years; (3) 3 years; or (4) abstaining from voting on the proposal.

PROPOSAL 3: THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR 1 YEAR AS THE FREQUENCY OF THE NON-BINDING ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.

2023 Proxy Statement65

Equity Compensation Plan Information

The following table provides information as of December 31, 20202022 regarding the number of shares of our common stock that may be issued under our equity compensation plans.

 

December 31, 2020 A B C
  Number of Securities    
  to be Issued Weighted Average Number of Securities Remaining
  upon Exercise of Exercise Price of Available for Future Issuance Under
  Outstanding Options, Outstanding Options, Equity Compensation Plans (Excluding
Plan Category Warrants and Rights Warrants and Rights Securities Reflected in Column A)
Equity Compensation Plans Approved by Stockholders 5,378,311(1) $        73.71(2) 3,006,912(3)
Equity Compensation Plans Not Approved by Stockholders   
Total 5,378,311 $            73.71 3,006,912
December 31, 2022 A  B  C 
Plan Category Number of Securities to
be Issued upon Exercise
of Outstanding Options,
Warrants and Rights
  Weighted Average
Exercise Price of
Outstanding Options,
Warrants and Rights
  Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation Plans
(Excluding Securities
Reflected in Column A)
 
Equity Compensation Plans
Approved by Stockholders
  5,131,740(1)     $104.23(2)  8,114,678(3)
Equity Compensation Plans Not
Approved by Stockholders
         
Total  5,131,740  $104.23   8,114,678 
(1)Includes 3,965,4523,499,301 shares issuable pursuant to outstanding stock options, 302,781510,289 shares issuable pursuant to outstanding restricted stock unitsRSUs (includes 98,04377,153 vested restricted stock unitsRSUs on which settlement into shares has been deferred by certain of our non-employee directors and shares issuable pursuant to restricted stock unitsRSUs acquired through the deemed reinvestment of dividend equivalents) and 1,110,0781,122,150 shares issuable pursuant to outstanding performance shares unitsPSUs (assumes maximum achievement of the applicable performance goals (equivalent to 607,836 performance shares units627,888 PSUs at target) and includes shares issuable pursuant to performance share unitsPSUs acquired through the deemed reinvestment of dividend equivalents) under our 2013 Long-Term Incentive Plan..
(2)Excludes restricted stock unitsRSUs and performance share unitsPSUs that convert to shares of common stock from determination of Weighted Average Exercise Price.
(3)Includes 362,544870,676 shares available under our Coworker Stock Purchase Plan (“CSPP”). The CSPP provides the opportunity for eligible coworkers to acquire shares of our common stock at a 5% discount. There is no compensation expense associated with the CSPP.

 

 2021 Proxy Statement    53

2023 Proxy Statement66
 

PROPOSAL 3 —4

Ratification of Selection of Independent Registered Public Accounting Firm

 

Engagement of Independent Registered Public Accounting Firm

 

The Audit Committee of the Board of Directors is responsible for the appointment, compensation, evaluation, retention and oversight of the work performed by the Company’s independent registered public accounting firm (“Independent Auditor”). The Audit Committee approved the appointment of Ernst & Young LLP (“EY”) as the Company’s Independent Auditor for 2021.2023. EY has served as the Company’s Independent Auditor since 2011. The Audit Committee reviews the performance and independence of the Independent Auditor annually.

 

The Audit Committee and the Board believe that the continued retention of EY to serve as the Company’s Independent Auditor is in the best interests of the Company and its stockholders. Although the Company is not required to seek stockholder approval or ratification of this appointment, the Board believes that doing so is consistent with good corporate governance practices. If the appointment is not ratified, the Audit Committee will explore the reasons for stockholder rejection and will reconsider the appointment. Even if the appointment is ratified, the Audit Committee may, in its discretion, direct the appointment of a different Independent Auditor if the Audit Committee determines that such a change would be in the best interests of the Company and its stockholders. Representatives of EY are expected to be present at the Annual Meeting, will have an opportunity to make a statement if they desire to do so, and will be available to respond to questions.

 

In determining whether to reappoint the Independent Auditor, the Audit Committee annually considers several factors, including:

In determining whether to reappoint the Independent Auditor, the Audit Committee annually considers several factors, including:
Technical expertise;
The quality and efficiency of work performed;
The quality of discussions and feedback;
Management’s input on EY’s overall performance;
The mandatory rotation of the Independent Auditor’s lead engagement partner every five years;
Data related to audit quality and performance, including recent PCAOB inspection reports on the firm;
Independence and objectivity; and
Reasonableness of fees
In conjunction with the mandated rotation of the Independent Auditor’s lead engagement partner, the Audit Committee Chair and management are involved in the selection of EY’s lead engagement partner.

 

In conjunction with the mandated rotation of the Independent Auditor’s lead engagement partner, the Audit Committee Chair and management are involved in the selection of EY’s lead engagement partner.

 2021 Proxy Statement    54

2023 Proxy Statement67
 

Fees Paid to EY

 

The following is a summary and description of fees for services provided by EY in 20202022 and 2019.2021.

 

Global Fees (In

(In thousands)

 

  Years Ended
  December 31,
Service 2020  2019
Audit fees   $3,644  $3,264
Audit-related fees  29   28
Tax fees  33   212
Total fees $3,706  $3,504
  Years Ended December 31,
Service 2022  2021
Audit fees  $4,247    $4,172
Audit-related fees  33   645
Tax fees  593   18
Total fees $4,873  $4,835

 

Audit FeesFees. . Consists principally of fees related to the integrated audit of the Company’s consolidated financial statements and internal control over financial reporting, and the review of the consolidated financial statements included in the Company’s quarterly reports on Form 10-Q. Also includes services and procedures performed in connection with the Company’s SEC filings related to securities offerings as well as other SEC filings.filings, and statutory audits.

 

Audit-Related FeesFees. . Consists of fees related to employee benefit plans.plans and financial due diligence.

 

Tax FeesFees. . Consists principally of fees related to tax advice, tax compliance and tax due diligence.

 

Audit Committee Approval Policies and Procedures

 

Pursuant to its charter, the Audit Committee is responsible for pre-approving all audit and permissible non-audit services provided to the Company by its independent registered public accounting firm, subject to any exceptions in the Exchange Act. The Audit Committee may delegate to one or more of its members the authority to grant such pre-approvals, provided that any decisions of such member or members to grant pre-approvals must be presented to the full Audit Committee at its next scheduled meeting.

 

The services provided by EY were pre-approved by the Audit Committee. The Audit Committee has considered whether the provision of the above-noted services is compatible with maintaining the independence of the Independent Auditor and has determined, consistent with advice from EY, that the provision of such services has not adversely affected EY’s independence.

 

The Board of Directors and the Audit Committee recommend a vote FOR ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021.

PROPOSAL 4: THE BOARD OF DIRECTORS AND THE AUDIT COMMITTEE RECOMMEND A VOTE FOR RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2023.

 

 2021 Proxy Statement    55

2023 Proxy Statement68
 

AUDIT COMMITTEE REPORT

Audit Committee Report

 

The Audit Committee is comprised of sixfive independent directors. The Committee operates under a written charter adopted by the Board, which is available on the Governance section of the Company’s Investor Relations website at www.cdw.cominvestor.cdw.com.

 

Management is responsible for the Company’s financial statements and overall financial reporting process, including the Company’s internal controls. Management also is responsible for reporting on the effectiveness of the Company’s internal control over financial reporting. The Independent Auditor is responsible for conducting an independent audit in accordance with generally accepted auditing standards and issuing an opinion on the accuracy of the Company’s consolidated financial statements. The independent registered public accounting firm also is responsible for issuing an attestation report on the effectiveness of the Company’s internal control over financial reporting based upon its audit. The Audit Committee is responsible for monitoring and oversight of these processes.

 

As part of its oversight responsibilities, the Audit Committee discusses with, and receives regular status reports from, the Independent Auditor and the head of the Company’s internal audit function (the “Internal Auditor”) on the overall scope and plans for their audits of the Company, including their scope and plans for evaluating the effectiveness of internal control over financial reporting. The Audit Committee meets with the Independent Auditor, with and without management present, and with the Company’s Chief Financial Officer, Controller and Chief Accounting Officer, Internal Auditor, General Counsel, and Chief Technology Officer and other members of management to discuss, among other things, the items noted below; the results of EY and the Internal Auditor’s audits of the Company; the quality of the financial reporting process; the performance of the Independent Auditor and the Internal Auditor; the Company’s compliance and ethics programs; enterprise risk management; and cybersecurity.

 

Prior to the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20202022 with the SEC, the Audit Committee:

 

Reviewed and discussed with management the Company’s audited consolidated financial statements included in the Form 10-K and considered management’s view that the financial statements present fairly, in all material respects, the Company’s financial condition and results of operations.
Reviewed and discussed with management and the Independent Auditor, the effectiveness of the Company’s internal control over financial reporting, including management’s report and the Independent Auditor’s attestation report on that topic.
Discussed with the Independent Auditor the matters related to the conduct of its audit that are required to be communicateddiscussed by auditors to audit committeesthe applicable requirements of the Public Company Accounting Oversight Board (“PCAOB”) and the SEC and matters related to the fair presentation of the Company’s financial condition and results of operations, including critical accounting estimates and judgments.
Received the required written communicationsdisclosures and the letter from the Independent Auditor that disclose all relationships that may reasonably be thought to bear on itsrequired by applicable requirements of the PCAOB regarding the Independent Auditor’s communications with the Audit Committee concerning independence, and to confirm its independence from the Company. Based upon these communications, the Audit Committeehas discussed with the Independent Auditor its independence from the Company.Independent Auditor’s independence. In considering the independence of the Independent Auditor, the Audit Committee took into consideration the amount and nature of the fees paid to the firm for non-audit services, as described above.

 

In reliance on the review and discussions described above, the Audit Committee has recommended to the Board of Directors that the audited consolidated financial statements be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020,2022, for filing with the SEC.

 

Respectfully submitted by the Audit Committee of the Board of Directors.

 

Virginia C. Addicott Chair

James A. Bell,
Benjamin D. Chereskin
Anthony R. Foxx*
Chair

Marc E. Jones*

David W. Nelms

Donna F. Zarcone

 

**Appointed January 1, 2021to the Committee as of February 6, 2023

 

 2021 Proxy Statement    56

2023 Proxy Statement69

 

PROPOSAL 4 —5

Approval of the Amendment to the Company’s Certificate of Incorporation to EliminateAllow Stockholders the Supermajority Voting Requirement in Article Eleven andRight to Make Certain Non-Substantive ChangesCall Special Meetings

 

This Proposal 4 relates to each of the proposed amendments described below:

Removal of the Supermajority Voting Requirement in Article Eleven

Article Eleven of our Certificate of Incorporation currently provides that no provision of Article Six, Article Seven, Article Eight, Article Ten, Article Eleven or Article Twelve (the “Affected Charter Provisions”) of our Certificate of Incorporation may be altered, amended or repealed in any respect, nor may any provision of our Certificate of Incorporation or our Bylaws inconsistent therewith be adopted, unless such alteration, amendment, repeal or adoption is approved byAfter careful consideration, our Board of Directorshas unanimously adopted, and affirmative vote of holders of at least 66 2/3% of the voting power of all outstanding shares of stock entitled to vote generally in the election of directors, voting together as a single class, at a meeting of the Company’srecommends that our stockholders called for that purpose. Article Six relates to the number and class of directors, the election and term of directors, newly created directorships and filling vacancies, the removal of directors and advance notice requirements for stockholder proposals. Article Seven relates to limitation of liability of directors. Article Eight relates to stockholder action by written consent and special meetings of stockholders. Article Ten relates to business combinations with interested stockholders. Article Eleven relates to the required vote for amendmentsapprove, an amendment (the “Proposed Special Meeting Right Amendment”) to our Certificate of Incorporation to enable the adoption of a special meeting right for stockholders. If stockholders approve the Proposed Special Meeting Right Amendment, as described in more detail below, the Company’s Bylaws will be amended to specify the procedures for calling a special meeting. The Proposed Special Meeting Right Amendment is set forth in Article Eight of the Certificate of Incorporation attached as Appendix C, with deleted text indicated by red strikethroughs and Bylaws. Article Twelve relatesnew text underlined in red. This summary of the Proposed Special Meeting Right Amendment is qualified in its entirety by reference to exclusive forum for certain actions.Appendix C.

 

The Proposed Special Meeting Right Amendment

As part

Delaware law does not grant stockholders of a corporation the absolute right to call or to request that the corporation call a special meeting. Rather, it provides that special meetings of stockholders may be called by the board of directors or by such person or persons as may be authorized by the certificate of incorporation or by the bylaws of the corporation. The Certificate of Incorporation currently allows special meetings of stockholders to be called by or at the direction of the Board pursuant to a written resolution adopted by the affirmative vote of the majority of the total number of directors. If this Proposed Special Meeting Right Amendment is approved by stockholders, special meetings may also be called by the Board or the Chair of the Board upon the written request of stockholders holding at least 25% of our outstanding shares of common stock and who otherwise comply with the requirements set forth in the Bylaws. The Proposed Special Meeting Right Amendment will not affect our Board’s ongoing evaluationexisting authority to call special meetings of stockholders.

Purpose and Effect of the Proposed Special Meeting Right Amendment

Provisions disallowing stockholders to call special meetings are intended to serve the best interests of stockholders as a whole by avoiding the potential for abuse of the right by a small minority of shareholders for self-interested actions and the associated substantial expenses and business disruption. The Board recognizes that convening a special meeting can result in substantial expenses to CDW and the diversion of significant time and attention of our corporate governance practicesBoard and reviewmanagement away from their primary focus of current corporate governance trends,operating our business and creating long-term stockholder value. However, following the 2022 annual meeting, where stockholders expressed support for a non-binding stockholder proposal to allow action by written consent without a meeting, the Board consideredrecognizes that stockholders consider the advantagesability to act in between annual meetings to be an important right. To balance these interests, the Board is submitting the Proposed Special Meeting Right Amendment to stockholder vote, which, together with the proposed changes to the Bylaws, would allow a significant minority of shareholders to call special meetings that they deem necessary to discuss critical, time-sensitive issues that cannot wait until our next annual meeting.

To better inform the Board’s recommendation, CDW sought feedback from stockholders during the robust engagement effort launched following the 2022 annual meeting, including their preferences for the ownership threshold required to exercise the right. While our stockholders expressed a variety of preferences and disadvantagesranges, either in the engagement or in their published policies, we found broad support for a 25% ownership threshold, which was a significant factor in driving the Proposed Special Meeting Right Amendment. See “Adoption of Special Meeting Right in Response to 2022 Written Consent Stockholder Proposal” for more information regarding our engagement and the feedback we received from our stockholders regarding this supermajority voting requirement. After careful consideration,matter.

Additionally, a 25% ownership threshold is consistent with market practice. According to data collected by FactSet, as of March 20, 2023, approximately 50.9% of the S&P 500 companies that afford a Special Meeting Request Right have set the ownership threshold at or greater than 25%. The Board believes that such a threshold, together with certain procedural requirements described further below, strikes an appropriate balance between enhancing stockholder rights, by ensuring that special meetings can be called to act on extraordinary and urgent matters, and protecting the long-term interests of CDW and our stockholders, by minimizing the risk that one or a small minority of stockholder(s) will pursue special interests that are not aligned with our stockholders more broadly and cause us to unduly incur substantial costs and distractions.

In light of these considerations, and upon the recommendation of the Nominating and Corporate Governance Committee, the Board adopted resolutions declaring it advisable to amend the Certificate of Incorporation to enable the adoption of the Special Meeting Right, and resolved to submit the Proposed Special Meeting Right Amendment to our stockholders for consideration.

Additional Information

The Proposed Special Meeting Right Amendment is binding. If stockholders approve the Proposed Special Meeting Right Amendment by the requisite vote, CDW will file with the Secretary of State of the State of Delaware a Certificate of Amendment to the Certificate of Incorporation setting forth the Proposed Special Meeting Right Amendment, shortly following the annual

2023 Proxy Statement70

meeting, to incorporate the approved amendment. The Proposed Special Meeting Right Amendment will become effective upon the effectiveness of the Certificate of Amendment with the Secretary of State of the State of Delaware. The Special Meeting Bylaw Amendments described below will also become effective at such time.

If stockholders do not approve the Proposed Special Meeting Right Amendment by the requisite vote, then the Certificate of Amendment setting forth the Proposed Special Meeting Right Amendment will not be filed with the Secretary of State of the State of Delaware, the Special Meeting Bylaw Amendments will not become effective and holders of our common stock will not have the ability to require the Company to call a special meeting of stockholders.

PROPOSAL 5: THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE APPROVAL OF THE AMENDMENT OF THE CERTIFICATE OF INCORPORATION TO ALLOW STOCKHOLDERS THE RIGHT TO CALL SPECIAL MEETINGS.

Overview of Related Changes to the Bylaws

If the Proposed Special Meeting Right Amendment is approved by the stockholders, the Bylaws will be amended to specify the procedures for stockholder-requested special meetings by adding the language substantially in the form attached as Appendix D (the “Special Meeting Bylaw Amendments”), with deleted text indicated by red strikethroughs and new text underlined in red. Set forth below is a summary of the Special Meeting Bylaw Amendments. This summary of the Special Meeting Bylaw Amendments is qualified in its entirety by reference to Appendix D.

Ownership Provisions

The Special Meeting Bylaw Amendments require CDW to call a special meeting of stockholders upon the written request of one or more stockholders who own shares representing at least 25% of the voting power of our outstanding common stock. The proponent for the special meeting request and such proponent’s affiliates must have continuously held the shares included in meeting the 25% ownership for at least one year prior to the special meeting request and must comply with other requirements set forth in the Bylaws.

To request the calling of a special meeting, a stockholder of record must first submit a request in writing that the Board fix a record date for the purpose of determining stockholders entitled to request the calling of a special meeting. The Board shall fix a record date within 10 days after the receipt of a record date request in accordance with the requirements of the Bylaws. Multiple special meeting requests will be considered together for purposes of the 25% ownership threshold if they identify substantially the same purpose and are dated and received within 60 days of the earliest dated request that was properly submitted. Under the Special Meeting Bylaw Amendments, any reduction in the number of shares that count toward the 25% ownership threshold would be treated as a revocation of a special meeting request with respect to those shares.

Information Provisions

The Special Meeting Bylaw Amendments provide that any proponent for the special meeting and such proponent’s affiliates must furnish information that is the same in all material respects as what would be required when stockholders seek to propose action or nominate directors at a stockholders’ meeting under our advance notice bylaws. This is intended to promote transparency and to provide CDW and stockholders comparable information about matters that a stockholder seeks to present for a stockholder vote, whether the stockholder is seeking to use the advance notice process or special meeting right.

Additional Provisions

A special meeting called pursuant to the Special Meeting Bylaw Amendments would have to be held not more than 90 days after the Company receives a valid special meeting request. The Special Meeting Bylaw Amendments set forth certain procedural requirements that the Board believes are appropriate to avoid duplicative or unnecessary special meetings. Under these provisions, a special meeting request would not be valid if it:

does not comply with the requirements pertaining to special meeting requests set forth in the Bylaws or applicable law;
relates to an item of business that is not the proper subject of stockholder action under applicable law;
relates to an item of business that did not appear on the written request that resulted in the determination of the record date;
is delivered during the period commencing 90 days prior to the first anniversary of the preceding year’s annual meeting and ending on the date of the final adjournment of the next annual meeting of stockholders;
relates to an item of business that is identical or substantially similar to any item of business (a “Similar Item”) that was presented at a stockholders’ meeting held within 120 days before the special meeting request is delivered; and
the Board has called or calls for an annual or special meeting of stockholders to be held within 90 days after the special meeting request is delivered and the Board determines that the business of such meeting relates to a Similar Item.

The Special Meeting Bylaw Amendments would specify that the business to be transacted at a stockholder-requested special meeting would be limited to the business stated in a valid special meeting request and any additional business that the Board determines to include in the notice for such special meeting.

2023 Proxy Statement71

PROPOSAL 6

Approval of the Amendment to the Company’s Certificate of Incorporation to Reflect New Delaware Law Provisions Regarding Officer Exculpation

After careful consideration, our Board has unanimously adopted, and recommends that our stockholders approve, an amendment to our Certificate of Incorporation to provide for the elimination or limitation of monetary liability of certain officers of the Company for certain actions (the “Proposed Exculpation Amendment”). Our Certificate of Incorporation currently limits the monetary liability of our directors in certain circumstances pursuant to, and consistent with, Section 102(b)(7) of the Delaware General Corporation Law (the “DGCL”). Effective August 1, 2022, Section 102(b)(7) of the DGCL was amended to permit a corporation’s certificate of incorporation to include a provision eliminating or limiting monetary liability for certain senior corporate officers for certain breach of fiduciary duty actions.

The Proposed Exculpation Amendment

In light of this update of the DGCL, we are proposing to amend the Company’s Certificate of Incorporation to add a provision exculpating certain of the Company’s officers from liability in specific circumstances, as permitted by Delaware law. As amended, Section 102(b)(7) of the DGCL only permits, and our Proposed Exculpation Amendment would only permit, exculpation for direct claims (as opposed to derivative claims made by stockholders on behalf of the Company) and would not apply to breaches of the duty of loyalty, acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, or any transaction in which the officer derived an improper personal benefit. Furthermore, the Proposed Exculpation Amendment would not eliminate officers’ monetary liability for breach of fiduciary duty claims brought by the Company itself. The rationale for so limiting the scope of liability is to strike a balance between stockholders’ interest in accountability and their interest in the Company being able to attract and retain talented officers to work on its behalf.

Purpose and Effect of the Proposed Exculpation Amendment

The Nominating and Corporate Governance Committee believes that there is a need for directors and officers to remain free of the risk of financial ruin as a result of an unintentional misstep. Therefore, taking into account the narrow class and type of claims for which officers’ liability would be exculpated, and the benefits the Nominating and Corporate Governance Committee believes would accrue to the Company and its stockholders in the form of an enhanced ability to attract and retain talented officers, the Nominating and Corporate Governance Committee recommended to the Board an amendment to the Certificate of Incorporation to provide such exculpation to the extent permitted by Delaware law. Based on this recommendation, the Board determined that it would beis in the best interests of the Company and our stockholders to eliminateamend the supermajority voting requirement foundCertificate of Incorporation as described herein.

The full text of the Proposed Exculpation Amendment is set forth in Article Eleven in favor of a requirement that any amendmentSeven of the Affected Charter Provisions be approvedCertificate of Incorporation attached as Appendix C, with deleted text indicated by red strikethroughs and new text underlined in additionred. This summary of the Proposed Exculpation Amendment is qualified in its entirety by reference to approvalAppendix C.

Effect of our BoardApproval and Required Vote

The affirmative vote of Directors,the holders of a majority of the voting power of all outstanding shares of stock entitled to vote generally in the election of directors voting together as a single class, at a meeting of the Company’s stockholders called for that purpose.

Removal of Provision regarding Business Combinations with Interested Stockholders

Article Ten of our Certificate of Incorporation relates to transactions with Interested Stockholders (as defined in the Certificate of Incorporation). It replicates the provisions of Section 203 of the Delaware General Corporation Law (“DGCL”), with a limited exception no longer pertinent to the Company. Removing Article Ten from our Certificate of Incorporation will result in the Company being subject to Section 203 of the DGCL but, because Article Ten largely replicates Section 203, will have no substantive impact. Currently, approximately 92% of the companies in the S&P 500 incorporated in Delaware are subject to Section 203.

Article Ten currently provides that the Company expressly elects not to be subject to Section 203. As noted above, however, Article Ten then goes on to include provisions that replicate Section 203 in its entirety, save for one exception no longer pertinent to the Company. Specifically, Article Ten provides that the Company cannot engage in Business Combinations (as defined in our Certificate of Incorporation) with any Interested Stockholder (as defined in our Certificate of Incorporation) for a period of three years following the time that such stockholder became an Interested Stockholder, unless (a) prior to such time the Board approved either the Business Combination or the transaction which resulted in such stockholder becoming an Interested Stockholder; (b) the stockholder owned at least 85% of the Company’s shares of stock entitled to vote generally in the election of directors (excluding shares owned by persons who are directors and also officers of the Company and shares owned by certain employee stock plans) upon consummation of the transaction that resulted in the stockholder becoming an Interested Stockholder; or (c) at or subsequent to such time the Business Combination is approved by the Board and authorized at an annual or special meeting of stockholders by the affirmative vote of at least 66 2/3% of the outstanding shares of stock entitled to vote generally in the election of directors not owned by such Interested Stockholder.

 2021 Proxy Statement    57

Although Article Ten of our Certificate of Incorporation is similar to Section 203 of the DGCL, the definition of “Interested Stockholder” in our Certificate of Incorporation excludes the Company’s former equity sponsors and their affiliates and associates, which requirement originated when the Company’s former equity sponsors controlled the Company. Our Board of Directors has determined that this exception is no longer relevant or necessary.

After careful consideration, and upon the recommendation of the Nominating and Corporate Governance Committee, the Board determined that it would be in the best interests of the Company and our stockholders to eliminate Article Ten of our Certificate of Incorporation. Our Nominating and Corporate Governance Committee and our Board believe that Section 203 of the DGCL sufficiently protects our stockholders against the concerns that Article Ten of our Certificate of Incorporation sought to address, making Article Ten no longer necessary now that the Company’s former equity sponsors no longer control the Company.

Removal of Other Obsolete Provisions

Article Six of our Certificate of Incorporation contains provisions related to the classification, term and removal of directors that by their terms will become obsolete at the upcoming 2021 annual meeting of stockholders (the “2021 Annual Meeting Provisions”). This is because our Board will be fully declassified as of the 2021 Annual Meeting.

Article Eight of our Certificate of Incorporation provides that so long as the Company’s former equity sponsors hold a majority of the then outstanding shares of stock of the Company entitled to vote generally in the election of directors, action by written consent may be taken by the Company’s stockholders and certain additional persons may call special meetings of stockholders of the Company (the “Equity Sponsor Provisions”). Because our former equity sponsors no longer hold a majority of our outstanding shares of stock entitled to vote generally in the election of directors, these provisions are obsolete.

After careful consideration, and upon the recommendation of the Nominating and Corporate Governance Committee, the Board determined that it would be in the best interests of the Company and our stockholders to eliminate the 2021 Annual Meeting Provisions and Equity Sponsor Provisions.

Effect of Approval and Required Vote

Stockholders are being asked to approve this Proposal 4. If stockholders approve this Proposal 4, Article Six, Article Eight, Article Ten and Article Eleven of the Certificate of Incorporation will be amended as shown on Appendix C. This description of the proposed amendments is qualified by the full text of the proposed amendment attached as Appendix C.

The affirmative vote of stockholders representing at least 66 2/3 % of the outstanding shares of stock entitled to vote generally in the election of directors is required to approve this proposal.the Proposed Exculpation Amendment. If stockholders approve this proposal, the Company intends toProposed Exculpation Amendment by the requisite vote, CDW will file a Sixth Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware promptly followinga Certificate of Amendment to the Annual Meeting, to reflect these amendments and, if approved by stockholders, the amendment described in Proposal 5.

The Board of Directors recommends a vote FOR the proposal to eliminate the supermajority voting requirement in Article Eleven of our Certificate of Incorporation andsetting forth the Proposed Exculpation Amendment, shortly following the annual meeting, to make certain non-substantive changes to our Certificate of Incorporation.

 2021 Proxy Statement    58

PROPOSAL 5 — Approval ofincorporate the approved amendment. The Proposed Exculpation Amendment to the Company’s Certificate of Incorporation to Eliminate Obsolete Competition and Corporate Opportunity Provision

Article Nine of our Certificate of Incorporation currently addresses certain matters involving the Company’s former equity sponsors and their affiliates. Specifically, Article Nine provides, among other things, that the Company’s former equity sponsors and their affiliates do not have a fiduciary duty to refrain from engaging in similar business activities as the Company and that the Company renounces any interest in business opportunities that are presented to them. We are, however, no longer controlled by our former equity sponsors. Accordingly, Article Nine is obsolete. It serves no purpose under the Company’s current ownership and governance structure.

After careful consideration, andwill become effective upon the recommendation of the Nominating and Corporate Governance Committee, the Board determined that it would be in the best interests of the Company and our stockholders to eliminate Article Nine of our Certificate of Incorporation. Among other benefits, removing Article Nine will help to reinforce that all of our directors and officers remain subject to the corporate opportunity doctrine.

Accordingly, stockholders are being asked to approve this Proposal 5. If stockholders approve this Proposal 5, Article Nineeffectiveness of the Certificate of Incorporation will be amended as shown on Appendix D. This description of the proposed amendment is qualified by the full text of the proposed amendment attached as Appendix D.

The affirmative vote of stockholders representing at least 80 % of the outstanding shares of stock entitled to vote generally in the election of directors is required to approve this proposal. If stockholders approve this proposal, the Company intends to file a Sixth Amended and Restated Certificate of IncorporationAmendment with the Secretary of State of the State of Delaware promptly following the Annual Meeting, to reflect this amendment and, if approved by stockholders, the amendments described in Proposal 4.Delaware.

 

The Board of Directors recommends a vote FOR the proposal to eliminate the provision in our Certificate of Incorporation governing competition and corporate opportunity with our former equity sponsors.

PROPOSAL 6: THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR APPROVAL OF THE PROPOSAL TO AMEND THE COMPANY’S CERTIFICATE OF INCORPORATION TO REFLECT NEW DELAWARE LAW PROVISIONS REGARDING OFFICER EXCULPATION.

 

 2021 Proxy Statement    59

2023 Proxy Statement72
 

PROPOSAL 6 — Approval of the CDW Corporation 2021 Long-Term Incentive Plan

On March 24, 2021, the Board approved the CDW Corporation 2021 Long-Term Incentive Plan (the “2021 LTIP”), subject to approval by our stockholders. The 2021 LTIP will replace the CDW Corporation Amended and Restated 2013 Long-Term Incentive Plan (the “2013 LTIP”). If the 2021 LTIP is approved, no awards will be granted under the 2013 LTIP after the 2021 LTIP becomes effective. As of March 9, 2021, there were 1,870,114 shares of common stock that remained available for future issuances under the 2013 LTIP (assuming outstanding performance awards are counted at the maximum vesting level), and which will terminate and cease to be available for future grants if the 2021 LTIP is approved by our stockholders.

If the 2021 LTIP is approved by stockholders, we will continue to be able to make awards of long-term equity incentives, which we believe are critical for attracting, motivating, rewarding and retaining a talented team who will contribute to our success. If the 2021 LTIP is not adopted by our stockholders, the Company will continue to operate the 2013 LTIP pursuant to its current provisions and we may be required to increase the cash component of our compensation mix which would inhibit our ability to align our executives’ interests with the interests of our stockholders, to recruit and retain new executives, key employees and non-employee directors, and motivate our current executives and key employees over a long-term horizon.

Equity Grant Practices

Outstanding Equity Awards

As of March 9, 2021, there were approximately 1,208,032 full value awards (that is, awards other than stock options and stock appreciation rights, and with performance-based awards counted assuming the maximum vesting level) issued and outstanding and approximately 3,955,756 stock options outstanding under the 2013 LTIP. As of that date, the weighted average exercise price of our outstanding stock options was $85.78, and the weighted average remaining contractual term for the outstanding stock options was 7.24 years. As noted above, as of March 9, 2021, 1,870,114 shares of common stock remained available for issuance under the 2013 LTIP.

Dilution

Annual dilution from our equity compensation program is measured as the total number of shares subject to equity awards granted in a given year, less cancellations and other shares returned to the reserve that year, divided by total shares outstanding at the end of the year. Annual dilution from our equity compensation program for fiscal year 2020 was 0.86%. Overhang is another measure of the dilutive impact of equity programs. Our overhang is equal to the number of shares subject to outstanding equity compensation awards plus the number of shares available to be granted, divided by the total number of outstanding shares. As of March 9, 2021, our overhang was 4.8%. As of March 9, 2021, the 6,600,000 shares being requested under the 2021 LTIP would bring our aggregate overhang to approximately 8.8%. Overhang percentages are based on approximately 141 million shares of common stock outstanding as of March 9, 2021.

Burn Rate

Burn rate is a measure of the number of shares subject to equity awards that we grant annually, which helps indicate the life expectancy of our equity plans and is another measure of stockholder dilution. We determine our burn rate by dividing the aggregate number of shares subject to awards granted during the year by the weighted average number of shares outstanding during the year. The Company’s burn rate for the past three fiscal years has been as follows:

     Full Value Awards         
     Restricted  Performance     Weighted Average   
  Options  Stock Units  Share Units  Options + Full  Number of Ordinary   
Year Granted  Granted  Earned*  Value Awards  Shares Outstanding  Burn Rate
2020  991,431   66,685   353,245   1,411,361   142,600,000   0.99%
2019  786,601   58,577   350,816   1,195,994   145,100,000   0.82%
2018  1,021,398   177,525   334,255   1,533,178   150,900,000   1.02%
*Performance awards are shown based on the number earned. CDW granted 253,307, 201,441, and 204,890 performance awards at target in 2020, 2019, and 2018, respectively.

Our three-year average Burn Rate is 0.94%.

 2021 Proxy Statement    60

Certain Features of

Frequently Asked Questions Concerning the 2021 LTIP

The following features of the 2021 LTIP are designed to reinforce alignment between the equity compensation arrangements awarded pursuant to the 2021 LTIP and our stockholders’ interests:

Awards will be subject to a one-year minimum vesting period, subject to limited exceptions set forth in the 2021 LTIP as described below and the Plan Committee’s (as defined below) ability to provide for accelerated exercisability or vesting of any award, including in cases of retirement, death, disability or a change in control, in the terms of the Award Agreement or otherwise;
No discounting of stock options or stock appreciation rights;
No repricing or replacement of underwater stock options or stock appreciation rights without stockholder approval;
No dividend equivalents on stock options or stock appreciation rights;
No dividends or dividend equivalents paid on unearned awards;
Prohibition of the recycling of shares used to pay the exercise price or taxes with respect to options and stock appreciation rights;
Annual non-employee director compensation limit, which cannot be amended without stockholder approval; and
No liberal definition of “change in control.”

Purposes of the 2021 LTIP

Equity-based compensation is a significant component of our compensation program and the 2021 LTIP is intended to serve the following purposes:

Align the interests of the Company’s stockholders and recipients of awards under the 2021 LTIP by increasing the proprietary interest of such recipients in the Company’s growth and success;
Advance the interests of the Company by attracting and retaining officers, other employees, non-employee directors, consultants, independent contractors and agents; and
Motivate such persons to act in the long-term best interests of the Company and its stockholders.

Under the 2021 LTIP, the Company may grant:

Non-qualified stock options;
Incentive stock options (within the meaning of Section 422 of the Internal Revenue Code);
Stock appreciation rights (“SARs”);
Restricted stock, restricted stock units and unrestricted stock (collectively, “Stock Awards”); and
Performance Awards.

Description of the 2021 LTIP

The following description is qualified in its entirety by reference to the plan document, a copy of which is attached as Appendix E and incorporated into this Proxy Statement by reference.

Administration

The 2021 LTIP will be administered by the Compensation Committee of the Board, or a subcommittee thereof, or such other committee designated by the Board (the “Plan Committee”), in each case consisting of two or more members of the Board. Each member of the Plan Committee is intended to be (i) a “non-employee director” within the meaning of Rule 16b-3 under the Exchange Act and (ii) “independent” within the meaning of the rules of NASDAQ.

Subject to the express provisions of the 2021 LTIP, the Plan Committee has the authority to select eligible persons to receive awards and determine all of the terms and conditions of each award. All awards are evidenced by an agreement containing such provisions not inconsistent with the 2021 LTIP as the Plan Committee approves. The Plan Committee also has authority to establish rules and regulations for administering the 2021 LTIP and to decide questions of interpretation or application of any provision of the 2021 LTIP. The Plan Committee may take any action such that (1) any outstanding options and SARs become exercisable in part or in full, (2) all or any portion of a restriction period on any outstanding awards lapse, (3) all or a portion of any performance period applicable to any outstanding awards lapse, and (4) any performance measures applicable to any outstanding award be deemed satisfied at the target, maximum or any other level.

The Plan Committee may delegate some or all of its power and authority under the 2021 LTIP to the Board, a subcommittee of the Board, a member of the Board, the President and Chief Executive Officer or other executive officer of the Company as the Plan Committee deems appropriate, except that it may not delegate its power and authority to a member of the Board, the President and Chief Executive Officer or any executive officer with regard to awards to persons subject to Section 16 of the Exchange Act.

 2021 Proxy Statement    61Annual Meeting

Available Shares

Under the 2021 LTIP, the number of shares of common stock initially be available for all awards, other than substitute awards granted in connection with a corporate transaction, will be (i) 6,600,000 shares plus (ii) any shares of common stock that are available for awards under the 2013 LTIP as of the effective date of the 2021 LTIP. This amount is subject to adjustment in the event of any equity restructuring that causes the per share value of shares of common stock to change, such as a stock dividend, stock split, spinoff, rights offering or recapitalization through an extraordinary cash dividend. The number of available shares will be reduced by the sum of the aggregate number of shares of common stock which become subject to outstanding awards. On the record date of March 24, 2021, the closing sales price per share of our common stock as reported on NASDAQ was $156.41.

To the extent that shares of common stock subject to an outstanding award granted under the 2021 LTIP or the 2013 LTIP are not issued or delivered by reason of (i) the expiration, termination, cancellation or forfeiture of such award (excluding shares of common stock subject to an option canceled upon settlement of a related tandem SAR or subject to a tandem SAR cancelled upon exercise of a related option) or (ii) the settlement of such award in cash, then such shares of common stock will again be available under the 2021 LTIP. Shares of common stock subject to an award granted under the 2021 LTIP or the 2013 LTIP, other than an option or SAR, will again become available for issuance under the 2021 LTIP if the shares are delivered to or withheld by the Company to pay the withholding taxes payable with respect to such award. Shares of common stock subject to an option or SAR granted under the 2021 LTIP or the 2013 LTIP will not again be available for issuance under the 2021 LTIP if such shares are (i) shares that were not issued or delivered upon the net settlement or net exercise of such option or SAR (including, without limitation, any shares withheld to pay the purchase price or withholding taxes of an option or SAR), (ii) shares delivered to the Company to pay the purchase price or the withholding taxes related to an outstanding option or SAR or (iii) shares repurchased by the Company on the open market with the proceeds of an option exercise.

Change in Control

Unless otherwise provided in an award agreement, in the event of a change in control of the Company, the Board (as constituted prior to such change in control) may, in its discretion, provide that (i) some or all outstanding options and SARs will become exercisable in full or in part, either immediately or upon a subsequent termination of employment, (ii) the restriction period applicable to some or all outstanding Stock Awards will lapse in full or in part, either immediately or upon a subsequent termination of employment, (iii) the performance period applicable to some or all outstanding awards will lapse in full or in part, and (iv) the performance measures applicable to some or all outstanding awards will be deemed satisfied at the target or any other level. In addition, in the event of a change in control, the Board may, in its discretion, require that shares of stock of the company resulting from such change in control, or the parent thereof, or other property be substituted for some or all of the shares of Company common stock subject to outstanding awards as determined by the Board, and/or require outstanding awards, in whole or in part, to be surrendered to the Company in exchange for a payment of cash, other property, shares of capital stock in the company resulting from the change in control, or the parent thereof, or a combination of cash, other property and shares.

Under the terms of the 2021 LTIP, a change in control is generally defined as (i) a change in our Board resulting in the incumbent directors ceasing to constitute at least a majority of our Board over a 24-month period, (ii) certain acquisitions of 35% or more of the Company’s then outstanding securities eligible to vote for the election of our Board, (iii) the consummation of certain mergers, consolidations, statutory share exchanges or similar corporate transactions involving the Company or any of its subsidiaries that requires the approval of the Company’s stockholders, or (iv) the consummation of a sale of all or substantially all of the Company’s assets or stockholder approval of a complete liquidation or dissolution of the Company.

No Repricing

The Plan Committee may not, without the approval of stockholders, (i) reduce the purchase price or base price of any previously granted stock option or SAR, (ii) cancel any previously granted stock option or SAR in exchange for another stock option or SAR with a lower purchase price or base price or (iii) cancel any previously granted stock option or SAR in exchange for cash or another award if the purchase price of such stock option or the base price of such SAR exceeds the fair market value of a share of common stock on the date of such cancellation, in each case, other than in connection with a change in control or pursuant to the plan’s adjustment provisions.

Clawback of Awards

The awards granted under the 2021 LTIP and any cash payment or shares of common stock delivered pursuant to an award are subject to forfeiture, recovery by the Company or other action pursuant to the applicable award agreement or any clawback or recoupment policy which the Company may adopt from time to time, including any such policy which the Company may be required to adopt under the Dodd-Frank Wall Street Reform and Consumer Protection Act and implementing rules and regulations thereunder, or as otherwise required by law.

 2021 Proxy Statement    62

Effective Date, Termination and Amendment

The 2021 LTIP will become effective as of the date of stockholder approval and will terminate as of the tenth anniversary of the date of such stockholder approval, unless earlier terminated by the Board. The Board may amend the 2021 LTIP at any time, subject to any requirement of stockholder approval required by applicable law, rule or regulation, including any rule of NASDAQ, and provided that no amendment may be made that seeks to modify the non-employee director compensation limit or the prohibition on repricing of stock options and SARs without stockholder approval under the 2021 LTIP or that materially impairs the rights of a holder of an outstanding award without the consent of such holder.

Eligibility

Participants in the 2021 LTIP will consist of such officers, other employees, non-employee directors, consultants, independent contractors and agents of the Company and its subsidiaries (and such persons who are expected to become any of the foregoing) as selected by the Plan Committee. As of March 9, 2021, approximately 10,100 employees and 11 non-employee directors would be eligible to participate in the 2021 LTIP.

Non-Employee Director Compensation Limit

Under the terms of the 2021 LTIP, the aggregate value of cash compensation and the grant date fair value of shares of common stock that may be awarded or granted during any fiscal year of the Company to any non-employee director will not exceed $950,000. The non-employee director compensation limit under the 2021 LTIP will not apply to distributions of previously deferred compensation under a deferred compensation plan maintained by the Company or compensation received by the director in his or her capacity as an executive officer or employee of the Company.

Minimum Vesting Conditions

Notwithstanding any other provision of the 2021 LTIP to the contrary, awards granted under the 2021 LTIP (other than cash-based awards) will vest no earlier than the first anniversary of the date on which the award is granted; provided, that the following awards shall not be subject to the foregoing minimum vesting requirement: any (i) substitute awards granted in connection with awards that are assumed, converted or substituted pursuant to a merger, acquisition or similar transaction entered into by the Company or any of its subsidiaries, (ii) shares delivered in lieu of fully vested cash obligations, (iii) awards to non-employee directors that vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year’s annual meeting, and (iv) additional awards the Plan Committee may grant, up to a maximum of five percent (5%) of the available share reserve authorized for issuance under the 2021 LTIP (subject to adjustment under the corporate capitalization provisions under the 2021 LTIP). The foregoing restriction does not apply to the Plan Committee’s discretion to provide for accelerated exercisability or vesting of any award, including in cases of retirement, death, disability or a change in control, in the terms of the award agreement or otherwise.

Stock Options and SARs

The 2021 LTIP provides for the grant of stock options and SARs. The Plan Committee will determine the conditions to the exercisability of each option and SAR.

Each option will be exercisable for no more than ten (10) years after its date of grant, except with respect to certain options that expire during blackout periods. If the option is an incentive stock option and the optionee owns greater than ten percent (10%) of the voting power of all shares of capital stock of the Company (a “ten percent holder”), then the option will be exercisable for no more than five years after its date of grant. Except in the case of substitute awards granted in connection with a corporate transaction, the exercise price of an option will not be less than 100% of the fair market value of a share of common stock on the date of grant, unless the option is an incentive stock option and the optionee is a ten percent holder, in which case the exercise price will be the price required by the Internal Revenue Code.

Each SAR will be exercisable for no more than ten (10) years after its date of grant, except with respect to certain SARs that expire during blackout periods. Other than in the case of substitute awards granted in connection with a corporate transaction, the base price of a SAR will not be less than 100% of the fair market value of a share of common stock on the date of grant, provided that the base price of a SAR granted in tandem with an option (a “tandem SAR”) will be the exercise price of the related option. A SAR entitles the holder to receive upon exercise (subject to withholding taxes) shares of common stock (which may be restricted stock) or, to the extent provided in the award agreement, cash or a combination thereof, with an aggregate value equal to the difference between the fair market value of the shares of common stock on the exercise date and the base price of the SAR.

 2021 Proxy Statement    63

All of the terms relating to the exercise, cancellation or other disposition of stock options and SARs (i) upon a termination of employment of a participant, whether by reason of disability, retirement, death or any other reason, or (ii) during a paid or unpaid leave of absence, are determined by the Plan Committee.

Notwithstanding anything in the award agreement to the contrary, the holder of an option or SAR will not be entitled to receive dividend equivalents with respect to the shares of common stock subject to such option or SAR.

Stock Awards

The 2021 LTIP provides for the grant of Stock Awards. The Plan Committee may grant a Stock Award as a restricted stock award, restricted stock unit award or unrestricted stock award. Restricted stock awards and restricted stock unit awards are subject to forfeiture if the holder does not remain continuously in the employment of the Company during the restriction period or if specified performance measures (if any) are not attained during the performance period. Unrestricted stock awards are not subject to any restriction periods or performance measures.

Unless otherwise set forth in a restricted stock award agreement, the holder of shares of restricted stock has rights as a stockholder of the Company, including the right to vote and receive dividends with respect to shares of restricted stock and to participate in any capital adjustments applicable to all holders of the Company’s common stock; provided, however, that any divided or other distribution paid with respect to shares subject to a restricted stock award will be deposited by the Company and will be subject to the same restrictions as the shares of Company common stock with respect to which such dividend or distribution was made.

The agreement awarding restricted stock units will specify (1) whether such award may be settled in shares of common stock, cash or a combination thereof; and (2) whether the holder will be entitled to receive dividend equivalents, and, if determined by the Plan Committee, interest on, or the deemed reinvestment of, any deferred dividend equivalents, with respect to the number of shares of common stock subject to such award. Any dividend equivalents credited with respect to restricted stock units will be subject to the same vesting and other restrictions as the restricted stock units to which they relate. Prior to settlement of a restricted stock unit, the holder of a restricted stock unit has no rights as a stockholder of the Company.

All of the terms relating to the satisfaction of performance measures and the termination of a restriction period or performance period relating to a Stock Award, or the forfeiture and cancellation of a Stock Award (i) upon a termination of employment, whether by reason of disability, retirement, death or any other reason, or (ii) during a paid or unpaid leave of absence, will be determined by the Plan Committee.

Performance Awards

The 2021 LTIP also provides for the grant of performance awards. The agreement relating to a performance award will specify whether such award may be settled in shares of common stock (including shares of restricted stock) or cash or a combination thereof. The agreement relating to a performance award will provide, in the manner determined by the Plan Committee, for the vesting of such performance award if the specified performance measures are satisfied or met during the specified performance period and for the forfeiture of such award if the specified performance measures are not satisfied or met during the specified performance period. Any dividends or dividend equivalents with respect to a performance award will be subject to the same vesting and other restrictions as such performance award. Prior to the settlement of a performance award in shares of common stock, the holder of such award has no rights as a stockholder of the Company with respect to such shares. All of the terms relating to the satisfaction of performance measures and the termination of a performance period, or the forfeiture and cancellation of a performance award upon (i) a termination of employment, whether by reason of disability, retirement, death or any other reason, or (ii) during a paid or unpaid leave of absence, will be determined by the Plan Committee.

Performance Measures

Under the 2021 LTIP, the grant, vesting, exercisability or payment of certain awards, or the receipt of shares of common stock subject to certain awards, may be made subject to the satisfaction of performance measures. The performance goals applicable to a particular award will be determined by the Plan Committee at the time of grant. One or more of the following business criteria for the Company, on a consolidated basis, and/or for specified subsidiaries, business or geographical units or operating areas of the Company (except with respect to the total shareholder return and earnings per share criteria) or on an individual basis, may be used by the Plan Committee in establishing performance measures under the 2021 LTIP: the attainment by a share of common stock of a specified fair market value for a specified period of time; increase in stockholder value; earnings per share; return on or net assets; return on equity; return on investments; return on capital or invested capital; total stockholder return; earnings or income of the Company before or after taxes and/or interest; earnings before interest, taxes, depreciation and amortization (“EBITDA”); EBITDA margin; operating income; revenues; operating expenses, attainment of expense levels or cost reduction goals; market share; cash flow, cash flow per share, cash flow margin or free cash flow;

 2021 Proxy Statement    64

interest expense; economic value created; gross profit or margin; operating profit or margin; net cash provided by operations; price-to-earnings growth; and strategic business criteria, consisting of one or more objectives based on meeting specified goals relating to market penetration, customer acquisition, business expansion, cost targets, customer satisfaction, reductions in errors and omissions, reductions in lost business, management of employment practices and employee benefits, supervision of litigation, supervision of information technology, quality and quality audit scores, efficiency, and acquisitions or divestitures, any combination of the foregoing, or such other goals as the Plan Committee may determine whether or not listed herein.

Each such goal may be expressed on an absolute or relative basis and may include comparisons based on current internal targets, the past performance of the Company (including the performance of one or more subsidiaries, divisions, or operating units) or the past or current performance of one or more other companies or market indices (or a combination of such past and current performance). In addition to the ratios specifically enumerated above, performance goals may include comparisons relating to capital (including, but not limited to, the cost of capital), shareholders’ equity, shares outstanding, assets or net assets, sales, or any combination thereof. In establishing a performance measure or determining the achievement of a performance measure, the Plan Committee may provide that achievement of the applicable performance measures may be amended or adjusted to include or exclude components of any performance measure, including, without limitation, foreign exchange gains and losses, asset writedowns, acquisitions and divestitures, change in fiscal year, unbudgeted capital expenditures, special charges such as restructuring or impairment charges, debt refinancing costs, extraordinary or noncash items, unusual, infrequently occurring, nonrecurring or one-time events affecting the Company or its financial statements or changes in law or accounting principles. Performance measures will be subject to such other special rules and conditions as the Plan Committee may establish at any time.

New Plan Benefits

The number of stock options or other forms of award that will be granted under the 2021 LTIP is not currently determinable. Information regarding awards granted in 2020 under the 2013 LTIP to the Named Executive Officers is provided in the “2020 Summary Compensation Table” and the “2020 Grants of Plan-Based Awards” table. Information regarding awards granted in 2020 under the 2013 LTIP to non-employee directors is provided in the “2020 Director Compensation” table.

Federal Income Tax Consequences

The following is a brief summary of certain United States federal income tax consequences generally arising with respect to awards under the 2021 LTIP. This discussion does not address all aspects of the United States federal income tax consequences of participating in the 2021 LTIP that may be relevant to participants in light of their personal investment or tax circumstances and does not discuss any state, local or non-United States tax consequences of participating in the 2021 LTIP. Each participant is advised to consult his or her particular tax advisor concerning the application of the United States federal income tax laws to such participant’s particular situation, as well as the applicability and effect of any state, local or non-United States tax laws before taking any actions with respect to any awards.

Section 162(m) of the Internal Revenue Code

Section 162(m) of the Internal Revenue Code generally limits to $1 million the amount that a publicly held corporation is allowed each year to deduct for the compensation paid to each of the corporation’s chief executive officer, the corporation’s chief financial officer and certain other current and former executive officers of the corporation.

Stock Options

A participant will not recognize taxable income at the time an option is granted and the Company will not be entitled to a tax deduction at that time. A participant will recognize compensation taxable as ordinary income (and subject to income tax withholding in respect of an employee) upon exercise of a non-qualified stock option equal to the excess of the fair market value of the shares purchased over their exercise price, and the Company will be entitled to a corresponding deduction, subject to the deduction limits under Section 162(m) of the Internal Revenue Code. A participant will not recognize income (except for purposes of the alternative minimum tax) upon exercise of an incentive stock option. If the shares acquired by exercise of an incentive stock option are held for the longer of two years from the date the option was granted and one year from the date it was exercised, any gain or loss arising from a subsequent disposition of those shares will be taxed as long-term capital gain or loss, and the Company will not be entitled to any deduction. If, however, those shares are disposed of

 2021 Proxy Statement    65

within the above-described period, then in the year of that disposition the participant will recognize compensation taxable as ordinary income equal to the excess of (1) the lesser of the amount realized upon that disposition and the fair market value of those shares on the date of exercise over (2) the exercise price, and the Company will be entitled to a corresponding deduction, subject to the deduction limits under Section 162(m) of the Internal Revenue Code.

SARs

A participant will not recognize taxable income at the time SARs are granted and the Company will not be entitled to a tax deduction at that time. Upon exercise, the participant will recognize compensation taxable as ordinary income (and subject to income tax withholding in respect of an employee) in an amount equal to the fair market value of any shares delivered and the amount of cash paid by the Company, and the Company will be entitled to a corresponding deduction, subject to the deduction limits under Section 162(m) of the Internal Revenue Code.

Stock Awards

A participant will not recognize taxable income at the time restricted stock is granted and the Company will not be entitled to a tax deduction at that time, unless the participant makes an election to be taxed at that time. If such election is made, the participant will recognize compensation taxable as ordinary income (and subject to income tax withholding in respect of an employee) at the time of the grant in an amount equal to the excess of the fair market value for the shares at such time over the amount, if any, paid for those shares. If such election is not made, the participant will recognize compensation taxable as ordinary income (and subject to income tax withholding in respect of an employee) at the time the restrictions constituting a substantial risk of forfeiture lapse in an amount equal to the excess of the fair market value of the shares at such time over the amount, if any, paid for those shares. The amount of ordinary income recognized by making the above-described election or upon the lapse of restrictions constituting a substantial risk of forfeiture is deductible by the Company as compensation expense, subject to the deduction limits under Section 162(m) of the Internal Revenue Code. In addition, a participant receiving dividends with respect to restricted stock for which the above-described election has not been made and prior to the time the restrictions constituting a substantial risk of forfeiture lapse will recognize compensation taxable as ordinary income (and subject to income tax withholding in respect of an employee), rather than dividend income, in an amount equal to the dividends paid and the Company will be entitled to a corresponding deduction, subject to the deduction limits under Section 162(m) of the Internal Revenue Code.

A participant will not recognize taxable income at the time a restricted stock unit is granted and the Company will not be entitled to a tax deduction at that time. Upon settlement of restricted stock units, the participant will recognize compensation taxable as ordinary income (and subject to income tax withholding in respect of an employee) in an amount equal to the fair market value of any shares delivered and the amount of any cash paid by the Company, and the Company will be entitled to a corresponding deduction, subject to the deduction limits under Section 162(m) of the Internal Revenue Code.

A participant who receives shares of common stock that are not subject to any restrictions under the 2021 LTIP will recognize compensation taxable as ordinary income on the date of grant in an amount equal to the fair market value of such shares on that date, and the Company will be entitled to a corresponding deduction, subject to the deduction limits under Section 162(m) of the Internal Revenue Code.

Performance Awards

A participant will not recognize taxable income at the time performance awards are granted and the Company will not be entitled to a tax deduction at that time. Upon settlement of performance awards, the participant will recognize compensation taxable as ordinary income (and subject to income tax withholding in respect of an employee) in an amount equal to the fair market value of any shares delivered and the amount of cash paid by the Company, and the Company will be entitled to a corresponding deduction, subject to the deduction limits under Section 162(m) of the Internal Revenue Code.

 

The Board of Directors recommends that stockholders vote FOR the approval of the CDW Corporation 2021 Long-Term Incentive Plan.

 2021 Proxy Statement    66

PROPOSAL 7 — Approval of the Amendment to the CDW Corporation Coworker Stock Purchase Plan

The Company’s stockholders are being asked to approve an amendment to the CDW Corporation Coworker Stock Purchase Plan (the “CSPP”), which would increase the number of shares of the Company’s common stock available for issuance under the CSPP by 800,000 shares. The CSPP was originally adopted by the Board in June 2013.

Certain Features of the CSPP

Options: At the beginning of each offering period, participating coworkers are granted options to purchase Company common stock at the end of the offering period based on payroll deductions accumulated during the offering period.
Eligible Participants: Only coworkers of the Company or a participating subsidiary will be eligible to be granted options under the CSPP and, in no event may a participant be granted an option under the CSPP following his or her termination date.
Shares Authorized: Subject to adjustment upon changes in capitalization of the Company as provided in the CSPP, the number of shares that will be available for issuance under the CSPP after giving effect to this amendment will be 1,130,798 shares (330,798 shares available for issuance as of March 9, 2021 plus 800,000 shares being requested under this proposal). Such number represents approximately 0.8% of the Company’s common stock outstanding as of March 9, 2021. As of the record date of March 24, 2021, the closing price of a share of the Company’s common stock was $156.41.
Purchase Price of Shares: The purchase price per share is equal to 95% of the fair market value of a share on the exercise date for such offering period; provided, however, that the Compensation Committee may determine a different per share purchase price provided that such per share purchase price is communicated to participants prior to the beginning of the offering period and provided that in no event will such per share purchase price be less than the lesser of (i) 85% of the fair market value of a share on the grant date or (ii) 85% of the fair market value of a share on the exercise date.

Description of the CSPP

The following description is qualified in its entirety by reference to the plan document, a copy of which is attached as Appendix F and incorporated into this Proxy Statement by reference.

Purpose

The purpose of the CSPP is to provide coworkers of the Company and participating subsidiaries with an opportunity to purchase Company common stock through accumulated payroll deductions.

Administration

The CSPP is administered by the Compensation Committee of the Board (the “Compensation Committee”). The Compensation Committee has the discretionary authority to do everything necessary and appropriate to administer the CSPP, including, without limitation, interpreting the provisions of the CSPP. All actions, decisions and determinations of, and interpretations by the Compensation Committee with respect to the CSPP will be final and binding upon all participants.

Shares Reserved

Originally, 1,700,000 shares of Company common stock, subject to adjustment for stock splits, stock dividends or other changes in the Company’s capital stock, were reserved for issuance under the CSPP. As of March 9, 2021, there were 330,798 shares of common stock that remained available for future issuances under the CSPP. If the amendment to the CSPP is approved by stockholders, the number of shares reserved for issuance under the CSPP will increase by 800,000 shares from 1,700,000 shares of Company common stock to 2,500,000 shares of Company common stock, subject to the adjustment

 2021 Proxy Statement    67

provisions included in the CSPP for stock splits, stock dividends and other changes in the Company’s capital stock. After giving effect to this amendment and shares previously issued under the CSPP, the number of shares that available for issuance under the CSPP will be 1,130,798 shares (330,798 shares available for issuance as of March 9, 2021 plus 800,000 shares being requested under this proposal). If the amendment is not adopted by our stockholders, the Company will continue to operate the CSPP pursuant to its current provisions.

Corporate Transactions

In the event of a proposed sale of all or substantially all of the assets of the Company, or the merger of the Company with or into another corporation, each outstanding option under the CSPP will be assumed or an equivalent option substituted by the successor corporation or a parent or subsidiary of the successor corporation, unless the Board determines, in the exercise of its sole discretion, that in lieu of such assumption or substitution to either terminate all outstanding options and return to each participant the payroll deductions credited to such participant’s purchase account or to provide for the offering period in progress to end on a date prior to the consummation of such sale or merger. In the event of the proposed dissolution or liquidation of the Company, the offering period then in progress would terminate immediately prior to the consummation of such proposed action, unless otherwise provided by the Board, and the Board may either provide for the purchase of shares as of the date on which such offering period terminates or return to each participant the payroll deductions credited to such participant’s purchase account.

Participation

Only coworkers of the Company or a participating subsidiary are eligible to be granted options under the CSPP and, in no event may a participant be granted an option under the CSPP following his or her termination date. In addition, no coworker may participate in an offering period if the employee owns 5% or more of the total combined voting power or value of our stock or the stock of any of our subsidiaries. A coworker will be eligible to participate on the first enrollment date that occurs at least 90 days after such coworker’s first date of employment with the Company or a participating subsidiary; provided, that such coworker properly completes and submits an election form by the deadline prescribed by the Company. As of March 9, 2021, approximately 10,000 coworkers of the Company and its participating subsidiaries were eligible to participate in the CSPP.

Payroll Deductions

A participant may elect to have payroll deductions made during an offering period equal to no less than 1% of the participant’s eligible compensation up to a maximum of 15% (or such greater amount as the Compensation Committee establishes from time to time). All payroll deductions made by a participant will be credited to his or her purchase account.

A participant may not make any additional payments into his or her purchase account. Unless otherwise determined by the Compensation Committee prior to the beginning of an offering period, no participant may purchase more than 1,250 shares of common stock during any offering period.

Purchase Price of Shares

The purchase price per share is equal to 95% of the fair market value of a share on the exercise date for such offering period; provided, however, that the Compensation Committee may determine a different per share purchase price provided that such per share purchase price is communicated to participants prior to the beginning of the offering period and provided that in no event will such per share purchase price be less than the lesser of (i) 85% of the fair market value of a share on the grant date or (ii) 85% of the fair market value of a share on the exercise date.

Offering Periods

Offering periods are three-month periods beginning each January 1st, April 1st, July 1st and October 1st or such other period designated by the Compensation Committee; provided that in no event will an offering period exceed twenty-seven (27) months.

 2021 Proxy Statement    68

Assignability of Options

Neither payroll deductions credited to a participant’s purchase account nor any rights with regard to the exercise of an option or to receive shares under the CSPP may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution) by the participant.

Termination of Employment

On the termination date of a participant for any reason prior to the applicable exercise date, whether voluntary or involuntary, and including termination of employment due to retirement, death or as a result of liquidation, dissolution, sale, merger or a similar event affecting the Company or a participating subsidiary, the corresponding payroll deductions credited to his or her purchase account will be returned to him or her or, in the case of the participant’s death, to the participant’s designated beneficiaries or estate, and his or her option will be automatically terminated.

Amendments and Termination

Subject to any requirement for stockholder approval under applicable law, the Board or the Compensation Committee may at any time and for any reason amend, modify, suspend, discontinue or terminate the CSPP without notice; provided that no participant’s existing rights in respect of existing options are adversely affected thereby. Without stockholder consent and without regard to whether any participant rights may be considered to have been “adversely affected,” the Board or the Compensation Committee will be entitled to change the purchase price, offering periods, limit or increase the frequency and/or number of changes in the amount withheld during an offering period, establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, permit payroll withholding in an amount less than or greater than the amount designated by a participant in order to adjust for delays or mistakes in the Company’s processing of properly completed withholding elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of shares for each participant properly correspond with amounts withheld from the participant’s compensation, and establish such other limitations or procedures as the Board or the Compensation Committee determines in its sole discretion advisable which are consistent with the CSPP.

New Plan Benefits

The benefits that might be received by participating employees under the CSPP cannot be determined because the benefits depend upon the degree of participation by employees and the trading price of the Company’s common stock in future offering periods.

Federal Income Tax Consequences

The following is a brief summary of certain United States federal income tax consequences generally arising with respect to participating in the CSPP. This discussion does not address all aspects of the United States federal income tax consequences of participating in the CSPP that may be relevant to participants in light of their personal investment or tax circumstances and does not discuss any state, local or non-United States tax consequences of participating in the CSPP. Each participant is advised to consult his or her particular tax advisor concerning the application of the United States federal income tax laws to such participant’s particular situation, as well as the applicability and effect of any state, local or non-United States tax laws before taking any actions with respect to participation in the CSPP.

In general, the CSPP is intended to be an “employee stock purchase plan” within the meaning of Section 423 of the Code. Under Section 423 of the Code, an eligible employee who elects to participate in the CSPP will not recognize any taxable income and the Company will not be entitled to a deduction at the time shares of the Company’s common stock are purchased by the employee. If an employee disposes of the common stock purchased under the CSPP within two years after the grant date (i.e., the first day of the offering period) or one year after the purchase date if later, the employee will recognize compensation taxable as ordinary income, and the Company will generally be entitled to a corresponding deduction, in an amount equal to the excess of the fair market value of the

 2021 Proxy Statement    69

stock on the purchase date over the purchase price. The employee’s cost basis in the shares will be increased by the amount of ordinary income recognized by the employee, and the employee will recognize capital gain or loss equal to the difference between the price at which the shares are later sold (or otherwise disposed of) and the cost basis for the shares, as so increased. The Company will not be entitled to any deduction with respect to the amount recognized by such participant as capital gain.

If an employee does not dispose of the common stock purchased under the CSPP until after the holding period described above, the employee will recognize compensation taxable as ordinary income in an amount equal to the lesser of (i) the excess of the fair market value of the shares at the time of disposition over the purchase price or (ii) the excess of the fair market value of the shares as of the first day of the offering period over the discounted purchase price determined as of the same date. The employee’s cost basis in the shares will be increased by the amount of ordinary income recognized by the employee. The portion of the gain that is in excess of the amount recognized as ordinary income, if any, is taxed as long-term capital gain. If the shares are sold (or otherwise disposed) at a price below the purchase price under the CSPP, the loss will be treated as long-term capital loss. The Company will not be entitled to any deduction with respect to a disposition of shares occurring under these circumstances.

The Board recommends that stockholders vote FOR the amendment to the CDW Corporation Coworker Stock Purchase Plan.

 2021 Proxy Statement    70

FREQUENTLY ASKED QUESTIONS CONCERNING THE ANNUAL MEETING

Why did I receive these proxy materials?

 

These proxy materials are first being distributed on or about April 8 7, 20212023 to stockholders of the Company in connection with the solicitation by our Board of Directors of proxies to be voted at the Annual Meeting of Stockholders on May 21, 2021,18, 2023, at 7:3010:00 a.m. CDT, in a virtual-only meeting format at www.virtualshareholdermeeting.com/CDW2021CDW2023, and any postponement or adjournment thereof. This proxy statement describes the matters on which you, as a stockholder of the Company, are entitled to vote. It also includes information that we are required to provide to you under SEC rules and that is designed to assist you in voting your shares.

 

Why did I receive a Notice of Internet Availability of Proxy Materials instead of printed proxy materials?

 

The SEC permits companies to furnish proxy materials to stockholders by providing access to these documents over the Internet instead of mailing printed copies, which can reduce costs of printing and impact on the environment. Accordingly, we mailed a Notice of Internet Availability of Proxy Materials (a “Notice”) to our stockholders. All stockholders may access our proxy materials on the Internet website referred to in the Notice.

If you received a Notice by mail and would like to receive a printed copy of our proxy materials, you should follow the instructions for obtaining such materials included in the Notice. If you own shares of our common stock in more than one account, such as individually and also jointly with your spouse, you may receive more than one Notice relating to these proxy materials.

 

What is “householding” and how does it affect me?

 

In addition to furnishing proxy materials over the Internet, the Company takes advantage of the SEC’s “householding” rules to reduce the costs of printing and delivery and impact on the environment. Under such rules, only one Notice or, if paper copies are requested, only one proxy statement and annual report, will be delivered to multiple stockholders sharing an address unless the Company has received contrary instructions from one or more of the stockholders. If you are a stockholder who resides in the same household with another stockholder and you wish to receive a separate proxy statement and annual report or Notice for each account, please contact Broadridge Financial Solutions toll free at 1-866-540-7095. You may also write to Broadridge Financial Solutions, Householding Department, 51 Mercedes Way, Edgewood, New York 11717. Any stockholder making such request will promptly receive a separate copy of the proxy materials, and separate copies of all future proxy materials. Any stockholder currently sharing an address with another stockholder, but nonetheless receiving separate copies of the materials, may request delivery of a single copy in the future by contacting Broadridge by telephone or mail as indicated above.

 

What is the purpose of the Annual Meeting?

 

At the Annual Meeting, of Stockholders, stockholders will be asked to vote (1) to elect the ten director nominees named in this proxy statement for a term expiring at the 2022 Annual Meeting of Stockholders,directors, (2) to approve, on an advisory basis, the compensation of our named executive officers, (3) to advise on the frequency of the advisory vote on named executive officer compensation, (4) to ratify the selection of the Company’s independent registered public accounting firm, (4) to approve the amendment to the Company’s certificate of incorporation to eliminate the supermajority voting in Article Eleven and make certain non-substantive changes, (5) to approve the amendment to the Company’s certificateCertificate of incorporationIncorporation to eliminateallow stockholders the obsolete competitionright to call special meetings and corporate opportunity provision, (6) to approve the CDW Corporation 2021 Long-Term Incentive Plan and (7)amendment to approve the amendmentCompany’s Certificate of the CDW Corporation Coworker Stock Purchase Plan.Incorporation to reflect new Delaware law provisions regarding officer exculpation. See the sections entitled “Proposal 1—Election of Directors,” “Proposal 2—Advisory Vote to Approve Named Executive Officer Compensation,” “Proposal 3—Advisory Vote on the Frequency of the Advisory Vote to Approve Named Executive Officer Compensation”, “Proposal 4—Ratification of Selection of Independent Registered Public Accounting Firm,”Firm”, “Proposal 4—5—Approval of the Amendment to the Company’s Certificate of Incorporation to EliminateAllow Stockholders the Supermajority

 2021 Proxy Statement    71

Voting Requirement in Article ElevenRight to Call Special Meetings” and to Make Certain Non-Substantive Changes,” “Proposal 5—6 – Approval of the Amendment to the Company’s Certificate of Incorporation to Eliminate Obsolete Competition and Corporate Opportunity Provision,” “Proposal 6— Approval of the CDW Corporation 2021 Long-Term Incentive Plan” and “Proposal 7— Approval of the Amendment to the CDW Corporation Coworker Stock Purchase Plan.Reflect New Delaware Law Provisions Regarding Officer Exculpation.” The Board of Directors does not know of any other matters to be brought before the meeting other than as set forth in the Notice of Annual Meeting of Stockholders.Meeting.

 

2023 Proxy Statement73

Who can attend the Annual Meeting?

 

Only holdersHolders of our common stock as of the close of business on the record date, which was March 24, 2021,22, 2023, or their duly appointed proxies, mayare invited to attend the Annual Meeting. To participate in the Annual Meeting online, please visit www.virtualshareholdermeeting.com/CDW2021CDW2023and enter the 16-digit control number included on your Notice of Internet Availability of Proxy Materials, proxy card or the instructions that accompanied your proxy materials. For beneficial holders who do not have a control number, please contact your broker, bank, or other nominee as soon as possible and no later than May 13, 2021, so that you can be provided with a control number and gain access to the meeting. If you do not have access to a 16-digit control number, you may access the meeting as a guest by going to www.virtualshareholdermeeting. com/CDW2021www.virtualshareholdermeeting.com/CDW2023, but you will not be able to vote during the meeting or ask questions.

 

A list of stockholders entitled to vote at the Annual Meeting will be available to stockholders for examination 10 days prior to the Annual Meeting. To review the list of stockholders, please contact Investor Relations at InvestorRelations@CDW.com. The stockholder list will also be available during the Annual Meeting on the meeting website.

 

Online check-in will begin at 7:159:45 a.m. CDT. We encourage you to access the Annual Meeting prior to the start time, leaving ample time for the check-in process. We will post a recording of the entire meeting, including appropriate questions received during the meeting and the Company’s answers, on our Investor Relations website at investor.cdw.comas soon as practicable after the Annual Meeting.

 

May stockholders ask questions at the Annual Meeting?

 

Yes. Stockholders will have the ability to submit questions during the annual meetingAnnual Meeting by using the directions on the meeting website. We intend to answer questions submitted during the meeting which are pertinent to the Company and the meeting matters, as time permits. Guidelines for submitting questions during the meeting arewill be available at www.virtualshareholdermeeting.com/CDW2021CDW2023.

 

What if I have technical difficulties or trouble accessing the Annual Meeting?

 

Beginning 15 minutes prior to the start of and during the meeting,Annual Meeting, we will have technicians ready to assist you with any technical difficulties you may have accessing the virtual Annual Meeting.meeting. If you encounter any difficulties accessing the virtual Annual Meeting or during the meeting time, please call the technical support number that will be posted on the meeting website.

 

Who is entitled to vote at the Annual Meeting?

 

Holders of our common stock as of the close of business on the record date, which was March 24, 2021,22, 2023, are entitled to notice of, and to vote at, the Annual Meeting. As of March 24, 2021,22, 2023, there were 140,523,893135,136,297 shares of our common stock outstanding and entitled to vote at the Annual Meeting, with each share entitled to one vote.

 

 2021 Proxy Statement    

72

How do I vote at the Annual Meeting?

 

Stockholders of record can vote in one of four ways:

 

By telephone—telephonePrior to the Annual Meeting, if you received printed copies of the proxy materials, you may use the toll-free telephone number shown on your Notice or proxy card;
Via the Internet—InternetPrior to the Annual Meeting, you may visit the Internet website indicated on your Notice or proxy card and follow the on-screen instructions;
By mail—mailPrior to the Annual Meeting, you may date, sign and promptly return your proxy card by mail in a postage prepaid envelope; or
During the virtual Annual Meeting—meetingIf you attend the virtual Annual Meeting using your 16-digit control number, you may vote during the virtual Annual Meeting.meeting.

 

Voting instructions for stockholders of record (including instructions for both telephonic and Internet voting) are provided on the Notice and theor proxy card. The telephone and Internet voting procedures are designed to authenticate stockholder identities, to allow stockholders to give voting instructions and to confirm that stockholders’ instructions have been recorded properly. A control number, located on the Notice and the proxy card, will identify stockholders, allow them to submit their proxies and confirm that their voting instructions have been properly recorded, and allow them to access the virtual Annual Meeting. Costs associated with telephone and electronic access, such as usage charges from telephone companies and Internet access providers, must be borne by the stockholder. If you submit your proxy by telephone or via the Internet, it will not be necessary to return your proxy card. The deadline for voting by telephone or via the Internet is 11:59 p.m. EDT on Wednesday, May 19, 2021.17, 2023.

 

If your shares are held through a broker, bank or other nominee, please follow the voting instructions on the form you receive from such institution. In such situations, the availability of telephone and Internet voting will depend on your institution’s voting procedures.

 

2023 Proxy Statement74

What if I do not vote or do not indicate how my shares should be voted on my proxy card?

 

If a stockholder of record does not return a signed proxy card or submit a proxy by telephone or via the Internet, and does not attend the virtual meeting and vote via webcast, his or her shares will not be voted. Shares of our common stock represented by properly executed proxies received by us or proxies submitted by telephone or via the Internet, which are not revoked, will be voted at the meeting in accordance with the instructions contained therein.

 

If you submit a properly completed proxy but do not indicate how your shares should be voted on a proposal, the shares represented by your proxy will be voted as the Board of Directors recommends on such proposal.

 

How can I change my votes or revoke my proxy after I have voted?

 

Any proxy signed and returned by a stockholder or submitted by telephone or via the Internet may be revoked or changed at any time before it is exercised at the Annual Meeting or any adjournments or postponements thereof by:

 

Mailing written notice of revocation or change to our Corporate Secretary at CDW Corporation, 200 North Milwaukee Avenue, Vernon Hills, Illinois 60061;
Delivering a later-dated proxy (either in writing, by telephone or via the Internet); or
Voting via webcast at the meeting.

 

Attendance at the meeting will not, in and of itself, constitute revocation of a proxy.

 

Will my votes be publicly disclosed?

 

No. As a matter of policy, stockholder proxies, ballots and tabulations that identify individual stockholders are not publicly disclosed and are available only to the inspector of election and certain employees, who are obligated to keep such information confidential.

 

Who will count the votes?

 

A representative of Broadridge Investor Communication Solutions will serve as the inspector of election for the Annual Meeting and will count the votes.

 

 2021 Proxy Statement    

73

What if other matters come up during the Annual Meeting?

 

The Board of Directors has no knowledge of any other matter to be submitted at the Annual Meeting. If any other matters properly come before the meeting, including a question of adjourning or postponing the meeting, the persons named in the proxies or their substitutes acting thereunder will have discretion to vote on such matters in accordance with their best judgment.

 

What constitutes a quorum at the Annual Meeting?

 

The presence at the Annual Meeting, of Stockholders, via webcast or represented by proxy, of the holders of a majority in voting power of the outstanding capital stock entitled to vote at the Annual Meeting is required to constitute a quorum to transact business at the Annual Meeting. Abstentions and broker non-votes will be counted toward the establishment of a quorum.

 

What if my shares of the Company’s common stock are held for me by a broker?

 

If you are the beneficial owner of shares held for you by a broker, your broker must vote those shares in accordance with your instructions. If you do not provide voting instructions to your broker, itwhether your broker can vote your shares will depend on the type of item being considered for vote, as to whether your broker can vote your shares:vote:

 

Non-Discretionary Items. The election of directors, the advisory vote to approve named executive officer compensation, the votes to approve amendments to our Certificateadvisory vote on the frequency of Incorporation, the advisory vote to approve named executive officer compensation, the CDW Corporation 2021 Long-Term Incentive Plan and vote to approve the amendment to the CDW Corporation Coworker Stock Purchase PlanCompany’s Certificate of Incorporation to allow stockholders the right to call special meetings and the vote to approve the amendment to the Company’s Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation may not be voted on by your broker if it has not received voting instructions.
Discretionary Items.The ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm is a discretionary item. Generally, brokers that do not receive voting instructions from beneficial owners may vote on this proposal in their discretion.

 

2023 Proxy Statement75

How many votes are required to approve each matter to be considered at the Annual Meeting?

 

Proposal 1: Election of ten director nominees named in this proxy statement. A majority of the votes cast at the meeting is required to elect each director nominee, which means that a nominee for director will be elected to the Board of Directors if the votes cast “FOR” the nominee’s election exceed the votes cast “AGAINST” such nominee’s election. Abstentions and broker non-votes are not considered votes cast for the foregoing purpose, and will have no effect on the election of nominees. If a director nominee fails to receive “FOR” votes representing at least a majority of votes cast and is an incumbent director, our Certificate of Incorporation requires the director to promptly tender his or her resignation to our Board of Directors, subject to acceptance by our Board. The Nominating and Corporate Governance Committee of our Board will then recommend to our Board, and our Board will decide, whether to accept or reject the tendered resignation, or whether other action should be taken.

 

Proposal 2: Advisory vote to approve named executive officer compensation. The affirmative vote of a majority of the shares of common stock present and entitled to vote thereon is required to approve, on an advisory, non-binding basis, the compensation paid to our named executive officers. Abstentions will be counted as present and entitled to vote on the proposal and will therefore have the effect of a negative vote. Broker non-votes will not be counted as present and entitled to vote on the proposal and will therefore have no effect on the outcome of the proposal.

 

Proposal 3: Advisory vote on the frequency of the advisory vote to approve named executive officer compensation. The advisory, non-binding vote with respect to the determination as to whether the advisory vote to approve named executive officer compensation shall occur every one, two or three years shall be decided by a plurality of the votes cast among the three alternatives. This means that the alternative receiving the most votes will be considered to be the expressed preference of the stockholders, even if those votes do not constitute a majority of the votes cast. Abstentions and broker non-votes will have no effect on the outcome of the proposal.

Proposal 4: Ratification of the selection of Ernst & Young LLP as the Company’scompany’s independent registered public accounting firm.The affirmative vote of a majority of the shares of common stock present and entitled to vote thereon is required to ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2021.2023. Abstentions will be counted as present and entitled to vote on the proposal and will therefore have the effect of a negative vote. We do not expect there to be any broker non-votes with respect to the proposal.

 

Proposal 4: Approval of the amendment to the Company’s certificate of incorporation to eliminate the supermajority voting requirement in Article Eleven and to make certain non-substantive changes. The affirmative vote of at least sixty-six and two-thirds percent (66 2/3%) of the issued and outstanding shares of our common stock is required to approve the amendments to our certificate of incorporation to eliminate supermajority voting in Article Eleven, and eliminate certain other obsolete provisions. Abstentions will be counted as shares issued and outstanding and will therefore have the effect of a negative vote. Broker non-votes will be counted

 2021 Proxy Statement    74

as shares issued and outstanding and will therefore have the effect of a negative vote.

Proposal 5: Approval of the amendment to the Company’s certificateCertificate of incorporationIncorporation to eliminate obsolete competition and corporate opportunity provision.allow stockholders the right to call special meetings. The affirmative vote of at least eighty percent (80%) of the issued and outstanding shares of our common stock is required to approve the amendment of our certificate of incorporation to eliminate the obsolete competition and corporate opportunity provision. Abstentions will be counted as shares issued and outstanding and will therefore have the effect of a negative vote. Broker non-votes will be counted as shares issued and outstanding and will therefore have the effect of a negative vote.

Proposal 6: Approval of the CDW Corporation 2021 Long-Term Incentive Plan. The affirmative voteholders of a majority of the sharesvoting power of common stock present andall of the outstanding shares entitled to vote thereon is required to approve the CDW Corporation 2021 Long-Term Incentive Plan.amendment to the Company’s Certificate of Incorporation to allow stockholders the right to call special meetings. Abstentions will be counted as present and entitled to vote on the proposal and will therefore have the effect of a negative vote. Broker non-votes will not be counted as present and entitled to vote on the proposal and will therefore have nothe effect on the outcome of the proposal.a negative vote.

 

Proposal 7:6: Approval of the amendment to the CDW Corporation Coworker Stock Purchase Plan.Company’s Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. The affirmative vote of the holders of a majority of the sharesvoting power of common stock present andall of the outstanding shares entitled to vote thereon is required to approve the amendment to the CDW Corporation Coworker Stock Purchase Plan.Company’s Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. Abstentions will be counted as present and entitled to vote on the proposal and will therefore have the effect of a negative vote. Broker non-votes will not be counted as present and entitled to vote on the proposal and will therefore have nothe effect on the outcome of the proposal.a negative vote.

 

Who pays to prepare, mail and solicit the proxies?

 

We will bear the costs of solicitation of proxies for the Annual Meeting of Stockholders, including preparation, assembly, printing and mailing of the Notice, this proxy statement, the annual report, the proxy card and any additional information furnished to stockholders. We have engaged Innisfree M&A Incorporated (“Innisfree”) to assist us in the solicitation of proxies. We will pay Innisfree a base fee of $20,000 plus customary costs and expenses for these services.

We also may reimburse persons representing beneficial owners of common stock for their costs of forwarding any solicitation materials to such beneficial owners. However, we do not reimburse or pay additional compensation to our own directors, officers or other employees for soliciting proxies.

 

 2021 Proxy Statement    75

OTHER BUSINESS

The Board of Directors has no knowledge of any other matter to be submitted at the Annual Meeting of Stockholders. If any other matter shall properly come before the Annual Meeting, including a question of adjourning or postponing the meeting, the persons named in the proxy card or their substitutes acting thereunder will have discretionary authority to vote the shares thereby represented in accordance with their best judgment.

Additional Company Information

 

A copy of our 20202022 Annual Report on Form 10-K is being furnished to stockholders concurrently herewith.

 

2023 Proxy Statement76

Stockholder Proposals for the 20222024 Annual Meeting

 

Proposals that stockholders wish to submit for inclusion in our proxy statement for our 20222024 Annual Meeting of Stockholders pursuant to Rule 14a-8 under the Exchange Act must be received by our Corporate Secretary at CDW Corporation, 200 North Milwaukee Avenue, Vernon Hills, Illinois 60061 no later than December 9, 2021,2023, unless the date of our 20212024 Annual Meeting is more than 30 days before or after May 20, 2022,18, 2024, in which case the proposal must be received a reasonable time before we begin to print and mail our proxy materials for our 20222024 Annual Meeting. Any stockholder proposal submitted for inclusion in our proxy statement must be eligible for inclusion in our proxy statement in accordance with the rules and regulations promulgated by the SEC.

 

With respect to proposals submitted by a stockholder for consideration at our 20222024 Annual Meeting but not for inclusion in our proxy statement for such Annual Meeting, timely notice of any stockholder proposal must be received by us in accordance with our Amended and Restated Bylaws no earlier than January 20, 202219, 2024 nor later than February 19, 2022,18, 2024, unless the date of our 20222024 Annual Meeting is more than 30 days before or after May 20, 2022,18, 2024, in which case notice by the stockholder to be timely must be so delivered by the later of (1) the tenth day following the first public announcement of the date of the 20222024 Annual Meeting and (2) the date which is 90 days prior to the date of the 20212024 Annual Meeting. Such notice must contain the information required by our Amended and Restated Bylaws.

 

Our Amended and Restated Bylaws permit a stockholder, or a group of up to 20 stockholders, who have held at least 3% of our outstanding common stock continuously for at least 3 years to nominate and include in our proxy materials director nominees, constituting up to two individuals or 20% of our Board, whichever is greater, if the stockholder(s) and nominee(s) satisfy the requirements specified in our Amended and Restated Bylaws. With respect to nominations submitted by a stockholder for inclusion in our proxy materials for our 20222024 Annual Meeting of Stockholders, timely notice of a proxy access nomination must be received by us in accordance with our Amended and Restated Bylaws no earlier than November 9, 20212023 and no later than December 9, 2021,2023, unless the date of our 20222024 Annual Meeting is more than 30 days before or after May 20, 2022,18, 2024, in which case notice by the stockholder to be timely must be so delivered by the later of (1) the tenth day following the first public announcement of the date of the 20222024 Annual Meeting and (2) the date which is 150 days prior to the anniversary date of the 20212024 Annual Meeting. Such notice must contain the information required by our Amended and Restated Bylaws.

 

In addition to satisfying the foregoing requirements under our Bylaws, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than March 19, 2024.

It is important that your proxy be returned promptly, whether by mail, by telephone or via the Internet. The proxy may be revoked at any time by you before it is exercised as described in this proxy statement. If you attend the virtual meeting via webcast, you may withdraw any proxy (including a telephonic or Internet proxy) and vote your own shares as described in this proxy statement.

 

By Order of the Board of Directors,

 

 

Frederick J. Kulevich

Senior Vice President, General Counsel

and Corporate Secretary

April
7, 2023

 

April 8 , 2021

 2021 Proxy Statement    76

2023 Proxy Statement77
 

APPENDIX

Appendix A

 

CDW CORPORATION AND SUBSIDIARIES NON-GAAP FINANCIAL MEASURE RECONCILIATIONS

Non-GAAP Financial Measure Reconciliations

 

We have included reconciliations of Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP income before income taxes, Non-GAAP net income, Non-GAAPNon- GAAP net income per diluted share and Free cash flow for the years ended December 31, 20202022 and 20192021 below. Non-GAAP operating income excludes, among other things, charges related to the amortization of acquisition-related intangible assets, equity-based compensation and the associated payroll taxes, a workforce reduction program, and acquisition and integration expenses. Non-GAAP operating income margin is defined as Non-GAAP operating income as a percentage of Net sales. Non-GAAP income before income taxes and Non-GAAP net income exclude, among other things, charges related to amortization of acquisition-related intangible assets,asset amortization, equity-based compensation, net loss on extinguishment of long-term debt, a workforce reduction program, acquisition and integration expenses, and the associated tax effects of each. With respect to Non-GAAP net income per diluted share, the numerator is Non-GAAP net income and the denominator is the weighted average number of shares outstanding as adjusted to give effect to dilutive securities. Free cash flow is defined as net cash provided byflows from operating activities minusless capital expenditures, plus/minusadjusted for the net change in accounts payable - inventory financing minus financing payments for revenue generating assets.and other financed purchases. Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP income before income taxes, Non-GAAP net income, Non-GAAP net income per diluted share and Free cash flow are considered non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance or financial position, or cash flowscondition that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). Non-GAAP measures used by the Companymanagement may differ from similar measures used by other companies, even when similar terms are used to identify such measures.

We believe that Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP income before income taxes, Non-GAAP net income and Non-GAAP net income per diluted share provide analysts, investors and Free cash flow providemanagement with helpful information regarding the underlying operating performance, as they remove the impact of our business and cash flows, including our ability to meet our future debt service, capital expenditures and working capital requirements. Our 2021 annual targets are provided on a non-GAAP basis because certain reconciling items are dependent on future events that either cannot be controlled, such as currency impacts or interest rates, or reliably predicted because theymanagement believes are not partreflective of underlying operating performance. Management uses these measures to evaluate period-over-period performance as management believes they provide a more comparable measure of the Company’s routine activities, suchunderlying business. We also present Free cash flow as refinancing activities or acquisitionwe believe this measure provides more information regarding our liquidity and integration expenses.capital resources. Certain non-GAAP financial measures are also used to determine certain components of performance-based compensation.

 

NON-GAAP OPERATING INCOME

Non-GAAP Operating Income

 

(dollars in millions) Year Ended December 31,
(unaudited) 2020  2019 
Operating income, as reported $1,179.2  $1,133.6 
Amortization of intangibles(a)  158.1   178.5 
Equity-based compensation  42.5   48.5 
Workforce reduction charges  8.5    
Other adjustments(b)  16.3   7.8 
Non-GAAP operating income $1,404.6  $1,368.4 
Non-GAAP operating income margin  7.6%  7.6%
  Year Ended December 31,
(dollars in millions)
(unaudited)
 2022  2021 
Operating income, as reported $1,735.2  $1,419.0 
Amortization of intangibles(a)  167.9   94.9 
Equity-based compensation  91.1   72.6 
Acquisition and integration expenses  48.3   54.3 
Other adjustments  8.0   4.6 
Non-GAAP operating income $2,050.5  $1,645.4 
Non-GAAP operating income margin  8.6%  7.9%

(a)Includes amortization expense for acquisition-related intangible assets, primarily customer relationships, customer contracts, and trade names.

(b)Includes other expenses such as payroll taxes on equity-based compensation, expenses related to the relocation of the downtown Chicago office, and acquisition and integration expenses.2023 Proxy Statement78

 2021 Proxy Statement77
 

NON-GAAP NET INCOME

Non-GAAP Net Income And Non-GAAP Net Income Per Diluted Share

 

  Year Ended December 31, 2020 Year Ended December 31, 2019 
(dollars in millions)
(unaudited)
 Income
before
income
taxes
  Income tax
expense(a)
  Net
income
  Effective
tax
rate
 Income
before
income
taxes
  Income
tax
expense(a)
  Net
income
  Effective
tax rate
 
US GAAP, as reported $1,002.3  $(213.8) $788.5   21.3% $949.7  $(212.9) $736.8   22.4%
Amortization of intangibles(b)  158.1   (36.8)  121.3       178.5   (44.6)  133.9     
Equity-based compensation  42.5   (37.0)  5.5       48.5   (36.6)  11.9     
Net loss on extinguishments of long-term debt  27.3   (6.8)  20.5       22.1   (5.5)  16.6     
Workforce reduction charges  8.5   (2.1)  6.4                  
Other adjustments(c)  16.3   (4.1)  12.2       7.8   (4.9)  2.9     
Non-GAAP $1,255.0  $(300.6) $954.4   24.0% $1,206.6  $(304.5) $902.1   25.2%
  Year Ended December 31, 2022     Year Ended December 31, 2021
(dollars in millions)
(unaudited)
  Income before
income taxes
  Income tax
expense(a)
  Net
income
  Effective
tax rate
  Income before
income taxes
  Income tax
expense(a)
  Net
income
  Effective
tax rate
 
US GAAP, as reported      $1,487.8     $(373.3) $1,114.5   25.1%       $1,297.8      $(309.2)   $988.6   23.8%
Amortization of intangibles(b)  167.9   (44.6)  123.3       94.9   (18.9)  76.0     
Equity-based compensation  91.1   (30.4)  60.7       72.6   (42.6)  30.0     
Acquisition and integration expenses  48.3   (12.4)  35.9       54.3   (10.4)  43.9     
Gain on sale of equity method investment               (36.0)  8.5   (27.5)    
Net loss on extinguishments of long-term debt  1.6   (0.4)  1.2       6.0   (1.5)  4.5     
Other adjustments  8.0   (2.1)  5.9       4.6   (1.2)  3.4     
Non-GAAP $1,804.7  $(463.2) $1,341.5   25.7% $1,494.2  $(375.3) $1,118.9   25.1%
Net income per diluted share, as reported          8.13               7.04     
Non-GAAP net income per diluted share          9.79               7.97     
Shares used in computing US GAAP and Non-GAAP net income per diluted share          137.0               140.5     

(a)Income tax on non-GAAP adjustments includes excess tax benefits associated with equity-based compensation.
(b)Includes amortization expense for acquisition-related intangible assets, primarily customer relationships, customer contracts and trade names.
(c)Includes other expenses such as payroll taxes on equity-based compensation, expenses related to the relocation of the downtown Chicago office, and acquisition and integration expenses.

 

NET INCOME AND NON-GAAP NET INCOME PER DILUTED SHARE

Free Cash Flow

 

(dollars and shares in millions, except per share amounts) Year Ended December 31,
(unaudited)  2020  2019 % Change
Net income, as reported $788.5 $736.8 7.0%
Weighted-average common shares outstanding - Diluted  144.8  147.8  
US GAAP Net income per diluted share $5.45 $4.99 9.2%
Non-GAAP net income $954.4 $902.1 5.8%
Weighted-average common shares outstanding - Diluted  144.8  147.8  
Non-GAAP net income per diluted share $6.59 $6.10 8.0%

  Year Ended December 31,
(dollars in millions)
(unaudited)
 2022  2021 
Net cash provided by operating activities $1,335.9  $784.6 
Capital expenditures  (127.8)  (100.0)
Net change in accounts payable – inventory financing  84.6   (161.8)
Financing payments for revenue generating assets     (46.1)
Free cash flow $1,292.7  $476.7 

 

FREE CASH FLOW

(dollars in millions)Year Ended December 31,
(unaudited) 2020  2019 
Net cash provided by operating activities $1,314.3  $1,027.2 
Capital expenditures  (158.0)  (236.3)
Net change in accounts payable - inventory financing  93.0   (1.3)
Financing payments for revenue generating assets  (18.1)   
Free cash flow $1,231.2  $789.6 

 20212023 Proxy Statement7879
 

APPENDIX

Appendix B

 

FORWARD-LOOKING STATEMENTS

Forward-Looking Statements

 

This proxy statement includes forward-looking statements regarding management’s expectations for our future performance and other events that are forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual results or other events to differ materially from those described in such statements. For a discussion of forward-looking statements and factors that could cause our actual performance to differ materially from these expectations, see the sections entitled “Forward-Looking Statements” and “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 20202022 and in CDW’s subsequent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.SEC. CDW undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

 

 20212023 Proxy Statement7980

 

APPENDIX

Appendix C

 

Proposed Amendments to the Certificate of Incorporation

PROPOSED AMENDMENTS TO THE COMPANY’S

SEVENTH AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION


OF
CDW CORPORATION

 

Article Six*   *   *   *

 

Section 3. ClassesThe undersigned, being an authorized officer of Directors.UntilCDW Corporation, a corporation duly organized and existing under and by virtue of the 2021 annual meetinglaws of stockholders, the directorsState of Delaware (the “Corporation”), does hereby certify as follows:

FIRST: The original Certificate of Incorporation of the Corporation other than those whowas filed with the Delaware Secretary of State on May 25, 2007 under the name VH Holdings, Inc.

SECOND: That an Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State on October 5, 2007. The Second Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State on October 11, 2007. The Third Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State on March 7, 2008. The Fourth Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State on August 17, 2010. The Fifth Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State on June 13, 2013 and a Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation was filed with the Delaware Secretary of State on each of May 19, 2016, May 23, 2018 and May 20, 2021, respectively. The Sixth Restated Certificate of Incorporation was filed with the Delaware Secretary of State on May 20, 2021 (the “Sixth Restated Certificate of Incorporation”);

THIRD: This Seventh Amended and Restated Certificate of Incorporation (this “Certificate of Incorporation”) amends and restates the Sixth Restated Certificate of Incorporation of the Corporation in its entirety to read as set forth on Exhibit A attached hereto and made a part hereof; and

FOURTH: This Certificate of Incorporation was duly adopted by the Board of Directors of the Corporation and by the stockholders of the Corporation, in accordance with Sections 242 and 245 of the Delaware General Corporation Law.

*   *   *   *   *

IN WITNESS WHEREOF, the undersigned does hereby certify under penalties of perjury that this Certificate of Incorporation is the act and deed of the undersigned and the facts stated herein are true and accordingly has hereunto set his or her hand this [•]th day of [•], 2023.

CDW Corporation,
a Delaware corporation
By:
Name:
Title:

2023 Proxy Statement81

Exhibit A

SIXTHSEVENTH AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
CDW CORPORATION
ARTICLE ONE

The name of the corporation is CDW Corporation (the “Corporation”).

ARTICLE TWO

The address of the Corporation’s registered office in the State of Delaware is 251 Little Falls Drive, Wilmington, County of New Castle County, 19808. The name of its registered agent at such address is Corporation Service Company. The registered office and/or registered agent of the Corporation may be electedchanged from time to time by resolution of the holdersBoard of Directors of the Corporation (the “Board of Directors”).

ARTICLE THREE

The nature of the business of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the DGCL.

ARTICLE FOUR

Section 1. Authorized Shares. The total number of shares of all classes of capital stock which the Corporation shall have authority to issue is 1,100,000,000 shares, consisting of:

1.100,000,000 shares of Preferred Stock, par value $0.01 per share (the “Preferred Stock”); and
2.1,000,000,000 shares of Common Stock, par value $0.01 per share (the “Common Stock”).

The Preferred Stock and the Common Stock shall have the rights, preferences and limitations set forth below.

Section 2. Preferred Stock. The Board of Directors is authorized, subject to limitations prescribed by law, to provide, by resolution or resolutions for the issuance of shares of Preferred Stock in one or more series, and with respect to each series, to establish the number of shares to be included in each such series, and to fix the voting powers (if any), designations, powers, preferences, and relative, participating, optional or other special rights, if any, of the shares of each such series, and any qualifications, limitations or restrictions thereof. The powers, preferences, and relative, participating, optional and other special rights of each series of Preferred Stock and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding. Subject to applicable law and within the limitations or restrictions stated in any resolution or resolutions of the Board of Directors fixing the number of shares constituting a series of Preferred Stock, the Board of Directors may increase or decrease (but not below the number of shares of any such series of Preferred Stock then outstanding) by resolution the number of shares of any such series of Preferred Stock. In the event that the number of shares of any series of Preferred Stock shall be so decreased, the shares constituting such decrease shall resume the undesignated status which such shares had prior to the adoption of the resolution originally fixing the number of shares of such series of Preferred Stock subject to the requirements of applicable law. The number of authorized shares of Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority in voting power of the outstanding shares of capital stock of the Corporation entitled to vote generally in an election of directors, without the separate vote of the holders of the Preferred Stock as a class, irrespective of the provisions of Section 242(b)(2) of the DGCL.

Section 3. Common Stock.

(a)Except as otherwise provided by the DGCL or this Sixth Seventh Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) and subject to the rights of holders of any series of Preferred Stock, all of the voting power of the stockholders of the Corporation shall be vested in the holders of the Common Stock. Each share of Common Stock shall entitle the holder thereof to one vote for each share held by such holder on all matters voted upon by the stockholders of the Corporation; provided, however, that, except as otherwise required by law, holders of Common Stock, as such, shall not be entitled to vote on any amendment to this Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to this Certificate of Incorporation (including any certificate of designations relating to any series of Preferred Stock).

2023 Proxy Statement82
(b)Except as otherwise required by law or expressly provided in this Certificate of Incorporation, each share of Common Stock shall have the same powers, rights and privileges and shall rank equally, share ratably and be identical in all respects as to all matters.
(c)Subject to the rights of the holders of Preferred Stock and to the other provisions of this Certificate of Incorporation, holders of Common Stock shall be entitled to receive equally, on a per share basis, such dividends and other distributions in cash, securities or other property of the Corporation as may be declared thereon by the Board of Directors from time to time out of assets or funds of the Corporation legally available therefor.
(d)In the event of any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, after payment or provision for payment of the Corporation’s debts and any other payments required by law and amounts payable upon shares of Preferred Stock ranking senior to the shares of Common Stock upon such dissolution, liquidation or winding up, if any, the remaining net assets of the Corporation shall be distributed to the holders of shares of Common Stock and the holders of shares of any other class or series ranking equally with the shares of Common Stock upon such dissolution, liquidation or winding up, equally on a per share basis. A merger or consolidation of the Corporation with or into any other corporation or other entity, or a sale or conveyance of all or any part of the assets of the Corporation (which shall not in fact result in the liquidation of the Corporation and the distribution of assets to its stockholders) shall not be deemed to be a voluntary or involuntary liquidation or dissolution or winding up of the Corporation within the meaning of this Paragraph (d).

ARTICLE FIVE

The Corporation is to have perpetual existence.

ARTICLE SIX

Section 1. Board of Directors. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors. In addition to the powers and authority expressly conferred upon them by statute or by this Certificate of Incorporation or the Bylaws of the Corporation (as amended, the “Bylaws”), the directors are hereby empowered to exercise all such powers and do all such acts and things as may be exercised or done by the Corporation.

Section 2. Number of Directors. Subject to any rights of the holders of any class or series of Preferred Stock to elect additional directors under specified circumstances, the number of directors which shall constitute the Board of Directors shall initially be three (3) and, thereafter, shall be divided into three classes, hereby designated Class I, Class II and Class III. Commencing with the 2021 annual meetingfixed from time to time exclusively by resolution of the stockholders, the classificationBoard.

Section 3. Classes of the directors shall terminate and allDirectors. All directors shall be of one class, other than those who may be elected by the holders of any series of Preferred Stock under specified circumstances.

 

Section 4. Election and Term of Office.

[Certain paragraphs outsideOffice. A nominee for director shall be elected to the Board of Directors at a duly called meeting of the scopestockholders at which a quorum is present if the votes of this amendment haveshares of capital stock of the Corporation present in person or represented by proxy at the meeting and entitled to vote in the election of directors cast “for” such nominee’s election exceed the votes of shares of capital stock of the Corporation present in person or represented by proxy at the meeting and entitled to vote in the election of directors cast “against” such nominee’s election (with “abstentions” and “broker non-votes” not counted as votes cast either “for” or “against” that nominee’s election); provided, however, that directors shall be elected by a plurality of the votes cast at any duly called meeting of the stockholders for which (i) the secretary of the Corporation receives a notice that a stockholder has nominated a person for election to the Board of Directors in compliance with the advance notice requirements for stockholder nominees for director set forth in the Bylaws of the Corporation; and (ii) such nomination has not been omitted].

Each director electedwithdrawn by such stockholder on or prior to the 2019 annualtenth (10th) day preceding the date the Corporation first mails its notice of meeting for such meeting to the stockholders. If directors are elected by a plurality of the votes cast, stockholders shall hold officenot be permitted to vote against a nominee.

If an incumbent director is not elected by a majority of votes cast (unless, pursuant to the immediately preceding paragraph, the director election standard is a plurality), the incumbent director shall promptly tender his or her resignation to the Board of Directors for consideration. The Nominating and Corporate Governance Committee will make a recommendation to the Board of Directors on whether to accept or reject the director’s resignation, or whether other action should be taken. The Board of Directors will act on the Nominating and Corporate Governance Committee’s recommendation and publicly disclose its decision within ninety (90) days from the date of the certification of the election results. An incumbent director who tenders his or her resignation for consideration will not participate in the Nominating and Corporate Governance Committee’s or the Board of Directors’ recommendation or decision, or any deliberations related thereto.

If a director’s resignation is accepted by the Board of Directors pursuant to this Section 4, or if a nominee for director is not elected and the nominee is not an incumbent director, then the Board of Directors may fill the resulting vacancy pursuant to the provisions of Section 5 of this Article Six or may decrease the size of the Board of Directors pursuant to Section 2 of this Article Six. If a director’s resignation is not accepted by the Board of Directors pursuant to this Section 4, such director will continue to serve until the annual meeting of stockholders for the year in which such director’s term expires and a successor ishas been duly elected and qualified or until his or her earlier death, resignation or removal. The term of the Class III directors elected at the 2016 annual meeting of stockholders shall expire at the 2019 annual meeting of stockholders, the term of the Class I directors elected at the 2017 annual meeting of stockholders shall expire at the 2020 annual meeting of stockholders and the term of the Class II directors elected at the 2018 annual meeting of stockholders shall expire at the 2021 annual meeting of stockholders. Commencing at the 2019 annual meeting of stockholders, directors succeeding those whose terms are then expiredremoval as hereinafter provided.

2023 Proxy Statement83

Directors shall be elected to hold office until the annual meeting of stockholders held in the year following the year of their election and a successor is duly elected and qualified or until his or her earlier death, resignation or removal. If any director who at the time of his or her most recent election or appointment to a term on the Board of Directors was an officer of the Corporation ceases to be an officer of the Corporation during such term as director, such director shall no longer be qualified to be a director and shall immediately cease to be a director without any further action unless otherwise determined by the Board of Directors. Nothing in this Certificate of Incorporation shall preclude a director from serving consecutive terms. Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall so provide.

 

Section 5. Newly-Created Directorships and Vacancies. Subject to the rights of the holders of any series of Preferred Stock then outstanding, newly created directorships resulting from any increase in the authorized number of directors or any vacancies in the Board of Directors resulting from death, resignation, disqualification, removal from office or any other cause may be filled only by resolution of a majority of the directors then in office, although less than a quorum, or by a sole remaining director. A director elected to fill a vacancy shall be elected for the unexpired term of his or her predecessor in office and until his or her successor is elected and qualified. A director chosen to fill a position resulting from an increase in the number of directors shall hold office until the next annual meeting of stockholders and until his or her successor is elected and qualified, or until his or her earlier death, resignation or removal. No decrease in the authorized number of directors shall shorten the term of any incumbent director.

Section 6. Removal of Directors.Directors. Subject to the rights of the holders of any series of Preferred Stock then outstanding and notwithstanding any other provision of this Certificate of Incorporation, directors may be removed with or without cause upon the affirmative vote of stockholders representing at least a majority of the voting power of the then outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors (“Voting Stock”), at a meeting of the Corporation’s stockholders called for that purpose; provided that at any time prior to the 2021 annual meeting of stockholders, directors may only be removed for cause and only upon the affirmative vote of stockholders representing at least sixty-six and two-thirds percent (66 2/3%) of the voting power of the then outstanding Voting Stock, at a meeting of the Corporation’s stockholders called for that purpose.purpose. Any director may resign at any time upon written notice to the Corporation.

 

Article EightSection 7. Rights of Holders of Preferred Stock. Notwithstanding the provisions of this ARTICLE SIX, whenever the holders of one or more series of Preferred Stock issued by the Corporation shall have the right, voting separately or together by series, to elect directors at an annual or special meeting of stockholders, the election, term of office, filling of vacancies and other features of such directorship shall be governed by the rights of such Preferred Stock as set forth in the certificate of designation governing such series.

 

Section 8. Advance Notice. Advance notice of stockholder nominations for the election of directors and of business to be brought by stockholders before any meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws of the Corporation.

ARTICLE SEVEN

Section 1. Limitation of Liability.

(a) To the fullest extent permitted by the DGCL as it now exists or may hereafter be amended (but, in the case of any such amendment, only to the extent such amendment permits the Corporation to provide broader rights than permitted prior thereto), no director or officer of the Corporation shall be liable to the Corporation or its stockholders for monetary damages arising from a breach of fiduciary duty as a director or officer. For purposes of this Article SEVEN, “officer” shall have the meaning provided in Section 102(b)(7) of the Delaware General Corporation Law, as it presently exists or may hereafter be amended from time to time.

(b) Any amendment, repeal or modification of the foregoing paragraph by the stockholders of the Corporation shall not adversely affect any right or protection of a director or officer of the Corporation existing at the time of such amendment, repeal or modification with respect to any act, omission or other matter occurring prior to such amendment, repeal or modification.

ARTICLE EIGHT

Section 1. Action by Written Consent.From and after the date (the “Trigger Date”) on which (i) Madison Dearborn Capital Partners V-A, L.P., Madison Dearborn Capital Partners V-C, L.P., Madison Dearborn Capital Partners V Executive-A, L.P. and MDCP Co-Investor (CDW), L.P. and their affiliates (collectively, “MDP Funds”) and (ii) Providence Equity Partners VI, L.P., Providence Equity Partners VI-A, L.P. and PEP Co-Investors (CDW), L.P. and their affiliates (collectively, “PEP Funds”), cease to beneficially own in the aggregate (directly or indirectly) at least a majority of the Voting Stock, any

Any action required or permitted to be taken by the Corporation’s stockholders may be effected only at a duly called annual or special meeting of the Corporation’s stockholders and the power of stockholders to consent in writing without a meeting is specifically denied.Priorto the Trigger Date, any action which is required or permitted to be taken by the Corporation’s stockholders may be taken without a meeting, without prior notice and without a vote if a consent or consents in writing, setting forth the action so taken, is signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares of the Corporation’s stock entitled to vote thereon were present and voted.

 

Section 2. Special Meetings of Stockholders. Subject to the rights of the holders of any series of Preferred Stock then outstanding and to the requirements of applicable law, special meetings of stockholders of the Corporation may be called

 2021 Proxy Statement80

only(i)by or at the direction of the Board of Directors pursuant to a written resolution adopted by the affirmative vote of the majority of the total number of directors that the Corporation would have if there were no vacancies, or (ii) priorsubject to the Trigger Date, (a)requirements and limitations in Section 3 of ARTICLE II of the Bylaws, by the ChairmanSecretary, the Chair of the Board or Vice Chairman of the Board of Directors upon the written request of one or more stockholders of Common Stock entitled to cast on the Corporation, (b) bymatter(s) to be brought before the Chief Executive Officer ofStockholder Requested Special Meeting (as defined in the Corporation, (c) by a resolution of the majority of the board of directors of the Corporation or (d) prior to the TriggerDate, by the Secretary of the Corporation at the request by written consent of the holders of at least tenBylaws) not less than twenty five percent (10%(25%) of the voting power of the thenall outstanding shares of Votingthe Common Stock as of the date of the request, which request complies with the procedures for calling a special meeting of stockholders as set forth in the manner provided for in the Bylaws, as may be amended from time to time. Any business transacted at any special meeting of stockholders shall be limited to matters relating to the purpose or purposes stated in the notice of the meeting.

 

Article Ten

Reserved.

Section 1. Section 203 of the DGCL. The Corporation expressly elects not to be subject to the provisions of Section 203 of the DGCL.

Section 2. Interested Stockholder Transactions. Notwithstanding any other provision in this Certificate of Incorporation to the contrary, the Corporation shall not engage in any Business Combination (as defined hereinafter) with any Interested Stockholder (as defined hereinafter) for a period of three years following the time that such stockholder became an Interested Stockholder, unless:

(a) prior to such time the Board of Directors approved either the Business Combination or the transaction which resulted in such stockholder becoming an Interested Stockholder;

(b) upon consummation of the transaction which resulted in such stockholder becoming an Interested Stockholder, such stockholder owned at least eighty-five percent (85%) of the Voting Stock of the Corporation outstanding at the time the transaction commenced, excluding for purposes of determining the Voting Stock outstanding (but not the outstanding Voting Stock owned by such Interested Stockholder) those shares owned (i) by Persons (as defined hereinafter) who are directors and also officers of the Corporation and (ii) employee stock plans of the Corporation in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

(c) at or subsequent to such time the Business Combination is approved by the Board of Directors and authorized at an annual or special meeting of stockholders by the affirmative vote of at least sixty-six and two-thirds percent (66 2/3%) of the outstanding Voting Stock which is not owned by such Interested Stockholder.

Section 3. Exceptions to Prohibition on Interested Stockholder Transactions. The restrictions contained in this ARTICLE TEN shall not apply if:

(a) a stockholder becomes an Interested Stockholder inadvertently and (i) as soon as practicable divests itself of ownership of sufficient shares so that the stockholder ceases to be an Interested Stockholder; and (ii) would not, at any time within the three- year period immediately prior to a Business Combination between the Corporation and such stockholder, have been an Interested Stockholder but for the inadvertent acquisition of ownership; or

(b) the Business Combination is proposed prior to the consummation or abandonment of and subsequent to the earlier of the public announcement or the notice required hereunder of a proposed transaction which (i) constitutes one of the transactions described in the second sentence of this Section 3(b) of ARTICLE TEN; (ii) is with or by a Person who either was not an Interested Stockholder during the previous three years or who became an Interested Stockholder with the approval of the Board of Directors; and (iii) is approved or not opposed by a majority of the directors then in office (but not less than one) who were directors prior to any Person becoming an Interested Stockholder during the previous three years or were recommended for election or elected to succeed such directors by a majority of such directors. The proposed transactions referred to in the preceding sentence are limited to (x) a merger or consolidation of the Corporation (except for a merger in respect of which, pursuant to Section 251(f) of the DGCL, no vote of the stockholders of the Corporation is required); (y) a sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of transactions), whether as part of a dissolution or otherwise, of assets of the Corporation or of any direct or indirect majority-owned subsidiary of the Corporation (other than to any direct or indirect wholly-owned subsidiary or to the Corporation) having an aggregate market value equal to fifty percent (50%) or more of either that aggregate market value of all of the assets of the Corporation determined on a consolidated basis or the aggregate market value of all the outstanding Stock (as defined hereinafter) of the Corporation; or (z) a proposed tender or exchange offer for fifty percent (50%) or more of the outstanding Voting Stock of the Corporation. The Corporation shall give not less than 20 days’ notice to all Interested Stockholders prior to the consummation of any of the transactions described in clause (x) or (y) of the second sentence of this Section 3(b) of ARTICLE TEN.

Section 4. Definitions. As used in this ARTICLE TEN only, and unless otherwise provided by the express terms of this ARTICLE TEN, the following terms shall have the meanings ascribed to them as set forth in this Section 4:

(a) “Affiliate” means a Person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, another Person;

(b) “Associate,” when used to indicate a relationship with any Person, means: (i) any corporation, partnership, unincorporated association or other entity of which such Person is a director,

 20212023 Proxy Statement8184
 
ARTICLE NINE

officer

Reserved.

ARTICLE TEN

Reserved.

ARTICLE ELEVEN

Section 1. Amendments to the Bylaws. In furtherance and not in limitation of the powers conferred by law, the Corporation’s Bylaws may be amended, altered or partnerrepealed and new bylaws made by (i) the Board or is, directly or indirectly,(ii) in addition to any other vote otherwise required by law, the owneraffirmative vote of twenty percent (20%) or morethe holders of any class of Voting Stock; (ii) any trust or other estate in which such Person has at least a twenty percent (20%) beneficial interest or as to which such Person serves as trustee or in a similar fiduciary capacity; and (iii) any relative or spouse of such Person, or any relative of such spouse, who has the same residence as such Person;

(c) “Business Combination” means:

(i) any merger or consolidationmajority of the Corporation or any direct or indirect majority-owned subsidiaryvoting power of the Corporation with (A) the Interested Stockholder, or (B) with any Person if the merger or consolidation is caused by the Interested Stockholder and as a result of such merger or consolidation Section 2 of this ARTICLE TEN is not applicable to the surviving entity;

(ii) any sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of transactions), except proportionately as a stockholder of the Corporation, to or with the Interested Stockholder, whether as part of a dissolution or otherwise, of assets of the Corporation or of any direct or indirect majority-owned subsidiary of the Corporation which assets have an aggregate market value equal to ten percent (10%) or more of either the aggregate market value of all the assets of the Corporation determined on a consolidated basis or the aggregate market value of all the outstanding Stock of the Corporation; or

(iii) any transaction which results in the issuance or transfer by the Corporation or by any direct or indirect majority-owned subsidiary of the Corporation of any Stock of the Corporation or of such subsidiary to the Interested Stockholder, except: (A) pursuant to the exercise, exchange or conversion of securities exercisable for, exchangeable for or convertible into Stock of the Corporation or any such subsidiary which securities were outstanding prior to the time that the Interested Stockholder became such; (B) pursuant to a merger under Section 251(g) or Section 253 of the DGCL; (C) pursuant to a dividend or distribution paid or made, or the exercise, exchange or conversion of securities exercisable for, exchangeable for or convertible into Stock of the Corporation or any such subsidiary which security is distributed, pro rata to all holders of a class or series of Stock of the Corporation subsequent to the time the Interested Stockholder became such; (D) pursuant to an exchange offer by the Corporation to purchase Stock made on the same terms to all holders of such Stock; or (E) any issuance or transfer of Stock by the Corporation; provided however, that in no case under items (C)-(E) of this Section 4(c)(iii) of ARTICLE TEN shall there be a related increase in the Interested Stockholder’s proportionate share of the Stock of any class or series of the Corporation or of the Voting Stock of the Corporation.

(d) “Control,” including the terms “controlling,” “controlled by” and “under common control with,” means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of stock or other equity interests, by contract or otherwise. A Person who is the owner of twenty percent (20%) or more of thethen outstanding Voting Stock, of any corporation, partnership, unincorporated association or other entity shall be presumed to have control of such entity, in the absence of proof by a preponderance of the evidence to the contrary; notwithstanding the foregoing, a presumption of control shall not apply where such Person holds Voting Stock, in good faith and not for the purpose of circumventing this ARTICLE TEN, as an agent, bank, broker, nominee, custodian or trustee for one or more owners who do not individually orvoting together as a group have control of such entity;single class.

 

(e) “Interested Stockholder” means any Person (other than the Corporation and any direct or indirect majority-owned subsidiary of the Corporation) that (i) is the owner of fifteen percent (15%) or more of the outstanding Voting Stock of the Corporation, or (ii) is an Affiliate or Associate of the Corporation and was the owner of fifteen percent (15%) or more of the outstanding Voting Stock of the Corporation at any time within the three-year period immediately prior to the date on which it is sought to be determined whether such Person is an Interested Stockholder, and the Affiliates and Associates of such Person. Notwithstanding anything in this ARTICLE TEN to the contrary, the term “Interested Stockholder” shall not include: (x) MDP, PEP or any of their Affiliates or Associates, including any investment funds managed, directly or indirectly, by MDP (including without limitation the MDP Funds), PEP (including without limitation the PEP Funds) or any other Person with whom any of the foregoing are acting as a group or in concert for the purpose of acquiring, holding, voting or disposing of shares of Stock of the Corporation, (y) any Person who would otherwise be an Interested Stockholder because of a transfer, sale, assignment, conveyance, hypothecation, encumbrance, or other disposition of five percent (5%) or more of the outstanding Voting Stock of the Corporation (in one transaction or a series of transactions) by any party specified in the immediately preceding clause (x) to such Person; provided, however, that such Person was not an Interested Stockholder prior to such transfer, sale, assignment, conveyance, hypothecation, encumbrance, or other disposition; or (z) any Person whose ownership of shares in excess of the fifteen percent (15%) limitation set forth herein is the result of action taken solely by the Corporation, provided that, for purposes of this clause (z), such Person shall be an Interested Stockholder if thereafter such Person acquires additional shares of Voting Stock of the Corporation, except as a result of further action by the Corporation not caused, directly or indirectly, by such Person;

(f) “Owner,” including the terms “own” and “owned,” when used with respect to any Stock, means a Person that individually or with or through any of its affiliates or associates beneficially owns such Stock, directly or indirectly; or has (A) the right to acquire such Stock (whether such right is exercisable immediately or only after the passage of time) pursuant to any agreement, arrangement or understanding, or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise; provided, however, that a Person shall not be deemed the owner of Stock tendered pursuant

 2021 Proxy Statement82

to a tender or exchange offer made by such Person or any of such Person’s Affiliates or Associates until such tendered Stock is accepted for purchase or exchange; or (B) the right to vote such Stock pursuant to any agreement, arrangement or understanding; provided, however, that a Person shall not be deemed the owner of any Stock because of such Person’s right to vote such Stock if the agreement, arrangement or understanding to vote such Stock arises solely from a revocable proxy or consent given in response to a proxy or consent solicitation made to 10 or more Persons; or has any agreement, arrangement or understanding for the purpose of acquiring, holding, voting (except voting pursuant to a revocable proxy or consent as described in (B) of this Section 4(f) of ARTICLE TEN), or disposing of such Stock with any other Person that beneficially owns, or whose affiliates or associates beneficially own, directly or indirectly, such Stock; provided, that, for the purpose of determining whether a Person is an Interested Stockholder, the Voting Stock of the Corporation deemed to be outstanding shall include Stock deemed to be owned by the Person through application of this definition of “owned” but shall not include any other unissued Stock of the Corporation which may be issuable pursuant to any agreement, arrangement or understanding, or upon exercise of conversion rights, warrants or options, or otherwise;

(g) “Person” means any individual, corporation, partnership, unincorporated association or other entity;

(h) “Stock” means, with respect to any corporation, capital stock and, with respect to any other entity, any equity interest; and

(i) “Voting Stock” means, with respect to any corporation, Stock of any class or series entitled to vote generally in the election of directors and, with respect to any entity that is not a corporation, any equity interest entitled to vote generally in the election of the governing body of such entity. Every reference to a percentage of Voting Stock shall refer to such percentage of the votes of such Voting Stock.

Article Eleven

Section 2. Amendments to this Certificate of Incorporation. The Corporation reserves the right at any time, and from time to time, to amend, alter, change or repeal any provision contained in this Certificate of Incorporation and other provisions authorized by the laws of the State of Delaware at the time in force may be added or inserted, in the manner now or hereafter prescribed herein and by law, and all rights, preferences and privileges of any nature conferred upon stockholders, directors or any other persons by and pursuant to this Certificate of Incorporation in its present form or as hereafter amended are granted subject to this reservation. Notwithstanding any other provision of this Certificate of Incorporation or the Bylaws of the Corporation, and notwithstanding the fact that a lesser percentage or separate class vote may be specified by law or otherwise, but in addition to any affirmative vote of the holders of any particular class or series of the capital stock required by law or otherwise, no provision of ARTICLE SIX, ARTICLE SEVEN, ARTICLE EIGHT, ARTICLE TEN, ARTICLE ELEVEN or ARTICLE TWELVE of this Certificate of Incorporation may be altered, amended or repealed in any respect, nor may any provision of this Certificate of Incorporation or the Bylaws inconsistent therewith be adopted, unless in addition to any other vote required by this Certificate of Incorporation or otherwise required by law, such alteration, amendment, repeal or adoption is approved by, in addition to any other vote otherwise required by law, the affirmative vote of holders of at leastsixty-six and two-thirds percent (66 2/3%)a majority of the voting power of all outstanding shares of Voting Stock, voting together as a single class, at a meeting of the Corporation’s stockholders called for that purpose.

 

 2021 Proxy Statement83

ARTICLE TWELVE

APPENDIX D

 

PROPOSED AMENDMENTS TO THE COMPANY’S CERTIFICATE OF INCORPORATION

Article Nine

Reserved.

Section 1. Certain Acknowledgments. In recognition and anticipation that (i) the principals, officers, members, managers and/or employeesThe Court of Madison Dearborn Partners, LLC (“MDP”) or Providence Equity Partners L.L.C. (“PEP”) or their Affiliated Companies (as defined below) may serve as directors or officersChancery of the Corporation, (ii) MDP, PEP and their Affiliated Companies engage and may continue to engage in the same or similar activities or related linesState of business as those in which the Corporation, directly or indirectly, may engage and/or other business activities that overlap with or compete with those in which the Corporation, directly or indirectly, may engage, and (iii) that the Corporation and its Affiliated Companies may engage in material business transactions with MDP, PEP and their Affiliated Companies, and that the Corporation is expected to benefit therefrom, the provisions of this ARTICLE NINE are set forth to regulate and define the conduct of certain affairs of the Corporation as they may involve MDP, PEP and/or their Affiliated Companies and/or their respective principals, officers, members, managers and/or employees, including any of the foregoing who serve as officers or directors of the Corporation (collectively, the “Exempted Persons”), and the powers, rights, duties and liabilities of the Corporation and its officers, directors and stockholders in connection therewith. As used in this Certificate of Incorporation, “Affiliated Companies”Delaware shall, mean (a) in respect of MDP or PEP, any entity that controls, is controlled by or under common control with MDP and/or PEP (other than the Corporation and any company that is controlled by the Corporation) and any investment funds managed, directly or indirectly, by MDP or PEP and (b) in respect of the Corporation, any company controlled by the Corporation.

Section 2. Competition and Corporate Opportunities. To the fullest extent permitted by applicable law, neither MDP, PEP nor any of their Affiliated Companies nor any of their respective Exempted Persons shall have any fiduciary duty to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as the Corporation or any of its Affiliated Companies, and no Exempted Person shall be liable to the Corporation or its stockholders for breach of any fiduciary duty solely by reason of any such activities of MDP, PEP, their Affiliated Companies or such Exempted Person. To the fullest extent permitted by applicable law, the Corporation, on behalf of itself and its Affiliated Companies, renounces any interest or expectancy of the Corporation and its Affiliated Companies in, or in being offered an opportunity to participate in, business opportunities that are from time to time presented to MDP, PEP, their Affiliated Companies or any of their respective Exempted Persons, even if the opportunity is one that the Corporation or its Affiliated Companies might reasonably be deemed to have pursued or had the ability or desire to pursue if granted the opportunity to do so, and each Exempted Person shall have no duty to communicate or offer such business opportunity to the Corporation or its Affiliated Companies and, to the fullest extent permitted by applicable law, shall not be liablethe sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any action asserting a claim against the Corporation, its directors, officers or employees arising pursuant to any provision of its Affiliated Companies for breachthe DGCL, this Certificate of any fiduciaryIncorporation (as may be amended, altered, changed or other duty, as a director, officerrepealed in accordance with Section 2 of ARTICLE ELEVEN) or stockholderthe Bylaws of the Corporation solelyor (iv) any action asserting a claim against the Corporation, its directors, officers or employees governed by reasonthe internal affairs doctrine, except for, as to each of (i) through (iv) above, any claim as to which the Court of Chancery determines that there is an indispensable party not subject to the jurisdiction of the fact that MDP, PEP, their Affiliated Companies or any such Exempted Person, acting in good faith, pursues or acquires such business opportunity, sells, assigns, transfers or directs such business opportunity to another person or fails to present such business opportunity, or information regarding such business opportunity,Court of Chancery (and the indispensable party does not consent to the Corporation or any of its Affiliated Companies, unless any such business opportunity is expressly offered to such Exempted Person solely in his or her capacity as an officer or directorpersonal jurisdiction of the Corporation.

Section 3. Certain Matters Deemed Not Corporate Opportunities. In addition to and notwithstandingCourt of Chancery within ten days following such determination), which is vested in the foregoingexclusive jurisdiction of a court or forum other than the Court of Chancery, or for which the Court of Chancery does not have subject matter jurisdiction. If any provision or provisions of this ARTICLE NINE, a corporate opportunityTWELVE shall not be deemedheld to belongbe invalid, illegal or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the Corporation if it is a business opportunity thatfullest extent permitted by law, the Corporation is not permitted to undertake under the termsvalidity, legality and enforceability of ARTICLE THREE or that the Corporation is not financially able or contractually permitted or legally able to undertake, or that is, from its nature, notsuch provisions in the lineany other circumstance and of the Corporation’s business or is of no practical advantage to it or that is one in which the Corporation has no interest or reasonable expectancy.

Section 4. Amendment of this Article. Notwithstanding anything to the contrary elsewhere contained in this Certificate of Incorporation, and in addition to any vote required by applicable law, the affirmative vote of the holders of at least eighty percent (80%) of the voting power of the then outstanding shares of Voting Stock, voting together as a single class, shall be required to alter, amend or repeal, or to adopt any provision inconsistent with, this ARTICLE NINE; provided however, that neither the alteration, amendment or repealremaining provisions of this ARTICLE NINE nor the adoptionTWELVE (including, without limitation, each portion of any provisionsentence of this CertificateARTICLE TWELVE containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of Incorporation

 2021 Proxy Statement84

inconsistent with this ARTICLE NINEsuch provision to other persons or entities and circumstances shall apply tonot in any way be affected or have any effect on the liability or alleged liability of any Exempted Person for or with respect to any activities or opportunities which such Exempted Person becomes aware prior to such alteration, amendment, repeal or adoption.

Section 5. Deemed Notice.impaired thereby. Any person or entity purchasing or otherwise acquiring any interest in any shares of the Corporation shall be deemed to have notice of and to have consented to the provisions of this ARTICLE NINE.TWELVE.

 

Section 6. Severability. To the extent that any provision or part of any provision of this ARTICLE NINE is found to be invalid or unenforceable, such invalidity or unenforceability shall not affect the validity or enforceability of any other provision or part of any other provision of this ARTICLE NINE.* * * * *

 

 20212023 Proxy Statement85
 

APPENDIX E

Appendix D

 

Special Meeting Bylaw Amendments

AMENDED AND RESTATED BYLAWS
OF
CDW CORPORATION 2021 LONG-TERM INCENTIVE PLAN

 

I. INTRODUCTION

A Delaware corporation

 

1.1Purposes. The purposes of the CDW Corporation 2021 Long-Term Incentive Plan (this “Plan”) are (i) to align the interests of the Company’s stockholders and the recipients of awards under this Plan by increasing the proprietary interest of such recipients in the Company’s growth and success, (ii) to advance the interests of the Company by attracting and retaining officers, other employees, Non-Employee Directors, consultants, independent contractors and agents and (iii) to motivate such persons to act in the long-term best interests of the Company and its stockholders.

(Adopted as of [], 2023)

 

1.2Certain Definitions.
ARTICLE I
OFFICES

 

Section 1. Offices. CDW Corporation (the AgreementCorporationshall mean) may have an office or offices other than its registered office at such place or places, either within or outside the written or electronic agreement evidencing an award hereunder between the Company and the recipientState of such award.

Blackout Periodshall have the meaning set forth in Section 2.1(b).

Boardshall meanDelaware, as the Board of Directors of the Company.Corporation (the “Board of Directors”) may from time to time determine or the business of the Corporation may require.

 

Business CombinationARTICLE IIshall have the meaning set forth in Section 5.8(b)(iii).

MEETINGS OF STOCKHOLDERS

 

ChangeSection 1. Place of Meetings. The Board of Directors may designate a place, if any, either within or outside the State of Delaware, as the place of meeting for any annual meeting or for any special meeting. The Board of Directors may, in Controlits sole discretion, determine that a meeting shall havenot be held at any place, but shall instead be held solely by means of remote communication in accordance with Section 211(a) of the meaning set forth in Section 5.8(b)General Corporation Law of the State of Delaware, as amended (the “DGCL”).

 

CodeSection 2. Annual Meeting. An annual meeting of the stockholders shall mean the Internal Revenue Code of 1986,be held at such date and time as amended.

Committeeshall mean the Compensation Committeeis specified by resolution of the Board or a subcommittee thereof, orof Directors. At the annual meeting, stockholders shall elect directors to succeed those whose terms expire at such annual meeting and transact such other committee designatedbusiness as properly may be brought before the annual meeting pursuant to Section 11 of this ARTICLE II. The Board of Directors may postpone, reschedule or cancel any annual meeting of stockholders previously scheduled by the Board in each case, consisting of two or more members of the Board, each of whom is intended to be (i) a “Non-Employee Director” within the meaning of Rule 16b-3 under the Exchange Act and (ii) “independent” within the meaning of the rules of the Nasdaq Global Select Market or, if the Common Stock is not listed on the Nasdaq Global Select Market, within the meaning of the rules of the principal stock exchange on which the Common Stock is then traded.Directors.

 

Common Stockshall mean the common stock, par value $0.01 per share, of the Company, and all rights appurtenant thereto.Section 3. Special Meetings.

 

Companyshall mean CDW Corporation, a Delaware corporation, or any successor thereto.

(a)Special meetings of the stockholders may only be called in the manner provided in theSubject to Section 2 of ARTICLE EIGHT of the Corporation’s certificate of incorporation as then in effect (the “Certificate of Incorporation”). Business transacted at any, special meetings of the stockholders may be called, at any time for any purpose or purposes, by the Chair of the Board or the Board of Directors. A special meeting of stockholders shall be limited to the purposes stated in the noticealso be called by the Secretary upon the written request of one or more stockholders entitled to cast on the matter(s) to be brought before the Stockholder Requested Special Meeting (as defined below), representing not less than twenty five percent (25%) of the voting power of all outstanding shares of the Corporation’s common stock as of the date of the request (“Requisite Percentage”) through the date of the meeting; provided, however, that a special meeting requested by one or more stockholders pursuant to this Section 3 (a “Stockholder Requested Special Meeting”) shall be called by the Secretary only if the Meeting Requesting Person (as defined below) complies with this Section 3 and applicable law. Special meetings may not be called by any other person or persons. The Chair of the Board, the Chief Executive Officer or the Board of Directors may postpone, reschedule or cancel any special meeting of stockholders previously scheduledcalled by the Boardany of Directorsthem.
(b)No business may be transacted at a special meeting of stockholders other than business that is either (x) Proposed Business (as defined below) stated in a valid Special Meeting Request (as defined below), (y) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board of Directors or (z) otherwise properly brought before a special meeting by or at the direction of the Board of Directors or the chair of the meeting. For purposes hereof, a “Meeting Requesting Person” shall mean each of the following: (A) the stockholder of record making the request to fix a Requested Record Date (as defined below) for the purpose of determining the stockholders entitled to request that the Secretary call a special meeting, (B) the beneficial owner or beneficial owners, if different from the stockholder of record, on whose behalf such request is made or (C) any affiliates of such stockholder of record or

 

Company Voting Securitiesshall have the meaning set forth in Section 5.8(b)(ii).

Exchange Actshall mean the Securities Exchange Act of 1934, as amended.

Fair Market Valueshall mean the closing transaction price of a share of Common Stock as reported on the Nasdaq Global Select Market on the date as of which such value is being determined or, if the Common Stock is not listed on the Nasdaq Global Select Market, the closing transaction price of a share of Common Stock on the principal national stock exchange on which the Common Stock is traded on the date as of which such value is being determined or, if there shall be no reported transactions for such date, on the next preceding date for which transactions were reported; provided, however, that the Company may in its discretion use the closing transaction price of a share of Common Stock on the day preceding the date as of which such value is being determined to the extent the Company determines such method is more practical for administrative purposes, such as for purposes of tax withholding. If the Common Stock is not listed on a national stock exchange or if Fair Market Value for any date cannot be so determined, Fair Market Value shall be determined by the Committee by whatever means or method as the Committee, in the good faith exercise of its discretion, shall at such time deem appropriate and in compliance with Section 409A of the Code.

Free-Standing SARshall mean an SAR which is not granted in tandem with, or by reference to, an option, which entitles the holder thereof to receive, upon exercise, shares of Common Stock (which may be Restricted Stock) or, to the extent provided in the applicable Agreement, cash or a combination thereof, with an aggregate value equal to the excess of the Fair Market Value of one share of Common Stock on the date of exercise over the base price of such SAR, multiplied by the number of such SARs which are exercised.

Incentive Stock Optionshall mean an option to purchase shares of Common Stock that meets the requirements of Section 422 of the Code, or any successor provision, which is intended by the Committee to constitute an Incentive Stock Option.

Incumbent Directorsshall have the meaning set forth in Section 5.8(b)(i).

 20212023 Proxy Statement86
 
beneficial owner(s). No stockholder may request that the Secretary call a special meeting of stockholders pursuant to this Section 3 unless a stockholder of record has first submitted a request in writing that the Board of Directors fix a record date (a “Requested Record Date”) for the purpose of determining stockholders entitled to request that the Secretary call such special meeting, which request shall be in proper form and timely delivered to the Secretary at the principal executive office of the Corporation. To be in proper form, such request shall: (i) bear the signature(s) and the date of signature(s) by the stockholder(s) of record, holding the Requisite Percentage, submitting such request and set forth the name and address of such stockholder(s) as they appear in the Corporation’s books; (ii) include a reasonably brief description of the purpose or purposes of the special meeting, the business proposed to be conducted at the special meeting (the “Proposed Business”) and the reasons for conducting the Proposed Business at the special meeting; and (iii) as to each item of Proposed Business, each Meeting Requesting Person and each Stockholder Associated Person (as defined in Section 11(f)(vii) of ARTICLE II but substituting “Meeting Requesting Person” in all places where a reference to the stockholder giving the notice is made in such definition), include the information required to be set forth in a notice under Section 11(a)(iii) of ARTICLE II as if the Proposed Business were to be considered at an annual meeting of stockholders, except that for purposes of this Section 3(b) (iii), the term “Meeting Requesting Person” shall be substituted for the references to and requirements of the stockholder giving the notice or proposing a business in all places it appears in Section 11(a)(iii) of ARTICLE II of these Bylaws. For the avoidance of doubt, the requirements under Section 11(a)(iii) of ARTICLE II shall include Section 11(a)(iii)(I) of ARTICLE II that requires compliance with the requirements under Sections 11(b)(iii)(G) through (Y) of ARTICLE II of these Bylaws.
(c)Within ten (10) business days after the Secretary receives a request to fix a Requested Record Date in proper form that is otherwise in compliance with this Section 3 from any stockholder of record, the Board of Directors may adopt a resolution fixing a Requested Record Date for the purpose of determining the stockholders entitled to request that the Secretary call a Stockholder Requested Special Meeting, which date shall not precede the date upon which the resolution fixing the Requested Record Date is adopted by the Board. Notwithstanding anything in this Section 3 to the contrary, no Requested Record Date shall be fixed if the Board of Directors determines that the request or requests to call a Stockholder Requested Special Meeting that would otherwise be submitted following such Requested Record Date could not comply with the requirements set forth in clause (ii) or (vii) of Section 3(e) below.
(d)Without qualification, a Stockholder Requested Special Meeting shall not be called unless (i) one or more stockholders owning as of the Requested Record Date the Requisite Percentage timely provide one or more requests to call such special meeting in writing and in proper form to the Secretary at the principal executive office of the Corporation, and (ii) each Calling Person (as defined below) must have continuously held all their shares included in such Requisite Percentage for at least one (1) year prior to the date such Special Meeting Request (as defined below) is delivered to the Corporation (the “Required Holding Period”). To be timely for purposes of this Section 3(d), a stockholder’s request to call a special meeting must be delivered to the Secretary at the principal executive office of the Corporation not later than the sixtieth (60th) day following the Requested Record Date. In no event shall any adjournment, recess, judicial stay, rescheduling, deferral or postponement of any special meeting (including a Stockholder Requested Special Meeting) or the announcement thereof commence a new time period (or extend any time period) for the giving of a stockholder’s notice or the delivering of a stockholder’s request. To be in proper form for purposes of this Section 3, a stockholder request to call a special meeting shall include the signature(s) and the date of each signature by the stockholder(s), holding the Requisite Percentage, submitting such request and set forth (i) if each such stockholder is a stockholder of record, the name and address of such stockholder as they appear in the Corporation’s books and if such stockholder is not a stockholder of record, the name and address of such stockholder, (ii) a brief description of the Proposed Business, (iii) the text of the proposal with respect to the Proposed Business (including the complete text of any resolutions proposed for consideration and, in the event that such Proposed Business includes a proposal to amend these Bylaws, the text of the proposed amendment), (iv) the reasons for conducting the Proposed Business at the special meeting, (v) unless such stockholder is a Solicited Stockholder (as defined below), as to each item of Proposed Business, each Calling Person (as defined below) and each Stockholder Associated Person (as defined in Section 11(f)(vii) of ARTICLE II but substituting “Calling Person” in all places where a reference to the stockholder giving the notice is made in such definition), the information required to be set forth in a notice under Section 11(a)(iii) of ARTICLE II of these Bylaws as if the Proposed Business were to be considered at an annual meeting of stockholders, except that for purposes of this Section 3(d), the term “Calling Person” shall be substituted for the references to the stockholder giving the notice or proposing a business in all places such person is referred to in Section 11(a)(iii) of ARTICLE II of these Bylaws (for the avoidance of doubt, the requirements under Section 11(a)(iii) of ARTICLE II shall include the requirement under Section 11(a)(iii)(I) of ARTICLE II to comply with the requirements under Section 11(b)(iii)(G) through (Y) of ARTICLE II), (vi) documentary evidence that the shares included in such Requisite Percentage have been owned continuously for the one-year period by each Calling Person, and (vii) an acknowledgment by each stockholder, on whose behalf a Special Meeting Request is being made (or their respective duly authorized agents) that any reduction in the number of shares owned by such persons as of the date of delivery of the Special Meeting Request and through the meeting date below the Requisite Percentage shall constitute a revocation of the Special Meeting Request, and a commitment to promptly notify the Corporation of any such decrease. For purposes hereof, a “Calling Person” means the stockholder of record submitting the request to call a special meeting or if different from the stockholder of record, the beneficial owner or beneficial owners submitting the request to call a special meeting or any affiliate of such stockholder of record or beneficial owner(s); “Solicited Stockholder” means any stockholder that has provided a request to call a special meeting in response to a solicitation made pursuant to, and in accordance with, Section 14 of the Exchange Act, and the rules and regulations promulgated thereunder by way of a definitive consent solicitation statement filed with the SEC under the Exchange Act; and “Special Meeting Request” refers to

Non-Employee Directorshall mean any director of the Company who is not an officer or employee of the Company or any Subsidiary.

 

Nonqualified Stock Optionshall mean an option to purchase shares of Common Stock which is not an Incentive Stock Option.

Non-Qualifying Transactionshall have the meaning set forth in Section 5.8(b)(iii).

Parent Corporationshall have the meaning set forth in Section 5.8(b)(iii).

Performance Awardshall mean a right to receive an amount of cash, Common Stock, or a combination of both, contingent upon the attainment of specified Performance Measures within a specified Performance Period.

Performance Measuresshall mean the criteria and objectives, established by the Committee, which shall be satisfied or met (i) as a condition to the grant or exercisability of all or a portion of an option or SAR or (ii) during the applicable Restriction Period or Performance Period as a condition to the vesting of the holder’s interest, in the case of a Restricted Stock Award, of the shares of Common Stock subject to such award, or, in the case of a Restricted Stock Unit Award or Performance Award, to the holder’s receipt of the shares of Common Stock subject to such award or of payment with respect to such award. One or more of the following business criteria for the Company, on a consolidated basis, and/or for specified subsidiaries, business or geographical units or operating areas of the Company (except with respect to the total shareholder return and earnings per share criteria) or on an individual basis, may be used by the Committee in establishing Performance Measures under this Plan: the attainment by a share of Common Stock of a specified Fair Market Value for a specified period of time; increase in stockholder value; earnings per share; return on or net assets; return on equity; return on investments; return on capital or invested capital; total stockholder return; earnings or income of the Company before or after taxes and/or interest; earnings before interest, taxes, depreciation and amortization (“EBITDA”); EBITDA margin; operating income; revenues; operating expenses, attainment of expense levels or cost reduction goals; market share; cash flow, cash flow per share, cash flow margin or free cash flow; interest expense; economic value created; gross profit or margin; operating profit or margin; net cash provided by operations; price-to-earnings growth; and strategic business criteria, consisting of one or more objectives based on meeting specified goals relating to market penetration, customer acquisition, business expansion, cost targets, customer satisfaction, reductions in errors and omissions, reductions in lost business, management of employment practices and employee benefits, supervision of litigation, supervision of information technology, quality and quality audit scores, efficiency, and acquisitions or divestitures, any combination of the foregoing, or such other goals as the Committee may determine whether or not listed herein. Each such goal may be expressed on an absolute or relative basis and may include comparisons based on current internal targets, the past performance of the Company (including the performance of one or more subsidiaries, divisions, or operating units) or the past or current performance of one or more other companies or market indices (or a combination of such past and current performance). In addition to the ratios specifically enumerated above, performance goals may include comparisons relating to capital (including, but not limited to, the cost of capital), shareholders’ equity, shares outstanding, assets or net assets, sales, or any combination thereof. In establishing a Performance Measure or determining the achievement of a Performance Measure, the Committee may provide that achievement of the applicable Performance Measures may be amended or adjusted to include or exclude components of any Performance Measure, including, without limitation, foreign exchange gains and losses, asset writedowns, acquisitions and divestitures, change in fiscal year, unbudgeted capital expenditures, special charges such as restructuring or impairment charges, debt refinancing costs, extraordinary or noncash items, unusual, infrequently occurring, nonrecurring or one-time events affecting the Company or its financial statements or changes in law or accounting principles. Performance Measures shall be subject to such other special rules and conditions as the Committee may establish at any time.

Performance Periodshall mean any period designated by the Committee during which (i) the Performance Measures applicable to an award shall be measured and (ii) the conditions to vesting applicable to an award shall remain in effect.

Prior Planshall mean the CDW Corporation Amended and Restated 2013 Long-Term Incentive Plan.

Restricted Stockshall mean shares of Common Stock which are subject to a Restriction Period and which may, in addition thereto, be subject to the attainment of specified Performance Measures within a specified Performance Period.

Restricted Stock Awardshall mean an award of Restricted Stock under this Plan.

Restricted Stock Unitshall mean a right to receive one share of Common Stock or, in lieu thereof and to the extent provided in the applicable Agreement, the Fair Market Value of such share of Common Stock in cash, which shall be contingent upon the expiration of a specified Restriction Period and which may, in addition thereto, be contingent upon the attainment of specified Performance Measures within a specified Performance Period.

Restricted Stock Unit Awardshall mean an award of Restricted Stock Units under this Plan.

Restriction Periodshall mean any period designated by the Committee during which (i) the Common Stock subject to a Restricted Stock Award may not be sold,

 20212023 Proxy Statement87

 

transferred, assigned, pledged, hypothecated or otherwise encumbered or disposed of, except as provided in this Plan or the Agreement relating to such award, or (ii) the conditions to vesting applicable to a Restricted Stock Unit Award shall remain in effect.

SARshall mean a stock appreciation right which may be a Free-Standing SAR or a Tandem SAR.

Stock Awardshall mean a Restricted Stock Award, Restricted Stock Unit Award or Unrestricted Stock Award.

Subsidiaryshall mean any corporation, limited liability company, partnership, joint venture or similar entity in which the Company owns, directly or indirectly, an equity interest possessing more than 50% of the combined voting power of the total outstanding equity interests of such entity.

Substitute Awardshall mean an award granted under this Plan upon the assumption of, or in substitution for, outstanding equity awards previously granted by a company or other entity in connection with a corporate transaction, including a merger, combination, consolidation or acquisition of property or stock; provided, however, that in no event shall the term “Substitute Award” be construed to refer to an award made in connection with the cancellation and repricing of an option or SAR.

Surviving Corporationshall have the meaning set forth in Section 5.8(b)(iii).

Tandem SARshall mean an SAR which is granted in tandem with, or by reference to, an option (including a Nonqualified Stock Option granted prior to the date of grant of the SAR), which entitles the holder thereof to receive, upon exercise of such SAR and surrender for cancellation of all or a portion of such option, shares of Common Stock (which may be Restricted Stock) or, to the extent provided in the applicable Agreement, cash or a combination thereof, with an aggregate value equal to the excess of the Fair Market Value of one share of Common Stock on the date of exercise over the base price of such SAR, multiplied by the number of shares of Common Stock subject to such option, or portion thereof, which is surrendered.

Tax Dateshall have the meaning set forth in Section 5.5.

Ten Percent Holdershall have the meaning set forth in Section 2.1(a).

Unrestricted Stockshall mean shares of Common Stock which are not subject to a Restriction Period or Performance Measures.

Unrestricted Stock Awardshall mean an award of Unrestricted Stock under this Plan.

1.3Administration. This Plan shall be administereda request to call a special meeting that was delivered to the Secretary by the Committee. Any one orstockholder(s) holding the Requisite Percentage and is timely, in proper form, and otherwise fully complies with the requirement under this Section 3.
(e)The Secretary shall not accept, and shall consider ineffective, any Special Meeting Request that (i) does not comply with this Section 3, (ii) relates to an item of business proposed to be transacted at the special meeting that is not a combinationproper subject for stockholder action under applicable law, (iii) includes an item of business proposed to be transacted at such meeting that did not appear on the written request that resulted in the determination of the following awards may be made under this Plan to eligible persons: (i) options to purchase shares of Common Stock inRequested Record Date, (iv) the form of Incentive Stock Options or Nonqualified Stock Options; (ii) SARs inSpecial Meeting Request is received by the form of Tandem SARs or Free-Standing SARs; (iii) Stock Awards inSecretary during the form of Restricted Stock, Restricted Stock Units or Unrestricted Stock; and (iv) Performance Awards. The Committee shall, subjectperiod commencing ninety (90) days prior to the terms of this Plan, select eligible persons for participation in this Plan and determine the form, amount and timing of each award to such persons and, if applicable, the number of shares of Common Stock subject to an award, the number of SARs, the number of Restricted Stock Units, the dollar value subject to a Performance Award, the purchase price or base price associated with the award, the time and conditions of exercise or settlementanniversary date of the awardprior year’s annual meeting of stockholders and all other terms and conditionsending on the date of the award, including, without limitation, the formfinal adjournment of the Agreement evidencingnext annual meeting of stockholders, (v) an identical or substantially similar item (a “Similar Item”) was presented at any meeting of stockholders held not more than one hundred twenty (120) days prior to receipt by the award. The CommitteeSecretary of the Special Meeting Request, (vi) the Board of Directors has called or calls for an annual or special meeting of Stockholders to be held within ninety (90) days after the Secretary receives the Special Meeting Request and the Board of Directors determines that the business of such meeting includes (among any other matters properly brought before the annual or special meeting) a Similar Item, or (vii) otherwise does not comply with applicable law.
(f)A stockholder may in its sole discretion and for any reasonrevoke a Special Meeting Request by written revocation delivered to the Secretary at any time take action such that (i) any or all outstanding options and SARs shall become exercisable in part or in full, (ii) all or a portionprior to the Stockholder Requested Special Meeting. If written revocation(s) of the Restriction Period applicableSpecial Meeting Request have been delivered to any outstanding awards shall lapse, (iii)the Secretary and the result is that (after giving effect to all or a portionrevocations) the Special Meeting Requests represent stockholders holding less than the Requisite Percentage from the date of such requests through the date of the Performance Periodmeeting, then: (i) if the notice of meeting has not already been mailed to stockholders, the Secretary shall refrain from mailing the notice of the Stockholder Requested Special Meeting or (ii) if the notice of meeting has already been mailed to stockholders, the Secretary shall revoke the notice of the meeting. If, subsequent to the refraining from mailing of the notice of meeting pursuant to clause (i) of the immediately preceding sentence or subsequent to the revocation of the notice of meeting pursuant to clause (ii) of the immediately preceding sentence, as applicable, (but in any event on or prior to any outstanding awards shall lapse and (iv) the Performance Measures (if any) applicable to any outstanding awards shall be deemed to be satisfiedsixtieth (60th) day after the Requested Record Date), the Secretary has received Special Meeting Requests from stockholders holding the Requisite Percentage, then, at the target, maximum or any other level. The Committee shall, subject tooption of the terms of this Plan, interpret this PlanBoard, either (A) the original record date and the application thereof, establish rulesmeeting date, time and regulations it deems necessary or desirablelocation for the administration of this Plan and may impose, incidental to the grant of an award, conditionsStockholder Requested Special Meeting set in accordance with Section 3(g) below shall apply with respect to the award,Stockholder Requested Special Meeting or (B) the Board of Directors may disregard the original Requested Record Date and meeting date, time and location for the Stockholder Requested Special Meeting from those originally set in accordance with Section 3(g) below and, within ten (10) days following the date on which the Secretary has received the Special Meeting Requests from stockholders holding the Requisite Percentage, set a new record date and meeting date, time and location for the Stockholder Requested Special Meeting (and, in such as limiting competitive employmentcase, notice of the Stockholder Requested Special Meeting shall be given in accordance with Section 4 of ARTICLE II).
(g)Subject to Section 3(f) above, within ten (10) days following the date on which the Secretary has received Special Meeting Requests in accordance with this Section 3 from stockholders holding the Requisite Percentage, the Board of Directors shall fix the record date and meeting date, time and location for the Stockholder Requested Special Meeting; provided, however, that the date of any such Stockholder Requested Special Meeting shall not be more than ninety (90) days after the date on which valid Special Meeting Requests from stockholders holding the shares to be included in such Requisite Percentage are delivered to the Secretary (and are not revoked). Notwithstanding anything in these Bylaws to the contrary, the Board of Directors may submit its own proposal or proposals for consideration at any Stockholder Requested Special Meeting. Subject to the foregoing provisions of this Section 3, the record date for the Stockholder Requested Special Meeting shall be fixed in accordance with Section 12 of ARTICLE II, and the Board of Directors shall provide notice of the Stockholder Requested Special Meeting in accordance with Section 4 of ARTICLE II.
(h)Notwithstanding anything in these Bylaws to the contrary, the (i) Secretary shall not be required to call a special meeting except in accordance with this Section 3. If the Board, in good faith, determines that any request to fix a Requested Record Date or Special Meeting Request was not properly made in accordance with this Section 3, or determines that the stockholders of record requesting that the Board of Directors fix such Requested Record Date or stockholders making the Special Meeting Request have not otherwise complied with this Section 3, then the Board of Directors shall not be required to fix such Requested Record Date, to fix a special meeting record date or to call and hold a special meeting. In addition to the requirements of this Section 3, each Meeting Requesting Person and stockholder making a Special Meeting Request shall comply with all requirements of applicable law, including all requirements of the Exchange Act, with respect to any request to fix a Requested Record Date or to call a special meeting.
(i)Any written notice, supplement, update or other activities. All such interpretations, rules, regulations and conditionsinformation required to be delivered by a stockholder to the Corporation pursuant to this Section 3 shall be conclusivesubject to the requirements under Section 11(b)(iii)(Y)(5) of ARTICLE II; provided, that no notice, supplement, update or other information delivered by registered or certified mail shall be deemed delivered until such notice, supplement, update or other information is actually received at the Corporation’s principal executive offices.
(j)Multiple Special Meeting Requests. In determining whether Special Meeting Requests have met the requirements of this Section 3, multiple Special Meeting Requests will be considered together only if (i) each Special Meeting Request identifies the same or substantially the same purpose or purposes of the Stockholder Requested Special Meeting and binding on all parties.the same or substantially the same items of business proposed to be brought before the Stockholder Requested Special Meeting, and (ii) such Special Meeting Requests have been dated and delivered to the Secretary within sixty (60) days of the delivery to the Secretary of the earliest dated Special Meeting Request

  

The Committee may delegate some or all of its power and authority hereunder to the Board or, subject to applicable law, to a subcommittee of the Board, a member of the Board, the President and Chief Executive Officer or such other executive officer of the Company as the Committee deems appropriate; provided, however, that the Committee may not delegate its power and authority to a member of the Board or the President and Chief Executive Officer or other executive officer of the Company with regard to the selection for participation in this Plan of an officer, director or other person subject to Section 16 of the Exchange Act or decisions concerning the timing, pricing or amount of an award to such an officer, director or other person.

No member of the Board or Committee, and neither the President and Chief Executive Officer nor any other executive officer to whom the Committee delegates any of its power and authority hereunder, shall be liable for any act, omission, interpretation, construction or determination made in connection with this Plan in good faith, and the members of the Board and the Committee and the President and Chief Executive Officer or other executive officer shall be entitled to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including attorneys’ fees) arising therefrom to the full extent permitted by law (except as otherwise may be provided in the Company’s Certificate of Incorporation and/or By-laws) and under any directors’ and officers’ liability insurance that may be in effect from time to time.

 20212023 Proxy Statement88
 
relating to such item(s) of business. A Calling Person may revoke a Special Meeting Request at any time by written revocation delivered to the Secretary and if, following such revocation, there are outstanding unrevoked requests from Meeting Requesting Persons holding less than the Requisite Percentage, the Board of Directors may, in its discretion, cancel the Stockholder Requested Special Meeting.

A majority

Section 4. Notice of Meetings. Whenever stockholders are required or permitted to take action at a meeting, notice of the Committeemeeting shall be given that shall state the place, if any, date, and time of all meetings of the stockholders, the means of remote communications, if any, by which stockholders and proxyholders not physically present may be deemed to be present in person and vote at such meeting, the record date for determining the stockholders entitled to vote at the meeting, if such date is different from the record date for determining stockholders entitled to notice of the meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called, shall be given, not less than 10 nor more than 60 days before the date on which the meeting is to be held, to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of the meeting, except as otherwise provided herein or required by law (meaning, here and hereinafter, as required from time to time by the DGCL or the Certificate of Incorporation).

(a)Form of Notice. All such notices shall be delivered in writing or in any other manner permitted by the DGCL. If mailed, such notice shall be deemed given when deposited in the United States mail, postage prepaid, addressed to the stockholder at his, her or its address as the same appears on the records of the Corporation. If given by facsimile telecommunication, such notice shall be deemed given when directed to a number at which the stockholder has consented to receive notice by facsimile. Subject to the limitations of Section 4(c) of this ARTICLE II, if given by electronic transmission, such notice shall be deemed to be delivered: (i) by electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice; (ii) if by a posting on an electronic network together with separate notice to the stockholder of such specific posting, upon the later of (x) such posting and (y) the giving of such separate notice; and (iii) if by any other form of electronic transmission, when directed to the stockholder. An affidavit of the secretary or an assistant secretary of the Corporation, the transfer agent of the Corporation or any other agent of the Corporation that the notice has been given shall, in the absence of fraud, be prima facie evidence of the facts stated therein.
(b)Waiver of Notice. Whenever notice is required to be given under any provisions of the DGCL, the Certificate of Incorporation or these Bylaws (these “Bylaws”), a written waiver thereof, signed by the stockholder entitled to notice, or a waiver by electronic transmission by the person or entity entitled to notice, whether before or after the time stated therein, shall be deemed equivalent to notice. Neither the business to be transacted at, nor the purpose of, any meeting of the stockholders of the Corporation need be specified in any waiver of notice of such meeting. Attendance of a stockholder of the Corporation at a meeting of such stockholders shall constitute a waiver of notice of such meeting, except when the stockholder attends for the express purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened.
(c)Notice by Electronic Transmission. Without limiting the manner by which notice otherwise may be given effectively to stockholders of the Corporation pursuant to the DGCL, the Certificate of Incorporation or these Bylaws, any notice to stockholders of the Corporation given by the Corporation under any provision of the DGCL, the Certificate of Incorporation or these Bylaws shall be effective if given by a form of electronic transmission consented to by the stockholder of the Corporation to whom the notice is given. Any such consent shall be deemed revoked if: (i) the Corporation is unable to deliver by electronic transmission two (2) consecutive notices given by the Corporation in accordance with such consent; and (ii) such inability becomes known to the secretary or an assistant secretary of the Corporation or to the transfer agent or other person responsible for the giving of notice. However, the inadvertent failure to treat such inability as a revocation shall not invalidate any meeting or other action. For purposes of these Bylaws, except as otherwise limited by applicable law, the term “electronic transmission” means any form of communication not directly involving the physical transmission of paper that creates a record that may be retained, retrieved and reviewed by a recipient thereof, and that may be directly reproduced in paper form by such recipient through an automated process.

Section 5. List of Stockholders. The officer who has charge of the stock ledger of the Corporation shall prepare and make available, no later than the tenth (10th) day before each meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, provided, however, if the record date for determining the stockholders entitled to vote is less than ten (10) days before the meeting date, the list shall reflect the stockholders entitled to vote as of the tenth (10th) day before the meeting date, arranged in alphabetical order and showing the address of each such stockholder and the number of shares registered in the name of each such stockholder. Nothing contained in this section shall require the Corporation to include electronic mail addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period of ten (10) days ending on the day before the meeting date: (a) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (b) during ordinary business hours, at the principal place of business of the Corporation. In the event the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation.

Section 6. Quorum. The holders of a majority in voting power of the outstanding capital stock entitled to vote at the meeting, present in person or represented by proxy, shall constitute a quorum. The actsquorum at all meetings of the Committee shall be either (i) actsstockholders, except as otherwise provided by law, by the Certificate of Incorporation or these Bylaws. If a quorum is not present, the chair of the meeting or the holders of a majority of the members ofvoting power present in person or represented by proxy at the Committee presentmeeting and entitled to vote at anythe meeting at whichmay adjourn the meeting to another time and/or place from time to time until a quorum isshall be present or (ii) acts approved in writingrepresented by allproxy. When a specified item of the members of the Committee withoutbusiness requires a meeting.

 

1.4Eligibility. Participants in this Plan shall consist of such officers, other employees, Non-Employee Directors, consultants, independent contractors, agents and persons expected to become officers, other employees, Non-Employee Directors, consultants, independent contractors and agents of the Company and its Subsidiaries as the Committee in its sole discretion may select from time to time. The Committee’s selection of a person to participate in this Plan at any time shall not require the Committee to select such person to participate in this Plan at any other time. Except as provided otherwise in an Agreement, for purposes of this Plan, references to employment by the Company shall also mean employment by a Subsidiary, and references to employment shall include service as a Non-Employee Director, consultant, independent contractor or agent. The Committee shall determine, in its sole discretion, the extent to which a participant shall be considered employed during any periods during which such participant is on a leave of absence. The aggregate value of cash compensation and the grant date fair value of shares of Common Stock that may be awarded or granted during any fiscal year of the Company to any Non-Employee Director, for his or her services as a Non-Employee Director, shall not exceed $950,000; provided, further, that this limit shall not apply to distributions of previously deferred compensation under a deferred compensation plan maintained by the Company or compensation received by the director in his or her capacity as an executive officer or employee of the Company.

1.5Shares Available. Subject to adjustment as provided in Section 5.7 and to all other limits set forth in this Plan, the number of shares of Common Stock that shall initially be available for all awards under this Plan, other than Substitute Awards, shall be (i) 6,600,000 shares plus (ii) any shares of Common Stock that are available for awards under the Prior Plan as of the effective date of this Plan. Subject to adjustment as provided in Section 5.7, no more than 6,600,000 shares of Common Stock in the aggregate may be issued under the Plan in connection with Incentive Stock Options. The number of shares of Common Stock that remain available for future grants under the Plan shall be reduced by the sum of the aggregate number of shares of Common Stock which become subject to outstanding options, outstanding Free-Standing SARs, outstanding Stock Awards and outstanding Performance Awards denominated in shares of Common Stock, other than Substitute Awards.

To the extent that shares of Common Stock subject to an outstanding option, SAR, Stock Award or Performance Award granted under the Plan or a Prior Plan, other than Substitute Awards, are not issued or delivered by reason of (i) the expiration, termination, cancellation or forfeiture of such award (excluding shares subject to an option cancelled upon settlement in shares of a related Tandem SAR or shares subject to a Tandem SAR cancelled upon exercise of a related option) or (ii) the settlement of such award in cash, then such shares of Common Stock shall again be available under this Plan. Shares of Common Stock subject to an award granted under this Plan or the Prior Plan, other than an option or SAR, shall again become available for issuance under this Plan if such shares are delivered to or withheld by the Company to pay the withholding taxes payable with respect to such award. Shares of Common Stock subject to an option or SAR granted under this Plan or the Prior Plan shall not again be available for issuance under this Plan if such shares are (i) shares that were not issued or delivered upon the net settlement or net exercise of such option or stock-settled SAR (including, without limitation, any shares withheld to pay the purchase price or withholding taxes of an option or stock-settled SAR), (ii) shares delivered to the Company to pay the purchase price or the withholding taxes related to such outstanding option or SAR or (iii) shares repurchased by the Company on the open market with the proceeds of an option exercise.

The number of shares of Common Stock available for awards under this Plan shall not be reduced by (i) the number of shares of Common Stock subject to Substitute Awards or (ii) available shares under a stockholder approved plan of a company or other entity which was a party to a corporate transaction with the Company (as appropriately adjusted to reflect such corporate transaction) which become subject to awards granted under this Plan (subject to applicable stock exchange requirements).

Shares of Common Stock to be delivered under this Plan shall be made available from authorized and unissued shares of Common Stock, or authorized and issued shares of Common Stock reacquired and held as treasury shares or otherwise or a combination thereof.

1.6Minimum Vesting Conditions. Notwithstanding any other provision of the Plan to the contrary, awards granted under the Plan (other than cash-based awards) shall vest no earlier than the first anniversary of the date on which the award is granted; provided, that the following awards shall not be subject to the foregoing minimum vesting requirement: any (i) Substitute Awards granted in connection with awards that are assumed, converted or substituted pursuant to a merger, acquisition or similar transaction entered into by the Company or any of its Subsidiaries, (ii) Shares delivered in lieu of fully vested cash obligations, (iii) Awards to Non-Employee Directors that vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year’s annual meeting, and (iv) any additional awards the Committee may grant, up to a maximum of five percent (5%) of the available share reserve authorized for issuance under the Plan pursuant to Section 1.5 (subject to adjustment under Section 5.7); and, provided, further, that the foregoing restriction does not apply to the Committee’s discretion to provide for accelerated exercisability or vesting of any award, including in cases of retirement, death, disability or a Change in Control, in the terms of the Award Agreement or otherwise.

 20212023 Proxy Statement89
 

vote by a class or series (if the Corporation shall then have outstanding shares of more than one class or series) voting as a class or series, the holders of a majority in voting power of the outstanding stock of such class or series shall constitute a quorum (as to such class or series) for the transaction of such item of business.

 

II. STOCK OPTIONS AND STOCK APPRECIATION RIGHTSSection 7. Adjourned Meetings. When a meeting is adjourned or recessed, notice need not be given of the adjourned or recessed meeting (including an adjournment taken to address a technical failure to convene or continue a meeting using remote communication) if the time and place, if any, thereof, and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person or represented by proxy and vote at such adjourned or recessed meeting, are (i) announced at the meeting at which the adjournment or recess is taken, (ii) displayed during the time scheduled for the meeting, on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means of remote communication or (iii) set forth in the notice of meeting given in accordance with these Bylaws. At the adjourned or recessed meeting the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment or recess is for more than thirty (30) days, a notice of the adjourned or recessed meeting shall be given to each stockholder of record entitled to vote at the meeting. If after the adjournment or recess a new record date for stockholders entitled to vote is fixed for the adjourned or recessed meeting, the Board of Directors shall fix a new record date for notice of such adjourned or recessed meeting, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors and, except as otherwise required by law, shall not be more than sixty (60) days nor less than ten (10) days before the date of such adjourned or recessed meeting, and shall give notice of the adjourned or recessed meeting to each stockholder of record entitled to vote at such adjourned or recessed meeting as of the record date fixed for notice of such adjourned or recessed meeting.

 

Section 8. Vote Required. When a quorum is present, all matters other than the election of directors shall be determined by the affirmative vote of the majority of voting power of capital stock present in person or represented by proxy at the meeting and entitled to vote on the subject matter, unless by express provisions of an applicable law, the rules of any stock exchange upon which the Corporation’s securities are listed or the Certificate of Incorporation a different vote is required, in which case such express provision shall govern and control the vote required on such matter.

Section 9. Voting Rights. Except as otherwise provided by the DGCL, the Certificate of Incorporation, the certificate of designation relating to any outstanding class or series of preferred stock or these Bylaws, each stockholder entitled to vote at any meeting of stockholders shall be entitled to one vote in person or by proxy for each share of capital stock held by such stockholder which has voting power upon the matter in question. Voting at meetings of stockholders need not be by written ballot.

Section 10. Proxies. Each stockholder entitled to vote at a meeting of stockholders or to express consent to corporate action in writing without a meeting may authorize another person or persons to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. A duly executed proxy shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power. A proxy may be made irrevocable regardless of whether the interest with which it is coupled is an interest in the stock itself or an interest in the Corporation generally. Any stockholder directly or indirectly soliciting proxies from other stockholders must use a proxy card color other than white, which shall be reserved for the exclusive use by the Board.

Section 11. Advance Notice of Stockholder Business and Director Nominations; Inclusion of Stockholder Director Nominations in Corporation’s Proxy Materials.

2.1(a)Stock Options. The Committee may, in its discretion, grant options to purchase sharesBusiness at Annual Meetings of Common Stock to such eligible persons as may be selected by the Committee. Each option, or portion thereof, that is not an Incentive Stock Option shall be a Nonqualified Stock Option. To the extent that the aggregate Fair Market Value (determined as of the date of grant) of shares of Common Stock with respect to which options designated as Incentive Stock Options are exercisable for the first time by a participant during any calendar year (under this Plan or any other plan of the Company, or any parent or Subsidiary) exceeds the amount (currently $100,000) established by the Code, such options shall constitute Nonqualified Stock Options.
Options shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of this Plan, as the Committee shall deem advisable:Stockholders.

 

 (a)(i)NumberOnly such business (other than nominations of Sharespersons for election to the Board of Directors, which must be made in compliance with and Purchase Price. The numberare governed exclusively by Section 11(b) or Section 11(c), as applicable, of shares of Common Stock subject tothis ARTICLE II) shall be conducted at an option and the purchase price per share purchasable upon exerciseannual meeting of the optionstockholders as shall be determinedhave been brought before the meeting (A) as specified in the Corporation’s notice of meeting (or any supplement thereto) given by or at the Committee; provided, however, that the purchase price per share purchasable upon exercise of an option shall not be less than 100%direction of the Fair Market ValueBoard of Directors or any duly authorized committee thereof, (B) by or at the direction of the Board of Directors or any committee thereof, or (C) by any stockholder of the Corporation who (1) was a sharestockholder of Common Stock on the date of grant of such option; provided further, that if an Incentive Stock Option shall be granted to any person who,record at the time such option is granted, owns capital stock possessing more than 10 percentof giving of notice provided for in Section 11(a) of this ARTICLE II and through the time of the total combined voting powermeeting, (2) is entitled to vote at the meeting and (3) complies with the notice procedures set forth in Section 11(a) of all classesthis ARTICLE II. For the avoidance of capital stockdoubt, the foregoing clause (C) of this Section 11(a)(i) of ARTICLE II shall be the Company (orexclusive means for a stockholder to propose such business (other than business included in the Corporation’s proxy materials pursuant to Rule 14a-8 under the Securities Exchange Act of any parent or Subsidiary) (a1934, as amended (theTen Percent HolderExchange Act”), the purchase price per share shall not be less than the price (currently 110%) before an annual meeting of Fair Market Value) required by the Code in order to constitute an Incentive Stock Option.stockholders.
   
 (ii)NotwithstandingFor any business (other than nominations of persons for election to the foregoing,Board of Directors, which must be made in compliance with and are governed exclusively by Section 11(b) or Section 11(c), as applicable, of this ARTICLE II) to be properly brought before an annual meeting by a stockholder, the stockholder must have given timely notice thereof in proper written form as described in Section 11(a)(iii) of this ARTICLE II to the Secretary; any such proposed business must be a proper matter for stockholder action and the stockholder and the Stockholder Associated Person (as defined in Section 11(f) of this ARTICLE II) must have acted in accordance with the representations set forth in the caseSolicitation Statement (as defined in Section 11(a)(iii) of an option that isthis ARTICLE II) required by these Bylaws. To be timely, a Substitute Award,stockholder’s notice for such business must be received by the purchase price per shareSecretary at the principal executive offices of

2023 Proxy Statement90
the Corporation in proper written form not less than ninety (90) days and not more than one hundred twenty (120) days prior to the first anniversary of the shares subjectpreceding year’s annual meeting of stockholders; provided, however, that if and only if the annual meeting is not scheduled to be held within a period that commences thirty (30) days before such anniversary date and ends thirty (30) days after such anniversary date, or if no annual meeting was held in the preceding year, such stockholder’s notice must be received not earlier than the one hundred twentieth (120th) day prior to such option may be less than 100%annual meeting and by the later of (A) the Fair Market Value per share ontenth (10th) day following the day the Public Announcement (as defined in Section 11(f) of this ARTICLE II) of the date of grant,the annual meeting is first made by the Corporation and (B) the date which is ninety (90) days prior to the date of the annual meeting. In no event shall any adjournment, recess, judicial stay, rescheduling, deferral or postponement of an annual meeting or the announcement thereof commence a new time period (or extend any time period) for the giving of a stockholder’s notice as described above. Notices delivered pursuant to Section 11(a) of this ARTICLE II) will be deemed received on any given day if received prior to the close of business on such day.

(iii)To be in proper written form, a stockholder’s notice to the Secretary must set forth as to each matter of business the stockholder proposes to bring before the annual meeting
(A)a reasonably brief description of the business desired to be brought before the annual meeting, the full text of the proposal or business (including the full text of any resolutions or actions proposed for consideration and if such business includes a proposal to amend the Certificate of Incorporation or these Bylaws, the specific language of the proposed amendment), the reasons for conducting such business at the annual meeting and all other information relating to such business that would be required to be disclosed in a proxy statement or other filing required to be made by such stockholder or any Stockholder Associated Person (as defined in Section 11(f) of this ARTICLE II) in connection with the solicitation of proxies in support of such proposed business by such stockholder or any Stockholder Associated Person pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder,
(B)the name and address of the stockholder proposing such business, as they appear on the Corporation’s books and records, the name and address (if different from the Corporation’s books and records) of such proposing stockholder, the name and address of any Stockholder Associated Person covered by clauses (C) through (I) below,
(C)(1) the class or series and number of shares of stock of the Corporation which are, directly or indirectly held of record or beneficially owned by such stockholder or by any Stockholder Associated Person (including any rights to acquire beneficial ownership at any time in the future, whether such right is exercisable immediately or only after the passage of time or the fulfillment of a condition) and the date or dates on which such shares were acquired and the investment intent of such acquisition, (2) a description of any Derivative Positions (as defined in Section 11(f) of this ARTICLE II) directly or indirectly held or beneficially owned by such stockholder or any Stockholder Associated Person, and (3) whether and to the extent to which a Hedging Transaction (as defined in Section 11(f) of this ARTICLE II) has been entered into by or on behalf of such stockholder or any Stockholder Associated Person,
(D)(1) a complete and accurate description of all agreements, arrangements or understandings between such stockholder or any Stockholder Associated Person and any other person or entity (including their names) in connection with the proposal of such business by such stockholder and (2) a description of any material interest of such stockholder, any Stockholder Associated Person or such other person or entity in such business proposed by such stockholder, if any,
(E)a representation that such stockholder is a stockholder of record of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the annual meeting to bring such business before the meeting and an acknowledgement that, if such stockholder does not appear to present such proposed business at such meeting, the Corporation need not present such proposed business for a vote at such meeting notwithstanding that proxies in respect of such vote may have been received by the Corporation,
(F)all other information related to such stockholder or any Stockholder Associated Person, or such stockholder’s or any Stockholder Associated Person’s associates, that would be required to be disclosed in a proxy statement or other filing required to be made in connection with the solicitation of proxies or consents (even if a solicitation is not involved) by such stockholder or Stockholder Associated Person in support of the business proposed to be brought before the meeting pursuant to Section 14 of the Exchange Act, and the rules and regulations promulgated thereunder and
(G)a representation as to whether such stockholder or any Stockholder Associated Person intends or is part of a group which intends to deliver a proxy statement and/or form of proxy to the holders of at least the percentage of the Corporation’s outstanding capital stock required to approve the proposal or otherwise to solicit proxies or votes from stockholders in support of the proposal (such representation, a “Solicitation Statement”).
(H)In addition, any stockholder who submits a notice pursuant to Section 11(a) of this ARTICLE II is required to update and supplement the information disclosed in such notice, if necessary, in accordance with Section 11(e) of this ARTICLE II.
(I)The requirements under Sections 11(b)(iii)(G) through (Y) of this ARTICLE II shall apply to a notice of a business proposal, the stockholder giving the notice of such proposal and any Stockholder Associated Person, mutatis mutandis.

2023 Proxy Statement91
(iv)Notwithstanding anything in these Bylaws to the contrary, no business (other than nominations of persons for election to the Board of Directors, which must be made in compliance with and are governed exclusively by Section 11(b) or Section 11(c), as applicable, of this ARTICLE II) shall be conducted at an annual meeting except in accordance with the procedures set forth in Section 11(a) of this ARTICLE II.

(b)Nominations at Annual Meetings of Stockholders.

(i)Only persons who are nominated in accordance and compliance with the procedures set forth in this Section 11(b) of ARTICLE II (and, if applicable, the procedures set forth in Section 11(c) of this ARTICLE II) shall be eligible for election to the Board of Directors at an annual meeting of stockholders.
(ii)Nominations of persons for election to the Board of Directors of the Corporation may be made at an annual meeting of stockholders only (A) by or at the direction of the Board of Directors or any committee thereof, (B) by any stockholder of the Corporation who (1) was a stockholder of record at the time of giving of notice provided for in this Section 11(b) of ARTICLE II and through the time of the annual meeting, (2) is entitled to vote at the meeting and (3) complies with the notice procedures set forth in this Section 11(b) of ARTICLE II, or (C) by an Eligible Stockholder (as defined below) in accordance with the procedures set forth in Section 11(c) of this ARTICLE II. For the avoidance of doubt, clauses (B) and (C) of this Section 11(b)(ii) of ARTICLE II shall be the exclusive means for a stockholder to make nominations of persons for election to the Board of Directors at an annual meeting of stockholders. The number of nominees a stockholder may nominate for election at a meeting may not exceed the number of directors to be elected at such meeting, and for the avoidance of doubt, no stockholder shall be entitled to make additional or substitute nominations following the expiration of the time periods set forth in this Section 11(b) of ARTICLE II. For nominations to be properly brought by a stockholder at an annual meeting of stockholders pursuant to clause (B) of this Section 11(b)(ii) of ARTICLE II, the stockholder must have given timely notice thereof in proper written form as described in Section 11(b)(iii) of this ARTICLE II to the Secretary and the stockholder and the Stockholder Associated Person must have acted in accordance with the representations set forth in the Nomination Solicitation Statement required by these Bylaws. To be timely, such stockholder’s notice for the nomination of persons for election to the Board of Directors must be received by the Secretary at the principal executive offices of the Corporation in proper written form not less than ninety (90) days and not more than one hundred twenty (120) days prior to the first anniversary of the preceding year’s annual meeting of stockholders; provided, however, that if and only if the excess of: (a)annual meeting is not scheduled to be held within a period that commences thirty (30) days before such anniversary date and ends thirty (30) days after such anniversary date, or if no annual meeting was held in the aggregate Fair Market Value (aspreceding year, such stockholder’s notice must be received not earlier than the one hundred twentieth (120th) day prior to such annual meeting and by the later of (I) the tenth (10th) day following the day the Public Announcement of the date such Substitute Award is granted) of the annual meeting is first made by the Corporation and (II) the date which is ninety (90) days prior to the date of the annual meeting. In no event shall any adjournment, recess, judicial stay, rescheduling, deferral or postponement of an annual meeting or the announcement thereof commence a new time period (or extend any time period) for the giving of a stockholder’s notice as described above. Notices delivered pursuant to this Section 11(b) of ARTICLE II will be deemed received on any given day if received prior to the close of business on such day.
(iii)To be in proper written form, a stockholder’s notice to the Secretary shall set forth

(A)as to each person that the stockholder proposes to nominate for election or re-election as a director of the Corporation,
(1)the name, age, business address and residence address of the proposed nominee,
(2)the principal occupation or employment of the proposed nominee,
(3)the class or series and number of shares of capital stock of the Corporation which are directly or indirectly owned beneficially or of record by the proposed nominee,
(4)the date such shares were acquired and the investment intent of such acquisition,
(5)a description of all direct and indirect compensation and other material monetary agreements, arrangements or understandings, written or oral, during the past three (3) years, and any other material relationships, between or among such proposed nominee or any of such proposed nominee’s affiliates or associates (each as defined below), on the one hand, and any stockholder or any Stockholder Associated Person (as defined below), on the other hand, including all information that would be required to be disclosed pursuant to Item 404 promulgated under Regulation S-K as if such stockholder and any Stockholder Associated Person were the “registrant” for purposes of such rule and the proposed nominee were a director or executive officer of such registrant,
(6)a description of any business or personal interests that could reasonably be expected to place such proposed nominee in a potential conflict of interest with the Corporation or any of its subsidiaries and
(7)all other information relating to such proposed nominee or such proposed nominee’s associates that would be required to be disclosed in a proxy statement or other filings required to be made by such stockholder or any Stockholder Associated Person in connection with the solicitation of proxies or consents for a contested election of directors (even if an election

2023 Proxy Statement92

contest or proxy solicitation is not involved), or is otherwise required, pursuant to Section 14 of the Exchange Act, and the rules and regulations promulgated thereunder (including such person’s written consent to being named in the proxy statement as a nominee, if applicable, and to serving if elected),

(B)as to the stockholder giving the notice, the name and address of such stockholder, as they appear on the Corporation’s books and records, the residence name and address (if different from the Corporation’s books) of such proposing stockholder, and the name and address of any Stockholder Associated Person covered by clauses (C) through (Y) below,
(C)(1) the class or series and number of shares of stock of the Corporation which are directly or indirectly held of record or beneficially owned (specifying the type of ownership) by such stockholder or by any Stockholder Associated Person with respect to the Corporation’s securities (including any rights to acquire beneficial ownership at any time in the future, whether such right is exercisable immediately or only after the passage of time or the fulfillment of a condition), the date or dates on which such shares were acquired and the investment intent of such acquisition, (2) a description of any Derivative Positions directly or indirectly held or beneficially held by such stockholder or any Stockholder Associated Person, and (3) whether and the extent to which a Hedging Transaction has been entered into by or on behalf of such stockholder or any Stockholder Associated Person,
(D)a complete and accurate description of all agreements, arrangements or understandings (including financial transactions and direct or indirect compensation), written or oral, between such stockholder or any Stockholder Associated Person and each proposed nominee and any other person or entity (including their names) pursuant to which the nomination(s) are to be made by such stockholder,
(E)a representation that such stockholder is a holder of record of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to nominate the persons named in its notice, and an acknowledgment that, if such stockholder does not appear to present such proposed nominees at such meeting, the Corporation need not present such proposed nominees for a vote at such meeting, notwithstanding that proxies in respect of such vote may have been received by the Corporation,
(F)all other information relating to such stockholder or any Stockholder Associated Person, or such stockholder’s or any Stockholder Associated Person’s associates, that would be required to be disclosed in a proxy statement or other filings required to be made in connection with the solicitation of proxies or consents for a contested election of directors (even if an election contest or proxy solicitation is not involved), or otherwise required, pursuant to Section 14 of the Exchange Act, and the rules and regulations promulgated thereunder,
(G)a representation from such stockholder as to whether such stockholder or any Stockholder Associated Person intends or is part of a group which intends to (1) solicit proxies in support of the election of any proposed nominee in accordance with Rule 14a-19 under the Exchange Act, (2) engage in a solicitation (within the meaning of Exchange Act Rule 14a- 1(l)) with respect to the nomination or other business, as applicable, and if so, the name of each participant (as defined in Item 4 of Schedule 14A under the Exchange Act) in such solicitation or (3) deliver a proxy statement and/or form of proxy to the holders of a sufficient number of the Corporation’s outstanding shares reasonably believed by such stockholder or any Stockholder Associated Person, as the case may be, to elect each proposed nominee or otherwise to solicit proxies or votes from stockholders in support of the nomination (such representation, a “Nomination Solicitation Statement”),
(H)the name of each nominee holder for, and number of, any securities of the Corporation owned beneficially but not of record by such stockholder or any Stockholder Associated Person and any pledge by such stockholder or any Stockholder Associated Person with respect to any of such securities,
(I)a complete and accurate description of all agreements, arrangements or understandings, written or oral, including any Derivative Positions or Hedging Transactions that have been entered into by, or on behalf of, such stockholder or any Stockholder Associated Person, the effect or intent of which is to mitigate loss, manage risk or benefit from changes in the price of any securities of the Corporation, or maintain, increase or decrease the voting power of such stockholder or any Stockholder Associated Person with respect to securities of the Corporation, whether or not such instrument or right shall be subject to the Substitute Award, over (b) the aggregate purchase price thereof does not exceed the excess of: (x) the aggregate fair market value (assettlement in underlying shares of stock of the time immediately precedingCorporation and without regard to whether such agreement, arrangement or understanding is required to be reported on a Schedule 13D, 13F or 13G in accordance with the transaction giving riseExchange Act,
(J)any substantial interest, direct or indirect (including any existing or prospective commercial, business or contractual relationship with the Corporation), by security holdings or otherwise, of such stockholder or any Stockholder Associated Person in the Corporation or any affiliate thereof, other than an interest arising from the ownership of Corporation securities where such stockholder or any Stockholder Associated Person receives no extra or special benefit not shared on a pro rata basis by all other holders of the same class or series,
(K)a complete and accurate description of all agreements, arrangements or understandings, written or oral, (1) between or among such stockholder and any of the Stockholder Associated Person or (2) between or among such stockholder or any

2023 Proxy Statement93
Stockholder Associated Person and any other person or entity (naming each such person or entity), including (x) any proxy, contract, arrangement, understanding or relationship pursuant to which such stockholder or any Stockholder Associated Person, directly or indirectly, has a right to vote any security of the Corporation (other than any revocable proxy given in response to a solicitation made pursuant to, and in accordance with, Section 14(a) of the Exchange Act by way of a solicitation statement filed on Schedule 14A) and (y) any understanding, written or oral, that such stockholder or any Stockholder Associated Person may have reached with any stockholder of the Corporation (including the name of such stockholder) with respect to how such stockholder will vote such stockholder’s shares in the Corporation at any meeting of the Corporation’s stockholders or take other action in support of any proposed nominee or other business, or other action to be taken, by such stockholder or any Stockholder Associated Person,
(L)any rights to dividends on the shares of the Corporation owned beneficially by such stockholder or any Stockholder Associated Person that are separated or separable from the underlying shares of the Corporation,
(M)any proportionate interest in shares of the Corporation, Derivative Positions or Hedging Transactions held, directly or indirectly, by a general or limited partnership, limited liability company or similar entity in which such stockholder or any Stockholder Associated Person (1) is a general partner or, directly or indirectly, beneficially owns an interest in a general partner of such general or limited partnership or (2) is the manager, managing member or, directly or indirectly, beneficially owns an interest in the manager or managing member of such limited liability company or similar entity,
(N)any significant equity interests or any Derivative Positions or Hedging Transactions in any principal competitor of the Corporation held by such stockholder or any Stockholder Associated Person,
(O)any direct or indirect interest of such stockholder or any Stockholder Associated Person in any contract or arrangement with the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation (including any employment agreement, collective bargaining agreement or consulting agreement),
(P)a description of any material interest of such stockholder or any Stockholder Associated Person in the proposed nominee,
(Q)a representation that (I) neither such stockholder nor any Stockholder Associated Person has breached any contract or other agreement, arrangement or understanding with the Corporation except as disclosed to the Substitute Award,Corporation pursuant hereto and (II) such fair marketstockholder and each Stockholder Associated Person has complied, and will comply, with all applicable requirements of state law and the Exchange Act with respect to the matters set forth in this Section 11(b),
(R)a complete and accurate description of any performance-related fees (other than asset-based fees) to which such stockholder or any Stockholder Associated Person may be entitled as a result of any increase or decrease in the value of the Corporation’s securities, any Derivative Positions or Hedging Transactions, including any such fees to which members of any Stockholder Associated Person’s immediate family sharing the same household may be entitled,
(S)(1) a description of the investment strategy or objective, if any, of such stockholder or any Stockholder Associated Person who is not an individual and (2) a copy of the prospectus, offering memorandum or similar document and any presentation, document or marketing material provided to third parties (including investors and potential investors) to solicit an investment in the stockholder or any Stockholder Associated Person that contains or describes the stockholder’s or such Stockholder Associated Person’s performance, personnel or investment thesis or plans or proposals with respect to the Corporation,
(T)all information that would be required to be determinedset forth in a Schedule 13D filed pursuant to Rule 13d-1(a) under the Exchange Act or an amendment pursuant to Rule 13d-2(a) under the Exchange Act if such a statement were required to be filed under the Exchange Act by such stockholder or any Stockholder Associated Person, or such stockholder’s or any Stockholder Associated Person’s associates (regardless of whether such person or entity is actually required to file a Schedule 13D), including a description of any agreement that would be required to be disclosed by such stockholder, any Stockholder Associated Person or any of their respective associates pursuant to Item 5 or Item 6 of Schedule 13D,
(U)a certification that such stockholder and each Stockholder Associated Person has complied with all applicable federal, state and other legal requirements in connection with such stockholder’s or Stockholder Associated Person’s acquisition of shares of stock or other securities of the Committee)Corporation and such stockholder’s or Stockholder Associated Person’s acts or omissions as a stockholder of the Corporation, if such stockholder or Stockholder Associated Person is or has been a stockholder of the Corporation,
(V)a complete and accurate description of any pending or, to such stockholder’s knowledge, threatened legal proceeding in which such stockholder or any Stockholder Associated Person is a party or participant involving the Corporation or, to such stockholder’s knowledge, any current or former officer, director, affiliate or associate of the Corporation,
(W)identification of the names and addresses of other stockholders (including beneficial owners) known by such stockholder to have provided financial support for the nomination(s) or other business proposal(s) submitted by such stockholder and, to the extent

2023 Proxy Statement94
known, the class and number of all shares of the Corporation’s stock owned beneficially or of record by such other stockholder(s) or other beneficial owner(s), and
(X)(1) if the stockholder (or the beneficial owner(s) on whose behalf such stockholder is submitting a notice to the Corporation) is not a natural person, the identity of each natural person associated with such stockholder (or beneficial owner(s)) responsible for the formulation of and decision to propose the business or nomination to be brought before the meeting (such person or persons, the “Responsible Person”), the manner in which such Responsible Person was selected, any fiduciary duties owed by such Responsible Person to the equity holders or other beneficiaries of such stockholder (or beneficial owner(s)), the qualifications and background of such Responsible Person and any material interests or relationships of such Responsible Person that are not shared generally by any other record or beneficial holder of the shares of any class or series of the predecessor companycapital stock of the Corporation and that reasonably could have influenced the decision of such stockholder (or beneficial owner(s)) to propose such business or nomination to be brought before the meeting and (2) if the stockholder or any Stockholder Associated Person (or the beneficial owner(s) on whose behalf such stockholder is submitting a notice to the Corporation) is a natural person, the qualifications and background of such natural person and any material interests or relationships of such natural person that are not shared generally by any other record or beneficial holder of the shares of any class or series of the capital stock of the Corporation and that reasonably could have influenced the decision of such stockholder (or beneficial owner(s)) to propose such business or nomination to be brought before the meeting.
(Y)(1) In addition, any stockholder who submits a notice pursuant to this Section 11(b) of ARTICLE II is required to update and supplement the information disclosed in such notice, if necessary, in accordance with Section 11(e) of this ARTICLE II and shall comply with Section 11(g) of this ARTICLE II.
(2)The Corporation may require any stockholder who submits a notice pursuant to this Section 11 of ARTICLE II to furnish such other information as the Corporation may reasonably require to determine the eligibility or suitability of a proposed nominee to serve as a director of the Corporation or that could be material to a reasonable stockholder’s understanding of the independence, or lack thereof, of such proposed nominee, under the listing standards of each securities exchange upon which the Corporation’s securities are listed, any applicable rules of the Securities and Exchange Commission, any publicly disclosed standards used by the Board of Directors in selecting nominees for election as a director and for determining and disclosing the independence of the Corporation’s directors, including those applicable to a director’s service on any of the committees of the Board of Directors, or the requirements of any other laws or regulations applicable to the Corporation. If requested by the Corporation, any supplemental information required under this paragraph shall be provided by a stockholder within ten (10) days after it has been requested by the Corporation. In addition, the Board of Directors may require any proposed nominee to submit to interviews with the Board of Directors or any committee thereof, and such proposed nominee shall make himself or herself available for any such interviews within ten (10) days following any reasonable request therefor from the Board or any committee thereof.
(3)If any information submitted pursuant to this Section 11(b) by any stockholder nominating individuals for election or reelection as a director or proposing business (including in a Stockholder Requested Special Meeting) for consideration at a stockholder meeting shall be inaccurate in any material respect (as determined by the Board of Directors or a committee thereof), such information shall be deemed not to have been provided in accordance with this Section 11(b). Any such stockholder shall notify the Secretary in writing at the principal executive offices of the Corporation of any inaccuracy or change in any information submitted pursuant to this Section 11(b) (including if any stockholder or any Stockholder Associated Person no longer intends to solicit proxies in accordance with the representations made pursuant to Section 11(b)(iii)(G)) within two (2) business days after becoming aware of such inaccuracy or change, and any such notification shall clearly identify the inaccuracy or change, it being understood that no such notification may cure any deficiencies or inaccuracies with respect to any prior submission by such stockholder. Upon written request of the Secretary on behalf of the Board of Directors (or a duly authorized committee thereof), any such stockholder shall provide, within seven (7) business days after delivery of such request (or such other period as may be specified in such request), (I) written verification, reasonably satisfactory to the Board of Directors, any committee thereof or any authorized officer of the Corporation, to demonstrate the accuracy of any information submitted by such stockholder pursuant to this Section 11(b) and (II) a written affirmation of any information submitted by such stockholder pursuant to this Section 11(b) as of an earlier date. If a stockholder fails to provide such written verification or affirmation within such period, the information as to which written verification or affirmation was requested may be deemed not to have been provided in accordance with this Section 11(b).
(4)If (I) any stockholder or any Stockholder Associated Person provides notice pursuant to Rule 14a-19(b) under the Exchange Act with respect to any proposed nominee and (II) such stockholder or Stockholder Associated Person subsequently (x) notifies the Corporation that such stockholder or Stockholder Associated Person no longer intends to solicit proxies in support of the election or reelection of such proposed nominee in accordance with Rule 14a-19(b) under the Exchange Act or (y) then fails to comply with the requirements of Rule 14a-19(a)(2) or Rule 14a-19(a)(3) under the Exchange Act, then the Corporation shall disregard any proxies solicited for such proposed nominee (subject to applicable law). Upon request by the Corporation, if any stockholder provides notice pursuant to Rule 14a-19(b) under the Exchange Act, such stockholder

2023 Proxy Statement95
shall deliver to the Secretary, no later than five (5) business days prior to the applicable meeting date, reasonable evidence that the requirements of Rule 14a-19(a)(3) under the Exchange Act have been satisfied.
(5)Any written notice, supplement, update or other entity that were subjectinformation required to be delivered by a stockholder to the grant assumedCorporation pursuant to this Section 11(b) must be given by personal delivery, by overnight courier or substitutedby registered or certified mail, postage prepaid, to the Secretary at the Corporation’s principal executive offices;

provided, however, that the disclosures in the subclauses (A) through (Y) in this Section 11(b)(iii) of ARTICLE II shall not include any such disclosures with respect to the ordinary course business activities of any broker, dealer, commercial bank, trust company or other nominee who is a stockholder giving notice solely as a result of being the stockholder directed to prepare and submit the notice required by these Bylaws on behalf of a beneficial owner.

(iv)Notwithstanding anything in Section 11(b)(ii) of this ARTICLE II to the contrary, if the number of directors to be elected to the Board of Directors is increased and there is no Public Announcement naming all of the nominees for director or specifying the size of the increased Board of Directors made by the Company, over (y)Corporation at least 10 days prior to the aggregate purchase pricelast day a stockholder may deliver a notice of nomination in accordance with Section 11(b)(ii), a stockholder’s notice required by Section 11(b)(ii) of this ARTICLE II shall also be considered timely, but only with respect to nominees for any new positions created by such increase, if it shall be received by the Secretary at the principal executive offices of the Corporation not later than the close of business on the tenth day following the day on which such Public Announcement is first made by the Corporation.

(c)Inclusion of Stockholder Director Nominations in the Corporation’s Proxy Materials.

(i)Subject to the provisions of these Bylaws, the Corporation shall include in its proxy statement and on its form of proxy for an annual meeting of stockholders, the name of, and shall include in any such proxy statement the Additional Information (as defined below) relating to, any eligible person nominated for election as a director of the Corporation (a “Stockholder Nominee”) by any stockholder or group of no more than 20 stockholders that satisfies the requirements of this Section 11(c) of ARTICLE II (such person or group, an “Eligible Stockholder”) and that includes in the written notice required by this Section 11(c) of ARTICLE II (the “Notice of Proxy Access Nomination”) a written statement electing to have its nominee included in the Corporation’s proxy materials. For purposes of this Section 11(c) of ARTICLE II, “Additional Information” shall consist of (A) information concerning the Stockholder Nominee and the Eligible Stockholder that the Corporation determines is required to be disclosed in the Corporation’s proxy statement by Section 14 of the Exchange Act and/or the rules and regulations promulgated thereunder and (B) if the Eligible Stockholder so elects, a statement set forth in the Notice of Proxy Access Nomination for inclusion in the proxy statement in support of such sharesnomination as described in Section 11(c)(v)(E) of this ARTICLE II (subject, without limitation, to Section 11(c)(vi) of this ARTICLE II).
   
 (b)(ii)Option Period and Exercisability.The period during which an option may be exercised shall be determined by the Committee; provided, however, that no option shall be exercised later than ten (10) years after its date of grant; provided further, that if an Incentive Stock Option shall be granted to a Ten Percent Holder, such optionCorporation shall not be exercised laterrequired to include in any proxy materials for an annual meeting of stockholders a number of Stockholder Nominees greater than five years after its date20% of grant; providedthe number of directors in office as of the last day on which a Notice of Proxy Access Nomination may be delivered pursuant to this Section 11(c) of ARTICLE II (the “Proxy Access Nomination Deadline”), further,rounded down to the nearest whole number but not less than two (the “Maximum Number of Nominees”). Notwithstanding the foregoing, the Maximum Number of Nominees shall be reduced by the number of (A) Stockholder Nominees that are subsequently withdrawn or that the Board of Directors itself decides to nominate at such annual meeting of stockholders, (B) incumbent directors who were Stockholder Nominees at any of the preceding two annual meetings of stockholders, and (C) incumbent directors or director candidates (including, without limitation, candidates who are not Stockholder Nominees) that in either case will be included in the Corporation’s proxy materials with respect to a Nonqualified Stock Option, ifsuch annual meeting as unopposed (by the expirationCorporation) nominees pursuant to any agreement, arrangement or other understanding with any stockholder or group of stockholders (other than any such agreement, arrangement or understanding entered into in connection with an acquisition of capital stock, by the stockholder or group of stockholders, from the Corporation). In the event that one or more vacancies for any reason occurs on the Board of Directors after the Proxy Access Nomination Deadline but prior to the date of the annual meeting of stockholders, and the Board of Directors resolves to reduce the size of the Board of Directors in connection therewith, the Maximum Number of Nominees shall be calculated based on the number of directors in office as so reduced. In the event that the number of Stockholder Nominees submitted by Eligible Stockholders pursuant to this Section 11(c) of ARTICLE II exceeds the Maximum Number of Nominees, each Eligible Stockholder shall select one Stockholder Nominee for inclusion in the Corporation’s proxy statement until the Maximum Number of Nominees is reached, going in the order of the amount (greatest to least) of voting power of the Corporation’s capital stock entitled to vote on the election of directors as disclosed in the Notice of Proxy Access Nomination submitted to the Corporation. If the Maximum Number of Nominees is not reached after each Eligible Stockholder has selected one Stockholder Nominee, this selection process shall continue as many times as necessary, following the same order each time, until the Maximum Number of Nominees is reached. If any Stockholder Nominee selected pursuant to such determination later (1) withdraws from the election (or his or her nomination is withdrawn by the Eligible Stockholder) or (2) is determined not to satisfy the requirements of this Section 11(c) of ARTICLE II, no other nominee or nominees (other than any Stockholder Nominees already determined to be included in the Corporation’s proxy materials who continue to satisfy the requirements of this Section 11(c) of ARTICLE II) shall be included in the Corporation’s proxy materials or otherwise be eligible for election pursuant to this Section 11(c) of ARTICLE II.

2023 Proxy Statement96

(iii)In order to make a nomination pursuant to this Section 11(c) of ARTICLE II and in order for such nomination to be voted upon, an Eligible Stockholder must have owned at least 3% of the Corporation’s outstanding common stock as of the most recent date for which such amount is given in any filing by the Corporation with the Securities and Exchange Commission prior to the submission of the Notice of Proxy Access Nomination (the “Required Shares”) continuously for a period of three years as of both the date the Notice of Proxy Access Nomination is received by the Secretary in accordance with this Section 11(c) of ARTICLE II and the record date for determining the stockholders eligible to vote at the annual meeting of stockholders, and must continue to own the Required Shares through the annual meeting date. For purposes of this Section 11(c) of ARTICLE II, an Eligible Stockholder shall be deemed to “own” only those outstanding shares of the Corporation’s common stock as to which the stockholder possesses both (A) the full voting and investment rights pertaining to the shares and (B) the full economic interest in (including the opportunity for profit and risk of loss on) such shares; provided, however, that the number of shares calculated in accordance with clauses (A) and (B) shall not include any shares (1) sold by or on behalf of such stockholder or any of its affiliates in any transaction that has not yet settled or closed, including any short sale, (2) borrowed by or on behalf of such stockholder or any of its affiliates for any purposes or purchased by such stockholder or any of its affiliates pursuant to an agreement to resell, or (3) subject to any option, occurswarrant, forward contract, swap, contract of sale, other derivative or similar instrument or agreement entered into by or on behalf of such stockholder or any of its affiliates, whether any such instrument or agreement is to be settled with shares or with cash based on the notional amount or value of outstanding shares of the Corporation, in any such case which instrument or agreement has, is intended to have, or if exercised by either party thereto would have, the purpose or effect of (i) reducing in any manner, to any extent or at any time in the future, such stockholder’s or any of its affiliates’ full right to vote or direct the voting of any such shares, and/or (ii) hedging, offsetting or altering to any degree gain or loss arising from the full economic ownership of such shares by such stockholder or any of its affiliates. Notwithstanding the foregoing, an Eligible Stockholder “owns” shares held in the name of a nominee or other intermediary so long as the Eligible Stockholder retains the right to instruct how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares. An Eligible Stockholder’s ownership of shares shall be deemed to continue during any period whenin which the participant is prohibited from tradingstockholder has (x) loaned such shares, provided that such stockholder has the power to recall such shares on not more than five business days’ notice, has recalled such loaned shares within five business days of being notified that its Stockholder Nominee will be included in securitiesthe Corporation’s proxy materials for the relevant annual meeting of stockholders (and holds any voting power over such shares) and holds such shares (and voting power) through the date of the Company pursuant to the Company’s insider trading policyannual meeting of stockholders or (y) delegated any voting power over such shares by means of a proxy, power of attorney or other policy ofinstrument or arrangement, provided that such stockholder has the Company or during a period when the exercise ofpower to revoke such option would violate applicable securities laws (each, a “Blackout Period”),delegation at any time without condition and the Fair Market Value of a share of Common Stock exceeds the exercise price of the Optionhas revoked such delegation as of the record date on which such Option is scheduled to expire, thenfor the period during which such optionannual meeting of stockholders. The terms “owned,” “ownership,” “owning” and other variations of the word “own” shall be exercisable shall be extended to the date that is 30 days after the expiration of such Blackout Period. The Committee may, in its discretion, establish Performance Measures which shall be satisfied or met as a condition to the grant of an option or to the exercisability of all or a portion of an option. The Committee shall determine whether an option shall become exercisable in cumulative or non-cumulative installments and in part or in full at any time. An exercisable option, or portion thereof, may be exercised only with respect to whole shares of Common Stock.have correlative meanings.
   
 (c)(iv)MethodFor the purpose of Exercise. An option may be exercised (i) by giving written notice to the Company specifyingcalculating the number of whole sharesstockholders that constitutes an “Eligible Stockholder” for purposes of Common Stockthis Section 11(c) of ARTICLE II, a group of funds that are (A) under common management and investment control, (B) under common management and funded primarily by the same employer, or (C) a “group of investment companies,” as such term is defined in Section 12(d)(1)(G)(ii) of the Investment Company Act of 1940, as amended, (or any successor rule) (a “Qualifying Fund”) shall be treated as one stockholder, provided that (1) each fund included with a Qualifying Fund otherwise meets the requirements set forth in this Section 11(c) of ARTICLE II and (2) such group of funds shall provide, together with the Notice of Proxy Access Nomination, documentation evidencing such group’s status as a Qualifying Fund. No stockholder, alone or together with any of its affiliates, may be a member of more than one group constituting an Eligible Stockholder, and if any person appears as a member of more than one group, it shall be deemed to be purchased and accompanying such notice with payment therefor in full (or arrangement made for such payment toa member of the Company’s satisfaction) either (A) in cash, (B) by delivery (either actual delivery or by attestation procedures established bygroup that has the Company)largest ownership of shares of Common Stock having a Fair Market Value, determined ascommon stock of the dateCorporation. In the event of exercise, equala nomination pursuant to this Section 11(c) of ARTICLE II by a group of stockholders, each provision in this Section 11(c) of ARTICLE II that requires the Eligible Stockholder to provide any written statements, representations, undertakings, agreements or other instruments or to meet any other conditions shall be deemed to require each stockholder that is a member of such group to provide such statements, representations, undertakings, agreements or other instruments and to meet any other conditions; provided, however, that the requirement to own the Required Shares shall apply to the aggregate purchase price payable by reason of such exercise, (C) authorizing the Company to withhold whole shares of Common Stock which would otherwise be delivered having an aggregate Fair Market Value, determined asownership of the date of exercise, equalgroup in the aggregate. Should any stockholder withdraw from, or be deemed ineligible to participate in, a group constituting an Eligible Stockholder at any time prior to the amount necessaryannual meeting of stockholders, such group shall only be deemed to satisfy such obligation, (D) in cashown the shares held by a broker-dealer acceptable to the Company to whom the optionee has submitted an irrevocable notice of exercise or (E) a combination of (A), (B) and (C), in each case to the extent set forth in the Agreement relating to the option, (ii) if applicable, by surrendering to the Company any Tandem SARs which are cancelled by reasonremaining members of the exercisegroup. A breach of the option and (iii)any obligation, agreement, representation or warranty under this Section 11(c) of ARTICLE II by executing such documents as the Company may reasonably request. No sharesany member of Common Stocka group constituting an Eligible Stockholder shall be issued and no certificate representing shares of Common Stock shall be delivered until the full purchase price therefor and any withholding taxes thereon, as described in Section 5.5, have been paid (or arrangement made for such payment to the Company’s satisfaction).

2.2Stock Appreciation Rights. The Committee may, in its discretion, grant SARs to such eligible persons as may be selecteddeemed a breach by the Committee. The Agreement relating to an SAR shall specify whether the SAR is a Tandem SAR or a Free-Standing SAR.

 2021 Proxy Statement90

SARs shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of this Plan, as the Committee shall deem advisable:

(a)Number of SARs and Base Price. The number of SARs subject to an award shall be determined by the Committee. Any Tandem SAR related to an Incentive Stock Option shall be granted at the same time that such Incentive Stock Option is granted. The base price of a Tandem SAR shall be the purchase price per share of the related option. The base price of a Free-Standing SAR shall be determined by the Committee; provided, however, that such base price shall not be less than 100% of the Fair Market Value of a share of Common Stock on the date of grant of such SAR (or, if earlier, the date of grant of the option for which the SAR is exchanged or substituted).Eligible Stockholder.
   
 (v)NotwithstandingTo be timely, the foregoing,Eligible Stockholder’s Notice of Proxy Access Nomination must be delivered to the Secretary at the principal executive offices of the Corporation in proper written form not less than one hundred twenty (120) days and not more than one hundred fifty (150) days prior to the first anniversary of the date (as stated in the Corporation’s proxy materials) the definitive proxy statement was first distributed to stockholders in connection with the preceding year’s annual meeting of stockholders; provided, however, that if and only if the annual meeting is not scheduled to be held within thirty (30) days before or after the first anniversary of the preceding year’s annual meeting of stockholders, or if no annual meeting was held in the preceding year, such Notice of Proxy Access Nomination must be delivered by the later of the tenth day following the day the Public Announcement of the date of the annual meeting is first made and the date which is one hundred fifty (150) days prior to the date of the annual meeting. In no event shall the adjournment or postponement of an annual meeting of stockholders (or any Public Announcement

2023 Proxy Statement97

thereof) commence a new time period (or extend any time period) for the giving of a Notice of Proxy Access Nomination. To be in proper form, the Notice of Proxy Access Nomination shall set forth or be submitted with the following:

(A)A copy of the Schedule 14N relating to the Stockholder Nominee that has been or concurrently is filed with the Securities and Exchange Commission in accordance with Rule 14a-18 under the Exchange Act (or any successor rule thereto);
(B)Written notice of nomination of the Stockholder Nominee, which notice includes the following additional information, agreements, representations and warranties by the Eligible Stockholder:

(1)all information required from nominating stockholders and stockholder nominees with respect to the nomination of directors pursuant to Section 11(b) of this ARTICLE II;
(2)the details of any relationship that existed within the three years preceding the submission of the Notice of Proxy Access Nomination and that would have been required to be described pursuant to Item 6(e) of Schedule 14N (or any successor item) if such relationship existed on the date of the submission of the Schedule 14N;
(3)a description of any agreement, arrangement or understanding with respect to the nomination between or among such stockholder and/or any beneficial owner, if any, on whose behalf the nomination is made, any of their respective affiliates or associates, and any others acting in concert with any of the foregoing;
(4)the details of any position of the Stockholder Nominee as an officer or director of any competitor (that is, any entity that produces products or provides services that compete with or are alternatives to the products produced or services provided by the Corporation or its affiliates) or significant supplier or customer of the Corporation within the three years preceding the submission of the Notice of Proxy Access Nomination;
(5)a representation and warranty that the Eligible Stockholder (i) acquired the Required Shares in the ordinary course of business and neither acquired, nor is holding, such shares for the purpose or with the effect of influencing or changing control of the Corporation; (ii) has not engaged in, and will not engage in, and has not and will not be a “participant” in another person’s, “solicitation” within the meaning of Rule 14a-1(l) under the Exchange Act (without reference to the exception in Section 14a-(l)(2)(iv)) (or any successor rules) with respect to the annual meeting of stockholders, other than with respect to nominees of such Eligible Stockholder or nominees of the Board of Directors; (iii) has not nominated and will not nominate for election to the Board of Directors any person other than the Stockholder Nominee(s); (iv) agrees to comply with all laws, rules and regulations applicable to the use, if any, of soliciting material; (v) will provide facts, statements and other information in all communications with the Corporation and its stockholders that are or will be, as applicable, true and correct in all material respects and do not and will not omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading; (vi) meets the eligibility requirements set forth in these Bylaws; and (vii) will maintain qualifying ownership of the Required Shares at least through the date of the annual meeting of stockholders;
(6)a representation that, within five business days after each of the date of the Notice of Proxy Access Nomination and the record date for the annual meeting of stockholders, the Eligible Stockholder will provide documentary evidence from each record holder of the Required Shares (and from each intermediary through which the Required Shares are or have been held during the requisite three-year holding period) evidencing the continuous ownership by the Eligible Stockholder of the Required Shares for at least three years as of the date of the Notice of Proxy Access Nomination and the record date, respectively;
(7)a representation that the Stockholder Nominee: (i) qualifies as independent (including with respect to all committees of the Board of Directors) under the listing standards and rules of each exchange upon which the Corporation’s common stock is listed, any applicable rules of the Securities and Exchange Commission and any publicly disclosed standards used by the Board of Directors in determining and disclosing independence of the Corporation’s directors; (ii) is a “non-employee director” for the purposes of Rule 16b-3 under the Exchange Act (or any successor rule); (iii) meets the director qualification requirements, if any, set forth in publicly disclosed corporate governance policies and guidelines of the Corporation; and (iv) is not and has not been subject to any event specified in Rule 506(d)(1) of Regulation D (or any successor rule) under the Securities Act of 1933 or Item 401(f) of Regulation S-K (or any successor rule) under the Exchange Act, without reference to whether the event is material to an evaluation of the ability or integrity of the Stockholder Nominee;
(8)a representation that the Schedule 14N relating to the Stockholder Nominee and provided in accordance with this Section 11(c)(v) of ARTICLE II is accurate and complete, and fully complies with the requirements of Schedule 14N under the Exchange Act; and
(9)a representation and warranty that the Stockholder Nominee’s candidacy will not and, if elected, the Stockholder Nominee’s membership on the Board of Directors would not, violate applicable state or federal law or the listing standards or rules of any exchange upon which the Corporation’s common stock is listed;

2023 Proxy Statement98
(C)An executed agreement pursuant to which the Eligible Stockholder agrees:

(1)to comply with all applicable laws, rules, regulations and listing standards in connection with the nomination, solicitation and election of the Stockholder Nominee;
(2)to file any written solicitation or other communication with the Corporation’s stockholders relating to one or more of the Corporation’s directors or director nominees or any Stockholder Nominee with the Securities and Exchange Commission, regardless of whether any such filing is required under rule or regulation or whether any exemption from filing is available for such materials under any rule or regulation;
(3)to refrain from distributing any form of proxy for the annual meeting of stockholders other than the form distributed by the Corporation;
(4)to assume all liability stemming from any action, suit or proceeding concerning any actual or alleged legal or regulatory violation arising out of any communication by the Eligible Stockholder with the Corporation, its stockholders or any other person in connection with the nomination or election of directors, including the Notice of Proxy Access Nomination;
(5)to indemnify and hold harmless (jointly with all other group members, in the case of an SARa group member) the Corporation and each of its directors, officers and employees individually against any liability, loss, damages, expenses or other costs (including attorneys’ fees) incurred in connection with any threatened or pending action, suit or proceeding, whether legal, administrative or investigative, against the Corporation or any of its directors, officers or employees arising out of or relating to any nomination, solicitation, or other activity by the Eligible Stockholder in connection with its efforts to elect a Stockholder Nominee pursuant to this Section 11(c) of ARTICLE II; and
(6)in the event that any information included in the Notice of Proxy Access Nomination, or any other communication by the Eligible Stockholder (including with respect to any group member), with the Corporation, its stockholders or any person in connection with the nomination or election of directors ceases to be true and accurate in all material respects (or due to a subsequent development omits a material fact necessary to make the statements made not misleading), or that the Eligible Stockholder (including any group member) has failed to continue to satisfy the eligibility requirements described in Section 11(c)(iii) of this ARTICLE II, to promptly (and in any event within 48 hours of discovering such misstatement or omission) notify the Corporation and any other recipient of such communication of the misstatement or omission in such previously provided information and of the information that is required to correct the misstatement or omission; it being understood that providing any such notification shall not be deemed to cure any such defect or limit the Corporation’s right to omit a Substitute Award,Stockholder Nominee from its proxy materials pursuant to this Section 11(c) of ARTICLE II;

(D)An executed agreement pursuant to which the base price per shareStockholder Nominee consents to being named in the Corporation’s proxy statement and form of proxy (and will not agree to be named in any other person’s proxy statement or form of proxy with respect to the annual meeting of stockholders) as a nominee and to serving as a director of the Corporation if elected, and represents and agrees that such Stockholder Nominee is in compliance with all applicable publicly disclosed corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Corporation;
(E)If desired, a statement for inclusion in the proxy statement in support of the Stockholder Nominee’s candidacy, provided that such statement (1) shall not exceed 500 words, (2) shall fully comply with Section 14 of the Exchange Act and the rules and regulations thereunder, including Rule 14a-9, and (3) is provided at the same time as the relevant Notice of Proxy Access Nomination; and
(F)In the case of a nomination by a group constituting an Eligible Stockholder, the designation by all group members of one group member as the exclusive member to interact with the Corporation on behalf of all members of the group for purposes of this Section 11(c) of ARTICLE II and to act on behalf of all group members with respect to matters relating to the nomination, including withdrawal of the nomination.

The information, statements, representations, undertakings, agreements, documents and other obligations required by this Section 11(c) (v) of ARTICLE II shall be provided (1) with respect to and executed by each group member, in the case of a group, and (2) with respect to the persons specified in Instruction 1 to Items 6(c) and (d) of Schedule 14N (or any successor item) in the case of an Eligible Stockholder or group member that is an entity. The Notice of Proxy Access Nomination shall be deemed submitted on the date on which all information and documents referred to in this Section 11(c)(v) of ARTICLE II (other than such information and documents explicitly contemplated in this Section 11(c)(v) of ARTICLE II to be provided after the date the Notice of Proxy Access Nomination) have been delivered to, or, if sent by mail, received by the Secretary at the principal executive offices of the Corporation. Notwithstanding any other provision of these Bylaws, the Corporation may in its sole discretion solicit against, and include in the proxy statement its own statements or other information relating to, any Eligible Stockholder and/or Stockholder Nominee, including any information provided to the Corporation with respect to the foregoing.

(vi)Notwithstanding anything to the contrary, the Corporation may omit from its proxy materials any information not timely provided in accordance with these Bylaws or any information that is provided pursuant to this Section 11(c) of ARTICLE II, including all or any

2023 Proxy Statement99

portion of the statement in support of the Stockholder Nominee included in the Notice of Proxy Access Nomination, if the Corporation in good faith determines that: (A) such information directly or indirectly impugns the character, integrity or personal reputation of, or directly or indirectly makes charges concerning improper, illegal or immoral conduct or associations, without factual foundation, with respect to, any person; (B) such information is not true in any material respect (or omits a material fact necessary in order to make the statements made not misleading); (C) the inclusion of such information in the proxy materials would otherwise violate any applicable law, rule or regulation; or (D) the inclusion of such information in the proxy materials would impose a material risk of liability upon the Corporation.

(vii)Notwithstanding anything to the contrary in this Section 11(c) of ARTICLE II, the Corporation shall not be required to include in its proxy materials any Stockholder Nominee or information concerning such Stockholder Nominee, nor shall a vote be required to occur with respect to any such Stockholder Nominee at any such meeting (notwithstanding that proxies in respect of such vote may have been received by the Corporation), if:

(A)the Corporation receives a notice (whether or not subsequently withdrawn) that a stockholder intends to nominate any candidate for election to the Board of Directors at the annual meeting of stockholders pursuant to the advance notice requirements for stockholder nominees for director set forth in Section 11(b) of this ARTICLE II;
(B)the Stockholder Nominee or the Eligible Stockholder has engaged in or is engaged in, or has been or is a “participant” in another person’s, “solicitation” within the meaning of Rule 14a-1(l) under the Exchange Act (without reference to the exception in Section 14a-(l)(2)(iv)) (or any successor rules) with respect to the annual meeting of stockholders, other than with respect to nominees of such Eligible Stockholder or nominees of the Board of Directors;
(C)if another person is engaging in a “solicitation” within the meaning of Rule 14a-1(l) under the Exchange Act (without reference to the exception in Section 14a-(l)(2)(iv)) (or any successor rules) with respect to the annual meeting of stockholders, other than with respect to nominees of the Board of Directors;
(D)the Stockholder Nominee’s nomination or election to the Board of Directors would cause the Corporation to be in violation of the Corporation’s Bylaws or Certificate of Incorporation, the listing standards or rules of any exchange upon which the Corporation’s common stock is listed, or any applicable law, rule or regulation;
(E)the Stockholder Nominee was nominated for election to the Board of Directors pursuant to this Section 11(c) of ARTICLE II at one of the Corporation’s two preceding annual meetings of stockholders and either withdrew or became ineligible or unavailable or did not receive a number of votes cast in favor of his or her election at least equal to 25% of the shares present in person or by proxy and entitled to vote at such meeting;
(F)the Stockholder Nominee is or has been within the past three years, an officer or director of a competitor, as defined in Section 8 of the Clayton Antitrust Act of 1914, as amended;
(G)the Stockholder Nominee is subject to any order of the type specified in Rule 506(d) of regulations promulgated under the Securities Act of 1933;
(H)the Eligible Stockholder has failed to continue to satisfy the eligibility requirements described in Section 11(c)(iii) of this ARTICLE II, any of the representations and warranties made in the Notice of Proxy Access Nomination is not or ceases to be true and accurate in all material respects (or omits a material fact necessary to make the statement not misleading), the Stockholder Nominee becomes unwilling or unable to serve on the Board of Directors, or any violation or breach occurs of the obligations, agreements, representations or warranties of the Eligible Stockholder or the Stockholder Nominee under this Section 11(c) of ARTICLE II;
(I)the Stockholder Nominee is not independent (including with respect to any committees of the Board of Directors) under the listing standards or rules of any exchange upon which the Corporation’s common stock is listed, any applicable rules of the Securities and Exchange Commission, or any publicly disclosed standards used by the Board of Directors in determining and disclosing the independence of the Corporation’s directors; or
(J)the Eligible Stockholder or, in the case of a nomination by a group, the designated lead group member, fails to appear at the annual meeting of stockholders to present any nomination submitted by such SARstockholder or group pursuant to this Section 11(c) of ARTICLE II.

Notwithstanding the foregoing, if any of the conditions set forth in clause (B) are satisfied, then no Stockholder Nominees shall be included in the proxy materials and no Stockholder Nominee shall be eligible or qualified for director election.

(viii)This Section 11(c) of ARTICLE II shall be the exclusive means for stockholders to include nominees for election as a director of the Corporation in the Corporation’s proxy statement and on its form of proxy for an annual meeting of stockholders. For the avoidance of doubt, the provisions of this Section 11(c) of ARTICLE II shall not apply to a special meeting of stockholders, and the Corporation shall not be required to include a director nominee of a stockholder or any other person in the Corporation’s proxy statement or form of proxy for any special meeting of stockholders.

2023 Proxy Statement100
(d)Special Meetings of Stockholders. Only such business (other than Proposed Business as defined in Section 3 of ARTICLE II of these Bylaws) shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant to the notice of meeting. Only persons who are nominated in accordance and compliance with the procedures set forth in this Section 11(d) of ARTICLE II shall be eligible for election to the Board of Directors at a special meeting of stockholders at which directors are to be elected. Nominations of persons for election to the Board of Directors may be less than 100%made at a special meeting of stockholders at which directors are to be elected pursuant to the notice of meeting only (i) by or at the direction of the Fair Market Value per shareBoard of Directors or any committee thereof or (ii) provided that the Board of Directors has determined that directors are to be elected at such special meeting, by any stockholder of the Corporation who (A) was a stockholder of record at the time of giving of notice provided for in this Section 11(d) of ARTICLE II and through the time of the special meeting, (B) is entitled to vote at the meeting and (C) complies with the notice procedures provided for in this Section 11(d) of ARTICLE II. For the avoidance of doubt, the foregoing clause (ii) of this Section 11(d) of ARTICLE II shall be the exclusive means for a stockholder to propose nominations of persons for election to the Board of Directors at a special meeting of stockholders at which directors are to be elected, as previously determined by the Board of Directors. For nominations to be properly brought by a stockholder at a special meeting of stockholders, the stockholder must have given timely notice thereof in proper written form as described in this Section 11(d) of ARTICLE II to the Secretary. To be timely, a stockholder’s notice for the nomination of persons for election to the Board of Directors must be received by the Secretary at the principal executive offices of the Corporation not earlier than the 120th day prior to such special meeting and not later than the close of business on the later of the 90th day prior to such special meeting or the tenth day following the day on which a Public Announcement is first made of the date of grant, provided,the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. In no event shall any adjournment, recess, judicial stay, rescheduling, deferral or postponement of a special meeting or the announcement thereof commence a new time period (or extend any time period) for the giving of a stockholder’s notice as described above. Notices delivered pursuant to this Section 11(d) of ARTICLE II will be deemed received on any given day if received prior to the close of business on such day. To be in proper written form, such stockholder’s notice shall set forth all of the information required by, and otherwise be in compliance with, Section 11(b)(iii) of this ARTICLE II. In addition, any stockholder who submits a notice pursuant to this Section 11(d) of ARTICLE II is required to update and supplement the information disclosed in such notice, if necessary, in accordance with Section 11(e) of this ARTICLE II and shall comply with Section 11(g) of this ARTICLE II.
(e)Update and Supplement of Stockholder’s Notice. Any stockholder who submits a notice of proposal for business (including in a Stockholder Requested Special Meeting) or nomination for election pursuant to this Section 11 of ARTICLE II (other than an Eligible Stockholder who submits a Notice of Proxy Access Nomination pursuant to Section 11(c) of this ARTICLE II, in which case the requirements set forth in Section 11(c) shall govern such Eligible Stockholder’s obligations to update and supplement its Notice of Proxy Access Nomination) is required to update and supplement the information disclosed in such notice, if necessary, so that the excess of: (a)information provided or required to be provided in such notice shall be true and correct (A) as of the aggregate Fair Market Value (asrecord date for determining the stockholders entitled to notice of the meeting of stockholders and (B) as of the date that is ten (10) business days prior to such Substitute Award is granted)meeting of the shares subjectstockholders or any adjournment, rescheduling or postponement thereof, and such update and supplement shall (i) be received by the Secretary at the principal executive offices of the Corporation (x) not later than the Close of Business on the fifth (5th) business day after the record date for determining the stockholders entitled to receive notice of such meeting (in the case of an update and supplement required to be made as of the record date, under clause (A)), and (y) not later than the Close of Business on the eighth (8th) business day prior to the Substitute Award, over (b)date for the aggregate base pricemeeting of stockholders or any adjournment, rescheduling or postponement thereof does(and, if not exceedpracticable, on the excess of: (x)first practicable date prior to the aggregate fair market value (asdate to which the meeting has been adjourned, rescheduled or postponed) (in the case of the time immediately preceding the transaction giving riseupdate and supplement required to be made as of ten (10) business days prior to the Substitute Award, such fair market valuemeeting of stockholders or any adjournment or postponement thereof, pursuant to clause (B)), (ii) be determined by the Committee) of the shares of the predecessor company or other entity that were subjectmade only to the grant assumedextent that information has changed since such stockholder’s prior submission and (iii) clearly identify the information that has changed since such stockholder’s prior submission. For the avoidance of doubt, any information provided pursuant to this Section 11(e) of ARTICLE II shall not be deemed to cure any deficiencies or substitutedinaccuracies in a notice previously delivered pursuant to this Section 11 of ARTICLE II and shall not extend the time period for by the Company, over (y)delivery of notice pursuant to this Section 11 of ARTICLE II. If a stockholder fails to provide such written update within such period, the aggregate base priceinformation as to which such written update relates may be deemed not to have been provided in accordance with this Section 11 of such shares.ARTICLE II.
(f)Definitions. For purposes of this Section 11 of ARTICLE II, the term:

(i)Affiliate” and “Associate” each shall have the respective meanings set forth in Rule 12b-2 under the Exchange Act;
   
 (b)(ii)Exercise PeriodBeneficial owner and Exercisability. The periodbeneficially owned” shall have the meaning set forth for the exercise of an SAR shall be determined by the Committee; provided, however, that no SAR shall be exercised later than ten (10) years after its date of grant; provided further, that no Tandem SAR shall be exercised later than the expiration, cancellation, forfeiture or other terminationsuch terms in Section 13(d) of the related option; provided, further, if the expiration date of an SAR occurs during any Blackout Period, and the Fair Market Value of a share of Common Stock exceeds the base price of the SAR as of the date on which such SAR is scheduled to expire, then the period during which such SAR shall be exercisable shall be extended to the date that is 30 days after the expiration of such Blackout Period. The Committee may, in its discretion, establish Performance Measures which shall be satisfied or met as a condition to the grant of an SAR or to the exercisability of all or a portion of an SAR. The Committee shall determine whether an SAR may be exercised in cumulative or non-cumulative installments and in part or in full at any time. An exercisable SAR, or portion thereof, may be exercised, in the case of a Tandem SAR, only with respect to whole shares of Common Stock and, in the case of a Free-Standing SAR, only with respect to a whole number of SARs. If an SAR is exercised for shares of Restricted Stock, a certificate or certificates representing such Restricted Stock shall be issued in accordance with Section 3.3(c), or such shares shall be transferred to the holder in book entry form with restrictions on the shares duly noted, and the holder of such Restricted Stock shall have such rights of a stockholder of the Company as determined pursuant to Section 3.3(d). Prior to the exercise of a stock-settled SAR, the holder of such SAR shall have no rights as a stockholder of the Company with respect to the shares of Common Stock subject to such SAR.Exchange Act;
   
 (c)(iii)MethodClose of Exercise. A Tandem SAR may be exercised (i) by giving written notice toBusiness” shall mean 5:00 p.m. Eastern Time on any calendar day, whether or not the Company specifying the number of whole SARs which are being exercised, (ii) by surrendering to the Company any options which are cancelled by reason of the exercise of the Tandem SAR and (iii) by executing such documents as the Company may reasonably request. A Free-Standing SAR may be exercised (A) by giving written notice to the Company specifying the whole number of SARs which are being exercised and (B) by executing such documents as the Company may reasonably request. No shares of Common Stock shall be issued and no certificate representing shares of Common Stock shall be delivered until any withholding taxes thereon, as described in Section 5.5, have been paid (or arrangement made for such payment to the Company’s satisfaction).

2.3Termination of Employment or Service. All of the terms relating to the exercise, cancellation or other disposition of an option or SAR (i) upon a termination of employment with or service to the Company of the holder of such option or SAR, as the case may be, whether by reason of disability, retirement, death or any other reason, or (ii) during a paid or unpaid leave of absence, shall be determined by the Committee and set forth in the applicable award Agreement.
2.4Dividend Equivalents. Notwithstanding anything in an Agreement to the contrary, the holder of an option or SAR shall not be entitled to receive dividend equivalents with respect to the number of shares of Common Stock subject to such option or SAR.
2.5No Repricing. The Committee shall not without the approval of the stockholders of the Company, (i) reduce the purchase price or base price of any previously granted option or SAR, (ii) cancel any previously granted option or SAR in exchange for another option or SAR with a lower purchase price or base price or (iii) cancel any previously granted option or SAR in exchange for cash or another award if the purchase price of such option or the base price of such SAR exceeds the Fair Market Value of a share of Common Stock on the date of such cancellation, in each case, other than in connection with a Change in Control or the adjustment provisions set forth in Section 5.7.

 2021 Proxy Statement91

III. STOCK AWARDS

3.1Stock Awards. The Committee may, in its discretion, grant Stock Awards to such eligible persons as may be selected by the Committee. The Agreement relating to a Stock Award shall specify whether the Stock Awardday is a Restricted Stock Award, Restricted Stock Unit Award or Unrestricted Stock Award.
3.2Terms of Unrestricted Stock Awards. Subject to Section 1.5, the number of shares of Common Stock subject to an Unrestricted Stock Award shall be determined by the Committee. Unrestricted Stock Awards shall not be subject to any Restriction Periods or Performance Measures. Upon the grant of an Unrestricted Stock Award, subject to the Company’s right to require payment of any taxes in accordance with Section 5.5, a certificate or certificates evidencing ownership of the requisite number of shares of Common Stock shall be delivered to the holder of such award or such shares shall be transferred to the holder in book entry form.
3.3Terms of Restricted Stock Awards. Restricted Stock Awards shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of this Plan, as the Committee shall deem advisable.

(a)Number of Shares and Other Terms. The number of shares of Common Stock subject to a Restricted Stock Award and the Restriction Period, Performance Period (if any) and Performance Measures (if any) applicable to a Restricted Stock Award shall be determined by the Committee.business day;
   
 (b)(iv)Vesting and Forfeiture. The Agreement relatingDerivative Positions” means, with respect to a Restricted Stock Awardstockholder or any Stockholder Associated Person, any derivative positions including, without limitation, any short position, profits interest, forward, future, swap, option, warrant, convertible security, stock appreciation right or similar right, repurchase agreement or arrangement, borrowed or loaned share and so-called “stock borrowing” agreement or arrangement or similar right with an exercise or conversion privilege or a settlement payment or mechanism at a price related to any class or series of shares of the Corporation or with a value derived in whole or in part from the value of any class or series of shares of the Corporation, whether or not such instrument or right shall provide,be subject to settlement in the manner determined byunderlying class or

2023 Proxy Statement101
series of capital stock of the Committee,Corporation or otherwise and any performance-related fees (other than an asset-based fee) to which such stockholder or any Stockholder Associated Person is entitled to based, directly or indirectly, on any increase or decrease in its discretion, andthe value of shares of capital stock of the Corporation, the effect or intent of which is to mitigate loss, manage risk or benefit from changes in the price of any securities of the Corporation, or maintain, increase or decrease the voting power of such stockholder or any Stockholder Associated Person with respect to securities of the Corporation, whether or not such instrument or right shall be subject to the provisionssettlement in underlying shares of this Plan, for the vestingcapital stock of the shares of Common Stock subjectCorporation and without regard to whether such award (i) ifagreement, arrangement or understanding is required to be reported on a Schedule 13D, 13F or 13G in accordance with the holder of such award remains continuously in the employment of the Company during the specified Restriction Period and (ii) if specified Performance Measures (if any) are satisfied or met during a specified Performance Period, and for the forfeiture of the shares of Common Stock subject to such award (x) if the holder of such award does not remain continuously in the employment of the Company during the specified Restriction Period or (y) if specified Performance Measures (if any) are not satisfied or met during a specified Performance Period.Exchange Act;
   
 (c)(v)Stock Issuance. DuringHedging Transaction” means, with respect to a stockholder or any Stockholder Associated Person, any hedging or other transaction (such as borrowed or loaned shares) or series of transactions, or any other agreement, arrangement or understanding, the Restriction Period,effect or intent of which is to mitigate loss, manage risk or benefit from changes in the price of any securities of the Corporation, or maintain, increase or decrease the voting power or economic or pecuniary interest of such stockholder or any Stockholder Associated Person with respect to the Corporation’s securities, whether or not such instrument or right shall be subject to settlement in underlying shares of Restricted Stock shall be held by a custodian in book entry form with restrictions on such shares duly noted or, alternatively, a certificate or certificates representing a Restricted Stock Award shall be registered in the holder’s name and may bear a legend, in addition to any legend which may be required pursuant to Section 5.6, indicating that the ownershipcapital stock of the shares of Common Stock represented byCorporation and without regard to whether such certificateagreement, arrangement or understanding is subjectrequired to the restrictions, terms and conditions of this Plan and the Agreement relating to the Restricted Stock Award. All such certificates shall be deposited with the Company, together with stock powersreported on a Schedule 13D, 13F or other instruments of assignment (including a power of attorney), each endorsed in blank with a guarantee of signature if deemed necessary or appropriate, which would permit transfer to the Company of all or a portion of the shares of Common Stock subject to the Restricted Stock Award in the event such award is forfeited in whole or in part. Upon termination of any applicable Restriction Period (and the satisfaction or attainment of applicable Performance Measures), subject to the Company’s right to require payment of any taxes13G in accordance with Section 5.5, the restrictions shall be removed from the requisite number of any shares of Common Stock that are held in book entry form, and all certificates evidencing ownership of the requisite number of shares of Common Stock shall be delivered to the holder of such award.Exchange Act;
   
 (d)(vi)RightsPublic Announcement” means disclosure in a press release reported by the Dow Jones News Service, Associated Press, Business Wire, PR Newswire or comparable news service or in a document publicly filed by the Corporation with Respectthe Securities and Exchange Commission pursuant to Restricted Stock Awards. Unless otherwise set forth in the Agreement relating to a Restricted Stock Award, and subject to the terms and conditions of a Restricted Stock Award, the holder of such award shall have all rights as a stockholderSections 13, 14 or 15(d) of the Company, including, but not limited to, voting rights, the right to receive dividendsExchange Act; and the right to participate in any capital adjustment applicable to all holders of Common Stock; provided, however, that any dividend or other distribution paid with respect to shares subject to a Restricted Stock Award shall be deposited with the Company and shall be subject to the same restrictions as the shares of Common Stock with respect to which such dividend or distribution was made.

3.4Terms of Restricted Stock Unit Awards. Restricted Stock Unit Awards shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of this Plan, as the Committee shall deem advisable.

(a)Number of Shares and Other Terms. The number of shares of Common Stock subject to a Restricted Stock Unit Award and the Restriction Period, Performance Period (if any) and Performance Measures (if any) applicable to a Restricted Stock Unit Award shall be determined by the Committee.
   
 (b)(vii)VestingStockholder Associated Person” shall mean, with respect to any stockholder giving notice and Forfeiture. The Agreement relatingif different from such stockholder giving notice, any beneficial owner of shares of stock of the Corporation on whose behalf such stockholder is providing notice of any nomination or other business proposed, (A) any person controlling, directly or indirectly, or acting in concert with, such stockholder, (B) any beneficial owner of shares of stock of the Corporation owned of record or beneficially by such stockholder or any other Stockholder Associated Person (other than a stockholder that is a depositary), (C) any person directly or indirectly controlling, controlled by or under common control with such stockholder giving notice or beneficial owner(s), (D) any member of the immediate family of such stockholder giving notice or beneficial owner(s) sharing the same household, (E) any person or entity who is a member of a “group” (as such term is used in Rule 13d-5 under the Exchange Act (or any successor provision at law)) with, or is otherwise known by such stockholder or other Stockholder Associated Person to a Restricted Stock Unit Award shall provide,be acting in the manner determined by the Committee, in its discretion, and subjectconcert with, such stockholder, such beneficial owner(s) or any other Stockholder Associated Person with respect to the provisionsstock of this Plan, for the vestingCorporation, (F) any affiliate or associate of such Restricted Stock Unit Award (i)stockholder, such beneficial owner(s) or any other Stockholder Associated Person, (G) if the holdersuch stockholder or any such beneficial owner is not a natural person, any Responsible Person, (H) any participant (as defined in paragraphs (a)(ii)-(vi) of Instruction 3 to Item 4 of Schedule 14A) with such award remains continuously in the employment of the Company during the specified Restriction Periodstockholder, such beneficial owner(s) or any other Stockholder Associated Person with respect to any proposed business or nominations, as applicable and (ii) if specified Performance Measures (if any) are satisfied or met during a specified Performance Period, and for the forfeiture of the shares of Common Stock subject to such award (x) if the holder of such award does not remain continuously in the employment of the Company during the specified Restriction Period or (y) if specified Performance Measures (if any) are not satisfied or met during a specified Performance Period.(I) any proposed nominee.
   
(g)(c)SettlementSubmission of Vested Restricted Stock Unit Awards. TheQuestionnaire, Representation and Agreement relating. To be qualified to be a Restricted Stock Unit Award shall specify (i) whethernominee for election or reelection as a director of the Corporation, a person must deliver (in the case of a person nominated by a stockholder in accordance with Sections 11(b), 11(c) or 11(d) of this ARTICLE II, in accordance with the time periods prescribed for delivery of notice under such award may be settled in sharessections) to the Secretary at the principal executive offices of Common Stockthe Corporation a written questionnaire with respect to the background and qualification of such person and the background of any other person or cash or a combination thereof and (ii) whetherentity on whose behalf the holder thereofnomination is being made (which questionnaire shall be entitledprovided by the Secretary upon written request prior to receive dividend equivalents,submitting notice and which the Secretary shall provide to such stockholder within ten (10) days after receiving such request) and a written representation and agreement (in the form provided by the Secretary upon written request prior to submitting notice and which the Secretary shall provide to such stockholder within ten (10) days after receiving such request) that such person (i) is not and will not become a party to (A) any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director of the Corporation, will act or vote on any issue or question (a “Voting Commitment”) that has not been disclosed to the Corporation or (B) any Voting Commitment that could limit or interfere with such person’s ability to comply, if elected as a director of the Corporation, with such person’s fiduciary duties under applicable law, (ii) is not and will not become a party to any agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director that has not been disclosed therein, (iii) would be in compliance, and if determined byelected as a director of the Committee,Corporation will comply with all applicable rules of any securities exchanges upon which the Corporation’s securities are listed, the Certificate of Incorporation, these Bylaws, all applicable publicly disclosed corporate governance, ethics, conflict of interest, confidentiality, stock ownership and trading policies of the Corporation, (iv) consents to being named as a nominee in the Corporation’s proxy statement and form of proxy for the meeting, (v) intends to serve a full term as a director of the Corporation, if elected, and (vi) will provide facts, statements and other information in all communications with the Corporation and the Board that are or will be true and correct in all material respects and that do not and will not omit to state any material fact necessary in order to make the statements made, in light of the circumstances under which they are made, not misleading. A signed copy of each of the

 

 20212023 Proxy Statement92102

 
 interest on, orquestionnaire and the deemed reinvestment of, any deferred dividend equivalents, with respectwritten representation and agreement must be delivered to the numberCorporation within 10 days of shares of Common Stock subjectthe date that the Corporation makes such questionnaire or statement, as applicable, available to the stockholder seeking to make such nomination or to such award. Any dividend equivalents credited with respectnominee. The Corporation may also require any proposed nominee to Restricted Stock Units shallfurnish such other information as may reasonably be subjectrequired by the Corporation to determine the same vesting and other restrictions as the Restricted Stock Units to which they relate. Prior to the settlement of a Restricted Stock Unit Award, the holdereligibility of such award shall have no rightsproposed nominee to serve either as a stockholderdirector of the Company with respect to the shares of Common Stock subject to such award.
3.5Termination of EmploymentCorporation or Service. Allas an independent director of the terms relating to the satisfaction of Performance MeasuresCorporation under applicable Securities and Exchange Commission and stock exchange rules and the terminationCorporation’s publicly disclosed corporate governance guidelines, or that could be material to a reasonable stockholder’s understanding of the Restriction Period qualifications and/or Performance Period relating to a Stock Award,independence, or any forfeiture and cancellationlack thereof, of such award (i) upon a termination of employment with or service to the Company of the holder of such award, whether by reason of disability, retirement, death or any other reason, or (ii) during a paid or unpaid leave of absence, shall benominee, as determined by the Committee and set forth in the applicable award Agreement.

IV. PERFORMANCE AWARDS

4.1Performance Awards. The Committee may, in its discretion, grant Performance Awards to such eligible persons as may be selected by the Committee.Board of Directors’ sole discretion.
  
4.2(h)TermsAuthority of Performance AwardsChair; General Provisions. Performance AwardsExcept as otherwise provided by applicable law, the Certificate of Incorporation or these Bylaws, the Chair of the meeting shall have the power and duty to determine whether any nomination or other business proposed to be brought before the meeting was made or brought in accordance with the procedures set forth in these Bylaws and, if any nomination or other business is not made or brought in compliance with these Bylaws, to declare that such nomination or proposal of other business be disregarded and not acted upon and no vote shall be subjecttaken with respect to such nomination or proposed business, in each case, notwithstanding that proxies with respect to such vote may have been received by the following terms and conditions and shall contain such additional terms and conditions, not inconsistent withCorporation. Notwithstanding the termsforegoing provisions of this Plan, asSection 11 of ARTICLE II, unless otherwise required by law, if the Committee shall deem advisable.

(a)Value of Performance Awards and Performance Measures. The method of determining the valuestockholder (or a qualified representative of the Performance Award andstockholder) does not appear at the Performance Measures and Performance Period applicableannual or special meeting of stockholders of the Corporation to present a Performance Awardnomination or proposed business, such nomination shall be determineddisregarded and such proposed business shall not be transacted, notwithstanding that proxies in respect of such vote may have been received by the Committee.Corporation. For purposes of this Section 11 of ARTICLE II, to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders.
 
(i)Compliance with Exchange Act. Notwithstanding the foregoing provisions of these Bylaws, a stockholder shall also comply with all applicable requirements of the Exchange Act and the rules and regulations promulgated thereunder with respect to the matters set forth in these Bylaws; provided, however, that any references in these Bylaws to the Exchange Act or the rules and regulations promulgated thereunder are not intended to and shall not limit the requirements applicable to any nomination or other business to be considered pursuant to Section 11 of this ARTICLE II.
 (b)
(j)Vesting and ForfeitureEffect on Other Rights. The Agreement relatingNothing in these Bylaws shall be deemed to a Performance Award shall provide,(A) affect any rights of the stockholders to request inclusion of proposals in the manner determinedCorporation’s proxy statement pursuant to Rule 14a-8 under the Exchange Act, (B) confer upon any stockholder a right to have a nominee or any proposed business included in the Corporation’s proxy statement, except as set forth in the Certificate of Incorporation or these Bylaws, (C) affect any rights of the holders of any series of preferred stock to elect directors pursuant to any applicable provisions of the Certificate of Incorporation or (D) limit the exercise, the method or timing of the exercise of, the rights of any person granted by the Committee, in its discretion, and subjectCorporation to nominate directors, which rights may be exercised without compliance with the provisions of this Plan,Section 11 of ARTICLE II.

Section 12. Fixing a Record Date for Stockholder Meetings. In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, the Board of Directors may fix, except as otherwise required by law, in advance, a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall not be more than 60 days nor less than 10 days before the date of such meeting. If the Board of Directors so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless the Board of Directors determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such determination. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be the close of business on the next day preceding the day on which notice is first given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting in conformity herewith; and in such case shall also fix as the record date for stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance with the foregoing provisions of this Section 12 at the adjourned meeting.

Section 13. Action by Stockholders Without a Meeting. So long as stockholders of the Corporation have the right to act by written consent in accordance with Section 1 of ARTICLE EIGHT of the Certificate of Incorporation, the following provisions shall apply:

(a)Record Date. For the vestingpurpose of such Performance Award ifdetermining the specified Performance Measures are satisfiedstockholders entitled to consent to corporate action in writing without a meeting as may be permitted by the Certificate of Incorporation or met during the specified Performance Period and for the forfeiturecertificate of such award if the specified Performance Measures are not satisfied or met during the specified Performance Period.
(c)Settlement of Vested Performance Awards. The Agreementdesignation relating to any outstanding class or series of preferred stock, the Board of Directors may fix a Performance Awardrecord date, which record date shall specify whether such award may be settled in shares of Common Stock (including shares of Restricted Stock) or cash or a combination thereof. If a Performance Award is settled in shares of Restricted Stock, such shares of Restricted Stock shall be issued to the holder in book entry form or a certificate or certificates representing such Restricted Stock shall be issued in accordance with Section 3.3(c) and the holder of such Restricted Stock shall have such rights as a stockholder of the Company as determined pursuant to Section 3.3(d). Any dividends or dividend equivalents with respect to a Performance Award shall be subject to the same vesting and other restrictions as such Performance Award. Prior to the settlement of a Performance Award in shares of Common Stock, including Restricted Stock, the holder of such award shall have no rights as a stockholder of the Company.

4.3Termination of Employment or Service. All of the terms relating to the satisfaction of Performance Measures and the termination of the Performance Period relating to a Performance Award, or any forfeiture and cancellation of such award (i) upon a termination of employment with or service to the Company of the holder of such award, whether by reason of disability, retirement, death or any other reason, or (ii) during a paid or unpaid leave of absence, shall be determined by the Committee and set forth in the applicable award Agreement.

V.  GENERAL

5.1Effective Date and Term of Plan. This Plan shall be submitted to the stockholders of the Company for approval and, if approved, shall become effective as of the date of such stockholder approval. This Plan shall terminate on the tenth anniversary ofnot precede the date on which the Company’s stockholders approveresolution fixing the Plan, unless earlier terminatedrecord date is adopted by the Board; provided, however, that no Incentive Stock OptionsBoard of Directors, and which record date shall not be grantedmore than ten (10) (or the maximum number permitted by applicable law) days after the tenth anniversary of the date on which the Plan was approvedresolution fixing the record date is adopted by the Board. TerminationBoard of this PlanDirectors. Any stockholder of record seeking to have the stockholders authorize or take action by written consent shall, not affectby written notice to the terms or conditionsSecretary, request that the Board of Directors fix a record date, which notice shall include the text of any award granted prior to termination. Awards hereunder may be made at any time prior to the termination of this Plan. No awards shall be granted under the Prior Plan after this Plan becomes effective.
5.2Amendments. The Board may amend this Plan as it shall deem advisable; provided, however, thatproposed resolutions. If no amendment to the Plan shall be effective without the approval of the Company’s stockholders if (i) stockholder approval is requiredrecord date has been fixed by applicable law, rule or regulation, including any rule of the Nasdaq Global Select Market, or any other stock exchange on which the Common Stock is then traded, or (ii) such amendment seeks to modify the Non-Employee Director compensation limit set forth in Section 1.4 or the prohibition on repricing set forth in Section 2.5 hereof; provided further, that no amendment may materially impair the rights of a holder of an outstanding award without the consent of such holder.
5.3Agreement. Each award under this Plan shall be evidenced by an Agreement setting forth the terms and conditions applicable to such award. No award shall be valid until an Agreement is executed by the Company and, to the extent required by the Company, either executed by the recipient or accepted by the recipient by electronic means approved by the Company within the time period specified by the Company. Upon such execution or execution and electronic acceptance, and delivery of the Agreement to the Company, such award shall be effective as of the effective date set forth in the Agreement.

 

 20212023 Proxy Statement93103
 
5.4Non-Transferability. No awardthe Board of Directors pursuant to this Section 13(a) or otherwise within ten (10) days of receipt of a valid request by a stockholder, the record date for determining stockholders entitled to consent to corporate action in writing without a meeting, when no prior action by the Board of Directors is required pursuant to applicable law, shall be transferable other than by will, the laws of descent and distributionfirst date on which a signed written consent setting forth the action taken or proposed to be taken is delivered to the Corporation pursuant to beneficiary designation procedures approvedSection 13(b); provided, however, that if prior action by the Company or,Board of Directors is required by applicable law, the record date for determining stockholders entitled to consent to corporate action in writing without a meeting shall in such an event be at the extent expressly permitted inclose of business on the Agreement relating today on which the Board of Directors adopts the resolution taking such award, to the holder’s family members, a trust or entity established by the holder for estate planning purposes or a charitable organization designated by the holder, in each case, without consideration. Except to the extent permitted by the foregoing sentence or the Agreement relating to an award, each award may be exercised or settled during the holder’s lifetime only by the holder or the holder’s legal representative or similar person. Except as permitted by the second preceding sentence, no award may be sold, transferred, assigned, pledged, hypothecated, encumbered or otherwise disposed of (whether by operation of law or otherwise) or be subject to execution, attachment or similar process. Upon any attempt to so sell, transfer, assign, pledge, hypothecate, encumber or otherwise dispose of any award, such award and all rights thereunder shall immediately become null and void.prior action.
  
5.5(b)Tax WithholdingGenerally. Every written consent shall bear the date of signature of each stockholder who signs the consent, and no written consent shall be effective to take the corporate action referred to therein unless written consents signed by a sufficient number of stockholders to take such action are delivered to the Corporation, in the manner required by this Section 13, within sixty (60) (or the maximum number permitted by applicable law) days of the date of the earliest dated consent delivered to the Corporation in the manner required by this Section 13. The Companyvalidity of any consent executed by a proxy for a stockholder pursuant to an electronic transmission transmitted to such proxy holder by or upon the authorization of the stockholder shall be determined by or at the direction of the Secretary. A written record of the information upon which the person making such determination relied shall be made and kept in the records of the proceedings of the stockholders. Any such consent shall be inserted in the minute book as if it were the minutes of a meeting of stockholders. Prompt notice of the taking of the corporate action without a meeting by less than unanimous written consent shall be given by the Corporation (at its expense) to those stockholders who have not consented in writing and who, if the action had been taken at a meeting, would have been entitled to notice of the meeting if the record date for notice of such meeting had been the date that written consent signed by a sufficient number of holders to take the action were delivered to the Corporation.

Section 14. Conduct of Meetings.

(a)Generally. Meetings of stockholders shall be presided over by the Chair of the Board, if any, or in the Chair’s absence or disability by the Chief Executive Officer, or in the Chief Executive Officer’s absence or disability, by the President, or in the President’s absence or disability, by a Vice President, or in the absence or disability of the foregoing persons by a chairperson designated by the Board of Directors, or in the absence of such designation by a chairperson chosen at the meeting. The Secretary shall act as secretary of the meeting, but in the Secretary’s absence or disability the chair of the meeting may appoint any person to act as secretary of the meeting.
(b)Rules, Regulations and Procedures. The Board of Directors may adopt by resolution such rules, regulations and procedures for the conduct of any meeting of stockholders of the Corporation as it shall deem appropriate including, without limitation, such rules, guidelines and procedures as it may deem appropriate regarding the participation by means of remote communication of stockholders and proxyholders not physically present at a meeting, whether such meeting is to be held at a designated place or solely by means of remote communication. Except to the extent inconsistent with such rules, regulations and procedures as adopted by the Board of Directors, the chair of any meeting of stockholders shall have the right and authority to require, priorprescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chair, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the chair of the meeting, may include, without limitation, the following: (i) the establishment of an agenda or order of business for the meeting; (ii) rules and procedures for maintaining order at the meeting and the safety, health and security of those present; (iii) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation, their duly authorized and constituted proxies or such other persons as the chair of the meeting shall determine; (iv) restrictions on entry to the issuancemeeting after the time fixed for the commencement of the meeting; (v) limitations on the time allotted to questions or deliverycomments by participants; (vi) removal of any sharesstockholder or any other individual who refuses to comply with meeting rules, regulations or procedures; (vii) the conclusion, recess or adjournment of Common Stockthe meeting, regardless of whether a quorum is present, to a later date and time and at a place, if any, announced at the meeting; (viii) restrictions on the use of audio and video recording devices, cell phones and other electronic devices; (ix) rules, regulations or procedures for compliance with any state or local laws; and (x) procedures (if any) requiring attendees to provide the Corporation advance notice of their intent to attend the meeting. The chair of the meeting of stockholders, in addition to making any other determinations that may be appropriate to the conduct of the meeting, shall, if the facts warrant, determine and declare to the meeting that a nomination or matter or business was not properly brought before the meeting and if such chair should so determine, such chair shall so declare to the meeting and any such matter or business not properly brought before the meeting shall not be transacted or considered. Unless and to the extent determined by the Board of Directors or the paymentchair of any cash pursuant to an award made hereunder, payment by the holdermeeting, meetings of such award of any federal, state, local or other taxes which maystockholders shall not be required to be withheld or paidheld in connectionaccordance with such award. An Agreement may provide that (i) the Company shall withhold whole sharesrules of Common Stock which would otherwise be delivered to a holder, having an aggregate Fair Market Value determined asparliamentary procedure. The chair of the datemeeting shall determine and then announce at the obligationmeeting when the polls for each matter to withholdbe voted upon at the meeting will be opened and closed. After the polls close, no ballots, proxies or pay taxes arises in connection with an award (the “Tax Date”),votes or withhold an amount of cash which would otherwiseany revocations or changes thereto may be payable to a holder, in the amount necessary to satisfy any such obligation or (ii) the holder may satisfy any such obligation by anyaccepted. The chair of the following means: (A) a cash paymentmeeting shall have the power, for any reason, to the Company; (B) delivery (either actual delivery recess and/or by attestation procedures established by the Company)adjourn any meeting of stockholders to the Companyanother place, if any, date and time.
(c)Inspectors of previously owned whole shares of Common Stock having an aggregate Fair Market Value, determined as of the Tax Date, equal to the amount necessary to satisfy any such obligation; (C) authorizing the Company to withhold whole shares of Common Stock which would otherwise be delivered having an aggregate Fair Market Value, determined as of the Tax Date, or withhold an amount of cash which would otherwise be payable to a holder, equal to the amount necessary to satisfy any such obligation; (D) a cash payment by a broker-dealer acceptable to the Company to whom the participant has submitted an irrevocable notice of exercise or sale or (E) any combination of (A), (B)Elections. The Corporation may, and (C), in each case to the extent set forthrequired by law shall, in advance of any meeting of stockholders, appoint one or more inspectors of election to act at the Agreement relatingmeeting and make a written report thereof. One or more other persons may be designated as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the award. Shares of Common Stock to be delivered or withheld may not have an aggregate Fair Market Value in excesschair of the amount determinedmeeting shall appoint one or more inspectors to act at the meeting. Unless otherwise required by applying the minimum statutory withholding rate (or, if permitted by the Company, such other rate as will not cause adverse accounting consequences under the accounting rules then in effect, and is permitted under applicable IRS withholding rules); provided, however, that if a fraction of a share of Common Stock would be required to satisfy the minimum statutory withholding taxes, then the number of shares of Common Stock to be delivered or withheld may be rounded up to the next nearest whole share of Common Stock.
5.6Restrictions on Shares. Each award made hereunder shall be subject to the requirement that if at any time the Company determines that the listing, registration or qualification of the shares of Common Stock subject to such award upon any securities exchange or under any law, or the consent or approval of any governmental body, or the taking of any other action is necessary or desirable as a condition of, or in connection with, the delivery of shares thereunder, such shares shall not be delivered unless such listing, registration, qualification, consent, approval or other action shall have been effected or obtained, free of any conditions not acceptable to the Company. The Company may require that certificates evidencing shares of Common Stock delivered pursuant to any award made hereunder bear a legend indicating that the sale, transfer or other disposition thereof by the holder is prohibited except in compliance with the Securities Act of 1933, as amended, and the rules and regulations thereunder.
5.7Adjustment. In the event of any equity restructuring (within the meaning of Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation—Stock Compensation, or any successor or replacement accounting standard) that causes the per share value of shares of Common Stock to change, such as a stock dividend, stock split, spinoff, rights offering or recapitalization through an extraordinary cash dividend, the number and class of securities available under this Plan, the terms of each outstanding option and SAR (including the number and class of securities subject to each outstanding option or SAR and the purchase price or base price per share), the terms of each outstanding Restricted Stock Award and Restricted Stock Unit Award (including the number and class of securities subject thereto), and the terms of each outstanding Performance Award (including the number and class of securities subject thereto) shall be appropriately adjusted by the Committee, such adjustments to be made in the case of outstanding options and SARs without an increase in the aggregate purchase price or base price and in accordance with Section 409A of the Code. In the event of any other change in corporate capitalization, including a merger, consolidation, reorganization, or partial or complete liquidation of the Company, such equitable adjustments described in the foregoing sentence may be made as determined to be appropriate and equitable by the Committee to prevent dilution or enlargement of rights of participants. In either case, the decision of the Committee regarding any such adjustment shall be final, binding and conclusive.

 

5.8Change in Control.

(a)Subject to the terms of the applicable award Agreement, in the event of a Change in Control, the Board (as constituted prior to such Change in Control) may, in its discretion:

(i)provide that (A) some or all outstanding options and SARs shall become exercisable in full or in part, either immediately or upon a subsequent termination of employment, (B) the Restriction Period applicable to some or all outstanding Restricted Stock Awards and Restricted Stock Unit Awards shall lapse in full or in part, either immediately or upon a subsequent termination of employment, (C) the Performance Period

 20212023 Proxy Statement94104
 
 applicablelaw, inspectors may be officers, employees or agents of the Corporation. No person who is a candidate for an office at an election may serve as an inspector at such election. Each inspector, before entering upon the discharge of such inspector’s duties, shall take and sign an oath faithfully to some or all outstanding awardsexecute the duties of inspector with strict impartiality and according to the best of such inspector’s ability. The inspector shall lapse in full or in part,have the duties prescribed by law and (D)shall take charge of the Performance Measures applicable to some or all outstanding awardspolls and, when the vote is completed, shall make a certificate of the result of the vote taken and of such other facts as may be required by law. Every vote taken by ballots shall be deemed to be satisfied at the target or any other level;
(ii)require that shares of stock of the corporation resulting from such Change in Control, or a parent corporation thereof, or other property be substituted for some or all of the shares of Common Stock subject to an outstanding award, with an appropriate and equitable adjustment to such award as shall be determined by the Board in accordance with Section 5.7; and/or

(iii)require outstanding awards, in whole or in part, to be surrendered to the Company by the holder, and to be immediately cancelled by the Company, and to provide for the holder to receive (A) a cash payment or other property in an amount equal to (1) in the case of an option or an SAR, the aggregate number of shares of Common Stock then subject to the portion of such option or SAR surrendered multiplied by the excess, if any, of the Fair Market Value of a share of Common Stock as of the date of the Change in Control, over the purchase price or base price per share of Common Stock subject to such option or SAR, (2) in the case of a Stock Award or a Performance Award denominated in shares of Common Stock, the aggregate number of shares of Common Stock then subject to the portion of such award surrendered to the extent the Performance Measures applicable to such award have been satisfied or are deemed satisfied pursuant to Section 5.8(a)(i), multiplied by the Fair Market Value of a share of Common Stock as of the date of the Change in Control, and (3) in the case of a Performance Award denominated in cash, the value of the Performance Award then subject to the portion of such award surrendered to the extent the Performance Measures applicable to such award have been satisfied or are deemed satisfied pursuant to Section 5.8(a)(i); (B) shares of capital stock of the corporation resulting from or succeeding to the business of the Company pursuant to such Change in Control, or a parent corporation thereof, having a fair market value not less than the amount determined under clause (A) above; or (C) a combination of the payment of cash or other property pursuant to clause (A) above and the issuance of shares pursuant to clause (B) above.

(b)For purposes of this Plan, unless otherwise provided in an Agreement, “Change in Control” means the occurrence of any one of the following events (provided, however, that except with respect to subsection (iv) below any definition of Change in Control in an award Agreement may not provide that a Change in Control will occur prior to the consummation or effectiveness of a change in control of the Company and may not provide that a Change in Control will occur upon the announcement, commencement, stockholder approval or other potential occurrence of any event or transaction that, if completed, would result in a change in control of the Company):

(i)During any twenty-four (24) month period, individuals who, as of the beginning of such period, constitute the Board (the “Incumbent Directors”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the beginning of such period whose election or nomination for election was approvedcounted by a vote of at least a majority of the Incumbent Directors then on the Board (either by a specific voteduly appointed inspector or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection to such nomination) shall be an Incumbent Director; provided, however, that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board shall be deemed to be an Incumbent Director;
(ii)Any “person” (as such term is defined in the Exchange Act and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act) is or becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 35% or more of the combined voting power of the Company’s then outstanding securities eligible to vote for the election of the Board (the “Company Voting Securities”); provided, however, that the event described in this paragraph (ii) shall not be deemed to be a Change in Control by virtue of any of the following acquisitions: (A) by the Company or any Subsidiary; (B) by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Subsidiary; (C) by any underwriter temporarily holding securities pursuant to an offering of such securities; (D) pursuant to a Non-Qualifying Transaction, as defined in paragraph (iii), or (E) by any person of Company Voting Securities from the Company, if a majority of the Incumbent Board approves in advanceduly appointed inspectors.

 

ARTICLE III
DIRECTORS

Section 1. General Powers. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors. In addition to such powers as are herein and in the Certificate of Incorporation expressly conferred upon it, the Board of Directors shall have and may exercise all the powers of the Corporation, subject to the provisions of the laws of the State of Delaware, the Certificate of Incorporation and these Bylaws.

Section 2. Election. The directors shall be elected in accordance with the Certificate of Incorporation.

Section 3. Annual Meetings. The annual meeting of the Board of Directors shall be held without other notice than this Bylaw immediately after, and at the same place as, the annual meeting of stockholders.

Section 4. Regular Meetings and Special Meetings. Regular meetings, other than the annual meeting, of the Board of Directors may be held without notice at such time and at such place as shall from time to time be determined by resolution of the Board of Directors. Special meetings of the Board of Directors may be called by the Chair of the Board, if any, or by two or more directors then in office, and shall be held at the place, if any, on the date and at the time as he, she or they shall fix. Any and all business may be transacted at a special meeting of the Board of Directors.

Section 5. Notice of Meetings. Notice of regular meetings of the Board of Directors need not be given except as otherwise required by law or these Bylaws. Notice of each special meeting of the Board of Directors, and of each regular and annual meeting of the Board of Directors for which notice is required, shall be given by the Secretary as hereinafter provided in this Section 5. Such notice shall be state the date, time and place, if any, of the meeting. Notice of any special meeting, and of any regular or annual meeting for which notice is required, shall be given to each director at least (a) twenty-four (24) hours before the meeting if by telephone or by being personally delivered or sent by telex, telecopy, email or similar means, (b) five (5) days before the meeting if delivered by mail to the director’s residence or usual place of business or (c) on such shorter notice as the person or persons calling such meeting may deem necessary or appropriate in the circumstances. Such notice shall be deemed to be delivered when deposited in the United States mail so addressed, with postage prepaid, or when transmitted if sent by telex, telecopy, email or similar means. Neither the business to be transacted at, nor the purpose of, any special meeting of the Board of Directors need be specified in the notice or waiver of notice of such meeting.

Section 6. Waiver of Notice. Any director may waive notice of any meeting of directors by a writing signed by the director or by electronic transmission. Any member of the Board of Directors or any committee thereof who is present at a meeting shall be conclusively presumed to have waived notice of such meeting except when such member attends for the express purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened. Such member shall be conclusively presumed to have assented to any action taken unless his or her dissent shall be entered in the minutes of the meeting or unless his or her written dissent to such action shall be filed with the person acting as the secretary of the meeting before the adjournment thereof or shall be forwarded by registered mail to the secretary of the Corporation immediately after the adjournment of the meeting. Such right to dissent shall not apply to any member who voted in favor of such action.

Section 7. Chair of the Board, Quorum, Required Vote and Adjournment. The Board of Directors may elect, by the affirmative vote of a majority of the directors then in office, a Chair of the Board. The Chair of the Board must be a director and may be an officer of the Corporation. Subject to the provisions of these Bylaws and the direction of the Board of Directors, he or she shall perform all duties and have all powers which are commonly incident to the position of Chair of the Board or which are delegated to him or her by the Board of Directors, preside at all meetings of the stockholders and Board of Directors at which he or she is present and have such powers and perform such duties as the Board of Directors may from time to time prescribe. If the Chair of the Board is not present at a meeting of the Board of Directors, the Chief Executive Officer (if the Chief Executive Officer is a director and is not also the Chair of the Board) shall preside at such meeting, and, if the Chief Executive Officer is not present at such meeting, a majority of the directors present at such meeting shall elect one of the directors present at the meeting to so preside. A majority of the directors then in office shall constitute a quorum for the transaction of business. Unless by express provision of an applicable law, the Certificate of Incorporation or these Bylaws a different vote is required, the vote of a majority of directors present at a meeting at which a quorum is present at the time such matter is acted upon shall be the act of the Board of Directors. At any meeting of the Board of Directors, business shall be transacted in such order and manner as the Board of Directors may from time to time determine. If a quorum shall not be present at any meeting of the Board of Directors, the directors present

 20212023 Proxy Statement95105

 

thereat may, to the acquisition of beneficial ownership of 35% or more of Company Voting Securitiesfullest extent permitted by such person;law, adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present.

 

Section 8. Committees.

(a)(iii)The consummationBoard of a merger, consolidation, statutory share exchangeDirectors (i) may designate one or similar formmore committees, including an executive committee, consisting of corporate transaction involving the Company or any of its Subsidiaries that requires the approval of the Company’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), unless immediately following such Business Combination: (A) more than 50% of the total voting power of (1) the corporation resulting from such Business Combination (the “Surviving Corporation”), or (2) if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership of 100% of the voting securities eligible to elect directors of the Surviving Corporation (the “Parent Corporation”), is represented by Company Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable, is represented by shares into which such Company Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the voting power of such Company Voting Securities among the holders thereof immediately prior to the Business Combination; (B) no person (other than any employee benefit plan (or related trust) sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the beneficial owner, directly or indirectly, of 35%one or more of the total voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation, (or, if there is no Parentand any committees required by the rules and regulations of such exchange as any securities of the Corporation are listed. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the Surviving Corporation)committee. Except to the extent restricted by applicable law or the Certificate of Incorporation, each such committee, to the extent provided by the DGCL and (C)in the resolution creating it, shall have and may exercise all the powers and authority of the Board of Directors. Each such committee shall serve at the pleasure of the Board of Directors. Each committee shall keep regular minutes of its meetings and report the same to the Board of Directors upon request.
(b)Each committee of the Board of Directors may fix its own rules of procedure and shall hold its meetings as provided by such rules, except as may otherwise be provided by a resolution of the Board of Directors designating such committee. Unless otherwise provided in such a resolution, the presence of at least a majority of the members of the board of directorscommittee shall be necessary to constitute a quorum. All matters shall be determined by a majority vote of the Parent Corporation (or,members present at a meeting at which a quorum is present. Unless otherwise provided in such a resolution, in the event that a member and that member’s alternate, if therealternates are designated by the Board of Directors, of such committee is no Parent Corporation,or are absent or disqualified, the Surviving Corporation) following the consummationmember or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Business Combination were IncumbentBoard of Directors to act at the timemeeting in place of the Board’s approval of the execution of the initial agreement providing forany such Business Combination (any Business Combination which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed to be a “Non-Qualifying Transaction”);absent or disqualified member.
  
(c)(iv)The consummationNothing in this Section 8 of a sale of allARTICLE III shall in any way limit the exercise, method or substantially alltiming of the Company’s assets or the stockholdersexercise of, the Company approve a planrights of complete liquidation or dissolution of the Company.
Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because any person acquires beneficial ownership of more than 35% of the Company Voting Securities as a result of the acquisition of Company Voting Securitiesgranted by the Company which reducesthe number of Company Voting Securities outstanding; provided, that if after such acquisition by the Company such person becomes the beneficial owner of additional Company Voting Securities that increases the percentage of outstanding Company Voting Securities beneficially owned by such person, a Change in Control of the Company shall then occur.
SolelyCorporation with respect to the exercise, duties, composition or conduct of any award that constitutes “deferred compensation” subject to Section 409Acommittee of the Code and that is payable on accountBoard of a Change in Control (including any installments or stream of payments that are accelerated on account of a Change in Control), a Change in Control shall occur only if such event also constitutes a “change in the ownership”, “change in effective control”, and/or a “change in the ownership of a substantial portion of assets” of the Company as those terms are defined under Treasury Regulation §1.409A-3(i)(5), but only to the extent necessary to establish a time or form of payment that complies with Section 409A of the Code, without altering the definition of Change in Control for purposes of determining whether a participant’s rights to such Award become vested or otherwise unconditional upon the Change in Control.Directors.

Section 9.Action by Written Consent. Unless otherwise restricted by the Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board of Directors, or of any committee thereof, may be taken without a meeting if all members of the Board of Directors or such committee, as the case may be, consent thereto in writing or by electronic transmission, and the writing or writings or electronic transmission or transmissions are filed with the minutes of proceedings of the board or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form.

 

Section 10. Compensation. The Board of Directors shall have the authority to fix the compensation, including fees, reimbursement of expenses and equity compensation, of directors for services to the Corporation in any capacity, including for attendance of meetings of the Board of Directors or participation on any committees. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefor.

Section 11. Reliance on Books and Records. A member of the Board of Directors, or a member of any committee designated by the Board of Directors shall, in the performance of such member’s duties, be fully protected in relying in good faith upon records of the Corporation and upon such information, opinions, reports or statements presented to the Corporation by any of the Corporation’s officers or employees, or committees of the Board of Directors, or by any other person as to matters the member reasonably believes are within such other person’s professional or expert competence and who has been selected with reasonable care by or on behalf of the Corporation.

Section 12. Telephonic and Other Meetings. Unless restricted by the Certificate of Incorporation, any one or more members of the Board of Directors or any committee thereof may participate in a meeting of the Board of Directors or such committee by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other. Participation by such means shall constitute presence in person at a meeting.

ARTICLE IV
OFFICERS

Section 1. Number. The officers of the Corporation shall be elected by the Board of Directors and shall consist of a Chief Executive Officer, a President, one or more Vice Presidents, a Secretary, a Chief Financial Officer and such other officers and assistant officers as may be deemed necessary or desirable by the Board of Directors. Any number of offices may be held by the same person. In its discretion, the Board of Directors may choose not to fill any office for any period as it may deem advisable.

Section 2. Election and Term of Office. The officers of the Corporation shall be elected by the Board of Directors. The Chair of the Board, if any, shall be elected by the Board of Directors. Vacancies may be filled or new offices created and filled by the Board of Directors. Each officer shall hold office until a successor is duly elected and qualified or until his or her earlier death, resignation or removal as hereinafter provided.

Section 3. Removal. Any officer or agent elected by the Board of Directors may be removed with or without cause by the Board of Directors, a duly authorized committee thereof or by such officers as may be designated by a resolution of the Board of Directors, but such removal shall be without prejudice to the contract rights, if any, of the person so removed.

5.9Deferrals and Section 409A.

(a)The Committee may determine that the delivery of shares of Common Stock or the payment of cash, or a combination thereof, upon the exercise or settlement of all or a portion of any award (other than awards of Incentive Stock Options, Nonqualified Stock Options and SARs) made hereunder shall be deferred, or the Committee may, in its sole discretion, approve deferral elections made by holders of awards. Deferrals shall be for such periods and upon such terms as the Committee may determine in its sole discretion, subject to the requirements of Section 409A of the Code.
(b)Awards under the Plan are intended to comply with, or be exempt from, the applicable requirements of Section 409A of the Code and shall be limited, construed and interpreted in accordance with such intent. Although the Company does not guarantee any particular tax treatment, to the extent that any award is subject to Section 409A of the Code, it shall be paid in a manner that is intended to comply with Section 409A of the Code, including regulations and any other guidance issued by the Secretary of the Treasury and the Internal Revenue Service with respect thereto. In no event whatsoever shall the Company be liable for any additional tax, interest or penalties that may be imposed on the participant by Section 409A of the Code or any damages for failing to comply with Section 409A of the Code. Notwithstanding anything in the Plan or any Award Agreement to the contrary, each participant shall be solely responsible for the tax consequences of awards, and in no event shall the Company have any responsibility or liability if an award does not meet any applicable requirements of Section 409A. Although the Company intends to administer the Plan to prevent taxation under section 409A, the Company does not represent or warrant that

 20212023 Proxy Statement96106
 

Section 4. Vacancies. Any vacancy occurring in any office because of death, resignation, removal, disqualification or otherwise may be filled by the Board of Directors.

Section 5. Compensation. Compensation of all executive officers shall be approved by the Board of Directors or a duly authorized committee thereof, and no officer shall be prevented from receiving such compensation by virtue of his or her also being a director of the Corporation.

Section 6. Chief Executive Officer. The Chief Executive Officer shall have the powers and perform the duties incident to that position. The Chief Executive Officer shall, in the absence of the Chair of the Board, or if a Chair of the Board shall not have been elected, preside at each meeting of (a) the Board of Directors if the Chief Executive Officer is a director or (b) the stockholders. Subject to the powers of the Board of Directors and the Chair of the Board, the Chief Executive Officer shall be in general and active charge of the entire business and affairs of the Corporation, and shall be its chief policy making officer. The Chief Executive Officer shall have such other powers and perform such other duties as may be prescribed by the Board of Directors or provided in these Bylaws. The Chief Executive Officer is authorized to execute bonds, mortgages and other contracts requiring a seal, under the seal of the Corporation, except where required or permitted by law to be otherwise signed and executed and except where the signing and execution thereof shall be expressly delegated by the Board of Directors to some other officer or agent of the Corporation. Whenever the President is unable to serve, by reason of sickness, absence or otherwise, the Chief Executive Officer shall perform all the duties and responsibilities and exercise all the powers of the President.

Section 7. The President. The President of the Corporation shall, subject to the powers of the Board of Directors, the Chair of the Board and the Chief Executive Officer, have general charge of the business, affairs and property of the Corporation, and control over its officers, agents and employees. The President shall see that all orders and resolutions of the Board of Directors are carried into effect. The President is authorized to execute bonds, mortgages and other contracts requiring a seal, under the seal of the Corporation, except where required or permitted by law to be otherwise signed and executed and except where the signing and execution thereof shall be expressly delegated by the Board of Directors to some other officer or agent of the Corporation. The President shall have such other powers and perform such other duties as may be prescribed by the Chair of the Board, the Chief Executive Officer, the Board of Directors or as may be provided in these Bylaws.

Section 8. Vice Presidents. The Vice President, or if there shall be more than one, the Vice Presidents, in the order determined by the Board of Directors or the Chair of the Board, shall, in the absence or disability of the President, act with all of the powers and be subject to all the restrictions of the President. The Vice Presidents shall also perform such other duties and have such other powers as the Board of Directors, the Chair of the Board, the Chief Executive Officer, the President or these Bylaws may, from time to time, prescribe. The Vice Presidents may also be designated as Executive Vice Presidents or Senior Vice Presidents, as the Board of Directors may from time to time prescribe.

Section 9. The Secretary and Assistant Secretaries. The Secretary shall attend all meetings of the Board of Directors (other than executive sessions thereof) and all meetings of the stockholders and record all the proceedings of the meetings in a book or books to be kept for that purpose or shall ensure that his or her designee attends each such meeting to act in such capacity. Under the Board of Directors’ supervision, the Secretary shall give, or cause to be given, all notices required to be given by these Bylaws or by law; shall have such powers and perform such duties as the Board of Directors, the Chair of the Board, the Chief Executive Officer, the President or these Bylaws may, from time to time, prescribe; and shall have custody of the corporate seal of the Corporation. The Secretary, or an Assistant Secretary, shall have authority to affix the corporate seal to any instrument requiring it and when so affixed, it may be attested by his or her signature or by the signature of such Assistant Secretary. The Board of Directors may give general authority to any other officer to affix the seal of the Corporation and to attest the affixing by his or her signature. The Assistant Secretary, or if there be more than one, any of the assistant secretaries, shall in the absence or disability of the Secretary, perform the duties and exercise the powers of the Secretary and shall perform such other duties and have such other powers as the Board of Directors, the Chair of the Board, the Chief Executive Officer, the President, or Secretary may, from time to time, prescribe.

Section 10. The Chief Financial Officer. The Chief Financial Officer shall have the custody of the corporate funds and securities; shall keep full and accurate accounts of receipts and disbursements in books belonging to the Corporation as shall be necessary or desirable in accordance with applicable law or generally accepted accounting principles; shall deposit all monies and other valuable effects in the name and to the credit of the Corporation as may be ordered by the Chair of the Board or the Board of Directors; shall receive, and give receipts for, moneys due and payable to the Corporation from any source whatsoever; shall cause the funds of the Corporation to be disbursed when such disbursements have been duly authorized, taking proper vouchers for such disbursements; and shall render to the Board of Directors, at its regular meeting or when the Board of Directors so requires, an account of the Corporation; shall have such powers and perform such duties as the Board of Directors, the Chair of the Board, the Chief Executive Officer, the President or these Bylaws may, from time to time, prescribe.

Section 11. Appointed Officers. In addition to officers designated by the Board in accordance with this ARTICLE IV, the Chief Executive Officer may appoint other officers below the level of Board-appointed Vice President (including any officer with an Assistant title) as the Chief Executive Officer may from time to time deem expedient and may designate for such officers titles that appropriately reflect their positions and responsibilities. Such appointed officers shall have such powers and shall perform such duties as may be assigned to them by the Chief Executive Officer or the senior officer to whom they report, consistent with corporate policies. An appointed officer shall serve until the earlier of such officer’s resignation or such officer’s removal by the Chief Executive Officer at any time, either with or without cause.

the Plan or any award complies with Section 409A or any other provision of federal, state, local or other tax law.

5.10No Right of Participation, Employment or Service. Unless otherwise set forth in an employment agreement, no person shall have any right to participate in this Plan. Neither this Plan nor any award made hereunder shall confer upon any person any right to continued employment by or service with the Company, any Subsidiary or any affiliate of the Company or affect in any manner the right of the Company, any Subsidiary or any affiliate of the Company to terminate the employment or service of any person at any time without liability hereunder.
5.11Rights as Stockholder. No person shall have any right as a stockholder of the Company with respect to any shares of Common Stock or other equity security of the Company which is subject to an award hereunder unless and until such person becomes a stockholder of record with respect to such shares of Common Stock or equity security.
5.12Designation of Beneficiary. To the extent permitted by the Company, a holder of an award may file with the Company a written designation of one or more persons as such holder’s beneficiary or beneficiaries (both primary and contingent) in the event of the holder’s death or incapacity. To the extent an outstanding option or SAR granted hereunder is exercisable, such beneficiary or beneficiaries shall be entitled to exercise such option or SAR pursuant to procedures prescribed by the Company. Each beneficiary designation shall become effective only when filed in writing with the Company during the holder’s lifetime on a form prescribed by the Company. The spouse of a married holder domiciled in a community property jurisdiction shall join in any designation of a beneficiary other than such spouse. The filing with the Company of a new beneficiary designation shall cancel all previously filed beneficiary designations. If a holder fails to designate a beneficiary, or if all designated beneficiaries of a holder predecease the holder, then each outstanding award held by such holder, to the extent vested or exercisable, shall be payable to or may be exercised by such holder’s executor, administrator, legal representative or similar person.
5.13Governing Law. This Plan, each award hereunder and the related Agreement, and all determinations made and actions taken pursuant thereto, to the extent not otherwise governed by the Code or the laws of the United States, shall be governed by the laws of the State of Delaware and construed in accordance therewith without giving effect to principles of conflicts of laws.
5.14Foreign Employees. Without amending this Plan, the Committee may grant awards to eligible persons who are foreign nationals and/or reside outside the U.S. on such terms and conditions different from those specified in this Plan as may in the judgment of the Committee be necessary or desirable to foster and promote achievement of the purposes of this Plan and, in furtherance of such purposes the Committee may make such modifications, amendments, procedures, subplans and the like as may be necessary or advisable to comply with provisions of laws in other countries or jurisdictions in which the Company or its Subsidiaries operates or has employees.
5.15Awards Subject to Clawback. The awards granted under this Plan and any cash payment or shares of Common Stock delivered pursuant to an award are subject to forfeiture, recovery by the Company or other action pursuant to the applicable Agreement or any clawback or recoupment policy which the Company may adopt from time to time, including without limitation any such policy which the Company may be required to adopt under the Dodd-Frank Wall Street Reform and Consumer Protection Act and implementing rules and regulations thereunder, or as otherwise required by law.

 20212023 Proxy Statement97107
 

APPENDIX F

CDW CORPORATION COWORKER STOCK PURCHASE PLAN

(As AmendedSection 12. Other Officers, Assistant Officers and Restated, Effective May 20, 2021)

1.Purpose. The purpose of this Plan is to provide Coworkers of the Company and Participating Subsidiaries with an opportunity to purchase common stock of the Company through accumulated payroll deductions. It is the intention of the Company to have the Plan qualify as an “Employee Stock Purchase Plan” under Section 423 of the Code with respect to Offerings to Coworkers of the Company and its U.S. Subsidiaries. The provisions of the Plan, accordingly, shall be construed so as to extend and limit participation in Section 423 Subsidiaries in a manner consistent with the requirements of that Section of the Code. The Plan, as amended and restated as set forth herein, shall apply to Offering Periods beginning after May 20, 2021.

2.Definitions. As used herein, the terms set forth below have the meanings assigned to them in this Section 2 and shall include the plural as well as the singular.

1933 Act means the Securities Act of 1933,Agents. Officers, assistant officers and agents, if any, other than those whose duties are provided for in these Bylaws, shall have such authority and perform such duties as amended.

1934 Act means the Securities Exchange Act of 1934, as amended.

Board of Directors or Board means the Board of Directors of CDW Corporation.

BusinessDay shall mean a day on which The NASDAQ Global Select Market (“NASDAQ”) is open for trading.

Brokerage Account means the account in which the Purchased Shares are held.

Code means the Internal Revenue Code of 1986, as amended.

Committee means the Compensation Committeemay from time to time be prescribed by resolution of the Board of Directors orand, to the designeeextent not so provided, as generally pertain to their respective offices, subject to the control of the Compensation Committee.Board of Directors.

 

Company means CDWSection 13. Officers’ Bonds or Other Security. If required by the Board of Directors, any officer of the Corporation shall give a Delaware corporation.bond or other security for the faithful performance of his duties, in such amount and with such surety as the Board of Directors may require.

 

Compensation meansSection 14. Delegation of Authority. The Board of Directors may by resolution delegate the base pay receivedpowers and duties of such officer to any other officer or to any director, or to any other person whom it may select.

ARTICLE V
CERTIFICATES OF STOCK

Section 1. Form. The shares of stock of the Corporation shall be represented by certificates, provided that the Board of Directors may provide by resolution that some or all of any or all classes or series of its stock shall be uncertificated shares. Any such resolution shall not apply to shares represented by a Participant, plus commissions, overtimecertificate until such certificate is surrendered to the Corporation. If shares are represented by certificates, the certificates shall be in such form as required by applicable law and regular annual, quarterlyas determined by the Board of Directors. Each certificate shall certify the number of shares owned by such holder in the Corporation and monthly cash bonusesshall be signed by, or in the name of the Corporation by (i) the Chair of the Board, the President or a Vice President and vacation, holiday(ii) the Treasurer, an Assistant Treasurer, the Secretary or an Assistant Secretary of the Corporation designated by the Board of Directors. Any or all signatures on the certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed, or whose facsimile signature or signatures have been used on, any such certificate or certificates shall cease to be such officer, transfer agent or registrar of the Corporation whether because of death, resignation or otherwise before such certificate or certificates have been issued by the Corporation, such certificate or certificates may nevertheless be issued as though the person or persons who signed such certificate or certificates or whose facsimile signature or signatures have been used thereon had not ceased to be such officer, transfer agent or registrar of the Corporation at the date of issue. All certificates for shares shall be consecutively numbered or otherwise identified. The Board of Directors may appoint a bank or trust company organized under the laws of the United States or any state thereof to act as its transfer agent or registrar, or both in connection with the transfer of any class or series of securities of the Corporation. The Corporation, or its designated transfer agent or other agent, shall keep a book or set of books to be known as the stock transfer books of the Corporation, containing the name of each holder of record, together with such holder’s address and sick pay. Compensation does not include: (1) income relatedthe number and class or series of shares held by such holder and the date of issue. When shares are represented by certificates, the Corporation shall issue and deliver to each holder to whom such shares have been issued or transferred, certificates representing the shares owned by such holder, and shares of stock option awards, stock grantsof the Corporation shall only be transferred on the books of the Corporation by the holder of record thereof or by such holder’s attorney duly authorized in writing, upon surrender to the Corporation or its designated transfer agent or other agent of the certificate or certificates for such shares endorsed by the appropriate person or persons, with such evidence of the authenticity of such endorsement, transfer, authorization and other equity incentive awards, (2) partner sales incentive program awards (“SPIFs”), (3) expense reimbursements, (4) relocation-related payments, (5) benefit plan payments (including but not limited to short term disability pay, long term disability pay, maternity pay, military pay, tuition reimbursementmatters as the Corporation may reasonably require, and adoption assistance), (6) deceased pay, (7) income from non-cash and fringe benefits, (8) severance payments, and (9) other forms of compensation not specifically listed herein.

Coworker means any individual who is a common law employeeaccompanied by all necessary stock transfer stamps. In that event, it shall be the duty of the CompanyCorporation to issue a new certificate to the person entitled thereto, cancel the old certificate or certificates and record the transaction on its books. When shares are not represented by certificates, shares of stock of the Corporation shall only be transferred on the books of the Corporation by the holder of record thereof or by such holder’s attorney duly authorized in writing, with such evidence of the authenticity of such transfer, authorization and other matters as the Corporation may reasonably require, and accompanied by all necessary stock transfer stamps, and within a reasonable time after the issuance or transfer of such shares, the Corporation shall send the holder to whom such shares have been issued or transferred a written statement of the information required by applicable law. Unless otherwise provided by applicable law, the Certificate of Incorporation, Bylaws or any other Participating Subsidiary. For purposesinstrument, the rights and obligations of the Plan,holders of uncertificated stock and the employment relationshiprights and obligations of the holders of certificates representing stock of the same class and series shall be treated as continuing intact while the individual is on sick leaveidentical.

Section 2. Lost Certificates. The Corporation may issue or other leavedirect a new certificate or certificates or uncertificated shares to be issued in place of absence approvedany certificate or certificates previously issued by the CompanyCorporation alleged to have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the owner of the lost, stolen or destroyed certificate. When authorizing such issue of a new certificate or certificates or uncertificated shares, the Corporation may, in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen or destroyed certificate or certificates, or his or her legal representative, to give the Corporation a bond in such sum as it may direct, sufficient to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of any such certificate or the Participating Subsidiary, as appropriate, and inissuance of such new certificate or uncertificated shares.

Section 3. Registered Stockholders. The Corporation shall be entitled to recognize the caseexclusive right of a Section 423 Offering onlyperson registered on its records as the owner of shares of stock to receive dividends, to vote, to receive notifications and otherwise to exercise all the extent permitted under Section 423rights and powers of the Code. For purposes of the Plan, an individual who performs services for the Company or a Participating Subsidiary pursuant to an agreement (written or oral) that classifies such individual’s relationship with the Company or a Participating Subsidiary as other than a common law employeeowner. The Corporation shall not be considered an “employee” with respectbound to recognize any period precedingequitable or other claim to or interest in such share or shares of stock on the date on which a court or administrative agency issues a final determination that such individual is an “employee.”

Enrollment Date means the first Business Day of each Offering Period.

Exercise Date means the last Business Day of each Offering Period.

Fair Market Value on or aspart of any date means the “NASDAQ Official Closing Price” (as defined on www.nasdaq.com) (or such substantially similar successor price thereto)other person, whether or not it shall have express or other notice thereof, except as otherwise required by applicable law.

Section 4. Fixing a Record Date for a Share as reported on www.nasdaq.com (or a substantially similar successor website) on the relevant valuation datePurposes Other Than Stockholder Meetings or if no NASDAQ Official Closing Price is reported on such date, on the preceding day on which a NASDAQ Official Closing Price was reported; or, if the Shares are no longer listed on NASDAQ, the closing price for Shares as reported on the official website for such other exchange on which the Shares are listed.

Non-Section 423 Offering means an Offering that is not intended to qualify under Section 423 of the Code.

Offering means an offer of an Option under the Plan that may be exercised on the Exercise Date of an Offering Period. Unless otherwise specifiedActions by the Committee, each Offering to the Coworkers of the Company and each Offering to the coworkers of each Participating Subsidiary shall be deemed a separate Offering, even if the dates and other terms of the separate Offerings are identical, and the provisions of the Plan shall separately apply to each Offering. To the extent permitted by Section 423 of the Code, the terms of each separate Section 423 Offering need not be identical, providedWritten Consent. In order that the termsCorporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment or any rights or the Plan and an Offering together satisfy Section 423 of the Code. The terms of a Non-Section 423 Offering need not be identical.

 

Offering Period means every three-month period beginning each January 1st, April 1st, July 1st and October 1st or such other period designated by the Committee; provided that in no event shall an Offering Period exceed twenty-seven (27) months. The first Offering Period under the Plan commenced on January 1, 2014.

Option means an option granted under this Plan that entitles a Participant to purchase Shares.

 20212023 Proxy Statement98108
 

Participant meansstockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purposes of any other lawful action (other than stockholder meetings and stockholder written consents which are expressly governed by Sections 12 and 13 of ARTICLE II hereof), the Board of Directors may fix a Coworker who satisfiesrecord date, which record date shall not precede the requirementsdate upon which the resolution fixing the record date is adopted, and which record date shall be not more than 60 days prior to such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of Sections 3 and 5business on the day on which the Board of Directors adopts the resolution relating thereto.

ARTICLE VI
GENERAL PROVISIONS

Section 1. Dividends. Subject to the Certificate of Incorporation, dividends upon the shares of capital stock of the Plan.

ParticipatingSubsidiary means each Subsidiary that is listed on Schedule A hereto,Corporation may be declared and each other Subsidiary designatedpaid by the Board of Directors, in accordance with applicable law. Dividends may be paid in cash, in property or in shares of the Committee asCorporation’s theretofore unissued capital stock, subject to the provisions of applicable law and the Certificate of Incorporation. Before payment of any dividend, there may be set aside out of any funds of the Corporation available for dividends a Participating Subsidiary.reserve or reserves for any proper purpose. The Board of Directors may modify or abolish any such reserves in the manner in which they were created.

 

Plan means this CDW Corporation Coworker Stock Purchase Plan.

Purchase Account meansSection 2. Checks, Notes, Drafts, Etc. All checks, notes, drafts or other orders for the account used to purchase Shares throughpayment of money of the exercise of Options under the Plan.

Purchase PriceCorporation shall be 95%signed, endorsed or accepted in the name of the Fair Market ValueCorporation by such officer, officers, person or persons as from time to time may be authorized by the Board of Directors or by an officer or officers authorized by the Board of Directors to make such designation.

Section 3. Contracts. In addition to the powers otherwise granted to officers pursuant to ARTICLE IV hereof, the Board of Directors may authorize any officer or officers, or any agent or agents, in the name and on behalf of the Corporation to enter into or execute and deliver any and all deeds, bonds, mortgages, contracts and other obligations or instruments, and such authority may be general or confined to specific instances.

Section 4. Loans. Subject to compliance with applicable law (including Section 13(k) of the Securities Exchange Act of 1934), the Corporation may lend money to, or guarantee any obligation of, or otherwise assist any officer or other employee of the Corporation or of its subsidiaries, including any officer or employee who is a director of the Corporation or its subsidiaries, whenever, in the judgment of the directors, such loan, guaranty or assistance may reasonably be expected to benefit the Corporation. The loan, guaranty or other assistance may be with or without interest, and may be unsecured, or secured in such manner as the Board of Directors shall approve, including, without limitation, a pledge of shares of stock of the Corporation. Nothing in this section shall be deemed to deny, limit or restrict the powers of guaranty or warranty of the Corporation at common law or under any statute.

Section 5. Fiscal Year. The fiscal year of the Corporation shall be fixed by resolution of the Board of Directors.

Section 6. Corporate Seal. The Board of Directors may provide a corporate seal which shall be in the form of a Share oncircle and shall have inscribed thereon the Exercise Date for such Offering Period; provided, however, that the Committee may determine a different per share Purchase Price provided that such per share Purchase Price is communicated to Participants prior to the beginningname of the Offering PeriodCorporation and provided thatthe words “Corporate Seal, Delaware.” The seal may be used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise. Notwithstanding the foregoing, no seal shall be required by virtue of this Section.

Section 7. Voting Securities Owned By Corporation. Voting securities in no event shall such per share Purchase Price be less than the lesser of (i) 85% of the Fair Market Value of a Share on the applicable Enrollment Date or (ii) 85% of the Fair Market Value of a Share on the Exercise Date.

Purchased Shares means the full Shares issued or delivered pursuant to the exercise of Options under the Plan.

Section 423Offering means an Offering that is intended to qualify under Section 423 of the Code.

Shares means the common stock, par value $0.01 per share, of the Company.

Subsidiary means an entity, domestic or foreign, of which not less than 50% of the voting equity isany other Corporation held by the Company or a Subsidiary, whether or not such entity now exists or is hereafter organized or acquiredCorporation shall be voted by the Company or a Subsidiary; provided such entity is also a “subsidiary” within the meaning of Section 424Chair of the Code.Board, Chief Executive Officer, the President or the Chief Financial Officer, unless the Board of Directors specifically confers authority to vote with respect thereto, which authority may be general or confined to specific instances, upon some other person or officer. Any person authorized to vote securities shall have the power to appoint proxies, with general power of substitution.

 

Termination Date meansSection 8. Inspection of Books and Records. Subject to applicable law, the date on which a Participant terminates employmentBoard of Directors shall have power from time to time to determine to what extent and at what times and places and under what conditions and regulations the accounts and books of the Corporation, or on which the Participant ceases to provide servicesany of them, shall be open to the Companyinspection of the stockholders; and no stockholder shall have any right to inspect any account or a Subsidiarybook or document of the Corporation, except as an employee,conferred by the laws of the State of Delaware, unless and until authorized so to do by resolution of the Board of Directors.

Section 9. Facsimile Signatures. In addition to the provisions for use of facsimile signatures elsewhere specifically does not includeauthorized in these Bylaws, facsimile signatures of any period following that date whichofficer or officers of the ParticipantCorporation may be eligibleused whenever and as authorized by the Board of Directors.

Section 10. Section Headings. Section headings in these Bylaws are for convenience of reference only and shall not be given any substantive effect in limiting or otherwise construing any provision herein.

Section 11. Inconsistent Provisions. In the event that any provision of these Bylaws is or becomes inconsistent with any provision of the Certificate of Incorporation, the DGCL, or any other applicable law, the provision of these Bylaws shall not be given any effect to the extent of such inconsistency but shall otherwise be given full force and effect.

Section 12. Severability. To the extent any provision of these Bylaws would be, in receiptthe absence of other paymentsthis Section 12, invalid, illegal or unenforceable for any reason whatsoever, such provision shall be severable from the Companyother provisions of these Bylaws, and all provisions of these Bylaws shall be construed so as to give effect to the intent manifested by these Bylaws, including, in lieu of noticeto the maximum extent possible, the provision that would be otherwise invalid, illegal or termination or severance pay or as wrongful dismissal damages.unenforceable.

 

3.Eligibility.

(a)Only Coworkers of the Company or a Participating Subsidiary shall be eligible to be granted Options under the Plan and, in no event may a Participant be granted an Option under the Plan following his or her Termination Date.
(b)Any provisions of the Plan to the contrary notwithstanding, no Coworker shall be granted an Option under the Plan if (i) immediately after the grant, such Coworker (or any other person whose stock would be attributed to such Coworker pursuant to Section 424(d) of the Code) would own capital stock of the Company and/or hold outstanding Options or options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or of any of its Subsidiaries, or (ii) such Option would permit his or her rights to purchase stock under all employee stock purchase plans (described in Section 423 of the Code) of the Company and its Subsidiaries to accrue at a rate that exceeds twenty-five thousand dollars ($25,000) of the Fair Market Value of such stock (determined at the time each such Option is granted) for each calendar year in which such Option is outstanding at any time. For purposes of applying the limit described in clause (ii) above to a Participant in a Non-Section 423 Offering who is employed outside of the U.S., the exchange rate shall be determined on the last day of the applicable Offering Period. No Participant may purchase more than 1,250 Shares during any Offering Period.

4.Exercise of an Option. Options shall be exercised on behalf of Participants in the Plan every Exercise Date, using payroll deductions that have accumulated in the Participants’ Purchase Accounts during the immediately preceding Offering Period or that have been retained from a prior Offering Period pursuant to Section 8 hereof.

5.Participation.

(a)A Coworker shall be eligible to participate on the first Enrollment Date that occurs at least 90 days after such Coworker’s first date of employment with the Company or a Participating Subsidiary; provided, that such Coworker properly completes and submits an election form by the deadline prescribed by the Company. Participation in the Plan is voluntary.
(b)A Coworker who does not become a Participant on the first Enrollment Date on which he or she is eligible may thereafter become a Participant on any subsequent Enrollment Date by properly completing and submitting an election form by the deadline prescribed by the Company.
(c)Payroll deductions for a Participant shall commence on the first payroll date following the Enrollment Date and shall end on the last payroll date in the Offering Period to which such authorization is applicable, unless sooner terminated by the Participant as provided in Section 12 hereof.

6.Payroll Deductions.

(a)A Participant shall elect to have payroll deductions made during an Offering Period equal to no less than 1% of the Participant’s Compensation up to a maximum of 15% (or such greater amount as the Committee establishes from time to time). The amount of such payroll deductions shall be in whole percentages (for example, 3%, 12%, 15%). All payroll deductions made by a Participant shall be credited to his or her Purchase Account. A Participant may not make any additional payments into his or her Purchase Account. All such payroll deductions shall be made from the Participant’s Compensation after deduction of any tax, social security and national insurance contributions.
(b)A Participant may not increase or decrease the rate of payroll deductions during an Offering Period. A Participant may change his or her payroll deduction percentage under subsection (a) above for any subsequent Offering Period by properly completing and submitting an election change form in accordance with the procedures prescribed by the Committee. The change in amount shall be effective as of the first Enrollment Date following the date of filing of the election change form.

 20212023 Proxy Statement99109

 
ARTICLE VII
INDEMNIFICATION

Section 1. Right to Indemnification and Advancement. Each person who was or is made a party or is threatened to be made a party to or is otherwise involved (including involvement, without limitation, as a witness) in any actual or threatened action, suit or proceeding, whether civil, criminal, administrative or investigative (a “proceeding”), by reason of the fact that he or she is or was a director or officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan (an “indemnitee”), whether the basis of such proceeding is alleged action in an official capacity as a director or officer or in any other capacity while serving as a director or officer, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than permitted prior thereto), against all expense, liability and loss (including attorneys’ fees and related disbursements, judgments, fines, excise taxes, penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by such indemnitee in connection therewith and such indemnification shall continue as to an indemnitee who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the indemnitee’s heirs, executors and administrators; provided, however, that, except as provided in this Section 1 of this ARTICLE VII with respect to proceedings to enforce rights to indemnification, the Corporation shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors of the Corporation. The right to indemnification conferred in this Section 1 of ARTICLE VII shall be a contract right. In addition to the right to indemnification conferred herein, an indemnitee shall also have the right to be paid by the Corporation the expenses incurred in defending any such proceeding in advance of its final disposition (an “advance of expenses”); provided, however, that if and to the extent that the DGCL requires, an advance of expenses shall be made only upon delivery to the Corporation of an undertaking (an “undertaking”), by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal (a “final adjudication”) that such indemnitee is not entitled to be indemnified for such expenses under this Section 1 or otherwise. The Corporation may also, by action of its Board of Directors, provide indemnification and advancement to employees and agents of the Corporation.

Section 2. Procedure for Indemnification. Any indemnification of a director or officer of the Corporation or advance of expenses (including attorneys’ fees, costs and charges) under this Section 2 of ARTICLE VII shall be made promptly, and in any event within forty-five days (or, in the case of an advance of expenses, twenty days, provided that the director or officer has delivered the undertaking contemplated by Section 1 of this ARTICLE VII if required), upon the written request of the director or officer. If the Corporation denies a written request for indemnification or advance of expenses, in whole or in part, or if payment in full pursuant to such request is not made within forty-five days (or, in the case of an advance of expenses, twenty days, provided that the director or officer has delivered the undertaking contemplated by Section 1 of this ARTICLE VII if required), the right to indemnification or advances as granted by this ARTICLE VII shall be enforceable by the director or officer in any court of competent jurisdiction. Such person’s costs and expenses incurred in connection with successfully establishing his or her right to indemnification, in whole or in part, in any such action shall also be indemnified by the Corporation to the fullest extent permitted by applicable law. It shall be a defense to any such action (other than an action brought to enforce a claim for the advance of expenses where the undertaking required pursuant to Section 1 of this ARTICLE VII, if any, has been tendered to the Corporation) that the claimant has not met the standards of conduct which make it permissible under the DGCL for the Corporation to indemnify the claimant for the amount claimed, but the burden of such defense shall be on the Corporation to the fullest extent permitted by law. Neither the failure of the Corporation (including its Board of Directors, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Corporation (including its Board of Directors, independent legal counsel or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the claimant has not met the applicable standard of conduct.

Section 3. Insurance. The Corporation may purchase and maintain insurance on its own behalf and on behalf of any person who is or was or has agreed to become a director, officer, employee or agent of the Corporation or is or was serving at the request of the Corporation as a director, officer, partner, member, trustee, administrator, employee or agent of another corporation, partnership, joint venture, limited liability company, trust or other enterprise against any expense, liability or loss asserted against him or her and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify such person against such expenses, liability or loss under the DGCL.

Section 4. Service for Subsidiaries. Any person serving as a director, officer, partner, member, trustee, administrator, employee or agent of another corporation, partnership, limited liability company, joint venture, trust or other enterprise, at least 50% of whose equity interests are owned by the Corporation (a “subsidiary” for purposes of this ARTICLE VII) shall be conclusively presumed to be serving in such capacity at the request of the Corporation.

Section 5. Reliance. Persons who after the date of the adoption of this provision become or remain directors or officers of the Corporation or who, while a director or officer of the Corporation, become or remain a director, officer, employee or agent of a subsidiary, shall be conclusively presumed to have relied on the rights to indemnity, advance of expenses and other rights contained in this ARTICLE VII in entering into or continuing such service. The rights to indemnification and to the advance of expenses conferred in this ARTICLE VII shall

(c)Notwithstanding the foregoing, to the extent necessary to comply with Section 423(b)(8) of the Code and Section 3(b) hereof, a Participant’s payroll deductions may be decreased to zero percent (0%) at any time during an Offering Period. Payroll deductions shall recommence at the rate provided in such Participant’s election form at the beginning of the first Offering Period which is scheduled to end in the following calendar year, unless terminated by the Participant as provided in Section 12 hereof.

7.Grant of Option. On the applicable Enrollment Date, each Participant in an Offering Period shall be granted an Option to purchase on the next following Exercise Date a number of full Shares determined by dividing such Participant’s payroll deductions accumulated prior to such Exercise Date and retained in the Participant’s Purchase Account as of the Exercise Date by the applicable Purchase Price.
8.Exercise of Option. A Participant’s Option for the purchase of Shares shall be exercised automatically on the Exercise Date, and the maximum number of Shares subject to the Option shall be purchased for such Participant at the applicable Purchase Price with the accumulated payroll deductions in his or her Purchase Account. No fractional Shares shall be purchased; any payroll deductions accumulated in a Participant’s Purchase Account which are not sufficient to purchase a full Share shall be retained in the Purchase Account for the next subsequent Offering Period, subject to earlier withdrawal by the Participant as provided in Section 12 hereof. All other payroll deductions accumulated in a Participant’s Purchase Account and not used to purchase Shares on an Exercise Date shall be distributed to the Participant. During a Participant’s lifetime, a Participant’s Option is exercisable only by him or her. The Company shall satisfy the exercise of all Participants’ Options for the purchase of Shares through (a) the issuance of authorized but unissued Shares, (b) the transfer of treasury Shares, (c) the purchase of Shares on behalf of the applicable Participants on the open market through an independent broker and/or (d) a combination of the foregoing.
9.Issuance of Stock. The Shares purchased by each Participant shall be issued in book entry form and shall be considered to be issued and outstanding to such Participant’s credit as of the end of the last day of each Offering Period. The Committee may permit or require that shares be deposited directly in a Brokerage Account with one or more brokers designated by the Committee or to one or more designated agents of the Company, and the Committee may use electronic or automated methods of share transfer. The Committee may require that Shares be retained with such brokers or agents for a designated period of time and/or may establish other procedures to permit tracking of disqualifying dispositions of such shares, and may also impose a transaction fee with respect to a sale of Shares issued to a Participant’s credit and held by such a broker or agent. The Committee may permit Shares purchased under the Plan to participate in a dividend reinvestment plan or program maintained by the Company, and establish a default method for the payment of dividends.
10.Approval by Stockholders. Notwithstanding the above, the Plan was expressly made subject to the approval of the stockholders of the Company within 12 months before or after the date the Plan was adopted by the Board, and such stockholder approval was obtained in the manner and to the degree required under applicable federal and state law.

11.Administration.

(a)Powers and Duties of the Committee. The Plan shall be administered by the Committee. Subject to the provisions of the Plan, Section 423 of the Code and the regulations thereunder, the Committee shall have the discretionary authority to determine the time and frequency of granting Options, the terms and conditions of the Options and the number of Shares subject to each Option. The Committee shall also have the discretionary authority to do everything necessary and appropriate to administer the Plan, including, without limitation, interpreting the provisions of the Plan (but any such interpretation shall not be inconsistent with the provisions of Section 423 of the Code). The Committee may delegate its duties and authority to any of the Company’s officers or employees as it determines to be appropriate. All actions, decisions and determinations of, and interpretations by the Committee or its delegate with respect to the Plan shall be final and binding upon all Participants and upon their executors, administrators, personal representatives, heirs and legatees. No member of the Board of Directors or the Committee and no officer or director to whom the Committee has delegated its duties and authority shall be liable for any action, decision, determination or interpretation made in good faith with respect to the Plan or any Option granted hereunder. Each Section 423 Offering shall be administered so as to ensure that all Participants have the same rights and privileges as are provided by Section 423(b)(5) of the Code.
(b)Administrator. The Company, Board or the Committee may engage the services of a brokerage firm or financial institution (the “Administrator”) to perform certain ministerial and procedural duties under the Plan including, but not limited to, mailing and receiving notices contemplated under the Plan, determining the number of Purchased Shares for each Participant, maintaining or causing to be maintained the Purchase Account and the Brokerage Account, disbursing funds maintained in the Purchase Account or proceeds from the sale of Shares through the Brokerage Account, and filing with the appropriate tax authorities proper tax returns and forms (including information returns) and providing to each Participant statements as required by law or regulation.
(c)Indemnification. Each person who is or shall have been (a) a member of the Board, (b) a member of the Committee, or (c) an officer or employee of the Company to whom authority was delegated in relation to this Plan, shall be indemnified and held harmless by the Company against and from any loss, cost, liability or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company’s approval, or paid by him or her in satisfaction of any judgment in any such claim, action, suit or proceeding against him or her; provided, however, that he or she shall give the Company an opportunity, at its own expense, to handle and defend the same before he

 20212023 Proxy Statement100110

 

apply to claims made against an indemnitee arising out of acts or omissions which occurred or occur both prior and subsequent to the adoption hereof. Any amendment, alteration or repeal of this ARTICLE VII that adversely affects any right of an indemnitee or its successors shall be prospective only and shall not limit, eliminate, or impair any such right with respect to any proceeding involving any occurrence or alleged occurrence of any action or omission to act that took place prior to such amendment or repeal.

Section 6. Non-Exclusivity of Rights; Continuation of Rights of Indemnification. The rights to indemnification and to the advance of expenses conferred in this ARTICLE VII shall not be exclusive of any other right which any person may have or hereafter acquire under the Certificate of Incorporation or under any statute, by-law, agreement, vote of stockholders or disinterested directors or otherwise. All rights to indemnification under this ARTICLE VII shall be deemed to be a contract between the Corporation and each director or officer of the Corporation who serves or served in such capacity at any time while this ARTICLE VII is in effect. Any repeal or modification of this ARTICLE VII or repeal or modification of relevant provisions of the DGCL or any other applicable laws shall not in any way diminish any rights to indemnification and advancement of expenses of such director or officer or the obligations of the Corporation arising hereunder with respect to any proceeding arising out of, or relating to, any actions, transactions or facts occurring prior to the final adoption of such repeal or modification.

Section 7. Merger or Consolidation. For purposes of this ARTICLE VII, references to the “Corporation” shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under this ARTICLE VII with respect to the resulting or surviving corporation as he or she would have with respect to such constituent corporation if its separate existence had continued.

Section 8. Savings Clause. If this ARTICLE VII or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the Corporation shall nevertheless indemnify and advance expenses to each person entitled to indemnification under Section 1 of this ARTICLE VII as to all expense, liability and loss (including attorneys’ fees and related disbursements, judgments, fines, excise taxes, penalties and amounts paid or to be paid in settlement) actually and reasonably incurred or suffered by such person and for which indemnification and advancement of expenses is available to such person pursuant to this ARTICLE VII to the fullest extent permitted by any applicable portion of this ARTICLE VII that shall not have been invalidated and to the fullest extent permitted by applicable law.

ARTICLE VIII
AMENDMENTS

These Bylaws may be amended, altered, changed or repealed or new Bylaws adopted only in accordance with Section 1 of ARTICLE ELEVEN of the Certificate of Incorporation.

ARTICLE IX
EMERGENCY BYLAWS

Section 1. Emergency Bylaws. This ARTICLE IX shall be operative during any emergency, disaster or catastrophe, as referred to in Section 110 of the DGCL or other similar emergency condition (including a pandemic), as a result of which a quorum of the Board of Directors or a committee thereof cannot readily be convened for action (each, an “Emergency”), notwithstanding any different or conflicting provision in the preceding Sections of these Bylaws or in the Certificate of Incorporation. To the extent not inconsistent with the provisions of this ARTICLE IX, the preceding Sections of these Bylaws and the provisions of the Certificate of Incorporation shall remain in effect during such Emergency, and upon termination of such Emergency, the provisions of this ARTICLE IX shall cease to be operative unless and until another Emergency shall occur.

Section 2. Meetings; Notice. During any Emergency, a meeting of the Board of Directors or any committee thereof may be called by any member of the Board of Directors or such committee or the Chair of the Board, the Chief Executive Officer, the President or the Secretary of the Corporation. Notice of the place, date and time of the meeting shall be given by any available means of communication by the person calling the meeting to such of the directors or committee members and Designated Officers (as defined below) as, in the judgment of the person calling the meeting, it may be feasible to reach. Such notice shall be given at such time in advance of the meeting as, in the judgment of the person calling the meeting, circumstances permit.

Section 3. Quorum. At any meeting of the Board of Directors called in accordance with Section 2 above, the presence or participation of three (3) directors shall constitute a quorum for the transaction of business, and at any meeting of any committee of the Board of Directors called in accordance with Section 2 above, the presence or participation of one (1) committee member shall constitute a quorum for the transaction of business. In the event that no directors are able to attend a meeting of the Board of Directors or any committee thereof, then the Designated Officers in attendance shall serve as directors or committee members, as the case may be, for the meeting, without any additional quorum requirement and will have full powers to act as directors or committee members, as the case may be, of the Corporation.

or she undertakes to handle and defend it on his or her own behalf, unless such loss, cost, liability or expense is a result of his or her own willful misconduct or except as expressly provided by statute.
The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled under the Company’s certificate of incorporation or bylaws, any contract with the Company, as a matter of law, or otherwise, or of any power that the Company may have to indemnify them or hold them harmless.
12.Withdrawal. A Participant may withdraw from the Plan by properly completing and submitting to the Company a withdrawal form in accordance with the procedures prescribed by the Committee, which must be submitted prior to the date specified by the Committee before the last day of the applicable Offering Period. Upon withdrawal, any payroll deductions credited to the Participant’s Purchase Account prior to the effective date of the Participant’s withdrawal from the Plan will be returned to the Participant. No further payroll deductions for the purchase of Shares will be made during subsequent Offering Periods, unless the Participant properly completes and submits an election form, by the deadline prescribed by the Company. A Participant’s withdrawal from an offering will not have any effect upon his or her eligibility to participate in the Plan or in any similar plan that may hereafter be adopted by the Company.
13.Termination of Employment. On the Termination Date of a Participant for any reason prior to the applicable Exercise Date, whether voluntary or involuntary, and including termination of employment due to retirement, death or as a result of liquidation, dissolution, sale, merger or a similar event affecting the Company or a Participating Subsidiary, the corresponding payroll deductions credited to his or her Purchase Account will be returned to him or her or, in the case of the Participant’s death, to the person or persons entitled thereto under Section 16, and his or her Option will be automatically terminated.
14.Interest. No interest shall accrue on the payroll deductions of a Participant in the Plan.
15.Stock.

(a)The stock subject to Options shall be common stock of the Company as traded on the NASDAQ or on such other exchange as the Shares may be listed.
(b)Subject to adjustment upon changes in capitalization of the Company as provided in Section 18 hereof, the maximum number of Shares which shall be made available for sale under the Plan shall be 2,500,000 Shares. If, on a given Exercise Date, the number of Shares with respect to which Options are to be exercised exceeds the number of Shares then available under the Plan, the Committee shall make a pro rata allocation of the Shares remaining available for purchase in as uniform a manner as shall be practicable and as it shall determine to be equitable.
(c)A Participant shall have no interest or voting right in Shares covered by his or her Option until such Option has been exercised and the Participant has become a holder of record of Shares acquired pursuant to such exercise.
16.Designation of Beneficiary. To the extent permitted by applicable law, the Committee may permit Participants to designate beneficiaries to receive any Purchased Shares or payroll deductions, if any, in the Participant’s accounts under the Plan in the event of such Participant’s death. Beneficiary designations shall be made in accordance with procedures prescribed by the Committee. If no properly designated beneficiary survives the Participant, the Purchased Shares and payroll deductions, if any, will be distributed to the Participant’s estate.

17.Assignability of Options. Neither payroll deductions credited to a Participant’s Purchase Account nor any rights with regard to the exercise of an Option or to receive Shares under the Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or as provided in Section 16 hereof) by the Participant. Any such attempt at assignment, transfer, pledge or other disposition shall be without effect, except that the Company may treat such act as an election to withdraw from an Offering Period in accordance with Section 12 hereof.
18.Adjustment of Number of Shares Subject to Options.

(a)Adjustment. Subject to any required action by the stockholders of the Company, the maximum number of securities available for purchase under the Plan, as well as the price per security and the number of securities covered by each Option under the Plan which has not yet been exercised shall be appropriately adjusted in the event of any a stock split, reverse stock split, stock dividend, combination or reclassification of the common stock of the Company, or any other increase or decrease in the number of Shares effected without receipt of consideration by the Company; provided, however, that conversion of any convertible securities of the Company shall not be deemed to have been “effected without receipt of consideration.” Such adjustment shall be made by the Board or the Committee, whose determination in that respect shall be final, binding and conclusive. If any such adjustment would result in a fractional security being available under the Plan, such fractional security shall be disregarded. Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of Shares subject to an Option. The Options granted pursuant to a Section 423 Offering shall not be adjusted in a manner that causes the Options to fail to qualify as options issued pursuant to an “employee stock purchase plan” within the meaning of Section 423 of the Code.
(b)Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, the Offering Period then in progress will terminate immediately prior to the consummation of such proposed action, unless otherwise provided by the Board, and the Board may either provide for the purchase of Shares as of the date on which such Offering Period terminates or return to each Participant the payroll deductions credited to such Participant’s Purchase Account.

 20212023 Proxy Statement101111

 

Section 4. Liability. No officer, director or employee of the Corporation acting in accordance with the provisions of this ARTICLE IX shall be liable except for willful misconduct.

 

Section 5. Amendments. At any meeting called in accordance with Section 2 above, the Board of Directors, or any committee thereof, as the case may be, may modify, amend or add to the provisions of this ARTICLE IX as it deems it to be in the best interests of the Corporation and as is practical or necessary for the circumstances of the Emergency.

Section 6. Repeal or Change. The provisions of this ARTICLE IX shall be subject to repeal or change by further action of the Board of Directors or by action of the stockholders pursuant to ARTICLE VIII of these Bylaws, but no such repeal or change shall modify the provisions of Section 4 above with regard to action taken prior to the time of such repeal or change.

Section 7. Definitions. For purposes of this ARTICLE IX, the term “Designated Officer” means an officer identified on a numbered list of officers of the Corporation who shall be deemed to be, in the order in which they appear on the list up until a quorum is obtained, directors of the Corporation or members of a committee of the Board of Directors, as the case may be, for purposes of obtaining a quorum during an Emergency, if a quorum of directors or committee members, as the case may be, cannot otherwise be obtained during such Emergency, which officers have been designated by the Board of Directors from time to time but in any event prior to such time or times as an Emergency may have occurred.

* * * * *

(c)Merger or Asset Sale. In the event of a proposed sale of all or substantially all of the assets of the Company, or the merger of the Company with or into another corporation, each outstanding Option shall be assumed or an equivalent option substituted by the successor corporation or a parent or subsidiary of the successor corporation, unless the Board determines, in the exercise of its sole discretion, that in lieu of such assumption or substitution to either terminate all outstanding Options and return to each Participant the payroll deductions credited to such Participant’s Purchase Account or to provide for the Offering Period in progress to end on a date prior to the consummation of such sale or merger.

19.Amendments or Termination of the Plan.

(a)The Board of Directors or the Committee may at any time and for any reason amend, modify, suspend, discontinue or terminate the Plan without notice; provided that no Participant’s existing rights in respect of existing Options are adversely affected thereby. To the extent necessary to comply with Section 423 of the Code (or any other applicable law, regulation or stock exchange rule), the Company shall obtain stockholder approval in such a manner and to such a degree as required.
(b)Without stockholder consent and without regard to whether any Participant rights may be considered to have been “adversely affected,” the Board or the Committee shall be entitled to change the Purchase Price, Offering Periods, limit or increase the frequency and/or number of changes in the amount withheld during an Offering Period, establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, permit payroll withholding in an amount less than or greater than the amount designated by a Participant in order to adjust for delays or mistakes in the Company’s processing of properly completed withholding elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Shares for each Participant properly correspond with amounts withheld from the Participant’s Compensation, and establish such other limitations or procedures as the Board or the Committee determines in its sole discretion advisable which are consistent with the Plan; provided, however, that changes to (i) the Purchase Price, (ii) the Offering Period, (iii) the maximum percentage of Compensation that may be deducted pursuant to Section 6(a) or (iv) the maximum number of Shares that may be purchased in an Offering Period, shall not be effective until communicated to Participants in a reasonable manner, with the determination of such reasonable manner in the sole discretion of the Board or the Committee.

20.No Other Obligations. The receipt of an Option pursuant to the Plan shall impose no obligation upon the Participant to purchase any Shares covered by such Option. Nor shall the granting of an Option pursuant to the Plan constitute an agreement or an understanding, express or implied, on the part of the Company to employ the Participant for any specified period.
21.Notices and Communication. Any notice or other form of communication which the Company or a Participant may be required or permitted to give to the other shall be provided through such means as designated by the Committee, including but not limited to any paper or electronic method.
22.Condition Upon Issuance of Shares.

(a)Shares shall not be issued with respect to an Option unless the exercise of such Option and the issuance and delivery of such Shares pursuant thereto shall comply with all applicable provisions of law, domestic or foreign, including, without limitation, the 1933 Act and the 1934 Act and the rules and regulations promulgated thereunder, and the requirements of any stock exchange upon which the Shares may then be listed, and shall be further subject to the approval of counsel for the Company with respect to such compliance.
(b)As a condition to the exercise of an Option, the Company may require the person exercising such Option to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required by any of the aforementioned applicable provisions of law.

23.General Compliance. The Plan will be administered and Options will be exercised in compliance with the 1933 Act, 1934 Act and all other applicable securities laws and Company policies, including without limitation, any insider trading policy of the Company.
24.Term of the Plan. The Plan became effective upon the earlier to occur of its adoption by the Board of Directors or its approval by the stockholders of the Company and shall continue in effect until terminated pursuant to Section 19.
25.Governing Law. The Plan and all Options granted hereunder shall be construed in accordance with and governed by the laws of the State of Delaware without reference to choice of law principles and subject in all cases to the Code and the regulations thereunder.
26.Non-U.S. Participants. To the extent permitted under Section 423 of the Code, without the amendment of the Plan, the Company may provide for the participation in the Plan by Coworkers who are subject to the laws of foreign countries or jurisdictions on such terms and conditions different from those specified in the Plan as may in the judgment of the Company be necessary or desirable to foster and promote achievement of the purposes of the Plan and, in furtherance of such purposes the Company may make such modifications, amendments, procedures, subplans and the like as may be necessary or advisable to comply with provisions of laws of other countries or jurisdictions in which the Company or the Participating Subsidiaries operate or have employees. Each subplan shall constitute a separate “offering” under this Plan in accordance with Treas. Reg. §1.423-2(a).

 20212023 Proxy Statement102112

 

SCHEDULE A

Participating Subsidiaries

1.CDW LLC
2.CDW Finance Corporation
3.CDW Government LLC
4.CDW Direct, LLC
5.CDW Logistics, Inc.
6.CDW Technologies LLC
7.CDW Canada Corp., effective October 1, 2016
8.CDW Limited, effective July 1, 2018

 2021 Proxy Statement103

CDW LEADERSHIP

 

Board of Directors

 

Virginia C. Addicott

Retired President and Chief Executive Officer,

FedEx Custom Critical

 

Steven W. Alesio*

Former Chairman and Chief Executive Officer,

Dun & Bradstreet Corporation

Barry K. Allen*
Operating Partner,

Providence Equity Partners L.L.C.;

President,

Allen Enterprises, LLC

James A. Bell

Retired Executive Vice President,

Corporate

President and Chief Financial Officer,

The Boeing Company

 

Benjamin D. Chereskin*

President,

Profile Capital Management LLC

Lynda M. Clarizio

Co-Founder and General Partner of The 98 and

Former Executive Vice President, Strategic Initiatives,

The Nielsen Company (US), LLC

 

Paul J. FinneganFinnegan*

Co-Chief Executive Officer,

Madison Dearborn Partners, LLC

 

Anthony R. Foxx

Chief Policy Officer & Senior Advisor to theFormer United States Secretary of Transportation

Marc E. Jones

Chairman, President &

and Chief Executive Officer,

Lyft, Inc.Aeris Communications

 

Christine A. Leahy

Chair, President and Chief Executive Officer,

CDW Corporation

Sanjay Mehrotra

President and Chief Executive Officer,

CDW Corporation

Sanjay Mehrotra

President and Chief Executive Officer,

Micron Technology, Inc.

 

David W. Nelms

Non-Executive ChairmanLead Independent Director of the Board,

CDW Corporation;

Retired Chairman and Chief Executive Officer,

Discover Financial Services, Inc.

 

Joseph R. Swedish

Retired Chairman, President and

Chief Executive Officer,

Anthem, Inc.

 

Donna F. Zarcone

Retired President and Chief Executive Officer,

The Economic Club of Chicago

 

Executive Committee

 

Christine A. Leahy

Chair, President and Chief Executive Officer

 

Jill M. Billhorn

Senior Vice President, Corporate Sales

 

Sona Chawla

Chief Growth and Innovation Officer

 

Mark C. Chong

Senior Vice President, Integration Lead

Elizabeth H. Connelly

Senior Vice President, Healthcare

Christina M. Corley

Chief Commercial and Operating Officer

Michael S. Drory

Senior Vice President, Strategy and MarketingCorporate Development

 

Elizabeth H. Connelly

Chief Human Resources Officer and

Senior Vice President, Coworker Services

Christina M. Corley

Chief Commercial and Operating Officer

Andrew J. Eccles

Senior Vice President, Integrated Technology Solutions

 

Douglas E. Eckrote

Senior Vice President, Small Business Sales and eCommerce

Collin B. Kebo

Senior Vice President and Chief Financial Officer

Robert F. Kirby

Senior Vice President, Public Sales

 

Frederick J. Kulevich

Senior Vice President, General Counsel and Corporate Secretary

 

Albert J. Miralles

Senior Vice President and Chief Financial Officer

Aletha C. Noonan

Senior Vice President,

Product and Partner Management

 

Christina V. RotherAnand J. Rao

Senior Vice President, Strategic InitiativesChief Marketing and Digital Officer

 

Sanjay Sood

Senior Vice President and Chief Technology Officer

 

Carolyn A. Wiesenhahn

Chief People Officer and Senior Vice President, Coworker Success

* Retiring immediately prior to the 20212023 Annual MeetingMeeting.

 

 20212023 Proxy Statement104113

 

 

 

 
0001402057 cdw:ChangeInFairValueAsOfVestingDateOfStockOptionAndStockAwardsGrantedInPriorYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember ecd:NonPeoNeoMember 2020-01-01 2020-12-31